10-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-K

(Mark One)

T ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Fiscal Year Ended June 25, 2011

OR

£ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File Number 001-34192

MAXIM INTEGRATED PRODUCTS, INC.

(Exact name of Registrant as specified in its charter)

Delaware	94-2896096
(State or other jurisdiction of Incorporation or organization)	(I.R.S. Employer Identification No.)

120 San Gabriel Drive

Sunnyvale, California 94086

(Address of Principal Executive Offices) (Zip Code)

Registrant's telephone number, including area code: (408) 737-7600

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Common stock, $0.001 par value Name of each exchange on which registered The NASDAQ Global Select Market

Securities registered pursuant to Section 12(g) of the Act: None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.    Yes T    No  £

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.    Yes £   No T

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Sections 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes T    No £

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).   Yes T    No £

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. T

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act. (Check One):

Large Accelerated Filer T Accelerated Filer  £ Non-accelerated Filer  £ (Do not check if a smaller reporting company) Smaller Reporting Company £

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes £    No T

The aggregate market value of the voting stock held by non-affiliates of the Registrant based upon the closing price of the common stock on December 25, 2010 as reported by The NASDAQ Global Select Market was $3,559,148,668. Shares of voting stock held by executive officers, directors and holders of more than 5% of the outstanding voting stock have been excluded from this calculation because such persons may be deemed to be affiliates. Exclusion of such shares should not be construed to indicate that any of such persons possesses the power, direct or indirect, to control the Registrant, or that any such person is controlled by or under common control with the Registrant.

Number of shares outstanding of the Registrant's Common Stock, $.001 par value, as of July 31, 2011: 294,814,489.

Documents Incorporated By Reference:

(1)Items 10, 11, 12, 13 and 14 of Part III incorporate information by reference from the Proxy Statement for the 2011 Annual Meeting of Stockholders, to be filed subsequently.

1

MAXIM INTEGRATED PRODUCTS

INDEX

	Forward Looking Statements	3
	Part I	4
Item 1.	Business	4
Item 1A.	Risk Factors	9
Item 1B.	Unresolved Staff Comments	16
Item 2.	Properties	16
Item 3.	Legal Proceedings	17
Item 4.	[Removed and Reserved]	18
	Part II	18
Item 5.	Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities	18
Item 6.	Selected Financial Data	20
Item 7.	Management's Discussion and Analysis of Financial Condition and Results of Operations	21
Item 7A.	Quantitative and Qualitative Disclosures about Market Risk	31
Item 8.	Financial Statements and Supplementary Data	32
Item 9.	Changes in and Disagreements with Accountants on Accounting and Financial Disclosure	32
Item 9A.	Controls and Procedures	32
Item 9B.	Other Information	35
	Part III	35
Item 10.	Directors, Executive Officers, and Corporate Governance	35
Item 11.	Executive Compensation	36
Item 12.	Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters	36
Item 13.	Certain Relationships and Related Transactions, and Director Independence	36
Item 14.	Principal Accountant Fees and Services	36
	Part IV	37
Item 15.	Exhibits and Financial Statement Schedules	37
Signatures		78

2

FORWARD-LOOKING STATEMENTS

This Annual Report on Form 10-K contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements are based on our current expectations and could be affected by the uncertainties and risk factors described throughout this filing and particularly in Part I, Item 1A - Risk Factors and in Part II, Item 7 - Management's Discussion and Analysis of Financial Condition and Results of Operations. These statements relate to, among other things, sales, gross margins, operating expenses, capital expenditures and requirements, liquidity, asset dispositions, product development and R&D efforts, manufacturing plans, pending litigation, effective tax rates, and tax reserves for uncertain tax positions, and are indicated by words or phrases such as "anticipate," "expect," "outlook," "foresee," "forecast," "believe," "could," "intend," "will," "plan," "seek," "project," and variations of such words and similar words or expressions. These statements involve risks and uncertainties that could cause actual results to differ materially from expectations. These forward-looking statements should not be relied upon as predictions of future events as we cannot assure you that the events or circumstances reflected in these statements will be achieved or will occur. For a discussion of some of the factors that could cause actual results to differ materially from our forward-looking statements, see the discussion on "Risk Factors" that appears in Part I, Item 1A of this Annual Report on Form 10-K and other risks and uncertainties detailed in this and our other reports and filings with the Securities and Exchange Commission ("SEC"). We undertake no obligation to update forward-looking statements to reflect developments or information obtained after the date hereof and disclaim any obligation to do so except as required by applicable laws.

3

PART I

ITEM 1. BUSINESS

Overview

Maxim Integrated Products, Inc. ("Maxim" or the "Company" and also referred to as "we," "our" or "us") designs, develops, manufactures and markets a broad range of linear and mixed-signal integrated circuits, commonly referred to as analog circuits, for a large number of customers in diverse geographical locations. The analog market is fragmented and characterized by diverse applications, numerous product variations and, with respect to many circuit types, relatively long product life cycles. Our objective is to develop and market both proprietary and industry-standard analog integrated circuits that meet the increasingly stringent quality and performance standards demanded by customers.

We are a Delaware corporation originally incorporated in California in 1983. We are headquartered in Sunnyvale, California. The mailing address for our headquarters is 120 San Gabriel Drive, Sunnyvale, California 94086, and our telephone number is (408) 737-7600. Additional information about us is available on our website at www.maxim-ic.com.

We make available through our website, free of charge, our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and any amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), as soon as reasonably practicable after they are electronically filed with or furnished to the SEC. We assume no obligation to update or revise any forward-looking statements in this Annual Report on Form 10-K, whether as a result of new information, future events or otherwise, unless we are required to do so by applicable laws. A copy of this Annual Report on Form 10-K is available without charge upon written request to: Investor Relations, Maxim Integrated Products, Inc., 120 San Gabriel Drive, Sunnyvale, California 94086.

The Mixed Signal Analog Integrated Circuit Market

All electronic signals generally fall into one of two categories, linear or digital. Linear (or analog) signals represent real world phenomena, such as temperature, pressure, sound, or speed, and are continuously variable over a wide range of values. Digital signals represent the "ones" and "zeros" of binary arithmetic and are either on or off.

Three general classes of semiconductor products arise from this distinction between linear and digital signals:

• digital devices, such as memories and microprocessors that operate primarily in the digital domain;

• linear devices such as amplifiers, references, analog multiplexers and switches that operate primarily in the analog domain; and

• mixed-signal devices such as data converter devices that combine linear and digital functions on the same integrated circuit and interface between the analog and digital domains.

Our strategy has been to target both the linear and mixed-signal markets, often collectively referred to as the analog market. However, some of our products are exclusively or principally digital. While our focus continues to be on the linear and mixed signal market, our capabilities in the digital domain enable development of new mixed signal and other products with highly sophisticated digital characteristics. Risks associated with pursuing this strategy are discussed in Item 1A - Risk Factors.

We operate in one reportable segment - the design, development, marketing and manufacturing of a broad range of linear and mixed signal integrated circuits.

Our linear and mixed signal products serve four major end-markets. These major end-markets and their corresponding market segments are noted in the table below:

4

MAJOR END-MARKET	MARKET SEGMENT
INDUSTRIAL	Automatic Test Equipment
	Automotive
	Control & Automation
	Electronic Instrumentation
	Medical
	Military & Aerospace
	Security
	Utility & Other Meters
	Other Industrial
COMMUNICATIONS	Basestations
	Network & Datacom
	Telecom
	Other Communications
CONSUMER	Cell Phones
	Digital Cameras
	Handheld Computers
	Home Entertainment & Appliances
	Other Consumer
COMPUTING	Data Storage
	Financial Terminals
	Notebook Computers
	Server & Desktop Computers
	Peripherals & Other Computer

Product Quality

We employ a system addressing quality and reliability of our products from initial design through wafer fabrication, assembly, testing and final shipment. We have received ISO 9001/2, TS 16949 and ISO 14001 certifications for all wafer fabrication, assembly, final test and shipping facilities. Reliability stress testing is performed on products manufactured and sold by Maxim, based on industry standard requirements, in an effort to detect and accelerate the presence of defects that may arise over the life of a product in order to ensure the reliability of our products.

Manufacturing

We primarily manufacture our own wafers and, to a lesser extent, utilize third-party silicon foundries to produce wafers. The majority of processed wafers are subjected to parametric and functional testing at our facilities. The broad range of products demanded by the analog integrated circuit market requires multiple manufacturing process technologies. As a result, many different process technologies are currently used for wafer fabrication of our products. Historically, wafer fabrication of analog integrated circuits has not required the state-of-the-art processing equipment, although newer processes do utilize and require such state-of-the-art facilities and equipment. In addition, hybrid and module products are manufactured using a complex multi-chip technology featuring thin-film, laser-trimmed resistors and other active or passive components. We rely on our own fabrication technologies and facilities to implement such manufacturing requirements. We also utilize unaffiliated manufacturing subcontractors. We are expanding our internal and external manufacturing and test capacity to meet future growth.

During fiscal years 2011, 2010 and 2009, most of our own wafer production occurred at one of our four owned wafer fabrication facilities consisting of the following:

Facility Location	Fiscal Year Acquired
Beaverton, Oregon	1994
San Jose, California	1998
Dallas, Texas	2001
San Antonio, Texas	2004

5

At the end of fiscal year 2009, we ceased wafer fabrication efforts in our Dallas, Texas facility and converted it into a wafer bump manufacturing facility. In fiscal year 2007, we entered into a supply agreement with Seiko Epson Corporation ("Epson"). In fiscal year 2010, we entered into a supply agreement with Powerchip Technology Corporation ("Powerchip") and Maxchip Electronics Corp. ("Maxchip") to provide 300mm and 200mm wafer capacity. Under these agreements, partner foundries (Epson, Powerchip and Maxchip) have manufactured some of our mixed-signal semiconductor products. These products are manufactured under rights and licenses using our proprietary technology at Epson's fabrication facility located in Sakata, Japan and at Powerchip and Maxchip's fabrication facilities in Hsinchu, Taiwan. In fiscal years 2011, 2010 and 2009 the products manufactured by our partner foundries represented 32%, 19% and 9%, respectively, of our total wafer production.

Our wafer bump manufacturing facility located in Dallas, Texas is used to manufacture products that utilize chip scale packaging ("CSP") or wafer level packaging ("WLP"). CSP or WLP enables integrated circuits to be attached directly to a printed circuit board without the use of a traditional plastic package. In addition, we utilize independent subcontractors to perform wafer bump manufacturing to the extent we do not have the internal capacity or capabilities to perform such services.

Once wafer manufacturing has been completed, wafers are generally sorted in order to determine which integrated circuits on each wafer are functional and which are defective. We currently perform the majority of wafer sort, final test and shipping activities at two facilities located in Cavite, the Philippines and Chonburi Province, Thailand. Our finished products ship directly from either Cavite, the Philippines or Chonburi Province, Thailand to customers worldwide or to other Company locations for sale to end-customers or distributors.  In addition, we utilize independent subcontractors to perform wafer sort.

Integrated circuit assembly is performed by foreign assembly subcontractors, located in the Philippines, Malaysia, Thailand, China, Taiwan, Singapore, South Korea and Japan, where wafers are separated into individual integrated circuits and assembled into a variety of packages.

After assembly has been completed, the majority of the assembled product is shipped back to our facilities located in Cavite, the Philippines or Chonburi Province, Thailand where the packaged integrated circuits undergo final testing and preparation for customer shipment. In addition, we utilize independent subcontractors to perform final testing.

With the introduction of 300mm wafers into our manufacturing network, we have enabled subcontractors located in Taiwan to perform wafer bumping and testing of 300mm wafers.

We currently perform substantially all of our module assembly operations in our facility in Batangas, Philippines. The Batangas, Philippines facility also performs wafer singulation and tape-and-reel of bumped (CSP or WLP) wafers.

Customers, Sales and Marketing

We market our products worldwide through a direct-sales and applications organization and through our own and other unaffiliated distribution channels to a broad range of customers in diverse industries. Our products typically require a sophisticated technical sales and marketing effort. Our sales organization is divided into domestic and international regions. Distributors and direct customers generally buy on an individual purchase order basis, rather than pursuant to long-term agreements.

Certain distributors have agreements with us which allow for price protection on certain inventory if we lower the price of our products. Certain distributor agreements also generally permit distributors to exchange a portion of certain purchases on a periodic basis. As is customary in the semiconductor industry, our distributors may market products which compete with our products.

Sales to certain international distributors are made under agreements which permit limited stock return privileges but not sales price rebates.  The agreements generally permit distributors to exchange a portion of their purchases on a periodic basis. See "Critical Accounting Policies" in Part II, Item 7 - Management's Discussion and Analysis of Financial Condition and Results of Operations and Note 2 to the Consolidated Financial Statements accompanying this Annual Report on Form 10-K, which contains information regarding our revenue recognition policy.

We derived approximately 30% of our fiscal 2011 revenue from sales made through distributors. Our primary distributor is Avnet Electronics which accounted for 14% and 12% of our revenues in fiscal years 2011 and 2010, respectively. Avnet, like our other distributors is not an end customer, but rather serves as a channel of sale to many end users of the Company's products. Samsung, our largest single customer, excluding distributors, accounted for approximately 12% of net revenues in fiscal years 2011 and 2010, and no other single customer accounted for more than 10% of revenue in fiscal year 2011, 2010 and 2009, not including distributors. No single product accounted for more than 10% of net revenues in fiscal years 2011, 2010 and 2009. Based on customers' ship-to locations, international sales accounted for approximately 85%, 85% and 82% of net revenues in fiscal years

6

2011, 2010 and 2009, respectively. See Note 12, "Segment Information" in the Notes to Consolidated Financial Statements in Item 15.

Seasonality

The seasonality for any specific period of time has generally not had a material impact on our results of operations. As explained in our risk factors in this report, our revenue is more likely to be influenced on a quarter to quarter basis by customer demand patterns.

Foreign Operations

We conduct business in numerous countries outside the United States. During fiscal 2011, we derived approximately 85% of our net revenues from customers in international markets. Our international business is subject to numerous risks, including fluctuations in foreign currency exchange rates and controls, import and export controls, and other laws, policies and regulations of foreign governments as further described in the risk factors in this report.

Backlog

At June 25, 2011 and June 26, 2010, our current quarter backlog was approximately $460 million and $614 million, respectively. We include in our backlog orders with customer request dates within the next 3 months. As is customary in the semiconductor industry, these orders may be canceled in most cases without penalty to customers. In addition, our backlog includes orders from domestic distributors for which revenues are not recognized until the products are sold by the distributors. Accordingly, we believe that our backlog at any time should not be used as a measure of future revenues. All backlog numbers have been adjusted for estimated future U.S. distribution ship and debit pricing adjustments. Please refer to the Risk Factor titled “Incorrect forecasts, reductions, cancellations or delays in orders for our products could adversely affect our results of operations” for the risks associated with backlog.

Research and Development

We believe that research and development is critical to our future success. Objectives for the research and development function include:

• product definition and development of proprietary products;

• design of parts for high yield and reliability;

• development of, and access to, manufacturing processes and advanced packaging; and

• development of hardware and software to support the acceptance and design-in of our products in the end customer's system.

Our research and development plans require engineering talent and tools for process technologies, test development, packaging development, product definition, electronic design automation ("EDA"), circuit design, software development and applications support. Research and development expenses were approximately $525.3 million, $474.7 million and $520.2 million in fiscal years 2011, 2010 and 2009, respectively.See "Research and Development" under Item 7, Management's Discussion and Analysis of Financial Condition and Results of Operations, for more information.

Competition

The mixed signal analog integrated circuit industry is intensely competitive, and virtually all major semiconductor companies presently compete with, or conceivably could compete with, some portion of our business.

We believe the principal elements of competition include:

• technical innovation, service and support;

• time to market;

• product performance and features;

• quality and reliability;

• product pricing and delivery capabilities;

• customized design and applications;

• business relationship with customers;

7

• experience, skill and productivity of employees and management; and

• manufacturing competence and inventory management.

Our principal competitors include, but are not limited to, Texas Instruments Inc., Analog Devices, Inc., Intersil Corporation, Linear Technology Corporation, and National Semiconductor Corporation which has entered into an agreement to be acquired by Texas Instruments. In addition, we expect increased competition in the future from other emerging and established companies. For further description of competitive factors that may affect our future business, please refer to the section entitled "Our operating results may be adversely affected by increased competition" contained in Part I, Item 1A of this Annual Report on Form 10-K.

Patents, Licenses, and Other Intellectual Property Rights

We rely upon both know-how and patents to develop and maintain our competitive position. There can be no assurance that others will not develop or patent similar technology or reverse engineer our products or that the confidentiality agreements with employees, consultants, silicon foundries and other suppliers and vendors will be adequate to protect our interests. Our products interface with other products, which may require us to obtain licenses that we do not have.

We hold and pursue intellectual property, including patents, trademarks and trade secrets, as appropriate for our markets and technologies. It is our policy to seek patent protection for significant inventions that may be patented, though we may elect, in appropriate cases, not to seek patent protection even for significant inventions if other protection, such as maintaining the invention as a trade secret, is considered more advantageous. In addition, we have registered certain of our mask sets under the Semiconductor Chip Protection Act of 1984, as amended. We hold a number of patents worldwide with expiration dates ranging from 2011 to 2031. We have also registered several of our trademarks with the U.S. Patent and Trademark Office and in foreign jurisdictions. Likewise, we have registered for and received certain copyrights.

There can be no assurance that any patent will be issued on pending applications or that any patent issued will provide substantive protection for the technology or product covered by it, please refer to the section entitled "We may be unable to adequately protect our proprietary rights, which may impact our ability to compete effectively" contained in Part I, Item 1A of this Annual Report on Form 10-K.

Employees

As of June 25, 2011, we employed 9,370 people of whom 4,468 were employed in the United States and 4,902 were employed outside the United States.

Environmental Regulations

To date, our compliance with foreign, federal, state and local laws and regulations that have been enacted to regulate the environment has not had a material adverse effect on our capital expenditures, earnings, or competitive or financial position. However, we could be subject to fines, suspension of production, alteration of our manufacturing processes or cessation of our operations if we fail to comply with present or future statutes and regulations governing the use, storage, handling, discharge or disposal of toxic, volatile or otherwise hazardous materials used in our manufacturing processes, please refer to the section entitled "Environmental liabilities could force us to expend significant capital and incur substantial costs" contained in Part I, Item 1A of this Annual Report on Form 10-K.

Executive Officers

For information regarding our current executive officers, please see Part III, Item 10 of this Annual Report on Form 10-K.

8

ITEM 1A. RISK FACTORS

The following risk factors and other information included in this Annual Report on Form 10-K should be carefully considered. The risks and uncertainties described below are not the only ones we face. Additional risks and uncertainties not presently known to us or that we presently deem less significant may also impair our business operations. Please also see the introductory section of this Annual Report on Form 10-K entitled "Forward-Looking Statements" for additional discussion regarding forward-looking statements. If any of the events or circumstances described in the following risk factors actually occurs, our business, operating results, and financial condition could be materially adversely affected.

Cyclicality in the semiconductor industry may adversely affect our results of operations

The semiconductor industry historically has been cyclical and subject to significant and often rapid increases and decreases in demand for products and services. These changes could have adverse effects on our results of operations and on the market price of our common stock. The results of our operations may be adversely affected in the future if demand for our products and services decreases or if we are unable to meet an increase in demand without significantly increasing the lead-time for the delivery of our products and services.

Incorrect forecasts, reductions, cancellations or delays in orders for our products could adversely affect our results of operations

As is customary in the semiconductor industry, customer orders may be canceled in most cases without penalty to the customers. Some customers place orders that require us to manufacture products and have available for shipment, even though the customer may be unwilling to make a binding commitment to purchase all, or even any, of the products. In other cases, we manufacture product based on forecasts of customer demands. As a result, we may incur inventory and manufacturing costs in advance of anticipated sales and are subject to the risk of cancellations of orders, potentially leading to an initial inflation of backlog followed by a sharp reduction. In addition, our backlog includes orders from domestic distributors for which revenues are not recognized until the ordered products are sold by the distributors. When combined with the risks of order cancellation, our backlog cannot be used as a measure of future revenue. Furthermore, orders or forecasts may be for products that meet the customer's unique requirements so that those canceled or unrealized orders would, in addition, result in an inventory of unsaleable products, causing potential inventory write-offs. As a result of lengthy manufacturing cycles for certain of the products, the amount of unsaleable products could be substantial. As a result, incorrect forecasts, reductions, cancellations or delays in orders for our products could adversely affect our operating results.

Our operating results may be adversely affected by unfavorable economic and market conditions

The economic environment could subject us to increased credit risk should customers be unable to pay us, or delay paying us, for previously purchased products. Accordingly, reserves for doubtful accounts and write-offs of accounts receivable may increase. In addition, weakness in the market for end users of our products could harm the cash flow of our distributors and resellers who could then delay paying their obligations to us or experience other financial difficulties. This would further increase our credit risk exposure and, potentially, cause delays in our recognition of revenue on sales to these customers.

If global economic and market conditions, or economic conditions in the United States or other key markets, deteriorate, we may experience material adverse effects on our business, operating results, and financial condition

Political conditions could materially affect our revenues and results of operations

We are subject to the political and legal risks inherent in international operations. Exposure to political instabilities, different business policies and varying legal standards could impact economic activity, which in turn, could lead to a contraction of customer demand or a disruption in our operations. We have been affected by these problems in the past, but none have materially affected our results of operations to date. Problems in the future or not-yet-materialized consequences of past problems, could affect deliveries of our product to our customers, possibly resulting in substantially delayed or lost sales and/or increased expenses that could materially adversely affect our financial condition and results of operations.

Our quarterly operating results may fluctuate, which could adversely impact our common stock price

We believe that period-to-period comparisons of our results of operations are not necessarily meaningful and should not be relied upon as indicators of future performance. Our operating results have in the past, and will continue to be, subject to quarterly fluctuations as a result of numerous factors, some of which may contribute to more pronounced fluctuations in an uncertain global economic environment. These factors include, but are not limited to, the following:

9

• Fluctuations in demand for our products and services, in part due to changes in general economic conditions and specific economic conditions in the semiconductor industry;

• Reduced visibility into our customers' spending plans and associated revenue;

• The level of price and product competition in our product markets;

• The impact of the uncertain economic and credit environment on our customers, channel partners, and suppliers, including their ability to obtain financing or to fund capital expenditures;

• The overall movement toward industry consolidations among our customers and competitors;

• Market acceptance of new products and product enhancements;

• Announcements and introductions of new products by us or our competitors;

• Deferrals of customer orders in anticipation of new products or product enhancements (introduced by us or our competitors);

• Our ability to meet increases in customer orders in a timely manner;

• Our ability to develop, introduce, and market new products and enhancements in a timely manner; and

• Our levels of operating expenses.

Our products may fail to meet new industry standards or requirements and the efforts to meet such industry standards or requirements could be costly

Many of our products are based on industry standards that are continually evolving. Our ability to compete in the future will depend on our ability to identify and ensure compliance with these evolving industry standards. The emergence of new industry standards could render our products incompatible with products developed by major systems manufacturers. As a result, we could be required to invest significant time and effort and to incur significant expense to redesign our products to ensure compliance with relevant standards. If our products are not in compliance with prevailing industry standards or requirements, we could miss opportunities to achieve crucial design wins which in turn could have a material adverse effect on our business, operations and financial results.

We may encounter difficulties in the implementation of a new manufacturing execution system, which may adversely affect our operations and financial reporting

We are in the process of implementing a new manufacturing execution system (“MES”) in our testing facilities that is scheduled to be completed by the end of fiscal year 2013 as part of our ongoing efforts to improve the quality and productivity of  our operations. Any difficulties in the implementation or operation of the MES system could increase the cost to test our products or disrupt the testing of our products which, in turn, could materially adversely affect our results of operation and financial reporting.

Our manufacturing operations may be interrupted or suffer yield problems

Given the nature of our products, it would be very time consuming, difficult, and costly to arrange for new manufacturing facilities to supply such products. Any prolonged inability to utilize one of our manufacturing facilities or a third party foundry, due to damages resulting from fire, natural disaster, unavailability of electric power, or labor unrest would have a material adverse effect on our results of operations and financial condition.

The manufacture and design of integrated circuits is highly complex. We may experience manufacturing problems in achieving acceptable yields or experience product delivery delays in the future as a result of, among other things, capacity constraints, equipment malfunctioning, construction delays, upgrading or expanding existing facilities or changing our process technologies, any of which could result in a loss of future revenues or increases in fixed costs. To the extent we do not achieve acceptable manufacturing yields or there are delays in wafer fabrication, our results of operations could be adversely affected.  In addition, operating expenses related to increases in production capacity may adversely affect our operating results if revenues do not increase proportionately.

Our independent distributors and sales representatives may terminate their relationship with us or fail to make payments on outstanding accounts receivable to us, which would adversely affect our financial results

A portion of our sales is realized through independent electronics distributors that are not under our control. These independent sales organizations generally represent product lines offered by several companies and thus could reduce their sales efforts applied to our products or terminate their representation of us. We require certain foreign distributors to provide a letter of credit to us in

10

an amount equal to the credit limit set for accounts receivable from such foreign distributors. The letter of credit provides for collection on accounts receivable from the foreign distributor should the foreign distributor default on their accounts receivable to us. Where credit limits have been established above the amount of the letter of credit, we are exposed for the difference. We do not require letters of credit from any of our domestic distributors and are not protected against accounts receivable default or bankruptcy by these distributors. The inability to collect open accounts receivable could adversely affect our results of operations and financial condition. Termination of a significant distributor, whether at our or the distributor's initiative, could be disruptive to our current business.

Our operating results may be adversely affected by increased competition

We experience intense competition from a number of companies, some of which have significantly greater financial, manufacturing, and marketing resources than us, as well as greater technical resources and proprietary intellectual property rights than us. The principal elements of competition include product performance, functional value, quality and reliability, technical service and support, price, diversity of product line and delivery capabilities. We believe we compete favorably with respect to these factors, although we may be at a disadvantage in comparison to larger companies with broader product lines and greater technical service and support capabilities. We cannot assure you that we will be able to compete successfully in the future against existing or new competitors or that our operating results will not be adversely affected by increased competition.

Our dependence on subcontractors for assembly, test, freight, and logistic services and certain manufacturing services may cause delays beyond our control in delivering products to our customers

We rely on subcontractors located in various parts of the world for assembly and CSP packaging services, freight and logistic services, and, to a lesser extent, wafer fabrication and test services. None of the subcontractors we currently use are affiliated with us. Reliability problems experienced by our subcontractors or the inability to replace any subcontractor could cause serious problems in delivery and quality resulting in potential product liability to us. Such problems could impair our ability to meet our revenue plan in the fiscal period impacted by the disruption. Failure to meet the revenue plan may materially adversely impact our results of operations. (For more information on subcontractor locations, please see Item 1. Business - Manufacturing)

Any disruptions in our sort, assembly, test, freight and logistic operations or in the operations of our subcontractors, including, but not limited to, the inability or unwillingness of any of our subcontractors to produce adequate supplies of processed wafers, integrated circuit packages or tested product conforming to our quality standards or their inability to provide timely delivery of products or services required by us, could adversely affect the continuity of product supply as well as damage our reputation, relationship and goodwill with customers. This, in turn, could have a material adverse effect on our results of operations. Furthermore, finding alternate sources of supply or initiating internal wafer processing for these products may not be economically feasible.

Shortage of raw materials or supply disruption of such raw materials could harm our business

The semiconductor industry has experienced a very large expansion of fabrication capacity and production worldwide over time. As a result of increasing demand from semiconductor, solar and other manufacturers, availability of certain basic materials and supplies, such as raw wafers and silicon on insulator wafers, chemicals, gases, polysilicon, silicon wafers, ultra-pure metals, lead frames and molding compounds, and of subcontract services, like epitaxial growth, ion implantation and assembly of integrated circuits into packages, has been limited from time to time over the past several years, and could come into short supply again if overall industry demand exceeds the supply of these materials and services in the future.

We purchase materials and supplies from many suppliers, some of which are sole-sourced. If the availability of these materials and supplies is interrupted, we may not be able to find suitable replacements. In addition, from time to time natural disasters can lead to a shortage of some of the above materials due to disruption of the manufacturer's production. We devote continuous efforts to maintain availability of all required materials, supplies and subcontract services. However, we do not have long-term agreements providing for all of these materials, supplies and services, and shortages could occur as a result of capacity limitations or production constraints on suppliers that could have a material adverse effect on our ability to achieve our production requirements.

Environmental liabilities could force us to expend significant capital and incur substantial costs

Various foreign and United States federal, state, and local government agencies impose a variety of environmental regulations on the storage, handling, use, discharge and disposal of certain chemicals, gases and other substances used or produced in the semiconductor manufacturing process. Compliance with these regulations has not had a material adverse effect on our capital expenditures, earnings, competitive or financial position. There can be no assurance, however, that interpretation and enforcement

11

of current or future environmental regulations will not impose costly requirements upon us. Any failure by us to not adequately control the storage, handling, use, discharge or disposal of regulated substances could result in fines, suspension of production, alteration of wafer fabrication processes and legal liability, which may materially adversely impact our financial condition, results of operations or liquidity.

We may be unable to adequately protect our proprietary rights, which may impact our ability to compete effectively

We rely upon know-how, trade secrets, and patents to develop and maintain our competitive position. There can be no assurance that others will not develop or patent similar technology, reverse engineer our products or that the confidentiality agreements upon which we rely will be adequate to protect our interests. Moreover, the laws of some foreign countries generally do not protect proprietary rights to the same extent as the United States, and we may encounter problems in protecting our proprietary rights in those foreign countries. Other companies have obtained patents covering a variety of semiconductor designs and processes, and we might be required to obtain licenses under some of these patents or be precluded from making and selling the infringing products, if these patents are found to be valid. There can be no assurance that we would be able to obtain licenses, if required, upon commercially reasonable terms or at all.

From time to time, we have received, and in the future may receive, notice of claims of infringement by our products on intellectual property rights of third parties. If one or more of our products or processes were determined to infringe on any such intellectual property rights of a third party, a court might enjoin us from further manufacture and/or sale of the affected products. We would then need to obtain a license from the holders of the rights and/or to re-engineer our products or processes in such a way as to avoid the alleged infringement. In the past, it has been common in the semiconductor industry for patent holders to offer licenses on reasonable terms and rates. Although the practice of offering licenses appears to be generally continuing, in some situations, typically where the patent directly relates to a specific product or family of products, patent holders have refused to grant licenses. In any of those cases, there can be no assurance that we would be able to obtain any necessary license on commercially reasonable terms acceptable to us, if at all, or that we would be able to re-engineer our products or processes in a cost effective manner to avoid infringement. An adverse result in litigation arising from such a claim could involve an injunction to prevent the sales of a material portion of our products, the reduction or elimination of the value of related inventories and the assessment of a substantial monetary award for damages related to past sales, all of which could have a material adverse effect on our results of operations and financial condition.

We may experience losses related to intellectual property indemnity claims

We provide intellectual property indemnification for certain customers, distributors, suppliers and subcontractors for attorney fees and damages and costs awarded against these parties in certain circumstances in which our products are alleged to infringe third party intellectual property rights, including patents, registered trademarks and copyrights. In certain cases, there are limits on and exceptions to our potential liability for indemnification relating to intellectual property infringement claims. We cannot estimate the amount of potential future payments, if any, that we might be required to make as a result of these agreements. To date, we have not been required to pay significant amounts for intellectual property indemnification claims. However, there can be no assurance that we will not have significant financial exposure under those intellectual property indemnification obligations.

Business interruptions from natural disasters could harm our business

We operate our business in worldwide locations. Some of our facilities and those of our subcontractors are located in geologically unstable areas of the world and are susceptible to damage from natural disasters. In the event of a natural disaster, we may suffer a disruption in our operations which could adversely affect our results of operations.

Our financial condition, operations and liquidity may be materially adversely affected in the event of a catastrophic loss for which we are self-insured

We are primarily self-insured with respect to many of our commercial risks and exposures. Based on management's assessment and judgment, we have determined that it is generally more cost effective to self-insure these risks. The risks and exposures we self-insure include, but are not limited to, fire, property and casualty, natural disasters, product defects, political risk, general liability, theft, counterfeits, patent infringement, certain employment practice matters and medical benefits for many of our domestic (United States) employees. We also maintain insurance contracts with independent insurance companies that provide certain of our employees with health (medical and dental) benefits, worker's compensation coverage, long-term disability income coverage, life insurance coverage and fiduciary insurance coverage for employee and Company funds invested under the Employee Retirement Income and Security Act. In addition, we maintain officer and director liability coverage and certain property insurance contracts with independent insurance companies. Should there be catastrophic loss from events such as fires, explosions or

12

earthquakes or other natural disasters, among many other risks, or adverse court or similar decisions in any area in which we are self-insured, our financial condition, results of operations and liquidity may be materially adversely affected.

Limitations in manufacturing capacity or delays in lead-time for delivery of products could adversely affect our future growth opportunities and results of operations

Our ability to successfully realize revenue growth relative to any future increase in customer demands for our products could be limited by our manufacturing capacity and other supply constraints. Our results of operations may be adversely affected if we fail to meet such increase in demand for our products without significantly increasing the lead-time required for our delivery of such products. Any significant increase in the lead-time for delivery of products may negatively affect our customer relationships, reputation as a dependable supplier of products and ability to obtain future design wins, while potentially increasing order cancellations, aged, unsaleable or otherwise unrealized backlog , and the likelihood of our breach of supply agreement terms. Any one of the foregoing factors could negatively affect our future revenue growth and results of operations.

We are subject to warranty claims and product liability

We face an inherent risk of exposure to product liability suits in connection with reliability problems which may be experienced by our customers. Our products are used by varying industries, including the transportation and medical industries. Failure of our products to perform to specifications could lead to substantial damage to both the end product in which our device has been placed and to the user of such end product. If a product liability claim is brought against us, the cost of defending the claim could be significant and any adverse determination could have a material adverse effect on our results of operations.

We manufacture and sell products into many global jurisdictions where our efforts to contractually limit liability for certain damages, including consequential, indirect and non-proximately caused damages, may not be enforceable or may be found by a court to not apply in a particular situation. Likewise, as we continue to partner with certain customers we may be required to accept increasing exposure for liability, including product liability. We believe these relationships with key customers will continue to increase. We continue to attempt to structure our customer relationships to reduce such liability exposures, however, any damages for such liability claims could materially adversely impact the Company financially. Should we choose to not enter into such relationships, our revenues and financial operations could be materially adversely affected.

We may be liable for additional production costs and lost revenues to certain customers with whom we have entered into customer supply agreements, if we are unable to provide a specific part at a certain quantity and product quality

We enter into contracts with certain customers whereby we commit to supply quantities of specified parts at a predetermined scheduled delivery date. The number of such arrangements continues to increase as this practice becomes more commonplace. Should we be unable to supply the customer with the specific part at the quantity and product quality desired on the scheduled delivery date, the customer may incur additional production costs. In addition, the customer may incur lost revenues due to a delay in receiving the parts necessary to have the end-product ready for sale to its customers or due to product quality issues which may arise. Under the customer supply agreements, we may be liable for direct additional production costs or lost revenues. If products were not shipped on time or were quality deficient, we may be liable for penalties and resulting damages. Such liability, should it arise, and/or our inability to meet these commitments to our customers may have a material adverse impact on our results of operations and financial condition and could damage our relationship, reputation and goodwill with the affected customers.

We may pursue acquisitions and investments that could harm our operating results and may disrupt our business

We have made and will continue to consider making strategic business investments, alliances and acquisitions we consider necessary to gain access to key technologies that we believe will augment our existing technical capability and support our business model objectives. Acquisitions, alliances and investments involve risks and uncertainties that may unfavorably impact our future financial performance. If integration of our acquired businesses is not successful, we may not realize the potential benefits of an acquisition or suffer other adverse effects that we currently do not foresee. We must implement our business processes and systems in the acquired operations and effectively integrate the different cultures of acquired business organizations into our own. We may also need to enter new markets in which we have no or limited experience and where competitors in such markets have stronger market positions.

Any of the foregoing, and other factors, could harm our ability to achieve anticipated levels of profitability from acquired businesses or to realize other anticipated benefits of acquisitions. In addition, because acquisitions of high technology companies are inherently risky, no assurance can be given that our previous or future acquisitions will be successful and will not adversely affect our business, operating results, or financial condition.

13

If we fail to enter into future vendor managed inventory arrangements or fail to supply the specific product or quantity under such arrangements, the results of our operations and financial condition may be materially adversely impacted

We enter into arrangements with certain original equipment manufacturers ("OEMs") and Electronic Manufacturing Services ("EMS") partners to consign quantities of certain products within close proximity of the OEMs and EMS partners' manufacturing location. The inventory is physically segregated at these locations and we retain title and risk of loss related to this inventory until such time as the OEM or EMS partner pulls the inventory for use in their manufacturing process. Once the inventory is pulled by the OEM or EMS partner, title and risk of loss pass to the customer, at which point we relieve inventory and recognize revenue and the related cost of goods sold. The specific quantities to be consigned are based on a forecast provided by the OEM or EMS partner. Generally, the arrangements with the OEMs and EMS partners provide for transfer of title and risk of loss once product has been consigned for a certain length of time.

We believe these arrangements will continue to grow in terms of number of customers and products and will increase in proportion to consolidated net revenues. It is our belief that revenues from such arrangements will eventually become significant to consolidated net revenues. Should we be unable or unwilling to enter into such agreements as requested by OEMs or EMS partners, our results of operations may be materially adversely impacted. Should we be unable to supply the specific product and quantity needed by the OEM or EMS partner as reflected in their forecast, we may be liable for damages, including, but not limited to, lost revenues and increased production costs which could have a material adverse impact on our results of operations and financial condition. Should we supply product in excess of the OEM or EMS partners actual usage, any inventory not consumed may become excess or obsolete which would result in an inventory write off that could materially adversely affect our results of operations.

Our stock price may be volatile

The market price of our common stock has fluctuated significantly. In the future, the market price of our common stock could be subject to significant fluctuations due to general economic and market conditions and in response to quarter-to-quarter variations including but not limited to the following:

• our anticipated or actual results of operations;

• announcements or introductions of new products by us or our competitors;

• anticipated or actual operating results of our customers, peers or competitors;

• technological innovations or setbacks by us or our competitors;

• conditions in our four major markets;

• the commencement or outcome of litigation or governmental investigations;

• change in ratings and estimates of our performance by securities analysts;

• announcements of merger or acquisition transactions;

• dividend changes;

• changes in our capital structure, including any decision we make in regard to the repurchase of our common stock;

• management changes;

• supply constraints;

• semiconductor industry cyclicality;

• our inclusion in certain stock indices;

• our ability to maintain compliance with the SEC reporting requirements; and

• other events or factors beyond our control.

The stock market in recent years has experienced extreme price and volume fluctuations that have affected the market prices of many high technology companies, particularly semiconductor companies. In some instances, these fluctuations appear to have been unrelated or disproportionate to the operating performance of the affected companies. Any such fluctuation could harm the market price of our common stock.

Our ability to service our debt obligations, including $300 million of senior unsecured notes, requires sufficient cash flow from our future operations

In June 2010, the Company issued $300 million in senior, unsecured debt due in 2013 with an effective interest rate of 3.49%. Interest is payable semi-annually on December 14 and June 14. The debt indenture includes covenants that limit the Company's ability to grant liens on its facilities and to enter into sale and leaseback transactions, which could limit the Company's ability to secure debt funding in the future, if needed.  In circumstances involving a change of control of the Company followed by a downgrade of the rating of the Company's notes, the Company would be required to make an offer to repurchase these notes at a

14

purchase price equal to 101% of the aggregate principal amount, plus accrued and unpaid interest. The Company's ability to repurchase the notes in such events may be limited by the Company's then-available financial resources or by the terms of other agreements to which the Company is a party. Although the Company currently has the funds necessary to retire this debt, funds might not be available to repay the notes when they come due in the future. 

If the Company fails to pay interest when due, or to repay the notes when due or materially breaches other loan covenants, it would constitute an event of default under the indenture governing the notes which, in turn, may also constitute an event of default under other obligations of the Company. Any event of default under the indenture or other obligations of the Company and any additional obligations and restrictions imposed as a result thereof could negatively impact our financial results.

Our financial results may be adversely affected by increased tax rates and exposure to additional tax liabilities

A number of factors may increase our future effective tax rates, including:

• the jurisdictions in which profits are determined to be earned and taxed;

• recent changes in our global structure that involve an increased investment in technology outside of the United States to better align asset ownership and business functions with revenues and profits;

• the resolution of issues arising from tax audits with various tax authorities;

• changes in the valuation of our deferred tax assets and liabilities;

• adjustments to estimated taxes upon finalization of various tax returns;

• increases in expenses not deductible for tax purposes, including impairments of goodwill in connection with acquisitions;

• changes in available tax credits;

• changes in share-based compensation;

• changes in tax laws or the interpretation of such tax laws, and changes in generally accepted accounting principles; and

• the repatriation of non-U.S. earnings for which we have not previously provided for U.S. taxes.

We are subject to taxation in various countries and jurisdictions. Significant judgment is required to determine tax liabilities on a worldwide basis. Our future tax rates could be affected by various changes in the composition of earnings in countries with different tax rates, changes in our global structure, changes in the valuation of our deferred tax assets and liabilities, or changes in the tax laws. Any significant increase in our future effective tax rates could reduce net income for future periods and may have a material adverse impact on our results of operations.

We may be subject to income tax liabilities under Section 409A of the Internal Revenue Code and other payroll taxes

In the past, a number of our outstanding stock option awards were granted at exercise prices below the fair market value of our stock on the appropriate accounting measurement date. Many of these options are potentially subject to option holder excise tax under Section 409A of the Internal Revenue Code (and, as applicable, similar excise taxes under state law or foreign law). In fiscal year 2008, we took action to cure certain options from exposure under Section 409A. However, there can be no assurance that such action cured all potential circumstances in which Section 409A would apply. Should it be determined that excise taxes under Section 409A were to apply and we decide to reimburse option holders for such taxes, our results of operations may be materially adversely affected. Also, we have determined that certain payroll taxes, interest and penalties may apply to us under various sections of the Internal Revenue Code, various state tax statutes, and tax statutes in various foreign jurisdictions. Maxim has reviewed these potential liabilities and accrued the estimated probable amount of such liabilities. There can be no assurance that our accruals covered all potential circumstances in which additional payroll taxes, interest and penalties would apply. Should it be found that additional payroll taxes, interest and penalties would apply, our results of operations may be materially adversely affected.

We may be materially adversely affected by currency fluctuations or changes in trade policies

We conduct our manufacturing and other operations in various worldwide locations. A portion of our operating costs and expenses at foreign locations are paid in local currencies. Many of the materials used in our products and much of the manufacturing process for our products are supplied by foreign companies or by our foreign operations, such as our test operations in the Philippines and Thailand. Approximately 85%, 85% and 82% of our net revenues in fiscal years 2011, 2010 and 2009, respectively, were shipped to foreign locations. Accordingly, both manufacturing and sales of our products may be adversely affected by political or economic conditions abroad. In addition, various forms of protectionist trade legislation are routinely proposed in the United States and certain foreign countries. A change in current tariff structures or other trade policies could adversely affect our foreign manufacturing

15

or marketing strategies. Currency exchange fluctuations could also decrease revenue and increase our operating costs, the cost of components manufactured abroad, and the cost of our products to foreign customers, or decrease the costs of products from our foreign competitors.

We are subject to U.S. Customs and Export Regulations

We are subject to U.S. Customs and Export Regulations, including U.S. International Traffic and Arms Regulations and similar laws, which collectively control import, export and sale of technologies by companies. Failure to comply with such regulations may result in civil and criminal enforcement, including monetary fines and possible injunctions against shipment of product, which could have a material adverse impact on our results of operations and financial condition.

If we fail to attract and retain qualified personnel, our business may be harmed

Our success depends to a significant extent upon the continued service of our chief executive officer, our other executive officers, and key management and technical personnel, particularly our experienced engineers and business unit managers, and on our ability to continue to attract, retain, and motivate qualified personnel. The loss of the services of one or several of our executive officers could have a material adverse effect on us. In addition, there could be a material adverse effect on us should the turnover rates for engineers and other key personnel increase significantly or should we be unable to continue to attract, motivate and retain qualified personnel. Should we lose an engineer who is key to a project's completion during the course of a particular project, the project's completion may be delayed. This delay could negatively affect customer relationships and goodwill and could have a material adverse effect on our results of operations.

Our certificate of incorporation contains certain anti-takeover provisions that may discourage, delay or prevent a hostile change in control of our Company

Our certificate of incorporation permits our Board of Directors to authorize the issuance of up to 2,000,000 shares of preferred stock and to determine the rights, preferences and privileges and restrictions applicable to such shares without any further vote or action by our stockholders. Any such issuance might discourage, delay or prevent a hostile change in control of our Company.

ITEM 1B. UNRESOLVED STAFF COMMENTS

None.

ITEM 2. PROPERTIES

Our headquarters is located in Sunnyvale, California. Manufacturing and other operations are conducted in several locations worldwide. The following table provides certain information regarding our principal owned general offices and manufacturing facilities at June 25, 2011:

16

Owned Property Location	Use(s)	Approximate Floor Space (sq. ft.)
Sunnyvale, California	Office space and engineering space	56,000
San Jose, California	Wafer fabrication, office space and administration	80,000
San Jose, California	Future Corporate headquarters, office space, engineering, manufacturing, administration, customer services, shipping, and other	435,000
N. Chelmsford, Massachusetts	Engineering, office space and administration	30,000
Beaverton, Oregon	Wafer fabrication, engineering, office space and administration	226,000
Hillsboro, Oregon	Engineering, manufacturing, office space and administration	325,000
Dallas, Texas	Dallas Semiconductor headquarters, office space, engineering, manufacturing, administration, wafer fabrication, customer service, warehousing, shipping, and other	657,000
Irving, Texas	Wafer fabrication space, office space and administration	622,000
San Antonio, Texas	Wafer fabrication, office space and administration	381,000
Cavite, the Philippines	Manufacturing, engineering, administration, office space, customer service, shipping, and other	234,000
Batangas, the Philippines	Manufacturing, engineering, office space and other	78,000
Chonburi Province, Thailand	Manufacturing, engineering, administration, office space, customer service, shipping, and other	144,000
Bangalore, India	Land	4.6 acres
Chandler, Arizona	Office space, engineering, and test	65,000

Several of the buildings at our corporate headquarters in Sunnyvale, California were sold in fiscal 2011 as we intend to relocate our corporate headquarters in 2012 to a location in San Jose, California. The buildings are being leased by us until renovations to our newly acquired campus in San Jose are complete and our employees are relocated to the new campus.

The Irving, Texas facility is not currently operational.

In addition to the property listed in the above table, we also lease sales, engineering, administration and manufacturing offices and other premises at various locations in the United States and overseas under operating leases, none of which are material to our future cash flows. These leases expire at various dates through 2025. We anticipate no difficulty in retaining occupancy of any of our manufacturing, office or sales facilities through lease renewals prior to expiration or through month-to-month occupancy or in replacing them with equivalent facilities.

We expect these facilities to be adequate for our business purposes through at least the next 12 months.

ITEM 3. LEGAL PROCEEDINGS

Legal Proceedings

The Company is subject to legal proceedings and claims that arise in the normal course of the Company's business. The Company does not believe that the ultimate outcome of such matters arising in the normal course of business will have a material adverse

17

effect on the financial position, results of operations or cash flows of the Company.

Indemnifications

The Company indemnifies certain customers, distributors, suppliers and subcontractors for attorney fees, damages and costs awarded against such parties in certain circumstances in which the Company's products are alleged to infringe third party intellectual property rights, including patents, registered trademarks or copyrights. The terms of the Company's indemnification obligations are generally perpetual from the effective date of the agreement. In certain cases, there are limits on and exceptions to the Company's potential liability for indemnification relating to intellectual property infringement claims.

Legal Fees Associated with Indemnification Obligations, Defense and Other Related Costs

Pursuant to the Company's charter documents and indemnification agreements, the Company has certain indemnification obligations to its officers and directors and certain former officers and directors. More specifically, the Company has separate written indemnification agreements with its current and former executive officers and directors. Pursuant to such obligations, the Company has incurred expenses related to legal fees and expenses advanced to certain former officers of the Company who were subject to civil suits and civil charges by the SEC in connection with Maxim's historical stock option granting practices. The Company expenses such amounts as incurred.     

ITEM 4. [Removed and Reserved]

PART II

ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

Our common stock is traded on the NASDAQ Global Select Market (formerly the NASDAQ National Market) ("NASDAQ") under the symbol MXIM. At July 31, 2011, there were 912 stockholders of record of our common stock.

The following table sets forth the range of the high and low closing prices by quarter for fiscal years 2011 and 2010:

	High	Low
Fiscal Year ended June 25, 2011
First Quarter	$18.54	$15.87
Second Quarter	$24.82	$17.81
Third Quarter	$28.10	$23.58
Fourth Quarter	$28.34	$23.79
	High	Low
Fiscal Year ended June 26, 2010
First Quarter	$19.31	$15.17
Second Quarter	$20.87	$16.67
Third Quarter	$20.59	$17.41
Fourth Quarter	$21.27	$16.66

The following table sets forth the dividends paid per share for fiscal years 2011 and 2010:

	Fiscal Years
	2011	2010
First Quarter	$0.21	$0.20
Second Quarter	$0.21	$0.20
Third Quarter	$0.21	$0.20
Fourth Quarter	$0.21	$0.20

18

Issuer Purchases of Equity Securities

The following table summarizes the activity related to stock repurchases for the three months ended June 25, 2011:

	Issuer Repurchases of Equity Securities
	(in thousands, except per share amounts)
	Total Number of Shares Purchased	Weighted Average Price Paid per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs	Maximum Amount That May Yet Be Purchased Under the Plans or Programs
Mar. 27, 2011 - Apr. 23, 2011	725	$	25.24	725	$	134,506
Apr. 24, 2011 - May 21, 2011	660	$	26.94	660	$	116,723
May 22, 2011 - Jun. 25, 2011	890	$	25.77	890	$	93,791
Total	2,275	$	25.94	2,275	$	93,791

In October 2008, the Board of Directors authorized the Company to repurchase up to $750 million of the Company's common stock from time to time at the discretion of the Company's management. This stock repurchase authorization has no expiration date. All prior authorizations by the Company's Board of Directors for the repurchase of common stock were canceled and superseded by this authorization.

During fiscal year 2011, the Company repurchased approximately 10.9 million shares of its common stock for $231.0 million. As of June 25, 2011, the Company had remaining authorization of $93.8 million for future share repurchases. The number of shares to be repurchased and the timing of such repurchases will be based on several factors, including the price of the Company's common stock and general market and business conditions.

Equity Compensation Plan Information

For important information regarding our equity compensation plans, please see Note 6, "Stock-Based Compensation," in the Notes to the Consolidated Financial Statements accompanying this Annual Report on Form 10-K.

Stock Performance Graph

The line graph below compares the cumulative total stockholder return on our common stock with the cumulative total return of the NASDAQ Composite Stock Index and the Philadelphia Semiconductor Index for the five years ended June 25, 2011. The graph and table assume that $100 was invested on June 23, 2006 (the last day of trading for the year ended June 24, 2006) in each of our common stock, the NASDAQ Composite Stock Index and the Philadelphia Semiconductor Index, and that all dividends were reinvested. Cumulative total stockholder returns for our common stock, the NASDAQ Composite Stock Index and the Philadelphia Semiconductor Index are based on our fiscal year.

19

	Base Year	Fiscal Year Ended
	June 24, 2006	June 30, 2007	June 28, 2008	June 27, 2009	June 26, 2010	June 25, 2011
Maxim Integrated Products, Inc.	100.00	105.97	68.80	55.83	62.97	90.40
NASDAQ Composite	100.00	122.71	109.15	86.65	104.81	125.05
Philadelphia Semiconductor index	100.00	112.52	82.87	59.06	79.05	88.12

ITEM 6. SELECTED FINANCIAL DATA

Set forth below is a summary of certain consolidated financial information with respect to the Company as of the dates and for the periods indicated. The data set forth below as of June 25, 2011 and June 26, 2010 and for each of the three years in the period ended June 25, 2011 are derived from and should be read in conjunction with, and are qualified by reference to, Item 7 - Management's Discussion and Analysis of Financial Condition and Results of Operations and Item 8 - Financial Statements and Supplementary Data, and notes thereto included elsewhere in this Annual Report on Form 10-K. The following selected financial data as of June 27, 2009, June 28, 2008, and June 30, 2007 and for the two years in the period ended June 28, 2008 is derived from our consolidated financial statements not included herein. The historical results are not necessarily indicative of the results to be expected in any future period.

20

	Fiscal Year Ended
	June 25, 2011			June 26, 2010			June 27, 2009			June 28, 2008			June 30, 2007
	(Amounts in thousands, except percentages and per share data)
Consolidated Statements of Income Data:
Net revenues	$	2,472,341		$	1,997,603		$	1,646,015		$	2,052,783		$	2,009,124
Cost of goods sold	942,377			804,537			797,138			804,083			782,494
Gross margin	$	1,529,964		$	1,193,066		$	848,877		$	1,248,700		$	1,226,630
Gross margin %	61.9		%	59.7		%	51.6		%	60.8		%	61.1		%
Operating income	$	673,039		$	292,050		$	17,378		$	426,053		$	352,413
% of net revenues	27.2		%	14.6		%	1.1		%	20.8		%	17.5		%
Net income	$	489,009		$	125,139		$	10,455		$	317,725		$	286,227
Earnings per share:
Basic net income per share	$	1.65		$	0.41		$	0.03		$	0.99		$	0.89
Diluted net income per share	$	1.61		$	0.40		$	0.03		$	0.98		$	0.87
Shares used in the calculation of
earnings per share:
Basic	296,755			304,579			310,805			320,553			320,434
Diluted	303,377			310,016			311,479			325,846			329,883
Dividends paid per share	$	0.84		$	0.80		$	0.80		$	0.75		$	0.62
	As of
	June 25, 2011			June 26, 2010			June 27, 2009			June 28, 2008			June 30, 2007
	(Amounts in thousands)
Consolidated Balance Sheet Data:
Cash and cash equivalents	$	962,541		$	826,512		$	709,348		$	1,013,119		$	577,068
Short-term investments	50,346			—			204,055			205,079			722,286
Total cash, cash equivalents and short-term investments	$	1,012,887		$	826,512		$	913,403		$	1,218,198		$	1,299,354
Working capital	$	1,313,512		$	1,174,096		$	1,316,175		$	1,627,406		$	1,615,669
Total assets	$	3,527,743		$	3,482,325		$	3,081,775		$	3,708,390		$	3,606,784
Long-term debt	$	300,000		$	300,000		$	—		$	—		$	—
Stockholders' equity	$	2,510,818		$	2,352,958		$	2,594,465		$	3,147,811		$	3,131,934

ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

You should read the following discussion and analysis in conjunction with our Consolidated Financial Statements and notes thereto included in Part II, Item 8 of this report and the risk factors included in Part I, Item 1A of this report, as well as "forward-looking statements" and other risks described herein and elsewhere in this report, before making an investment decision regarding our common stock.

Overview

We are a global company with manufacturing facilities in the United States, Philippines and Thailand, and sales offices and design centers throughout the world. We design, develop, manufacture and market linear and mixed-signal integrated circuits, commonly referred to as analog circuits, for a large number of customers in diverse geographical locations and are incorporated in the state of Delaware. We also provide a range of high-frequency process technologies and capabilities for use in custom designs. The analog market is fragmented and characterized by diverse applications, a great number of product variations and, with respect to many circuit types, relatively long product life cycles. The major end-markets in which we sell our products are the industrial,

21

communications, consumer and computing markets.

Critical Accounting Policies

The methods, estimates and judgments we use in applying our most critical accounting policies have a significant impact on the results we report in our financial statements. The SEC has defined the most critical accounting policies as the ones that are most important to the portrayal of our financial condition and results of operations, and that require us to make our most difficult and subjective accounting judgments, often as a result of the need to make estimates of matters that are inherently uncertain. Based on this definition, our most critical accounting policies include revenue recognition, which impact the recording of revenues; valuation of inventories, which impacts costs of goods sold and gross margins; the assessment of recoverability of long-lived assets, which impacts write-offs of fixed assets; assessment of recoverability of intangible assets and goodwill which impacts write-offs of goodwill and intangible assets; accounting for stock- based compensation, which impacts cost of goods sold, gross margins and operating expenses; accounting for income taxes, which impacts the income tax provision; and assessment of litigation and contingencies, which impacts charges recorded in cost of goods sold, selling, general and administrative expenses and income taxes. These policies and the estimates and judgments involved are discussed further below. We have other significant accounting policies that either do not generally require estimates and judgments that are as difficult or subjective, or it is less likely that such accounting policies would have a material impact on our reported results of operations for a given period. Our significant accounting policies are described in Note 2 to the Consolidated Financial Statements accompanying this Annual Report on Form 10-K.

Revenue Recognition

The Company recognizes revenue for sales to direct customers and sales to distributors upon shipment, provided that persuasive evidence of a sales arrangement exists, the price is fixed or determinable, title and risk of loss has transferred, collectability of the resulting receivable is reasonably assured, there are no customer acceptance requirements and we do not have any significant post-shipment obligations. We estimate returns for sales to direct customers and international distributors based on historical returns rates applied against current period gross revenues. Specific customer returns and allowances are considered within this estimate.

Sales to certain distributors are made pursuant to agreements allowing for the possibility of certain sales price rebates and for non-warranty product return privileges. The non-warranty product return privileges include allowing certain U.S. distributors to return a small portion of our products in their inventory based on their previous 90 days of purchases. Given the uncertainties associated with the levels of non-warranty product returns and sales price rebates that could be issued to U.S. distributors, we defer recognition of such revenue and related cost of goods sold until the product is sold by the U.S. distributors to their end-customers. Accounts receivable from direct customers, domestic distributors and international distributors are recognized and inventory is relieved upon shipment as title to inventories generally transfers upon shipment at which point we have a legally enforceable right to collection under normal terms. Accounts receivable related to consigned inventory is recognized when the customer takes title of such inventory from its consigned location at which point inventory is relieved, title transfers, and we have a legally enforceable right to collection under the terms of our agreement with the related customers.

The Company estimates potential future returns and sales allowances related to current period product revenue. Management analyzes historical returns, changes in customer demand and acceptance of products when evaluating the adequacy of returns and sales allowances.  Estimates made by us may differ from actual returns and sales allowances.  These differences may materially impact reported revenue and amounts ultimately collected on accounts receivable. Historically, such differences have not been material. At June 25, 2011 and June 26, 2010, the Company had $16.0 million and $15.0 million accrued for returns and allowances against accounts receivable, respectively. During fiscal years 2011 and 2010, the Company recorded $74.5 million and $67.5 million for estimated returns and allowances against revenues, respectively. These amounts were offset by $73.5 million and $62.8 million actual returns and allowances given during fiscal years 2011 and 2010, respectively.

Inventories

Inventories are stated at the lower of (i) standard cost, which approximates actual cost on a first-in-first-out basis, or (ii) market value. Our standard cost revision policy is to continuously monitor manufacturing variances and periodically revise standard costs. Because of the cyclical nature of the market, inventory levels, obsolescence of technology, and product life cycles, we generally write-down inventories to net realizable value based on 12 months forecasted product demand. Actual demand and market conditions may be lower than those projected by us. This difference could have a material adverse effect on our gross margin should inventory write-downs beyond those initially recorded become necessary. Alternatively, should actual demand and market conditions be more favorable than those estimated by us, gross margin could be favorably impacted. Historically, such differences have not been material. During fiscal years 2011, 2010 and 2009, we had inventory write-downs of $13.8 million, $3.7 million and $38.6 million, respectively.

22

Long-Lived Assets

We evaluate the recoverability of property, plant and equipment in accordance with ASC ("Accounting Standards Codification") No. 360, Accounting for the Property, Plant, and Equipment ("ASC No. 360"). We perform periodic reviews to determine whether facts and circumstances exist that would indicate that the carrying amounts of property, plant and equipment might not be fully recoverable. If facts and circumstances indicate that the carrying amount of property, plant and equipment might not be fully recoverable, we compare projected undiscounted net cash flows associated with the related asset or group of assets over their estimated remaining useful lives against their respective carrying amounts. In the event that the projected undiscounted cash flows are not sufficient to recover the carrying value of the assets, the assets are written down to their estimated fair values based on the expected discounted future cash flows attributable to the assets. Evaluation of impairment of property, plant and equipment requires estimates in the forecast of future operating results that are used in the preparation of the expected future undiscounted cash flows. Actual future operating results and the remaining economic lives of our property, plant and equipment could differ from our estimates used in assessing the recoverability of these assets. These differences could result in impairment charges, which could have a material adverse impact on our results of operations. We recorded impairment charges of $0.0 million, $8.3 million and $51.1 million during fiscal years 2011, 2010 and 2009, respectively.

Intangible Assets and Goodwill

We account for intangible assets in accordance with ASC No. 360. We review goodwill and purchased intangible assets with indefinite lives for impairment annually and whenever events or changes in circumstances indicate the carrying value of an asset may not be recoverable, such as when reductions in demand or significant economic slowdowns in the semiconductor industry are present. Reviews are performed to determine whether the carrying value of an asset is impaired, based on comparisons to undiscounted expected future cash flows. If this comparison indicates that there is impairment, the impaired asset is written down to fair value, which is typically calculated using: (i) quoted market prices or (ii) discounted expected future cash flows utilizing a discount rate consistent with the guidance provided in FASB Concepts Statement No. 7, Using Cash Flow Information and Present Value in Accounting Measurements. Impairment is based on the excess of the carrying amount over the fair value of those assets.

Goodwill is recorded as the difference, if any, between the aggregate consideration paid for an acquisition and the fair value of the net tangible and intangible assets acquired. In accordance with ASC No. 350, Intangibles-Goodwill and Other ("ASC 350"), we test goodwill for impairment at the reporting unit level (operating segment or one level below an operating segment) on an annual basis in the first quarter or more frequently if we believe indicators of impairment exist. The performance of the test involves a two-step process. The first step of the impairment test involves comparing the fair values of the applicable reporting units with their aggregate carrying values, including goodwill. We generally determine the fair value of our reporting units using the income approach methodology of valuation that includes the discounted cash flow method as well as other generally accepted valuation methodologies. If the carrying amount of a reporting unit exceeds the reporting unit's fair value, we perform the second step of the goodwill impairment test to determine the amount of impairment loss. The second step of the goodwill impairment test involves comparing the implied fair value of the affected reporting unit's goodwill with the carrying value of that goodwill. No impairment charges were recorded associated with our goodwill and intangible assets during fiscal years 2011, 2010, and 2009, respectively.

Stock-Based Compensation

We account for stock-based compensation in accordance with ASC 718, Compensation in Stock Compensation, ("ASC 718"). ASC 718 requires the recognition of the fair value of stock-based compensation for all stock-based payment awards, including grants of stock options and other awards made to our employees and directors in exchange for services, in the income statement. It also addresses transactions in which an entity incurs liabilities in exchange for goods or services that are based on the fair value of the entity's equity instruments or that may be settled by the issuance of those equity instruments. Accordingly, stock-based compensation cost is measured at the grant date, based on the fair value of the awards ultimately expected to vest and is recognized as an expense, on a straight-line basis, over the requisite service period. We use the Black-Scholes valuation model to measure the fair value of our stock-based awards utilizing various assumptions with respect to expected holding period, risk-free interest rates, stock price volatility and dividend yield. ASC 718 also requires forfeitures to be estimated at the time of grant and revised if necessary in subsequent periods if actual forfeitures or vesting differ from those estimates. Such revisions could have a material effect on our operating results. The assumptions we use in the valuation model are based on subjective future expectations combined with management judgment. If any of the assumptions used in the Black-Scholes model changes significantly, stock-based compensation for future awards may differ materially compared to the awards granted previously.

Accounting for Income Taxes

We must make certain estimates and judgments in the calculation of income tax expense, determination of uncertain tax positions,

23

and in the determination of whether deferred tax assets are more likely than not to be realized. The calculation of our income tax expense and income tax liabilities involves dealing with uncertainties in the application of complex tax laws and regulations.

ASC 740-10, Income Taxes, prescribes a recognition threshold and measurement framework for financial statement reporting and disclosure of tax positions taken or expected to be taken on a tax return. Under ASC 740-10, a tax position is recognized in the financial statements when it is more-likely-than not, based on the technical merits, that the position will be sustained upon examination, including resolution of any related appeals or litigation processes. A tax position that meets the recognition threshold is then measured to determine the largest amount of the benefit that has a greater than 50% likelihood of being realized upon settlement. Although we believe that the Company's computation of tax benefits to be recognized and realized are reasonable, no assurance can be given that the final outcome will not be different from what was reflected in our income tax provisions and accruals. Such differences could have a material impact on our net income and operating results in the period in which such determination is made. See Note 16 to the Consolidated Financial Statements accompanying this Annual Report on Form 10-K for further information related to ASC 740-10.

We evaluate our deferred tax asset balance and record a valuation allowance to reduce the net deferred tax assets to the amount that is more likely than not to be realized. In the event it is determined that the deferred tax assets to be realized in the future would be in excess of the net recorded amount, an adjustment to the deferred tax asset valuation allowance would be recorded. This adjustment would increase income, or additional paid in capital, as appropriate, in the period such determination was made. Likewise, should it be determined that all or part of the net deferred tax asset would not be realized in the future, an adjustment to increase the deferred tax asset valuation allowance would be charged to income in the period such determination is made. In assessing the need for a valuation allowance, historical levels of income, expectations and risks associated with estimates of future taxable income and ongoing prudent and practicable tax planning strategies are considered. Realization of our deferred tax asset is dependent primarily upon future U.S. taxable income. Our judgments regarding future profitability may change due to future market conditions, changes in U.S. or international tax laws and other factors. These changes, if any, may require possible material adjustments to the net deferred tax asset and an accompanying reduction or increase in net income in the period in which such determinations are made.

Litigation and Contingencies

From time to time, we receive notices that our products or manufacturing processes may be infringing the patent or intellectual property rights of others, notices of stockholder litigation or other lawsuits or claims against us. We periodically assess each matter in order to determine if a contingent liability in accordance with ASC No. 450, Accounting for Contingencies ("ASC 450"), should be recorded. In making this determination, management may, depending on the nature of the matter, consult with internal and external legal counsel and technical experts. We expense legal fees associated with consultations and defense of lawsuits as incurred. Based on the information obtained combined with management's judgment regarding all the facts and circumstances of each matter, we determine whether a contingent loss is probable and whether the amount of such loss can be estimated. Should a loss be probable and estimable, we record a contingent loss in accordance with ASC 450. In determining the amount of a contingent loss, we take into consideration advice received from experts in the specific matter, current status of legal proceedings, settlement negotiations which may be ongoing, prior case history and other factors. Should the judgments and estimates made by management be incorrect, we may need to record additional contingent losses that could materially adversely impact our results of operations. Alternatively, if the judgments and estimates made by management are incorrect and a particular contingent loss does not occur, the contingent loss recorded would be reversed thereby favorably impacting our results of operations.

Pursuant to the Company's charter documents and indemnification agreements, we have certain indemnification obligations to our officers and directors, and certain former officers and directors. More specifically, we have separate written indemnification agreements with our current and former executive officers and directors. Pursuant to such obligations, we have incurred substantial expenses related to legal fees for certain former officers of the Company subject to civil charges by the SEC and other governmental agencies in connection with Maxim's historical stock option granting practices. During fiscal year 2010, the Company recorded a $173.0 million charge in connection with an agreement to settle the class action complaint regarding its historical stock option granting practices and on July 23, 2010, the Company paid such amount into an escrow fund in accordance with the terms of the settlement. Please refer to Item 3, Legal Proceedings and Note 13, "Commitments and Contingencies" in the Notes to Consolidated Financial Statements included elsewhere in this report for more information on the litigation and associated settlement.

Results of Operations

The following table sets forth certain Consolidated Statements of Income data expressed as a percentage of net revenues for the periods indicated:

24

	June 25, 2011		June 26, 2010		June 27, 2009
Net revenues	100	%	100	%	100	%
Cost of goods sold	38.1	%	40.3	%	48.4	%
Gross margin	61.9	%	59.7	%	51.6	%
Operating expenses:
Research and development	21.2	%	23.8	%	31.6	%
Selling, general and administrative	11.8	%	12.1	%	12.1	%
Intangible asset amortization	0.8	%	0.5	%	0.4	%
In process research & development	—	%	—	%	0.2	%
Impairment of long-lived assets	—	%	0.4	%	3.1	%
Severance and restructuring expenses	0.1	%	—	%	1.7	%
Other operating expenses, net	0.8	%	8.3	%	1.4	%
Total operating expenses	34.7	%	45.1	%	50.6	%
Operating income	27.2	%	14.6	%	1.1	%
Interest (expense) income and other, net	(0.5	)%	0.4	%	1.0	%
Income before provision for income taxes	26.7	%	15.0	%	2.1	%
Provision for income taxes	7.0	%	8.8	%	1.5	%
Net income	19.7	%	6.2	%	0.6	%

The following table shows pre-tax stock-based compensation included in the components of the Consolidated Statements of Income reported above as a percentage of net revenues for the periods indicated:

	For the Year Ended
	June 25, 2011		June 26, 2010		June 27, 2009
Cost of goods sold	0.6	%	0.8	%	3.5	%
Research and development	2.2	%	2.7	%	6.1	%
Selling, general and administrative	1.0	%	1.2	%	2.3	%
	3.8	%	4.7	%	11.9	%

Net Revenues

We reported net revenues of $2,472.3 million, $1,997.6 million and $1,646.0 million in fiscal years 2011, 2010 and 2009, respectively. Our net revenues in fiscal year 2011 increased by 24% compared to our net revenues in fiscal year 2010. This increase occurred in three of our end markets due to increased demand for our products, resulting in increased units shipped and increased average selling prices. Revenue from industrial products were up 35%, consumer products were up 28% and communications products were up 26%. Computing products were flat year over year mainly due to exiting certain notebook products with low gross margin and focusing on a better mix, which resulted in a 16% decrease in notebook revenue that offset the growth in other market segments.

Our net revenues in fiscal year 2010 increased by 21% compared to our net revenues in fiscal year 2009. This increase occurred in all four of our end markets due to the increased demand for our products, an increase in units shipped, attributable to the overall recovery in the global economic environment. Revenue from communications products were up 15%, computing products were up 9%, consumer products were up 35% and industrial products were up 22%.

Approximately 85%, 85% and 82% of the Company's net revenues in fiscal years 2011, 2010 and 2009, respectively, were derived from customers located outside the United States, primarily in the Pacific Rim, Europe, and Japan. While the majority of these sales are denominated in U.S. dollars, the Company enters into foreign currency forward contracts to mitigate its risks on firm commitments and net monetary assets denominated in foreign currencies. The impact of changes in foreign exchange rates on net revenues and the Company's results of operations for fiscal years 2011, 2010 and 2009 were immaterial.

Gross Margin

Our gross margin as a percentage of net revenue was 61.9% in fiscal year 2011 compared to 59.7% in fiscal year 2010. The year over year improvements in gross margin is primarily due to improved factory utilization, product mix and decreased stock-based

25

compensation as a percentage of revenue.

Our gross margin as a percentage of net revenue was 59.7% in fiscal year 2010 compared to 51.6% in fiscal year 2009. The gross margin percentage increased in fiscal year 2010 from fiscal year 2009 primarily due to improved overall factory utilization, a decrease of $52.9 million or 3.2% of revenues in accelerated depreciation expense attributable to the closure of our Dallas wafer fabrication facility at the end of fiscal year 2009, decreased inventory write-downs of $34.9 million or 2.2% of revenues primarily due to improved inventory turnover and better management of our inventory levels, and decreased stock-based compensation expenses of $41.9 million or 2.7% of revenues, as described below under Stock-based Compensation. These gross margin improvements were partially offset by an increase in sales of lower margin products.

Research and Development

Research and development expenses were $525.3 million and $474.7 million for fiscal years 2011 and 2010, respectively, which represented 21.2% and 23.8% of net revenues, respectively. The increase in research and development expenses was largely attributable to an increase in salaries and bonuses of $28.1 million, primarily due to increased headcount and higher bonus levels in connection with increased profitability for fiscal year 2011.

Research and development expenses were $474.7 million and $520.2 million for fiscal years 2010 and 2009, respectively, which represented 23.8% and 31.6% of net revenues, respectively. The decrease in research and development expenses was primarily attributable to a reduction in stock-based compensation expenses of $46.8 million, as described below under Stock-based Compensation. Other contributing factors include a $19.3 million decrease in salaries, bonuses and benefits attributable to the transition of our field applications engineers and our business managers from research and development to selling, general and administrative functions, which was offset by an increase of $17.2 million in salaries, bonuses and benefits, primarily due to higher bonus levels in connection with increased profitability for fiscal year 2010.

The level of research and development expenditures as a percentage of net revenues will vary from period to period, depending, in part, on the level of net revenues and on our success in recruiting the technical personnel needed for our new product introductions and process development. We view research and development expenditures as critical to maintaining a high level of new product introductions, which in turn are critical to our plans for future growth.

Selling, General and Administrative

Selling, general and administrative expenses were $292.5 million and $242.1 million in fiscal years 2011 and 2010, respectively, which represented 11.8% and 12.1% of net revenues, respectively. The increase in selling, general, and administrative expenses for fiscal year 2011 as compared to fiscal year 2010 was largely attributable to an increase in salaries, bonuses, and benefits of $35.5 million, primarily due to increased headcount and higher bonus levels in connection with increased profitability for fiscal year 2011. In addition travel and expensed equipment increased $6.9 million due to our headcount and business growth requirements.

Selling, general and administrative expenses were $242.1 million and $199.2 million in fiscal years 2010 and 2009, respectively, which represented 12.1% of net revenues in both periods. The increase in selling, general, and administrative expenses for fiscal year 2010 as compared to fiscal year 2009 was largely attributable to an increase in salaries, bonuses, and benefits of $33.7 million, of which $14.4 million related to higher bonus levels in connection with increased profitability for fiscal year 2010, and an increase of $19.3 million was attributable to the transition of our field applications engineers and our business managers from research and development to selling, general and administrative functions. These increases were partially offset by decreased stock-based compensation expenses of $13.9 million, as described below under Stock-based Compensation.

The level of selling, general and administrative expenditures as a percentage of net revenues will vary from period to period, depending on the level of net revenues and our success in recruiting sales and administrative personnel needed to support our operations.

Intangible Asset Amortization Expenses

Intangible asset amortization expenses were $18.8 million and $10.5 million in fiscal years 2011 and 2010, respectively. The increase in intangible asset amortization expenses is primarily attributable to the acquisition of Teridian in the fourth quarter of fiscal year 2010 and Phyworks in the first quarter of fiscal year 2011.

Intangible asset amortization expenses were $10.5 million and $6.0 million in fiscal years 2010 and 2009, respectively. The increase in intangible asset amortization expenses is primarily attributable to the acquisition of Teridian in the fourth quarter of fiscal year 2010 and a full year of amortization of intangible assets associated with the fiscal year 2009 Zilog and Innova Card

26

acquisitions.

Impairment of Long-lived Assets

There were no impairment charges relating to long-lived assets in fiscal year 2011.

Impairment of long lived assets was $8.3 million in fiscal year 2010 and $51.1 million in the fiscal year 2009. The decrease in impairments during fiscal year 2010 was mainly due to write downs of the San Jose fabrication facility equipment and charges associated with excess testers and handlers in 2009. In fiscal year 2010, there was a charge of $5.0 million associated with end of line sorting and testing equipment due to changes in manufacturing technology. Additionally, $3.3 million was recorded in 2010 in relation to our Oregon wafer fabrication facility as a result of reduced wafer output requirements.

Severance and Restructuring Expenses

Severance and restructuring expenses were $1.2 million and $(0.7) million in fiscal years 2011 and 2010, respectively. The increase in severance and restructuring expenses is largely due to severance costs associated with the reorganization of one of Maxim's business units and to employees from the Teridian acquisition who remained employed for a temporary period following the completion of the acquisition for transitional purposes.

Severance and restructuring expenses were $(0.7) million and $28.1 million in fiscal years 2010 and 2009, respectively. The decrease in severance and restructuring expenses was largely due to the completion of the fiscal year 2009 restructuring program announced in the third quarter of fiscal year 2009 as a result of the global economic downturn and the resulting reduction in severance and medical benefit costs.

Other Operating Expenses, Net

Other operating expenses, net include legal and accounting fees directly attributable to the restatement of our previously filed financial statements completed in fiscal year 2009, cost reductions due to the reversal of accruals established in prior years for payroll taxes, interest and penalties related to the misdating of option grants and exercises and losses associated with our sale of the Maxim headquarters.

Other operating expenses, net were $19.1 million and $166.2 million in fiscal years 2011 and 2010, respectively, which represented 0.8% and 8.3% of net revenues, respectively. The decrease in other operating expenses, net was attributable to a $173.0 million fiscal 2010 charge in connection with an agreement to settle the class action complaint. See Note 13: Commitments and Contingencies. This was partially offset by $14.3 million loss on sale of our Sunnyvale headquarters in the second quarter of 2011.

Other operating expenses, net were $166.2 million and $23.0 million in fiscal years 2010 and 2009, respectively, which represented 8.3% and 1.4% of net revenues, respectively. The increase in other operating expenses, net was attributable to a $173.0 million charge in connection with an agreement to settle the class action complaint. This was partially offset by $16.4 million in income attributable to gains directly related to proceeds received as a result of the settlement of the derivative litigation during fiscal year 2010. See Note 13 "Commitments and Contingencies" to the Consolidated Financial Statements accompanying this report.

Interest (expense) income and Other, Net

Interest (expense) income and other, net were $(11.4) million in fiscal year 2011 and $8.0 million in fiscal year 2010, which represented (0.5)% and 0.4% of net revenues, respectively. The change is partially attributable to an increase of interest expense of $10.7 million related to our $300 million long-term debt issued in June 2010, a $4.6 million increase in foreign exchange losses in 2011 as compared to foreign exchange gains in 2010, and a reduction in interest income of $2.9 million resulting from lower average interest rates and reduced average cash and short term investment balances.

Interest income and other, net decreased to $8.0 million in fiscal year 2010 from $17.2 million in fiscal year 2009, which represented 0.4% and 1.0% of net revenues, respectively. The decrease is partially attributable to a reduction in interest income of $13.3 million resulting from lower average interest rates and reduced average cash and short term investment balances.

Provision for Income Taxes

Our annual income tax expense was $172.7 million, $174.9 million, and $24.2 million, in fiscal years 2011, 2010, and 2009, respectively. The effective tax rate was 26.1%, 58.3% and 69.8% for fiscal years 2011, 2010, and 2009, respectively. The Company's federal statutory tax rate is 35%.

27

The Company's income tax provision for the fiscal year 2011 was lower than the amount computed by applying the statutory tax rate primarily because of a $39.4 million benefit for the release of unrecognized tax benefits, including related interest, and earnings of foreign subsidiaries taxed at lower tax rates, partially offset by $8.1 million relating to fiscal year 2010 adjustments for differences between our finalized tax return and the tax provision originally recorded. The income tax provision for the fiscal year 2011 also included a $3.6 million one-time benefit for the retroactive extension of the federal research tax credit to January 1, 2010 by legislation that was signed into law on December 17, 2010.

The fiscal year 2010 and 2009 effective tax rates were higher than the statutory tax rate primarily due to losses of a foreign subsidiary for which no tax benefit was available. These foreign losses represent costs of ongoing research and development efforts as well as licensing rights to preexisting intangibles. The tax rate increase generated by the fiscal year 2009 foreign losses was partially offset by tax benefits from the retroactive extension of the Federal research tax credit by legislation enacted in the fiscal year 2009; certain executive compensation benefits in the fiscal year 2009; and prior year state tax provision to return adjustments recorded in the fiscal year 2009. 

Stock-based Compensation

The following tables show stock-based compensation expense by type of award, resulting tax effect, and related impact on earnings per share included in the Consolidated Statements of Income for fiscal years 2011, 2010, and 2009:

	For the Year Ended
	June 25, 2011		June 26, 2010		June 27, 2009
	(in thousands)
Cost of goods sold
Stock options	$	2,625	$	3,330	$	33,380
Restricted stock units	9,820		10,825		23,350
Employee stock purchase plan	1,556		1,065		370
Total	14,001		15,220		57,100
Research and development expense
Stock options	11,325		15,085		38,237
Restricted stock units	36,925		33,834		61,151
Employee stock purchase plan	5,436		5,146		1,442
Total	53,686		54,065		100,830
Selling, general and administrative expense
Stock options	6,120		8,130		21,390
Restricted stock units	18,944		15,056		16,665
Employee stock purchase plan	1,546		1,054		123
Total	26,610		24,240		38,178
Total stock-based compensation expense
Stock options	20,070		26,545		93,007
Restricted stock units	65,689		59,715		101,166
Employee stock purchase plan	8,538		7,265		1,935
Pre-tax stock-based compensation expense	94,297		93,525		196,108
Less: Income tax effect	25,457		25,041		67,430
Net stock-based compensation expense	$	68,840	$	68,484	$	128,678

Pre-tax stock based compensation increased to $94.3 million in fiscal year 2011 from $93.5 million in fiscal year 2010, which represented 3.8% and 4.7% of net revenues, respectively. The decrease in pre-tax stock based compensation as a percentage of revenue was primarily due to the increase in revenue by 24% while the pre-tax stock based compensation was relatively flat.

Pre-tax stock based compensation decreased to $93.5 million in fiscal year 2010 from $196.1 million in fiscal year 2009, which represented 4.7% and 11.9% of net revenues, respectively. The decrease in pre-tax stock based compensation was partially due to the recognition of $75.9 million in stock-based compensation expenses associated with the Company's tender offer and the recognition of $18.6 million associated with the Company's offer to cash settle stock options expiring in October 2008 offset by

28

a reversal of $52.2 million in expenses related to the true-up for previously forfeited options during the second quarter 2009 which did not recur in 2010. In addition expenses associated with restricted stock units and stock options declined due to the completion of vesting associated with higher priced grants offset by expense related to newer grants.

Recently Issued Accounting Pronouncements

In June 2011, the FASB issued Accounting Standards Update (“ASU”) relating to Comprehensive Income (Topic 220)-Presentation of Comprehensive Income (ASU 2011-05), to require an entity to present the total of comprehensive income, the components of net income, and the components of other comprehensive income either in a single continuous statement of comprehensive income or in two separate but consecutive statements. The ASU is effective for us in our third quarter of fiscal 2012 and should be applied retrospectively. We are currently evaluating the impact of our pending adoption of ASU 2011-05 on our consolidated financial statements.

In May 2011, the FASB issued ASU No. 2011-04, Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and International Financial Reporting Standards (Topic 820)-Fair Value Measurement (ASU 2011-04), to provide a consistent definition of fair value and ensure that the fair value measurement and disclosure requirements are similar between U.S. GAAP and International Financial Reporting Standards. ASU 2011-04 changes certain fair value measurement principles and enhances the disclosure requirements particularly for level 3 fair value measurements. ASU 2011-04 is effective for us in our first quarter of fiscal 2013 and should be applied prospectively. We are currently evaluating the impact of our pending adoption of ASU 2011-04 on our consolidated financial statements.

Backlog

At June 25, 2011 and June 26, 2010, our current quarter backlog was approximately $460 million and $614 million, respectively. We include in our backlog orders with customer request dates within the next three months. As is customary in the semiconductor industry, these orders may be canceled in most cases without penalty to the customers. In addition, our backlog includes orders from domestic distributors for which revenues are not recognized until the products are sold by the distributors. Accordingly, we believe that our backlog at any time should not be used as a measure of future revenues. All backlog amounts have been adjusted for estimated future U.S. distribution ship and debit pricing adjustments. Please refer to the Risk Factor titled “Incorrect forecasts, reductions, cancellations or delays in orders for our products could adversely affect our results of operations” for the risks associated with backlog.

Financial Condition, Liquidity and Capital Resources

As of June 25, 2011, our available funds consisted of $1,013 million in cash, cash equivalents and short-term investments. We anticipate that the available funds and cash generated from operations will be sufficient to meet cash and working capital requirements, including the anticipated level of capital expenditures, common stock repurchases, and dividend payments for at least the next twelve months.

Financial Condition

Cash flows were as follows:

	June 25, 2011			June 26, 2010			June 27, 2009
	(in thousands)
Net cash provided by operating activities	$	861,454		$	490,953		$	445,795
Net cash used in investing activities	(278,334		)	(241,648		)	(191,717		)
Net cash used in financing activities	(447,091		)	(132,141		)	(557,849		)
Net increase (decrease) in cash and cash equivalents	$	136,029		$	117,164		$	(303,771	)

Operating activities

Cash provided by operating activities is net income adjusted for certain non-cash items and changes in certain assets and liabilities.

Cash from operations for the year ended June 25, 2011 increased by approximately $370.5 million compared with the year ended June 26, 2010. This was due to an increase in net income of $363.9 million, a reduction in the receivables by $167.5 million and a reduction in other current assets by $132.6 million, over the year ended June 25, 2011, as compared to an increase over the year

29

ended June 26, 2010. These increases were offset by the payment of $173.0 million in July, 2010 relating to the litigation settlement, which was accrued for in fiscal 2010. (For more information on contingencies, see Note 13 to the Consolidated Financial Statements accompanying this report).

Cash from operations for the year ended June 26, 2010 increased by approximately $45.2 million compared with the year ended June 27, 2009. The increase was primarily attributable to an increase in net income and decreased non-cash charges of $167.5 million, offset by an increase in working capital of $97.9 million. This increase in working capital is primarily due to the accounts receivable increase of $131.5 million at the end of fiscal year 2010 compared to fiscal year 2009. Additionally, inventories decreased by $11.8 million compared to fiscal year 2009. Current liabilities increased by $263.7 million primarily due to the litigation settlement and an increase in income taxes payable, and to a lesser extent an increase in anticipated bonuses.

Investing activities

Investing cash flows consist primarily of capital expenditures, net investment purchases and maturities and acquisitions.

Cash used in investing activities increased by $36.7 million for the year ended June 25, 2011 compared with the year ended June 26, 2010. The increase was primarily due to $200.2 million proceeds from maturity of short-term investments in the fiscal year ended 2010, that did not recur in fiscal year 2011, $49.8 million relating to purchase of short-term investments and an increase of $26.5 million in net capital expenditures relating to Property, plant and equipment , including the proceeds from the sale of our Sunnyvale headquarters. The increase was offset by $235.9 million representing less cash used for acquisitions.

Cash used in investing activities was $241.6 million in fiscal year 2010 while cash used in investing activities was $191.7 million in fiscal year 2009. The increase in cash from investing activities was primarily attributable to the acquisition of Teridian for $312.8 million, net of cash, in the fourth quarter of fiscal year 2010, which was partially offset by proceeds from the maturities of available-for-sale securities of $200.2 million.

Financing activities

Financing cash flows consist primarily of repurchases of common stock, payment of dividends to stockholders and withholding tax payments associated with net share settlements of equity awards.

Net cash used in financing activities increased by approximately $315.0 million for the year ended June 25, 2011 compared with the year ended June 26, 2010. This increase was primarily due to cash proceeds from issuance of debt in 2010 of $298.6 million which did not reoccur in 2011.

Cash used in financing activities was $132.1 million in fiscal year 2010 and $557.8 million in fiscal year 2009. The decrease in cash used from financing activities was primarily due to the issuance of debt of $300 million in the fourth quarter of fiscal year 2010, the issuance of ESPP of $24.8 million, a decrease in repurchases of common stock of $44.2 million and a decrease in cash used pursuant to the RSU loan program of $35.6 million.

Liquidity and Capital Resources

Debt Levels

On June 17, 2010, we completed a public offering of $300 million aggregate principal amount of the Company's 3.45% senior unsecured and unsubordinated notes (the"Notes") due on June 14, 2013, with an effective interest rate of 3.49%. Interest on the Notes is payable semi-annually in arrears on June 14 and December 14 of each year.

The underwriting agreements governing the Notes contain covenants that provide limitations over the Company's creation or incurrence of liens or sale and lease-back transactions on any of its properties, or properties of its subsidiaries. Upon the occurrence of a change of control triggering event, each holder shall have the right to require the Company to buy their Notes at a purchase price equal to 101% of the principal amount, plus accrued and unpaid interest. The Company's ability to repurchase the senior notes in such event may be limited by law, by the indenture associated with the senior notes, by the Company's then-available financial resources or by the terms of other agreements to which the Company may be party at such time. If the Company fails to repurchase the senior notes as required by the indenture, it would constitute an event of default. In the event of default, the principal amount and interest will become due and payable immediately.

Available borrowing resources

As of June 25, 2011, we had the capacity to issue an unspecified amount of additional debt securities, common stock, preferred

30

stock, warrants, rights and units under the 2010 Shelf Registration Statement.

Subsequent acquisition

On July 18, 2011, we acquired SensorDynamics, a semiconductor company that develops proprietary sensor and microelectromechanical ("MEMS") solutions. SensorDynamics is based in Lebring, near Graz, Austria. The total cash consideration associated with the acquisition was approximately $130.0 million plus the assumption of approximately $34.0 million in debt.

Contractual Obligations

The following table summarizes the Company's significant contractual obligations at June 25, 2011, and the effect such obligations are expected to have on the Company's liquidity and cash flows in future periods. This table excludes amounts already recorded on our Consolidated Balance Sheet as current liabilities at June 25, 2011:

	Total		Less than 1 year		2-3 years		4-5 years		More than 5 years
	(Amounts in thousands)
Operating lease obligations (1)	$	44,489	$	12,808	$	15,478	$	8,005	$	8,198
Royalty obligations (2)	20,000		10,000		10,000		—		—
Long-term debt obligations (3)	300,000		—		300,000		—		—
Interest payments associated with long-term debt obligations (4)	20,441		10,350		10,091		—		—
Capital equipment and inventory related purchase obligations (5)	33,899		17,515		3,752		3,752		8,880
Total	$	418,829	$	50,673	$	339,321	$	11,757	$	17,078

(1) The Company leases some facilities under non-cancelable operating lease agreements that expire at various dates through

2025.

(2) Royalty obligations represent payments for licensed patents.

(3) Long-term debt represents amount due for the Company's 3.45% senior unsecured notes due 2013.

(4) Interest payments associated with the Company's 3.45% senior unsecured notes due 2013.

(5) Capital equipment purchase obligations represent commitments for purchase of property, plant and equipment. The Company orders some materials and supplies in advance or with minimum purchase quantities. The Company is obligated to pay for the materials and supplies when received.

Purchase orders for the purchase of the majority of our raw materials and other goods and services are not included above. Our purchase orders generally allow for cancellation without significant penalties. We do not have significant agreements for the purchase of raw materials or other goods specifying minimum quantities or set prices that exceed our expected short-term requirements.

As of June 25, 2011, our gross unrecognized income tax benefits were $117.4 million, which excludes $3.3 million of accrued interest and penalties. At this time, we are unable to make a reasonably reliable estimate of the timing of payments of these amounts, if any, in individual years due to uncertainties in the timing or outcomes of either actual or anticipated tax audits. As a result, these amounts are not included in the table above.

Off-Balance-Sheet Arrangements

As of June 25, 2011, the Company did not have any material off-balance-sheet arrangements, as defined in Item 303(a)(4)(ii) of SEC Regulation S-K.

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Interest Rate Risk

The Company's exposure to market risk for changes in interest rates relates primarily to the Company's cash and cash equivalents and the 3.45% fixed rate senior unsecured notes issued in June 2010 (See Note 5 "Financial Instruments" to the Consolidated Financial Statements accompanying this report). The Company does not use derivative financial instruments to hedge the risk of interest rate volatility. At June 25, 2011, the Company maintained a significant portfolio of money market fund investments, which

31

are included in cash and cash equivalents. These money market funds are all available on a daily basis.

Foreign Currency Risk

The Company generates revenues in various global markets based on orders obtained in non-U.S. currencies, primarily the Japanese Yen, the Euro and the British Pound. Maxim incurs expenditures denominated in non-US currencies, principally Philippine Pesos and Thailand Baht associated with the Company's manufacturing activities in the Philippines and Thailand, respectively, and expenditures for sales offices and research and development activities undertaken outside of the U.S. Maxim is exposed to fluctuations in foreign currency exchange rates primarily on orders and accounts receivable from sales in these foreign currencies and cash flows for expenditures in these foreign currencies. Maxim has established risk management strategies designed to reduce the impact of volatility of future cash flows caused by changes in the exchange rates for these currencies. These strategies reduce, but do not entirely eliminate, the impact of currency exchange rates movements. Maxim does not use derivative financial instruments for speculative or trading purposes. The Company routinely hedges its exposures to certain foreign currencies with various financial institutions in an effort to minimize the impact of certain currency exchange rate fluctuations. If a financial counter party to any of the Company's hedging arrangements experiences financial difficulties or is otherwise unable to honor the terms of the foreign currency hedge, the Company may experience financial losses.

For derivative instruments that are designated and qualify as cash flow hedges under ASC No. 815- Derivatives and Hedging, the effective portion of the gain or loss on the derivative is reported as a component of accumulated other comprehensive income (loss) and reclassified into earnings into the same financial statement line as the item being hedged, and in the same period or periods during which the hedged transaction affects earnings. Gains and losses on the derivative representing either hedge ineffectiveness or hedge components excluded from the assessment of effectiveness are recognized in interest and other (expense) income, net.

For derivative instruments that are not designated as hedging instruments under ASC No. 815, gains and losses are recognized in interest and other (expense) income, net. All derivatives are foreign currency forward contracts to hedge certain foreign currency denominated assets or liabilities. The gains and losses on these derivatives largely offset the changes in the fair value of the assets or liabilities being hedged.

Foreign exchange contracts

The net unrealized gain or loss, if any, is potentially subject to market and credit risk as it represents appreciation (decline) of the hedge position against the spot exchange rates. The net realized and unrealized gains or losses from hedging foreign currency denominated assets and liabilities were immaterial during the year ended June 25, 2011 and June 26, 2010.

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

The financial statements and supplementary data required by this Item are set forth at the pages indicated in Item 15(a) of this report.

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

None.

ITEM 9A. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our chief executive officer ("CEO") and our chief financial officer ("CFO"), evaluated the effectiveness of our disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act as of June 25, 2011. The purpose of these controls and procedures is to ensure that information required to be disclosed in the reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC rules, and that such information is accumulated and communicated to our management, including our CEO and our CFO, to allow timely decisions regarding required disclosures. Based on the evaluation, our management, including our CEO and our CFO, concluded that our disclosure controls and procedures were effective as of June 25, 2011.

32

Management's Annual Report on Internal Control over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act. Internal control over financial reporting is a process designed by, or under the supervision of, the Company's CEO and CFO and effected by the Company's Board of Directors, management, and others to provide reasonable assuranceregarding the reliability of financial reporting and the preparation of financial statementsfor external purposes in accordance with GAAP. Our management, with the participation of our CEO and our CFO, assessed the effectiveness of our internal control over financial reporting as of June 25, 2011. Management's assessment of internal control over financial reporting was conducted using the criteria in Internal Control - Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission ("COSO"). Our management has concluded that, as of June 25, 2011, our internal control over financial reporting was effective, in all material respects, based on these criteria. Deloitte & Touche LLP, an Independent Registered Public Accounting Firm, audited the effectiveness of the Company's internal control over financial reporting, as stated within their report which is included herein.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting during the quarter ended June 25, 2011 that have materially affected or are reasonably likely to materially affect, our internal control over financial reporting.

Inherent Limitations on the Effectiveness of Internal Controls

A system of internal control over financial reporting is intended to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements in accordance with GAAP and no control system, no matter how well designed and operated, can provide absolute assurance. The design of any control system is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Because of its inherent limitations, internal control over financial reporting may not prevent or detect financial statement errors and misstatements. Also, projection of any evaluation of effectiveness to future periods is subject to the risk that controls may become inadequate because of changes in conditions or that the degree of compliance with the policies or procedures may deteriorate.

33

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Board of Directors and Stockholders of

Maxim Integrated Products, Inc.

Sunnyvale, CA

We have audited the internal control over financial reporting of Maxim Integrated Products, Inc. and subsidiaries (the "Company") as of June 25, 2011, based on the criteria established in Internal Control - Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission. The Company's management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management's Annual Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company's internal control over financial reporting based on our audit.

We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

A company's internal control over financial reporting is a process designed by, or under the supervision of, the company's principal executive and principal financial officers, or persons performing similar functions, and effected by the company's board of directors, management, and other personnel to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company's internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company's assets that could have a material effect on the financial statements.

Because of the inherent limitations of internal control over financial reporting, including the possibility of collusion or improper management override of controls, material misstatements due to error or fraud may not be prevented or detected on a timely basis. Also, projections of any evaluation of the effectiveness of the internal control over financial reporting to future periods are subject to the risk that the controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of June 25, 2011, based on the criteria established in Internal Control - Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission.

We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the consolidated financial statements and financial statement schedule as of and for the year ended June 25, 2011 of the Company and our report dated August 5, 2011 expressed an unqualified opinion on those financial statements and financial statement schedule.

DELOITTE & TOUCHE LLP

San Jose, California

August 5, 2011

34

ITEM 9B. OTHER INFORMATION

None.

PART III

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

Other than as follows, the information required by this Item is incorporated by reference from the Company's Proxy Statement for the 2011 Annual Meeting of Stockholders under the headings "Audit Committee and Audit Committee Financial Expert," "Proposal 1 - Election of Directors" and "Compliance with Section 16(a) of the Securities Exchange Act of 1934."

Executive Officers of the Registrant

The following is information regarding our executive officers, including their positions and their ages as of June 25, 2011.

Name	Age	Position
Tunc Doluca	53	President and Chief Executive Officer
Bruce E. Kiddoo	50	Senior Vice President, Chief Financial Officer
David A. Caron	51	Vice President and Principal Accounting Officer
Vivek Jain	51	Senior Vice President, Manufacturing
Edwin Medlin	54	Vice President, General Counsel
Matthew J. Murphy	38	Vice President, Worldwide Sales and Marketing
Christopher J. Neil	45	Division Vice President, Conversion, Computer and Secure Products Division
Pirooz Parvarandeh	51	Group President, High Performance Analog Division
Charles G. Rigg	67	Senior Vice President
Vijay Ullal	52	Group President, Consumer Solutions Division
Steven Yamasaki	56	Vice President, Human Resources

Mr. Doluca has served as a director of Maxim as well as the President and Chief Executive Officer since January 2007. He joined Maxim in October 1984 and served as Vice President from 1994 to 2004. He was promoted to Senior Vice President in 2004 and Group President in May 2005. Prior to 1994, he served in a number of integrated circuit development positions.

Mr. Kiddoo joined Maxim in September 2007 as Vice President of Finance. On October 1, 2008, immediately following the completion of Maxim's restatement of previously filed financial statements, Mr. Kiddoo was appointed Chief Financial Officer and Principal Accounting Officer of Maxim and was appointed Senior Vice President in September 2009. Prior to joining Maxim, Mr. Kiddoo held various positions at Broadcom Corporation, a global semiconductor company, beginning in December 1999. Mr. Kiddoo served as Broadcom's Corporate Controller and Principal Accounting Officer from July 2002 and served as Vice President from January 2003. He also served as Broadcom's Acting Chief Financial Officer from September 2006 to March 2007.

Mr. Caron has served as Maxim's Corporate Controller since July 2003 and, prior to that, served as Maxim's Director of Accounting from December 1998 to July 2003.  Mr. Caron was appointed Vice President and Principal Accounting Officer in August 2010. Mr. Caron is a Certified Public Accountant in the state of California and holds a Bachelor of Science in Accounting from San Jose State University.  

Mr. Jain joined Maxim in April 2007 as Vice President responsible for our wafer fabrication operations. In June 2009 Mr. Jain was promoted to Senior Vice President with expanded responsibility for managing test and assembly operations in addition to wafer fabrication operations. Prior to joining Maxim, Mr. Jain was Plant Manager for several years at Intel Corporation's Technology Development and Manufacturing facility in Santa Clara, California responsible for 65nm flash manufacturing/transfer and development of 45nm flash technology. Mr. Jain has published over 30 papers and holds over 10 patents in the field of semiconductor technology.

Mr. Medlin joined Maxim in November 1999 as Director and Associate General Counsel. He was promoted to Vice President and Senior Counsel in April 2006 and appointed General Counsel in August 2010. Prior to joining Maxim, he was with the law firm of Ropers, Majeski, Kohn and Bentley from 1987 to 1994 where he held various positions, including director. From 1994 to 1997 he was with Fox Factory, Inc., a privately held manufacturing company where he held the positions of General Counsel, and later,

35

General Manager. From 1997 to 1999 he was with RockShox, Inc., a publicly traded corporation, where he held the positions of General Counsel and then Vice President of Global Sales and Marketing.

Mr. Murphy joined Maxim in July 1994 and was promoted to Vice President in November 2006. Prior to 2006, he served in a number of business unit and executive management positions.

Mr. Neil joined Maxim in September 1990 and was promoted to Vice President in April 2006.  Prior to 2006, he held several engineering and executive management positions.

Mr. Parvarandeh joined Maxim in July 1987 and served as Vice President from 1997 to 2005. He was promoted to Senior Vice President in 2004 and Group President in May 2005. Prior to 1997, he served in a number of integrated circuit development positions.

Mr. Rigg joined Maxim in August 1996 as Managing Director and General Counsel. He was promoted to Vice President in April 1999 and Senior Vice President in January 2007. Prior to joining Maxim, he was with Ropers, Majeski, Kohn and Bentley from 1970 to 1996 where he held various positions, including director.

Mr. Ullal joined Maxim in December 1989 and served as Vice President from 1996 to 2004. He was promoted to Senior Vice President in 2004 and Group President in January 2007. Prior to 2004, he served in a number of wafer fabrication operation and management positions.

Mr. Yamasakijoined Maxim in April 2010 as Vice President of Human Resources.  Prior to joining Maxim, he was Corporate Vice President of Human Resources of Applied Materials from 2008 to 2010, and was Executive Vice President of Human Resources of YRC Worldwide from 2004 to 2008. Before joining YRC Worldwide, Mr. Yamasaki was Vice President of Human Resources at ConAgra Foods Inc. and Honeywell International.

Code of Business Conduct and Ethics

We have a Code of Business Conduct and Ethics (the "Code of Ethics"), which applies to all directors and employees, including but not limited to our principal executive officer, principal financial officer and principal accounting officer. The Code of Ethics is designed to promote: (i) honest and ethical conduct, including the ethical handling of actual or apparent conflicts of interest arising from personal and professional relationships, (ii) full, fair, accurate, timely and understandable disclosure in reports and documents that we are required to file with the SEC and in other public communications, (iii) compliance with applicable governmental laws, rules and regulations, (iv) the prompt internal reporting of violations of the Code of Ethics to an appropriate person or group, and (v) accountability for adherence to the Code of Ethics. A copy of the Code of Ethics is available on our website at http://www.maxim-ic.com/company/policy. A hard copy of the Code of Ethics will be sent free of charge upon request.

ITEM 11. EXECUTIVE COMPENSATION

The information required by this item is incorporated by reference from the Company's Proxy Statement for the 2011 Annual Meeting of Stockholders under the headings "Director Compensation," "Compensation Discussion and Analysis," "Report of Compensation Committee" and "Executive Compensation."

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

The information required by this item is incorporated by reference from the Company's Proxy Statement for the 2011 Annual Meeting of Stockholders under the heading "Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters. "

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

The information required by this item is incorporated by reference from the Company's Proxy Statement for the 2011 Annual Meeting of Stockholders under the heading "Corporate Governance" and "Certain Relationships and Related Transactions."

ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES

The information required by this item is incorporated by reference from the Company's Proxy Statement for the 2011 Annual Meeting of Stockholders under the headings "Report of the Audit Committee" and "Principal Accountant Fees and Services."

36

PART IV

ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

(a) The following are filed as part of this Report:

		Page
(1)	Financial Statements.	38
	Consolidated Balance Sheets at June 25, 2011 and June 26, 2010	38
	Consolidated Statements of Income for each of the three years in the period ended June 25, 2011	39
	Consolidated Statements of Stockholders' Equity for each of the three years in the period ended June 25, 2011	40
	Consolidated Statements of Cash Flows for each of the three years in the period ended June 25, 2011	41
	Notes to Consolidated Financial Statements	42
	Report of Independent Registered Public Accounting Firm	76
(2)	Financial Statement Schedule.
	The following financial statement schedule is filed as part of this Annual Report on Form 10-K and should be read in conjunction with the financial statements.
	Schedule II - Valuation and Qualifying Accounts	77
	All other schedules are omitted because they are not applicable, or because the required information is included in the consolidated financial statements or notes thereto.
(3)	The Exhibits filed as a part of this Report are listed in the attached Index to Exhibits.

(b) Exhibits.

See attached Index to Exhibits.

37

MAXIM INTEGRATED PRODUCTS, INC.

CONSOLIDATED BALANCE SHEETS

(In thousands, except par value)

	June 25, 2011			June 26, 2010
ASSETS
Current assets:
Cash and cash equivalents	$	962,541		$	826,512
Short-term investments	50,346			—
Total cash, cash equivalents and short-term investments	1,012,887			826,512
Accounts receivable, net of allowances of $17,697 in 2011 and $17,438 in 2010	297,632			339,322
Inventories	237,928			206,040
Deferred tax assets	113,427			217,017
Income tax refund receivable	483			83,813
Other current assets	65,495			33,909
Total current assets	1,727,852			1,706,613
Property, plant and equipment, net	1,308,850			1,324,436
Intangible assets, net	204,263			194,728
Goodwill	265,125			226,223
Other assets	21,653			30,325
TOTAL ASSETS	$	3,527,743		$	3,482,325
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable	$	110,153		$	107,797
Income taxes payable	3,912			13,053
Accrued salary and related expenses	215,627			175,858
Accrued expenses	47,767			37,030
Deferred income on shipments to distributors	36,881			25,779
Accrual for litigation settlement	—			173,000
Total current liabilities	414,340			532,517
Long term debt	300,000			300,000
Income taxes payable	96,099			132,400
Deferred tax liabilities	183,715			136,524
Other liabilities	22,771			27,926
Total liabilities	1,016,925			1,129,367
Commitments and contingencies (Note 13)
Stockholders' equity:
Preferred stock, $0.001 par value
Authorized: 2,000 shares, issued and outstanding: none	—			—
Common stock, $0.001 par value
Authorized: 960,000 shares
Issued and outstanding: 295,780 in 2011 and 300,848 in 2010	296			301
Additional paid-in capital	—			—
Retained earnings	2,524,790			2,364,598
Accumulated other comprehensive loss	(14,268		)	(11,941		)
Total stockholders' equity	2,510,818			2,352,958
TOTAL LIABILITIES & STOCKHOLDERS' EQUITY	$	3,527,743		$	3,482,325

See accompanying Notes to Consolidated Financial Statements.

38

MAXIM INTEGRATED PRODUCTS, INC.

CONSOLIDATED STATEMENTS OF INCOME

(In thousands, except per share data)

	For the Years Ended
	June 25, 2011			June 26, 2010			June 27, 2009
Net revenues	$	2,472,341		$	1,997,603		$	1,646,015
Cost of goods sold (1)	942,377			804,537			797,138
Gross margin	1,529,964			1,193,066			848,877
Operating expenses:
Research and development (1)	525,308			474,652			520,228
Selling, general and administrative (1)	292,494			242,144			199,151
Intangible asset amortization	18,752			10,477			6,019
In process research & development	—			—			3,900
Impairment of long-lived assets	—			8,291			51,112
Severance and restructuring expenses	1,247			(699		)	28,124
Other operating expenses, net	19,124			166,151			22,965
Total operating expenses	856,925			901,016			831,499
Operating income	673,039			292,050			17,378
Interest (expense) income and other, net	(11,368		)	8,013			17,241
Income before provision for income taxes	661,671			300,063			34,619
Provision for income taxes	172,662			174,924			24,164
Net income	$	489,009		$	125,139		$	10,455
Earnings per share:
Basic net income per share	1.65			0.41			0.03
Diluted net income per share	1.61			0.40			0.03
Shares used in the calculation of earnings per share:
Basic	296,755			304,579			310,805
Diluted	303,377			310,016			311,479
Dividends paid per share	$0.84			$0.80			$0.80

(1) Includes stock-based compensation charges as follows:

Cost of goods sold	$	14,001	$	15,220	$	57,100
Research and development	$	53,686	$	54,065	$	100,830
Selling, general and administrative	$	26,610	$	24,240	$	38,178

See accompanying Notes to Consolidated Financial Statements.

39

MAXIM INTEGRATED PRODUCTS, INC.

CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY

	Common Stock					Additional						Accumulated other			Total
(In thousands)	Shares		Par Value			Paid-In Capital			Retained Earnings			Comprehensive Loss			Stockholders' Equity
Balance, June 28, 2008	320,553		321			251,478			2,901,139			(5,127		)	3,147,811
Components of comprehensive income:
Net income									10,455						10,455
Unrealized actuarial loss on post-retirement benefits, net of tax												(3,762		)	(3,762		)
Tax effect of the unrealized exchange loss on long-term intercompany receivable												552			552
Unrealized gain on available-for-sale investments, net of tax												681			681
Total comprehensive income															7,926
Repurchase of common stock	(18,132	)	(18		)	(174,172		)	(60,942		)				(235,132		)
Common stock issued under stock plans, net of shares withheld for employee taxes	3,598		3			(20,590		)							(20,587		)
Stock based compensation						162,010									162,010
Tax shortfall on settlement of equity instruments						(195,294		)	(21,541		)				(216,835		)
Modification of equity instruments to liability						(18,658		)							(18,658		)
Modification of liability instruments to equity						16,431									16,431
Dividends paid									(248,501		)				(248,501		)
Balance, June 27, 2009	306,019		306			21,205			2,580,610			(7,656		)	2,594,465
Components of comprehensive income:
Net income									125,139						125,139
Unrealized actuarial loss on post-retirement benefits, net of tax												(896		)	(896		)
Tax effect of the unrealized exchange gain on long-term intercompany receivable												(1,893		)	(1,893		)
Unrealized loss on available-for-sale investments, net of tax												(1,346		)	(1,346		)
Unrealized loss on forward-exchange contracts, net of tax												(150		)	(150		)
Total comprehensive income															120,854
Repurchase of common stock	(10,303	)	(10		)	(93,499		)	(97,396		)				(190,905		)
Common stock issued under stock plans, net of shares withheld for employee taxes	3,295		3			(29,475		)							(29,472		)
Stock based compensation						90,440									90,440
Tax shortfall on settlement of equity instruments						(15,748		)							(15,748		)
Derivative settlement, net of tax						3,512									3,512
Modification of equity instruments to liability						(1,205		)							(1,205		)
Common stock issued under Employee Stock Purchase Plan	1,837		2			24,770									24,772
Dividends paid									(243,755		)				(243,755		)
Balance, June 26, 2010	300,848		$	301		$	—		$	2,364,598		$	(11,941	)	$	2,352,958
Components of comprehensive income:
Net income									489,009						489,009
Unrealized actuarial loss on post-retirement benefits, net of tax												(289		)	(289		)
Tax effect of the unrealized exchange gain on long-term intercompany receivable												(2,369		)	(2,369		)
Unrealized loss on available-for-sale investments, net of tax												331			331
Total comprehensive income															486,682
Repurchase of common stock	(10,880	)	(11		)	(151,329		)	(79,672		)				(231,012		)
Common stock issued under stock plans, net of shares withheld for employee taxes	2,660		3			(28,839		)							(28,836		)
Stock Options Exercised	1,461		1			24,829									24,830
Stock based compensation						93,623									93,623
Tax benefit on settlement of equity instruments						30,546									30,546
Modification of liability instruments to equity						2,350									2,350
Common stock issued under Employee Stock Purchase Plan	1,691		2			28,820									28,822
Dividends paid									(249,145		)				(249,145		)
Balance, June 25, 2011	295,780		$	296		$	—		$	2,524,790		$	(14,268	)	$	2,510,818

See accompanying Notes to Consolidated Financial Statements.

40

MAXIM INTEGRATED PRODUCTS, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

	For the Years Ended
	June 25, 2011			June 26, 2010			June 27, 2009
Cash flows from operating activities:
Net income	$	489,009		$	125,139		$	10,455
Adjustments to reconcile net income to net cash provided by operating activities:
Stock-based compensation	94,297			93,525			196,108
Depreciation and amortization	205,062			167,523			205,423
Deferred taxes	140,084			29,090			202,352
In process research & development	—			—			3,900
Loss from sale of property, plant and equipment	12,946			272			2,695
Loss (gain) from sale of equity investments	—			148			(529		)
Tax benefit (shortfall) related to stock-based compensation	30,546			(15,748		)	(216,835		)
Excess tax benefit related to stock-based compensation	(12,869		)	(7,005		)	(670		)
Impairment of long lived assets	—			8,291			51,112
Changes in assets and liabilities:
Accounts receivable	43,256			(124,258		)	65,288
Inventories	(29,435		)	22,681			49,124
Other current assets	53,255			(79,319		)	3,226
Accounts payable	(4,746		)	41,191			(5,988		)
Income taxes payable	(45,318		)	17,384			15,545
Deferred income on shipments to distributors	11,102			9,020			(4,687		)
Accrued liabilities- tender offer payments above settlement date fair value	—			—			(8,665		)
Accrued liabilities - goodwill payments above settlement date fair value	(164		)	(1,328		)	(32,016		)
Accrued liabilities - litigation settlement	(173,000		)	173,000			—
All other accrued liabilities	47,429			31,347			(90,043		)
Net cash provided by operating activities	861,454			490,953			445,795
Cash flows from investing activities:
Purchases of property, plant and equipment	(175,253		)	(123,901		)	(135,429		)
Proceeds from sale of property, plant, and equipment	27,624			2,802			947
Acquisitions	(80,918		)	(316,784		)	(61,010		)
Other non-current assets	—			(3,998		)	873
Purchases of available-for-sale securities	(49,787		)	—			(5,524		)
Proceeds from sales/maturities of available-for-sale securities	—			200,233			8,426
Net cash used in investing activities	(278,334		)	(241,648		)	(191,717		)
Cash flows from financing activities
Excess tax benefit from stock-based compensation plans	12,869			7,005			670
Mortgage liability	(3,237		)	(40		)	(40		)
Equity settlements and payouts under the RSU loan program	26			(784		)	(50,432		)
Proceeds from derivative litigation settlement	—			2,460			—
Repayment of notes payable	(1,422		)	—			(3,827		)
Long-term debt, net of issuance costs	—			298,578			—
Issuance of common stock	24,830			(4,700		)	(20,587		)
Repurchase of common stock	(231,012		)	(190,905		)	(235,132		)
Dividends paid	(249,145		)	(243,755		)	(248,501		)
Net cash used in financing activities	(447,091		)	(132,141		)	(557,849		)
Net increase (decrease) in cash and cash equivalents	136,029			117,164			(303,771		)
Cash and cash equivalents:
Beginning of year	826,512			709,348			1,013,119
End of year	$	962,541		$	826,512		$	709,348
Supplemental disclosures of cash flow information:
Cash (refunded) paid, net during the year for income taxes	$	(15,529	)	$	217,140		$	21,650
Cash paid for interest	10,264			—			—
Noncash financing and investing activities:
Accounts payable related to property, plant and equipment purchases	$	22,841		$	6,894		$	15,712

See accompanying Notes to Consolidated Financial Statements.

41

MAXIM INTEGRATED PRODUCTS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

NOTE 1: NATURE OF OPERATIONS

Maxim Integrated Products, Inc. ("Maxim," the "Company," "we," "us" or "our"), incorporated in Delaware, designs, develops, manufactures, and markets a broad range of linear and mixed-signal integrated circuits, commonly referred to as analog circuits, for a large number of customers in diverse geographical locations. The Company also provides a range of high-frequency process technologies and capabilities for use in custom designs. The analog market is fragmented and characterized by diverse applications, a great number of product variations and, with respect to many circuit types, relatively long product life cycles. Maxim is a global company with manufacturing facilities in the United States, testing facilities in the Philippines and Thailand, and sales and circuit design offices throughout the world. Integrated circuit assembly is performed by foreign assembly subcontractors, located in the Philippines, Malaysia, Thailand, China, Taiwan, Singapore, Indonesia, South Korea and Japan, where wafers are separated into individual integrated circuits and assembled into a variety of packages. The major end-markets the Company's products are sold in are the communications, computing, consumer and industrial markets.

NOTE 2: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Fiscal Year

The Company has a 52-to-53-week fiscal year that ends on the last Saturday of June. Accordingly, every fifth or sixth year will be a 53-week fiscal year. Fiscal years 2011, 2010 and 2009 were 52-week fiscal years. Fiscal year 2012 will be a 53-week fiscal year.

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Such estimates relate to the useful lives and fair value of fixed assets, valuation allowance for deferred tax assets, reserves relating to uncertain tax positions, allowances for doubtful accounts, customer returns and allowances, inventory valuation, reserves relating to litigation matters, assumptions about the fair value of reporting units, accrued liabilities and reserves and assumptions related to the calculation of stock-based compensation. The Company bases its estimates and judgments on its historical experience, knowledge of current conditions and its beliefs of what could occur in the future, given available information. Actual results may differ from those estimates, and such differences may be material to the financial statements.

Basis of Presentation

The consolidated financial statements include the accounts of the Company and all of its majority-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. The condition for control of entities is the ownership of a majority voting interest and ability to otherwise exercise control over the entity.

Cash Equivalents and Short-term Investments

The Company considers all highly liquid financial instruments purchased with an original maturity of three months or less at the date of purchase to be cash equivalents. Cash and cash equivalents consist of demand accounts and money market funds. Short-term investments consist primarily of U.S. Agency debt securities with original maturities beyond three months at the date of purchase.

The Company's short-term investments are considered available-for-sale. Such securities are carried at fair market value based on market quotes. Unrealized gains and losses, net of tax, on securities in this category are reported as a separate component of stockholders' equity. Realized gains and losses on sales of investment securities are determined based on the specific identification method and are included in "Interest (expense) income and other, net" in the Consolidated Statements of Income.

Derivative Instruments

The Company generates revenues in various global markets based on orders obtained in non-U.S. currencies, primarily the Japanese Yen, the British Pound and the Euro. Maxim incurs expenditures denominated in non-US currencies, principally Philippine Pesos and Thailand Baht associated with the Company's manufacturing activities in the Philippines and Thailand, respectively. Maxim

42

MAXIM INTEGRATED PRODUCTS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

is exposed to fluctuations in foreign currency exchange rates primarily on orders and accounts receivable from sales in these foreign currencies and cash flows for expenditures in these foreign currencies. Maxim has established risk management strategies designed to reduce the impact of volatility of future cash flows caused by changes in the exchange rates for these currencies. These strategies reduce, but do not entirely eliminate, the impact of currency exchange rates movements.

Currency forward contracts are used to offset the currency risk of non-U.S. dollar-denominated assets and liabilities. The Company typically enters into currency forward contracts quarterly to hedge exposures associated with its expenditures denominated in Philippine Pesos and Thailand Baht. The Company enters into contracts each quarter for its accounts receivable and backlog denominated in Japanese Yen, British Pound and Euro. Changes in fair value of the underlying assets and liabilities are generally offset by the changes in fair value of the related currency forward contract.

The Company uses currency forward contracts to hedge exposure to variability in anticipated non-U.S. dollar denominated cash flows. These contracts are designated as cash flow hedges and recorded on the Consolidated Balance Sheets at their fair market value. The maturities of these instruments are generally less than 6 months. For derivative instruments that are designated and qualify as cash flow hedges, the effective portion of the gain or loss on the derivative is reported as a component of accumulated other comprehensive income (loss) and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings.  For derivative instruments that are not designated as hedging instruments gains and losses are recognized in "interest (expense) income and other, net" in the Consolidated Statements of Income.

Fair Value of Financial Instruments

Maxim measures certain financial assets and liabilities at fair value based on the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants. See Note 5 for a further discussion on fair value of financial instruments.

Inventories

Inventories are stated at the lower of (i) standard cost, which approximates actual cost on a first-in-first-out basis, or (ii) market value. Because of the cyclical nature of the market, inventory levels, obsolescence of technology, and product life cycles, the Company generally writes down inventories to net realizable value based on 12 months forecasted product demand.

Property, Plant and Equipment

Property, plant and equipment are stated at cost. Depreciation is primarily computed on the straight-line method over the estimated useful lives of the assets, which range from 2 to 15 years for machinery and equipment and up to 40 years for buildings and building improvements. Leasehold improvements are amortized over the lesser of their useful lives or the remaining term of the related lease. When assets are retired or otherwise disposed of, the cost and accumulated depreciation or amortization is removed from the accounts and any resulting gain or loss is reflected in operating expense in the Consolidated Statements of Income in the period recognized.

The Company evaluates the recoverability of property, plant and equipment in accordance with Accounting Standards Codification ("ASC") No. 360, Accounting for the Property, Plant, and Equipment. ("ASC No. 360"). The Company performs periodic reviews to determine whether facts and circumstances exist that would indicate that the carrying amounts of property, plant and equipment exceeds their fair values. If facts and circumstances indicate that the carrying amount of property, plant and equipment might not be fully recoverable, projected undiscounted net cash flows associated with the related asset or group of assets over their estimated remaining useful lives are compared against their respective carrying amounts. In the event that the projected undiscounted cash flows are not sufficient to recover the carrying value of the assets, the assets are written down to their estimated fair values. All long-lived assets to be disposed of are reported at the lower of carrying amount or fair market value, less expected selling costs.

Intangible Assets and Goodwill

The Company accounts for intangible assets in accordance with ASC No. 360. The Company reviews goodwill and purchased intangible assets with indefinite lives for impairment annually and whenever events or changes in circumstances indicate the carrying value of an asset may not be recoverable, such as when reductions in demand or significant economic slowdowns in the semiconductor industry are present. Reviews are performed to determine whether the carrying value of an asset is impaired, based on comparisons to undiscounted expected future cash flows. If this comparison indicates that there is impairment, the impaired asset is written down to fair value, which is typically calculated using: (i) quoted market prices or (ii) discounted expected future cash flows utilizing a discount rate consistent with the guidance provided in FASB Concepts Statement No. 7, Using Cash Flow

43

MAXIM INTEGRATED PRODUCTS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Information and Present Value in Accounting Measurements. Impairment is based on the excess of the carrying amount over the fair value of those assets.

Goodwill is recorded as the difference, if any, between the aggregate consideration paid for an acquisition and the fair value of the net tangible and intangible assets acquired. In accordance with ASC No. 350, Intangibles-Goodwill and Other, ("ASC 350"), the Company tests goodwill for impairment at the reporting unit level (operating segment or one level below an operating segment) on an annual basis in the first quarter or more frequently if the Company believes indicators of impairment exist. The performance of the test involves a two-step process. The first step of the impairment test involves comparing the fair values of the applicable reporting units with their aggregate carrying values, including goodwill. The Company generally determines the fair value of the Company's reporting units using the income approach methodology of valuation that includes the discounted cash flow method as well as other generally accepted valuation methodologies. If the carrying amount of a reporting unit exceeds the reporting unit's fair value, the Company performs the second step of the goodwill impairment test to determine the amount of impairment loss. The second step of the goodwill impairment test involves comparing the implied fair value of the affected reporting unit's goodwill with the carrying value of that goodwill. No impairment charges were recorded associated with our goodwill and intangible assets during fiscal years 2011, 2010, and 2009, respectively.

Product Warranty

The Company warrants its products to its customers generally for one year from the date of shipment, but in certain cases for longer periods. In certain other cases, the Company's product warranty may include significant financial responsibility beyond the cost of replacing the product. If there is a material increase in the rate of customer claims or the Company's estimates of probable losses relating to specifically identified warranty exposures are inaccurate, the Company may record a charge against future cost of sales. Warranty expense has historically been immaterial to the Company's financial statements.

Self-Insurance Accruals

The Company is self-insured with respect to defective product claims, employment practice claims, property and casualty and general liability. The Company's workers' compensation insurance has a $1.0 million deductible per case. Accruals are primarily based on the estimated, undiscounted cost of claims, which includes incurred-but-not-reported claims. Amounts accrued for defective product claims, employment practice claims, workers' compensation claims, property and casualty and general liability of $4.7 million and $4.4 million are included in accrued expenses as of June 25, 2011 and June 26, 2010, respectively.

In addition to the above, the Company is primarily self-insured with respect to healthcare benefits for most of its domestic employees. Accruals are primarily based on estimated incurred-but-not-reported claims. Amounts accrued for employee healthcare claims of $5.9 million and $5.6 million are included in accrued salary and related expenses as of June 25, 2011 and June 26, 2010, respectively.

Retirement Benefits

The Company periodically provides medical benefits to former employees pursuant to retirement agreements and other post-employment arrangements. The Company accounts for medical benefits to individuals pursuant to a documented plan under ASC No. 715, Compensation- Retirement Benefits, while one-off employment arrangements are treated as post-employment benefits recognized when the liability is incurred and the amount is estimable under ASC No. 712, Compensation-Nonretirement Postemployment Benefits, an amendment of ASC No. 715 ("ASC 712").

Income Taxes

The Company accounts for income taxes using an asset and liability approach as prescribed in ASC 740, Income Taxes.  The Company records the amount of taxes payable or refundable for the current and prior years and deferred tax assets and liabilities for the future tax consequences of events that have been recognized in the Company's financial statements or tax returns.  A valuation allowance is recorded to reduce deferred tax assets when it is more likely than not that a tax benefit will not be realized.

ASC 740-10 prescribes a recognition threshold and measurement framework for the financial statement reporting and disclosure of an income tax position taken or expected to be taken on a tax return. Under ASC 740-10, a tax position is recognized in the financial statements when it is more-likely-than-not, based on the technical merits, that the position will be sustained upon examination, including resolution of any related appeals or litigation processes. A tax position that meets the recognition threshold is then measured to determine the largest amount of the benefit that has a greater than 50% likelihood of being realized upon settlement.

44

MAXIM INTEGRATED PRODUCTS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

The calculation of tax liabilities involves significant judgment in estimating the impact of uncertainties in the application of complex tax laws across multiple tax jurisdictions. Although ASC 740-10 provides clarification on the accounting for uncertainty in income taxes recognized in the financial statements, the threshold and measurement attributes will continue to require significant judgment by management. Resolution of these uncertainties in a manner inconsistent with the Company's expectations could have a material impact on the Company's results of operations.

Revenue Recognition

The Company recognizes revenue for sales to direct customers and sales to distributors upon shipment, provided that persuasive evidence of a sales arrangement exists, the price is fixed or determinable, title and risk of loss has transferred, collectability of the resulting receivable is reasonably assured, there are no customer acceptance requirements and we do not have any significant post-shipment obligations. The Company estimates returns for sales to direct customers and international distributors based on historical returns rates applied against current period gross revenues. Specific customer returns and allowances are considered within this estimate.

Sales to certain distributors are made pursuant to agreements allowing for the possibility of certain sales price rebates and for non-warranty product return privileges. The non-warranty product return privileges include allowing certain U.S. distributors to return a small portion of our products in their inventory based on their previous 90 days of purchases. Given the uncertainties associated with the levels of non-warranty product returns and sales price rebates that could be issued to U.S. distributors, the Company defers recognition of such revenue and related cost of goods sold until the product is sold by the U.S. distributors to their end-customers. Accounts receivable from direct customers, domestic distributors and international distributors are recognized and inventory is relieved upon shipment as title to inventories generally transfers upon shipment at which point the Company has a legally enforceable right to collection under normal terms. Accounts receivable related to consigned inventory is recognized when the customer takes title of such inventory from its consigned location at which point inventory is relieved, title transfers, and the Company has a legally enforceable right to collection under the terms of our agreement with the related customers.

The Company estimates potential future returns and sales allowances related to current period product revenue.  Management analyzes historical returns, changes in customer demand and acceptance of products when evaluating the adequacy of returns and sales allowances.  Estimates made by the Company may differ from actual returns and sales allowances.  These differences may materially impact reported revenue and amounts ultimately collected on accounts receivable. Historically, such differences have not been material. At June 25, 2011 and June 26, 2010, the Company had $16.0 million and $15.0 million reserved for returns and allowances against accounts receivable, respectively. During fiscal years 2011 and 2010, the Company recorded $74.5 million and $67.5 million for estimated returns and allowances against revenues, respectively. These amounts were offset by $73.5 million and $62.8 million actual returns and allowances given during fiscal years 2011 and 2010, respectively.

Research and Development Costs

Research and development costs are expensed as incurred. Such costs consist primarily of expenditures for labor and benefits, masks, prototype wafers and depreciation.

Advertising

Advertising costs are expensed as incurred and included in selling, general and administrative expenses in the Consolidated Statements of Income. Advertising expenses were immaterial in fiscal years 2011, 2010, and 2009, respectively.

Shipping Costs

Shipping costs billed to customers are included in net revenues and the related shipping costs are included in cost of goods sold.

Stock-Based Compensation

Stock-based compensation cost is measured at the grant date, based on the fair value of the awards ultimately expected to vest and is recognized as an expense, on a straight-line basis, over the requisite service period. The Company uses the Black-Scholes valuation model to measure the fair value of its stock-based awards utilizing various inputs with respect to expected holding period, risk-free interest rates, stock price volatility and dividend yield.

ASC 718 also requires forfeitures to be estimated at the time of grant and revised if necessary in subsequent periods if actual

45

MAXIM INTEGRATED PRODUCTS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

forfeitures or vesting differ from those estimates. Such revisions could have a material effect on the Company's operating results. The assumptions the Company uses in the valuation model are based on subjective future expectations combined with management judgment. If any of the assumptions used in the Black-Scholes model changes, stock-based compensation for future awards may differ materially compared to the awards granted previously.

Restructuring

Post-employment benefits accrued for workforce reductions related to restructuring activities in the United States are accounted for under ASC 712. A liability for post-employment benefits is recorded when payment is probable, the amount is reasonably estimable, and the obligation relates to rights that have vested or accumulated. In accordance with ASC No. 420, Exit or Disposal Cost Obligations ("ASC 420"), generally costs associated with restructuring activities initiated outside the United States have been recognized when they are incurred.

The Company continually evaluates the adequacy of the remaining liabilities under its restructuring initiatives. Although the Company believes that these estimates accurately reflect the costs of its restructuring plans, actual results may differ, thereby requiring the Company to record additional provisions or reverse a portion of such provisions.

Foreign Currency Translation and Remeasurement

The U.S. dollar is the functional currency for the Company's foreign operations. Using the U.S. dollar as the functional currency, monetary assets and liabilities are remeasured at the year-end exchange rates. Certain non-monetary assets and liabilities are remeasured using historical rates. Statements of Income are remeasured at the average exchange rates during the year.

Earnings Per Share

Basic earnings per share are computed using the weighted average number of common shares outstanding during the period. Diluted earnings per share incorporate the potentially dilutive incremental shares issuable upon the assumed exercise of stock options, the assumed vesting of outstanding restricted stock units, and the assumed issuance of common stock under the stock purchase plan. The number of incremental shares from the assumed issuance of stock options is calculated by applying the treasury stock method. See Note 7 "Earnings Per Share" of these Notes to the Consolidated Financial Statements.

Litigation and Contingencies

From time to time, the Company receives notices that its products or manufacturing processes may be infringing the patent or intellectual property rights of others, notices of stockholder litigation or other lawsuits or claims against the Company. The Company periodically assesses each matter in order to determine if a contingent liability in accordance with ASC 450, should be recorded. In making this determination, management may, depending on the nature of the matter, consult with internal and external legal counsel and technical experts. The Company expenses legal fees associated with consultations and defense of lawsuits as incurred. Based on the information obtained combined with management's judgment regarding all the facts and circumstances of each matter, the Company determines whether a contingent loss is probable and whether the amount of such loss can be estimated. Should a loss be probable and estimable, the Company records a contingent loss in accordance with ASC 450. In determining the amount of a contingent loss, the Company takes into consideration advice received from experts in the specific matter, current status of legal proceedings, settlement negotiations which may be ongoing, prior case history and other factors. Should the judgments and estimates made by management be incorrect, the Company may need to record additional contingent losses that could materially adversely impact its results of operations. Alternatively, if the judgments and estimates made by management are incorrect and a particular contingent loss does not occur, the contingent loss recorded would be reversed thereby favorably impacting the Company's results of operations.

Pursuant to the Company's charter documents and indemnification agreements, the Company has certain indemnification obligations to its officers and directors, and certain former officers and directors. More specifically, the Company has separate written indemnification agreements with its current and former executive officers and directors. Pursuant to such obligations, the Company has incurred substantial expenses related to legal fees and expenses to certain former officers of the Company subject to civil charges by the SEC in connection with Maxim's historical stock option granting practices. The Company has also incurred substantial expenses related to legal fees and expenses advanced to certain current and former officers and directors who were defendants in the civil actions described above. The Company expenses such amounts as incurred.

46

MAXIM INTEGRATED PRODUCTS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Concentration of Credit Risk

Due to the Company's credit evaluation and collection process, bad debt expenses have not been significant. Credit risk with respect to trade receivables is limited because a large number of geographically diverse customers make up the Company's customer base, thus spreading the credit risk. The company derived approximately 30% of our fiscal 2011 revenue from sales made through distributors. Our primary distributor is Avnet Electronics. Avnet, like our other distributors are not end customers, but rather serve as a channel of sale to many end users of the Company's products. Avnet accounted for 14% and 12% of revenues in fiscal years 2011 and 2010, respectively, and 11% and 10% of accounts receivable in fiscal years 2011 and 2010, respectively. Samsung, our largest single customer, excluding distributors, accounted for approximately 12% and 12% of net revenues in fiscal year 2011 and 2010, respectively, and 18% and 13% of accounts receivable as of June 25, 2011 and June 26, 2010, respectively. No other single customer accounted for more than 10% of revenue or receivables in fiscal years 2011, 2010 and 2009.

The Company maintains cash, cash equivalents, and short-term investments with various high credit quality financial institutions, limits the amount of credit exposure to any one financial institution or instrument, and is exposed to credit risk in the event of default by these institutions to the extent of amounts recorded at the balance sheet date. To date, the Company has not incurred losses related to these investments.

Concentration of Other Risks

The semiconductor industry is characterized by rapid technological change, competitive pricing pressures, and cyclical market patterns. The Company's results of operations are affected by a wide variety of factors, including general economic conditions, both in the United States and abroad; economic conditions specific to the semiconductor industry and to the analog and mixed signal portion of that industry; demand for the Company's products; the timely introduction of new products; implementation of new manufacturing technologies; manufacturing capacity; the ability to manufacture efficiently; the availability of materials, supplies, machinery and equipment; competition; the ability to safeguard patents and intellectual property in a rapidly evolving market; and reliance on assembly and, to a small extent, wafer fabrication subcontractors and on independent distributors and sales representatives. As a result, the Company may experience substantial period-to-period fluctuations in future operating results due to the factors mentioned above or other factors.

Recently Issued Accounting Pronouncements

In June 2011, the FASB issued Accounting Standards Update (“ASU”) relating to Comprehensive Income (Topic 220)-Presentation of Comprehensive Income (ASU 2011-05), to require an entity to present the total of comprehensive income, the components of net income, and the components of other comprehensive income either in a single continuous statement of comprehensive income or in two separate but consecutive statements. The ASU is effective for us in our third quarter of fiscal 2012 and should be applied retrospectively. The Company is currently evaluating the impact of its pending adoption of ASU 2011-05 on its consolidated financial statements.

In May 2011, the FASB issued ASU No. 2011-04, Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and International Financial Reporting Standards (Topic 820)-Fair Value Measurement (ASU 2011-04), to provide a consistent definition of fair value and ensure that the fair value measurement and disclosure requirements are similar between U.S. GAAP and International Financial Reporting Standards. ASU 2011-04 changes certain fair value measurement principles and enhances the disclosure requirements particularly for level 3 fair value measurements. ASU 2011-04 is effective for us in our first quarter of fiscal 2013 and should be applied prospectively. The Company is currently evaluating the impact of its pending adoption of ASU 2011-04 on its consolidated financial statements.

NOTE 3: BALANCE SHEET COMPONENTS

Accounts receivables, net consist of:

	June 25, 2011			June 26, 2010
	(in thousands)
Accounts receivable	$	315,329		$	356,760
Returns and allowances	(17,697		)	(17,438		)
	$	297,632		$	339,322

47

MAXIM INTEGRATED PRODUCTS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

The components of inventories consist of:

	June 25, 2011		June 26, 2010
Inventory:	(In thousands)
Raw materials	$	18,419	$	16,747
Work-in-process	162,245		140,497
Finished goods	57,264		48,796
	$	237,928	$	206,040

Property, plant and equipment, net consist of:

	June 25, 2011			June 26, 2010
Property and equipment:	(In thousands)
Land	$	86,257		$	87,237
Buildings and building improvements	313,642			341,734
Machinery and equipment	1,978,827			1,872,349
	2,378,726			2,301,320
Less accumulated depreciation	(1,069,876		)	(976,884		)
	$	1,308,850		$	1,324,436

The Company recorded $156.3 million, $146.1 million and $191.1 million of depreciation expense in fiscal years 2011, 2010 and 2009, respectively.

NOTE 4: FAIR VALUE MEASUREMENTS

The FASB established a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. This hierarchy requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Three levels of inputs that may be used to measure fair value are:

Level 1 - Quoted (unadjusted) prices in active markets for identical assets or liabilities.

The Company's Level 1 assets consist of certain money market funds.

Level 2 - Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the asset or liability.

The Company's Level 2 assets and liabilities consist of certain money market funds, government agency securities and foreign currency forward contracts.

Level 3 - Unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.

Assets and liabilities measured at fair value on a recurring basis were as follows:

48

MAXIM INTEGRATED PRODUCTS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

	As of June 25, 2011								As of June 26, 2010
	Fair Value								Fair Value
	Measurements Using						Total		Measurements Using						Total
	Level 1		Level 2		Level 3		Balance		Level 1		Level 2		Level 3		Balance
	(in thousands)
Assets
Money market funds (1)	$	603,180	$	3,457	$	—	$	606,637	$	634,358	$	2,997	$	—	$	637,355
Government agency securities (2)	—		50,346		—		50,346		—		—		—		—
Foreign currency forward contracts	—		326		—		326		—		18		—		18
Total Assets	$	603,180	$	54,129	$	—	$	657,309	$	634,358	$	3,015	$	—	$	637,373
Liabilities
Foreign currency forward contracts	$	—	$	309	$	—	$	309	$	—	$	851	$	—	$	851
Total Liabilities	$	—	$	309	$	—	$	309	$	—	$	851	$	—	$	851

(1) Included in Cash and cash equivalents in the accompanying Consolidated Balance Sheets.

(2) Included in Short-term investments in the accompanying Consolidated Balance Sheets.

As of June 25, 2011 and June 26, 2010, none of the company's assets and liabilities were measured at fair value on a non-recurring basis.

NOTE 5: Financial Instruments

Short-term investments

Fair value as of June 25, 2011 were as follows:

	June 25, 2011
	Amortized Cost		Gross Unrealized Gain		Gross Unrealized Loss		Estimated Fair Value
	(in thousands)
Available‑for‑sale investments
Government agency securities	$	49,826	$	520	$	—	$	50,346
Total available‑for‑sale investments	$	49,826	$	520	$	—	$	50,346

Short-term investments as of June 26, 2010 ; none held.

Maxim did not recognize any impairment charges on such investments in fiscal years 2011, 2010 and 2009.

Contractual maturities of investments in available-for-sale debt securities at June 25, 2011 were as follows:

	June 25, 2011
	Amortized Cost		Estimated Fair Value
	(in thousands)
Due February 26, 2013	$	49,826	$	50,346
	$	49,826	$	50,346

The Company's interest (expense) income and other, net of $(11.4) million, $8.0 million and $17.2 million in fiscal years 2011, 2010 and 2009, respectively, include interest income and amortization and accretion of discounts and premiums, as well as realized gains and losses.

49

MAXIM INTEGRATED PRODUCTS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Gross gains and losses realized upon the sale of marketable securities were immaterial during fiscal years 2011, 2010 and 2009.

Derivative instruments and hedging activities

Foreign Currency Risk

The Company generates revenues in various global markets based on orders obtained in non-U.S. currencies, primarily the Japanese Yen, the Euro and the British Pound. Maxim incurs expenditures denominated in non-US currencies, principally Philippine Pesos and Thailand Baht associated with the Company's manufacturing activities in the Philippines and Thailand, respectively, and expenditures for sales offices and research and development activities undertaken outside of the U.S. Maxim is exposed to fluctuations in foreign currency exchange rates primarily on orders and accounts receivable from sales in these foreign currencies and cash flows for expenditures in these foreign currencies. Maxim has established risk management strategies designed to reduce the impact of volatility of future cash flows caused by changes in the exchange rates for these currencies. These strategies reduce, but do not entirely eliminate, the impact of currency exchange rates movements. Maxim does not use derivative financial instruments for speculative or trading purposes. The Company routinely hedges its exposures to certain foreign currencies with various financial institutions in an effort to minimize the impact of certain currency exchange rate fluctuations. If a financial counter party to any of the Company's hedging arrangements experiences financial difficulties or is otherwise unable to honor the terms of the foreign currency hedge, the Company may experience financial losses.

For derivative instruments that are designated and qualify as cash flow hedges under ASC No. 815- Derivatives and hedging, the effective portion of the gain or loss on the derivative is reported as a component of accumulated other comprehensive income (loss) and reclassified into earnings into the same financial statement line as the item being hedged, and in the same period or periods during which the hedged transaction affects earnings. Gains and losses on the derivative representing either hedge ineffectiveness or hedge components excluded from the assessment of effectiveness are recognized in interest and other (expense) income, net.

For derivative instruments that are not designated as hedging instruments under ASC No. 815, gains and losses are recognized in interest and other (expense) income, net. All derivatives are foreign currency forward contracts to hedge certain foreign currency denominated assets or liabilities. The gains and losses on these derivatives largely offset the changes in the fair value of the assets or liabilities being hedged.

Fair Value of Derivative Instruments in the Consolidated Balance Sheets

Maxim estimates the fair value of derivatives primarily based on pricing models using current market rates and records all derivatives on the balance sheet at fair value. The gross notional and fair value of derivative financial instruments in the Consolidated Balance Sheets were recorded as follows:

	As of June 25, 2011						As of June 26, 2010
	Gross Notional (1)		Other Current Assets		Accrued Expenses		Gross Notional (1)		Other Current Assets		Accrued Expenses
	(in thousands)
Derivatives designated as hedging instruments
Cash flow hedges:
Foreign exchange contracts	$	35,629	$	53	$	287	$	20,085	$	2	$	237
Derivatives not designated as hedging instruments
Foreign exchange contracts	26,342		273		22		32,281		16		614
Total derivatives	$	61,971	$	326	$	309	$	52,366	$	18	$	851

(1) Represents the face amounts of contracts that were outstanding as of June 25, 2011 and June 26, 2010, respectively.

50

MAXIM INTEGRATED PRODUCTS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Derivatives designated as hedging instruments

The following table provides the balances and changes in the accumulated other comprehensive income (loss) related to derivative instruments during the years ended June 25, 2011 and June 26, 2010.

	June 25, 2011			June 26, 2010
	(in thousands)
Beginning balance	$	(235	)	$	—
Loss reclassified to income	514			—
Amount recorded in other comprehensive loss	(513		)	(235		)
Ending balance	$	(234	)	$	(235	)

Maxim expects to reclassify an estimated net accumulated other comprehensive loss of $0.2 million, net of taxes, to earnings in the next twelve months along with the earnings effects of the related forecasted transactions in association with cash flow hedges.

The before-tax effect of cash flow derivative instruments for the years ended June 25, 2011 and June 26, 2010 was as follows:

	Gain (Loss) Reclassified from Accumulated OCI into Income (Effective portion)
		Year Ended
	Location	June 25, 2011			June 26, 2010
		(in thousands)
Cash Flow hedges:
Foreign exchange contracts	Net Revenues	$	(1,152	)	$	—
Foreign exchange contracts	Cost of goods sold	638			—
Total cash flow hedges		$	(514	)	$	—

The before-tax effect of cash flow derivative instruments not designated as hedging instruments on the Consolidated Statements of Income for the year ended June 25, 2011 and June 26, 2010 was as follows:

	Gain ( Loss) Recognized in Income on Derivative Instrument
		Years Ended
	Location	June 25, 2011			June 26, 2010
		(in thousands)
Foreign exchange contracts	Interest and other (expense) income, net	$	(1,893	)	$	1,444
Total		$	(1,893	)	$	1,444

Volume of Derivative Activity

Total net U.S. Dollar notional amounts for foreign currency forward contracts, presented by net currency purchase (sell), are as follows:

51

MAXIM INTEGRATED PRODUCTS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

In United States Dollars	June 25, 2011			June 26, 2010
	(in thousands)
Euro	$	1,542		$	(17,874	)
Japanese Yen	(5,156		)	(17,923		)
British Pound	(10,928		)	(3,512		)
Philippine Peso	17,140			6,576
Thai Bhat	3,523			2,327
Total	$	6,121		$	(30,406	)

Long- term debt

On June 17, 2010, the Company completed a public offering of $300 million aggregate principal amount of the Company's 3.45% senior unsecured and unsubordinated notes (the "Notes") due on June 14, 2013, with an effective interest rate of 3.49%. Interest on the Notes is payable semi-annually in arrears on June 14 and December 14 of each year, commencing December 14, 2010. The Notes are governed by a base and supplemental indenture dated June 10, 2010 and June 17, 2010, respectively, between the Company and Wells Fargo Bank, National Association, as trustee. The Company accounts for the Notes based on their amortized cost. The discount and expenses are being amortized to Interest and other (expense) income, net over the life of the Notes. Interest expenses associated with the Notes was $10.4 million and $0.3 million in fiscal years 2011 and 2010 , respectively, and is recorded in Interest (expense) income and other, net in the Consolidated Statements of Income.

The estimated fair value of Maxim's long-term debt was approximately $311 million at June 25, 2011. The estimated fair value of the debt is based primarily on quoted market prices observed for comparable notes that were recently traded as of the Balance sheet date.

As of June 25, 2011, Maxim had the capacity to issue an unspecified amount of additional debt securities, common stock, preferred stock, warrants, rights and units under the 2010 Shelf Registration Statement.

Other Financial Instruments

For the balance of Maxim's financial instruments, cash equivalents, accounts receivable, accounts payable and other accrued liabilities, the carrying amounts approximate fair value due to their short maturities.

NOTE 6: STOCK-BASED COMPENSATION

At June 25, 2011, the Company had five stock option plans and one employee stock purchase plan, including the Company's 1996 Stock Incentive Plan (the "1996 Plan"), 1993 Officer and Director Stock Option Plan, 1987 Stock Option Plan, 1987 Supplemental Stock Option Plan, Supplemental Non-employee Stock Option Plan and 2008 Employee Stock Purchase Plan ("2008 ESPP").

The following tables present stock-based compensation expense by type of award and resulting tax effect included in the Consolidated Statements of Income for fiscal year 2011, 2010, and 2009:

52

MAXIM INTEGRATED PRODUCTS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

	For the Year Ended
	June 25, 2011		June 26, 2010		June 27, 2009
	(in thousands)
Cost of goods sold
Stock options	$	2,625	$	3,330	$	33,380
Restricted stock units	9,820		10,825		23,350
Employee stock purchase plan	1,556		1,065		370
	14,001		15,220		57,100
Research and development expense
Stock options	11,325		15,085		38,237
Restricted stock units	36,925		33,834		61,151
Employee stock purchase plan	5,436		5,146		1,442
	53,686		54,065		100,830
Selling, general and administrative expense
Stock options	6,120		8,130		21,390
Restricted stock units	18,944		15,056		16,665
Employee stock purchase plan	1,546		1,054		123
	26,610		24,240		38,178
Total stock-based compensation expense
Stock options	20,070		26,545		93,007
Restricted stock units	65,689		59,715		101,166
Employee stock purchase plan	8,538		7,265		1,935
Pre-tax stock-based compensation expense	94,297		93,525		196,108
Less: Income tax effect	25,457		25,041		67,430
Net stock-based compensation expense	$	68,840	$	68,484	$	128,678

Modifications and Settlements

Tender Offer

In November 2008, the Company offered to purchase from employees up to 52.8 million shares underlying certain outstanding stock options for cash payments for the total potential cash consideration of $22.4 million. The amount of the cash payment was determined based on the Black-Scholes value of the eligible options utilizing the average stock price over the 20 trading days period preceding the date of the offer.

In December 2008, upon the closing of the offer, a total of 31.9 million shares underlying the eligible options had been tendered requiring the Company to remit an aggregate payment totaling $13.6 million. The Company accounted for the offer as a settlement under ASC Topic-718 Stock Based Compensation ("ASC 718"), which resulted in the recognition of $75.9 million in stock-based compensation expenses consisting of $8.7 million inadditional expense from settlements above fair value and $67.2 million associated with the unamortized compensation expense on the previously unvested tendered options. Settlement of the tendered options reduced deferred tax assets by $129.4 million, generated a tax benefit of $4.7 million, and resulted in a $124.7 million charge to additional paid in capital for the difference between the deferred tax assets and tax benefits associated with the tendered options.

The $75.9 million expense recognized in connection with the tender offer in the second quarter of fiscal year 2009 included the final true-up for $31.9 million tendered options, therefore, the Company also recorded in the same period a reversal of stock based compensation of $52.2 million related to the true-up for previously forfeited options.

53

MAXIM INTEGRATED PRODUCTS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Officer Option Repurchase

In December 2008, the Company repurchased 6.2 million outstanding stock options from officers for $1.8 million payable in installments over the greater of two years or the remaining vesting period associated with the options prior to their repurchase. The Company accounted for the repurchase as a modification under ASC 718 resulting in incremental compensation of $1.1 million which will be recognized over the payment period.

2009 Goodwill Program

In January 2009, the Company approved a program ("Goodwill Program") wherein non-officer employees holding options that were outstanding as of November 1, 2008 and which reached or will reach their contractual 10-year expiration term between November 2008 and December 2009 would be eligible for a payment in the form of cash or restricted stock units ("RSUs"). Payments exceeding $5,000 would be settled in restricted stock units that vest over three quarters and are contingent upon continued employment, while amounts below $5,000 would be settled in cash in a lump sum payment. The program was extended to officers in May 2009 except that payments exceeding $5,000 to officers were settled in restricted stock units vesting over six quarters.

The Company recorded a liability for the options settling in cash under the Goodwill Program. Options associated with payments being made in the form of restricted stock units under the Goodwill Program, which contain market and service conditions, are accounted for under the provisions of ASC 718. The Company recognized $0.2 million, and $5.4 million in stock based compensation expense related to this program during fiscal year 2011 and fiscal year 2010, respectively.

Share-Based Compensation and Other Adjustments resulting from the Blackout Period

On September 8, 2006, the SEC was notified that the Company would delay filing its Annual Report on Form 10K for the fiscal year ended June 24, 2006 as a result of the ongoing investigation into the Company's historical stock option granting practices. As a result of such delay, the Company suspended the issuance of shares upon exercise of stock options, vesting of RSUs and purchases of stock under the 1987 Employee Stock Participation Plan, as amended ("1987 ESPP") until the Company became current with all of its required SEC filings and its registration statements on Form S-8 became effective ("Blackout Period"). The Company instituted multiple programs in an attempt to compensate employees during the Blackout Period, as described below. The Company became current in its SEC filings, and its registration statements on Form S-8 became effective on September 30, 2008.

RSU Loan Program

In October 2006, the Company offered certain domestic employees an opportunity to receive cash in the form of a non-recourse loan ("RSU Loan") for common stock that they would have otherwise been able to receive in settlement for RSUs that vested during the Blackout Period. The program was not offered to executive officers or members of the Company's Board of Directors. Employees accepting the offer were also entitled to additional shares of common stock if the Company's stock price appreciated between the vesting date and the settlement date at the end of the Blackout Period. Employees foregoing the loan received shares of common stock at the conclusion of the Blackout Period. The Company also offered to cash-settle RSUs vesting during the Blackout Period held by foreign employees. The aforementioned loan offers were considered modifications of the RSUs triggering a change in the classification from equity to liability for all eligible awards vesting during the Blackout Period. The Company recorded a reclassification from additional paid-in-capital to accrued salary and related expenses of $19.4 million on the modification date and incremental compensation expense of $2.2 million from the modifications. Vesting of eligible awards and changes in stock price resulted in additional reclassifications from additional paid-in-capital to accrued salary and related expenses and additional compensation expenses in periods in which they occurred. The Company recorded $6.8 million and $50.2 million in stock based compensation expense in fiscal year 2009, and 2008, respectively. During fiscal years 2009 and 2008, the Company made cash payments of $35.6 million and $25.3 million pursuant to the RSU Loan program and $1.9 million and $4.3 million to cash-settle restricted stock units held by employees located outside the United States.

Extension of Options that Would Have Expired after Reaching 10-Year Contractual Term and Cash-Settlements of Expired Options

In September 2006, the Company approved the extension of the terms of vested stock options that would have expired during the Blackout Period as a result of the expiration of the 10-year contractual term. The extension was considered a modification under ASC 718. The incremental compensation expense of the modification was equal to the fair value of the option at the modification date after the extension compared to the fair value of the option prior to modification. The Company recognized additional compensation expense totaling $118.9 million for 8.3 million options in the three months ended September 23, 2006. The stock-based compensation expense adjustment was based on modified vested options held by employees that expired during the period

54

MAXIM INTEGRATED PRODUCTS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

from September 22, 2006 through the end of the Blackout Period.

In September 2007, as a result of changes in NASDAQ regulations, the Company decided to cash-settle substantially all options expiring during the Blackout Period ("goodwill payment") based on the price at which 10% of the daily close prices of the Company's common stock fall above this price for trading days from August 7, 2006 (the date on which the Company initiated a trading suspension on officers and other individuals) through the expiration date of the option. The cash payment is subject to the option holder executing a release of all claims relating to the option. The goodwill payment modification changed the classification of the associated awards from equity to liability instruments. The modification resulted in a reclassification from additional paid-in capital to accrued salary and related expenses of $126.8 million and incremental compensation expenses of $27.5 million. At the end of each period, the Company recognized changes in fair value of the options in its Consolidated Statements of Operations in the period of change until the options were settled.

On September 26, 2008, the Company offered certain employees, including certain officers of the Company, holding vested stock options that expired due to reaching their maximum 10-year terms in October 2008, certain cash goodwill payments contingent upon employee acceptance and signing of a release of claims related to the option. The Company cash-settled options to purchase 1.1 million option shares that expired in October 2008, with employees that accepted the offer. The cash-settlement resulted in a reduction of additional paid-in-capital of $0.3 million for the fair value of the underlying options on the settlement dates and incremental compensation expense of $4.3 million during the year ended June 26, 2010.

Fair Value

The fair value of share-based awards granted to employees under the Company's 1996 Plan and 2008 ESPP is estimated on the date of grant using the Black-Scholes option valuation model. Expected volatilities are based on the implied volatilities from traded options of the Company's common stock before the Company's common stock was delisted from NASDAQ on October 2, 2007. Subsequent to the Company's delisting, the Company began analyzing its expected volatilities based on historical volatilities from its traded common stock over a period equal to the expected term. The Company analyzed historical exercise patterns of relatively homogeneous groups of employees to estimate the expected holding period for options granted through December 29, 2008. Subsequent to the end of the second quarter of 2009, the Company began utilizing the simplified method under ASC-718, to estimate expected holding periods. This change was attributable to the significant impact resulting from the completion of the tender offer and the Company reducing the contractual term associated with new option grants from ten years to seven years. The risk-free interest rate is based on the U.S. Treasury yield. The Company determines the dividend yield by dividing the annualized dividends per share by the prior quarter's average stock price. The result is analyzed by the Company to decide whether it represents expected future dividend yield. As required by ASC 718, the Company also estimates forfeitures at the time of grant and makes revisions if the estimates change or the actual forfeitures differ from those estimates.

The fair value of each award granted in fiscal years 2011, 2010 and 2009 has been estimated at the date of grant using the Black-Scholes option valuation model and the following weighted-average assumptions:

	Stock Option Plan For the Year Ended
	June 25, 2011		June 26, 2010		June 27, 2009
Expected holding period (in years)	5.2		5.2		6.3
Risk-free interest rate	1.7	%	2.3	%	3.0	%
Expected stock price volatility	37.1	%	38.0	%	39.0	%
Dividend yield	4.2	%	4.5	%	4.1	%
	ESP Plan For the Year Ended
	June 25, 2011		June 26, 2010		June 27, 2009
Expected holding period (in years)	0.5		0.7		1.0
Risk-free interest rate	0.1	%	0.3	%	4.0	%
Expected stock price volatility	24.7	%	35.0	%	57.0	%
Dividend yield	3.3	%	4.4	%	6.1	%

The weighted-average fair value of stock options granted was $4.02, $4.23 and $3.61 per share for fiscal years 2011, 2010 and 2009, respectively. The weighted-average fair value of RSUs granted was $16.61, $16.20 and $11.91 per share for fiscal years

55

MAXIM INTEGRATED PRODUCTS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

2011, 2010 and 2009, respectively.

Stock Option Plans

1996 Stock Incentive Plan

The Company's 1996 Plan, which was previously approved by the Company's stockholders, permits the grant of up to 113.1 million shares. The 1996 Plan provides for the grant of stock options, restricted stock units and restricted stock. To date, the Company has only issued stock options and restricted stock units. Under the 1996 Plan, the exercise price for all stock options will not be less than the fair market value of the Company's common stock on the date of grant. Options granted under the 1996 Plan, as well as under the Company's other stock plans described above, generally vest over a period of up to five years and expire from five to ten years from the date of the grant or such shorter term as may be provided in the agreement.

At June 25, 2011, the Company had 15.5 million shares of its common stock available for issuance to employees and other option recipients under its 1996 Stock Incentive Plan, 1993 Officer and Director Stock Option Plan, 1987 Stock Option Plan, 1987 Supplemental Stock Option Plan, and Supplemental Non-employee Stock Option Plan.

The following table summarizes stock options outstanding, exercisable and vested and expected to vest as of June 25, 2011:

	Options			Weighted Average Remaining Contractual Term (In Years)	Aggregate Intrinsic Value (1)
	Number of Shares		Weighted Average Exercise Price
Balance at June 28, 2008	76,906,882		35.59
Options Granted	8,309,163		13.06
Options Exercised	(2,377	)	11.39
Options Cancelled	(55,613,752	)	35.89
Balance at June 27, 2009	29,599,916		28.83
Options Granted	3,671,459		18.08
Options Exercised	(47,327	)	12.86
Options Cancelled	(4,061,541	)	32.38
Balance at June 26, 2010	29,162,507		27.05
Options Granted	3,559,132		17.61
Options Exercised	(1,460,652	)	17.22
Options Cancelled	(2,928,501	)	33.67
Balance at June 25, 2011	28,332,486		25.62	3.7	$	119,500,252
Exercisable at June 25, 2011	16,468,585		$32.33	2.7	$	25,036,590
Vested and expected to vest, June 25, 2011	27,345,574		$25.93	3.7	$	112,428,729

(1) Aggregate intrinsic value represents the difference between the exercise price and the closing price per share of the Company's common stock on June 24, 2011, the last business day preceding the fiscal year end, multiplied by the number of options outstanding, exercisable or vested and expected to vest as of June 25, 2011.

56

MAXIM INTEGRATED PRODUCTS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

The following table summarizes information about stock options that were outstanding and exercisable at June 25, 2011:

	Outstanding Options			Options Exercisable
Range of Exercise Prices	Number Outstanding at June 25, 2011	Weighted Average Remaining Contractual Term (In years)	Weighted Average Exercise Price	Number Exercisable at June 25, 2011	Weighted Average Exercise Price
$12.00 - $18.04	9,496,988	5.03	$14.10	1,731,327	$12.95
$18.11 - $27.45	6,428,859	4.19	20.49	2,603,082	22.40
$28.52 - $43.00	10,614,912	2.52	35.57	10,357,209	35.69
$49.95 - $52.33	1,791,727	1.93	46.12	1,776,967	46.12
	28,332,486			16,468,585

During fiscal year 2011, the Company granted approximately 3.6 million stock options from its 1996 Plan with an estimated total grant date fair value of $14.3 million. The weighted average grant date fair values of stock options granted during fiscal years 2011, 2010 and 2009 were $4.02, $4.23 and $3.61, respectively. The total intrinsic value of options exercised during fiscal year 2011 was $11.8 million and insignificant in fiscal years 2010 and 2009, respectively. The total fair value of options vested during fiscal year 2011 was $23.0 million and insignificant in fiscal years 2010 and 2009, respectively. As of June 25, 2011, there was $33.2 million of total unrecognized compensation costs related to 11.9 million unvested stock options expected to be recognized over a weighted average period of approximately 2.5 years.

Restricted Stock Units

Restricted stock units ("RSUs") generally vest on a quarterly basis over a service period of up to five years from the grant date. The restricted stock units represent a promise by the Company to the employees to issue shares of its common stock in the future, provided the vesting criteria are satisfied. RSUs granted reduce the total number of shares available for issuance under the 1996 Plan by a factor of two. To the extent RSUs are returned back to the 1996 Plan, for example, due to cancellations, such RSUs would increase the number of shares available to grant by a factor of two.

The following table summarizes outstanding and expected to vest RSUs as of June 25, 2011 and their activity during fiscal year 2011, 2010 and 2009:

57

MAXIM INTEGRATED PRODUCTS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

	Number of Shares		Weighted Average Remaining Contractual Term (In Years)	Aggregate Intrinsic Value (1)
Balance at June 28, 2008	10,266,201
Restricted stock units granted	10,738,846
Restricted stock units released	(8,160,302	)
Restricted stock units cancelled	(977,416	)
Balance at June 27, 2009	11,867,329
Restricted stock units granted	4,259,756
Restricted stock units released	(4,813,738	)
Restricted stock units cancelled	(737,930	)
Balance at June 26, 2010	10,575,417
Restricted stock units granted	4,171,372
Restricted stock units released	(3,922,768	)
Restricted stock units cancelled	(823,283	)
Balance at June 25, 2011	10,000,738		2.5	239,894,343
Expected to vest at June 25, 2011	8,897,935		2.4	213,906,362

(1) Aggregate intrinsic value for RSUs represents the closing price per share of the Company's common stock on June 24, 2011, the last business day preceding the fiscal year end, multiplied by the number of RSUs outstanding, or expected to vest as of June 25, 2011.

The Company withheld shares worth $8.9 million related to employee withholding taxes based on the value of the RSUs on their vesting date as determined by the Company's closing stock price during the year ended June 25, 2011. The total payments for the employees' tax obligations to the taxing authorities are reflected as financing activities within the Consolidated Statements of Cash Flows.

The weighted average grant-date fair value of RSUs granted during fiscal years 2011, 2010 and 2009 was $16.61, $16.20 and $11.91, respectively. As of June 25, 2011, there was $122.8 million of unrecognized compensation cost related to 10.0 million unvested RSUs, which is expected to be recognized over a weighted average period of approximately 2.5 years.

2008 Employee Stock Purchase Plan

In December 2008, stockholders of the Company approved the creation of the 2008 Employee Stock Purchase Plan ("2008 ESPP"). Under the 2008 ESPP, the Company has reserved to date 8.0 million shares of its common stock for future issuance. The 2008 ESPP permits two purchases over a twelve month offer period. Pursuant to the terms of the 2008 ESPP, eligible employees may elect withholdings of up to 25% of eligible compensation to purchase shares of common stock at the lower of (i) 85% of the fair market value of the shares on the offer date or (ii) 85% of the fair market value of the shares on the purchase date. The 2008 ESPP does not permit employees to buy more than $25,000 worth of stock annually or 1,600 shares during an offer period.

The Company issued 1.7 million shares of its common stock for total consideration of $29.0 million related to the ESPP plan during the fiscal year ended June 25, 2011. As of June 25, 2011, the Company has remaining 4.0 million shares of its common stock reserved and available for future issuance under the 2008 ESPP.

NOTE 7: EARNINGS PER SHARE

Basic earnings per share are computed using the weighted average number of common shares outstanding during the period. For purposes of computing basic earnings per share, the weighted average number of outstanding shares of common stock excludes unvested RSUs. Diluted earnings per share incorporates the incremental dilutive shares issuable upon the assumed exercise of stock options, assumed release of unvested RSUs and assumed issuance of common stock under the employee stock purchase plans using the treasury stock method. As discussed in Note 6 herein, the Company cash-settled options that expired (reached the

58

MAXIM INTEGRATED PRODUCTS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

ten year contractual term) during the Blackout Period and cash-settled vested RSUs. These options and RSUs are considered liability instruments under ASC 718 and as such are excluded from the diluted earnings per share calculation.

The following table sets forth the computation of basic and diluted earnings per share:

	For the Year Ended
	June 25, 2011		June 26, 2010		June 27, 2009
	(In thousands, except per share data)
Numerator for basic earnings per share and diluted earnings
per share
Net income	$	489,009	$	125,139	$	10,455
Denominator for basic earnings per share	296,755		304,579		310,805
Effect of dilutive securities:
Stock options, RSUs, and ESPP	6,622		5,437		674
Denominator for diluted earnings per share	303,377		310,016		311,479
Earnings per share:
Basic	$	1.65	$	0.41	$	0.03
Diluted	$	1.61	$	0.40	$	0.03

Approximately 14.9 million, 21.1 million, and 29.6 million of the Company's stock awards were excluded from the calculation of diluted earnings per share for fiscal years 2011, 2010, and 2009, respectively. These options were excluded, as they were antidilutive. However, such options could be dilutive in the future.

NOTE 8: GOODWILL AND INTANGIBLE ASSETS

Goodwill

The Company classifies goodwill and acquired intangible assets within other assets in the Consolidated Balance Sheets. The Company's carrying value of goodwill was $265.1 million and $226.2 million at June 25, 2011 and June 26, 2010, respectively.

	Goodwill
Balance at June 26, 2010	$	226,223
Acquisition	42,564
Adjustments	(3,662		)
Balance at June 25, 2011	$	265,125

Intangible Assets

The useful lives of the significant definite lived intangible assets are as follows:

Asset	Life
Intellectual Property	5-10 years
Customer Relationships	5-10 years
Tradename	3 years
Backlog	1 year

59

MAXIM INTEGRATED PRODUCTS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Intangible assets consisted of the following:

	June 25, 2011						June 26, 2010
	Original Cost		Accumulated Amortization		Net		Original Cost		Accumulated Amortization		Net
	(in thousands)
Intellectual property	$	195,912	$	64,996	$	130,916	$	145,262	$	33,305	$	111,957
Customer relationships	88,630		24,915		63,715		87,030		11,745		75,285
Backlog	6,400		5,687		713		4,500		2,350		2,150
Tradename	1,700		981		719		1,400		264		1,136
Total amortizable purchased intangible assets	292,642		96,579		196,063		238,192		47,664		190,528
IPR&D	8,200		—		8,200		4,200		—		4,200
Total purchased intangible assets	$	300,842	$	96,579	$	204,263	$	242,392	$	47,664	$	194,728

The following table presents the amortization expense of intangible assets and its presentation in the Consolidated Statements of Income:

	For the Year Ended
	June 25, 2011		June 26, 2010		June 27, 2009
	(in thousands)
Cost of goods sold	$	30,164	$	10,999	$	8,024
Intangible Asset Amortization	18,752		10,477		6,019
Total Intangible Asset Amortization Expenses	$	48,916	$	21,476	$	14,043

The following table represents the estimated future amortization expense of intangible assets as of the end of fiscal year 2011:
Fiscal Year	Amount
	(in thousands)
2012	$	46,853
2013	42,022
2014	35,439
2015	33,131
2016	21,011
Thereafter	17,607
Total intangible assets	$	196,063

NOTE 9: ACQUISITIONS

Acquisitions in fiscal 2011

The purchase price allocation for acquisitions completed in fiscal year 2011 are set forth in the table below and reflects various preliminary fair value estimates and analysis, including preliminary work performed by third-party valuation specialists, which are subject to change within the measurement period as valuations are finalized.

Pro forma results of operations for these acquisitions have not been presented because they are not material to Maxim's consolidated results of operations, either individually or in the aggregate. Goodwill, which represents the excess of the purchase price over the net tangible and intangible assets acquired, is not deductible for tax purposes.

Aggregate purchase price allocation for Maxim's fiscal 2011 acquisitions:

60

MAXIM INTEGRATED PRODUCTS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

	In millions
Net tangible assets	$	(11.5	)
Amortizable intangible assets	52.6
In-process research and development ("IPR&D")	6.0
Goodwill(1)	42.6
Total purchase price (1)	$	89.7

(1) Includes $8.8 million of contingent consideration relating to the Calvatec acquisition.

CALVATEC

On May 31, 2011, the Company acquired Calvatec Ltd, based in Edinburgh, Scotland. Calvatec is a developer of highly integrated, analog, mixed-signal solutions, as well as design methods and flows for analog system-on-a-chip (SoCs). The total cash consideration associated with the acquisition was $8.2 million. The acquired assets included cash of $0.4 million. Maxim also recorded $8.8 million, representing the fair value of contingent consideration that would be payable in the future should Calvatec meets certain specified project milestones. Total contingent consideration that could be paid out under the agreement amounts to $12.5 million.

PHYWORKS

On September 7, 2010, the Company acquired Phyworks Limited. (“Phyworks”), a developer of high-speed communications integrated circuits. The total cash consideration associated with the acquisition was $76.0 million. The acquired assets included cash of $4.6 million, accounts receivable of $1.2 million, inventories of $2.9 million, $0.1 million in prepaid expenses and other current assets, and $0.4 million in fixed assets. The Company preliminarily allocated $1.9 million to customer order backlog, $47.1 million to Intellectual Property, $5.8 million to in-process research and development (“IPR&D”), $1.6 million to customer relationships, $0.3 million to tradename, and $26.1 million to goodwill. The Company also assumed $3.8 million in accounts payable and accrued liabilities and $12.2 million in deferred tax liabilities. We have included the financial results of Phyworks in our consolidated financial statements from the date of acquisition. The Company expects that none of the goodwill will be deductible for tax purposes.

Subsequent acquisition

SENSORDYNAMICS

On July 18, 2011, the Company acquired SensorDynamics, a semiconductor company that develops proprietary sensor and microelectromechanical ("MEMS") solutions. SensorDynamics is based in Lebring, near Graz, Austria. The total cash consideration associated with the acquisition was approximately $130.0 million plus the assumption of approximately $34.0 million in debt. The Company is in the process of preparing the preliminary purchase price allocation. Given the timing of the acquisition, further details to support these estimates are not yet available.

Acquisitions in prior years

TERIDIAN

On May 11, 2010, the Company completed its purchase of Teridian Semiconductor, Inc. (“Teridian”), a fabless mixed-signal semiconductor company focused on electricity metering and energy measurement for the smart grid. The total cash consideration associated with the acquisition was $314.9 million. The acquired assets included cash of $2.1 million, accounts receivable of $7.3 million, inventories of $14.0 million, $2.7 million in prepaid expenses and other current assets, $2.1 million in fixed assets, $4.3 million in customer order backlog, $85.6 million in Intellectual Property, $3.1 million of in process research and development, $44.7 million in customer relationships, $1.0 million in tradename, $13.8 million in deferred tax assets and $196.6 million in goodwill. The Company also assumed $14.1 million in accounts payable and accrued liabilities and $48.3 million in deferred tax liabilities. The company expects that none of the goodwill will be deductible for tax purposes.

61

MAXIM INTEGRATED PRODUCTS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

ZILOG

On February 18, 2009, the Company acquired the remote and secure product lines of Zilog Corporation, a publicly traded, fabless semiconductor company. The total cash consideration associated with the acquisition was $22.6 million consisting of $21.7 million in cash and $0.9 million in direct legal costs associated with the acquisition. The acquired assets included inventories of $2.9 million, $0.5 million in customer order backlog, $12.9 million in customer relationships, and $6.3 million in goodwill. The Company expects that all of the goodwill will be deductible for tax purposes.

INNOVA CARD

On December 29, 2008, the Company acquired Innova Card, a privately held, fabless semiconductor company focusing on advanced secure microcontroller technology for financial terminals. The total consideration associated with the acquisition was $13.5 million (including $8.1 million remitted to Innova Card equity shareholders upon close of the acquisition, $1.1 million to repay Innova Card debt, $3.8 million in future payments, and $0.5 million for legal and related acquisition costs). The acquired assets and liabilities included net working capital of $0.6 million, $0.2 million in fixed assets and other assets, $0.2 million in customer order backlog, $5.3 million in intellectual property, $3.0 million in customer relationships, and $4.2 million in goodwill.

During the fourth quarter of 2009, the Company remitted an additional $1.1 million to shareholders of Innova Card for additional working capital received pursuant to the agreement. The additional payment resulted in a corresponding increase in goodwill associated with the acquisition. The Company expects that none of the goodwill will be deductible for tax purposes.

MOBILYGEN

On October 27, 2008, the Company acquired Mobilygen Corporation ("Mobilygen"), a privately held, fabless semiconductor company with technology in H.264 video compression. The total consideration associated with the acquisition was $33.5 million consisting of $33.0 million cash and $0.5 million in direct legal costs associated with the acquisition. A portion of the cash consideration paid by the Company was used to retire all outstanding indebtedness of Mobilygen.

The Company allocated the acquisition cost to assets acquired and liabilities assumed based on their estimated fair values at the date of acquisition. The acquired assets included $1.5 million in tangible assets, $7.8 million of net deferred tax assets, $0.2 million in customer order backlog, $14.7 million in intellectual property, $4.2 million in customer relationships, $0.4 million in trademark and $2.2 million in goodwill. The Company recognized $3.9 million of research and development expense during the fiscal year 2009 in connection with this acquisition. In addition, the Company assumed $4.2 million of liabilities including $2.7 million in debt, which the Company paid off immediately after the acquisition was consummated.

The Company expects that none of the goodwill will be deductible for tax purposes.

NOTE 10: IMPAIRMENT OF LONG-LIVED ASSETS

End-of-Line Sorting and Testing Facilities

During the first quarter of fiscal year 2010, the Company identified certain assets as excess or obsolete, primarily due to changes in certain manufacturing technology. In connection with these circumstances, the Company recorded a charge for the write-down of equipment to its estimated fair value. The total charge of $5.0 million was included in impairment of long-lived assets in the Company's Consolidated Statements of Income. The Company has ceased depreciation and classified these assets as held for sale based on its intentions to sell the assets and has included $0.6 million in other assets in the Consolidated Balance Sheet as of June 26, 2010.

During the second quarter of fiscal year 2009, the Company identified certain assets as excess as a result of reductions in demand for product tested and sorted on certain equipment. In connection with these circumstances, the Company incurred an asset impairment charge of $43.8 million which is included in impairment of long-lived assets in the Company's Consolidated Statements of Income. The Company has classified these assets as held for sale based on their intentions to sell the assets and has included $3.6 million in other assets in the Consolidated Balance Sheet as of June 27, 2009.

Wafer Fabrication Facility, Oregon

During the first quarter of fiscal year 2010, as a result of reduced future wafer output requirements associated with equipment utilizing certain process technologies, the Company recorded a write-down of equipment to be sold to the equipment's estimated

62

MAXIM INTEGRATED PRODUCTS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

fair value. This charge of $3.3 million was included in impairment of long-lived assets in the Company's Consolidated Statements of Income. The Company has ceased depreciation and classified these assets as held for sale based on its intentions to sell the assets and has included $0.5 million in other assets in the Consolidated Balance Sheet as of June 26, 2010.

Wafer Fabrication Facility, San Jose

During the first quarter of fiscal year 2009, the Company recorded a $7.3 million asset impairment charge as a result of transferring certain wafer manufacturing production from its San Jose, California, wafer manufacturing facility to an outsourced Japanese manufacturing facility, Epson's Sakata, Japan, facility, and reductions in demand and reduced future capacity requirements.

The Company reached its conclusions regarding the asset impairment after conducting evaluations of the recoverability of the related manufacturing assets in accordance with ASC No. 360, Accounting for Property, Plant, and Equipment. The fair value of the equipment was determined after consideration of equipment specifications, quoted market prices of similar equipment and management's perception of demand for the equipment. The Company applied present value techniques to estimate fair value for certain of the equipment which they believe has limited marketability.

Dallas Wafer Fab Closure

In connection with the closure of the Dallas facility, the Company evaluated the recoverability of the facilities' manufacturing assets and concluded that there was no impairment. The Company also reevaluated the useful lives and salvage values of the fixed assets used in this manufacturing facility based on the new period of intended use. As a result of this review, the Company changed its depreciable lives and salvage values and recognized additional depreciation expense of $54.7 million for fiscal year 2009 related to this change in accounting estimate.

NOTE 11: RESTRUCTURING ACTIVITIES

Significant FY'10 Activities

Ireland Sales Operations Restructuring

In fiscal year 2010, the Company recorded approximately $3.0 million in restructuring costs associated with the reorganization of its international sales operations to Ireland.

Shutdown of Dallas Wafer Fabrication Facility

In fiscal year 2010, the Company recorded approximately $1.6 million in restructuring costs associated with the closure of the Dallas, Texas wafer manufacturing facility. These costs consisted of decommissioning of equipment at the facility and estimated severance and benefits associated with employees of the facility.

Change in Estimate

During fiscal year 2010, the Company recognized reversals of expense of approximately $5.3 million related to reductions in estimated benefits costs compared to amounts originally estimated.

Significant FY'09 Activities

San Jose Fab Rampdown

In fiscal year 2009, the Company continued its transfer of wafer manufacturing production from its San Jose, California wafer manufacturing facility to Epson's Sakata, Japan facility. In connection with the resulting termination of 78 employees, the Company recorded and paid approximately $2.1 million in severance and benefit arrangements.

Dallas Fab Closure

In fiscal year 2009, the Company recorded approximately $3.1 million in severance and benefit expenses in connection with the closure of the Dallas, Texas wafer manufacturing facility during the fourth quarter of fiscal year 2009.

63

MAXIM INTEGRATED PRODUCTS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Test Operation Cost Reduction

The Company continued its cost reduction efforts within the test operations function during fiscal year 2009 resulting in the recording of $3.4 million in severance and benefit expenses in connection with the involuntary termination of approximately 95 employees.

Cost Reduction of Business Units

In order to improve operational and selling efficiency, the Company reviewed its relative long term goals and decided to reduce development efforts in certain product lines and increase investment in others. During the second quarter of fiscal year 2009, the Company consolidated several product lines in business units which resulted in the termination of approximately 128 employees in the United States and total costs of approximately $6.1 million, consisting principally of severance and benefit payments.

The Company terminated certain international employees in certain business units during the third quarter of fiscal year 2009 and recognized an additional $0.6 million consisting principally of severance and benefit payments.

Cost Reduction of Selling, General and Administrative Groups

The Company also previously announced the decision to consolidate certain selling, general and administrative functions throughout the world, which resulted in the termination of approximately 44 employees and total costs consisting principally of severance and benefit payments of approximately $1.7 million in fiscal year 2009.

Cost Reduction in Domestic Manufacturing & Support Functions

During the third quarter of fiscal year 2009, as a result of the continued global economic weakness, the Company announced restructuring programs primarily in the manufacturing and support functions. These activities resulted in the eventual termination of approximately 382 employees (189 fab employees and 193 other employees in the US) between March and April 2009 and total costs of approximately $11.3 million, consisting principally of severance and medical benefit costs. These costs are included in restructuring expenses in the Consolidated Statements of Income.

Lease Restructuring

In addition to the Company's severance activities, the Company also decided to vacate certain leased offices in Greensboro, North Carolina, Santa Clara, California, Irving, Texas, and Swindon, United Kingdom, which resulted in a lease impairment of approximately $0.5 million during fiscal year 2009.

Change in Estimate

During fiscal year 2009 the Company recognized reversals of expense of approximately $4.6 million related to reductions in estimated benefits costs compared to amounts originally estimated.

Activity and liability balances related to the restructuring activity for fiscal year 2010 and fiscal year 2011 follows:

	Severance and Benefits
	(in thousands)
Balance at June 27, 2009	$	7,694
Restructuring accrual	4,558
Cash payments	(6,247		)
Changes in estimates	(5,257		)
Balance at June 26, 2010	$	748
Restructuring accrual	3,007
Cash payments	(3,640		)
Balance at June 25, 2011	$	115

64

MAXIM INTEGRATED PRODUCTS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

The Company has included this amount in accrued salary and related expenses in the Consolidated Balance Sheets.

NOTE 12: SEGMENT INFORMATION

The Company operates and tracks its results in one reportable segment. The Company designs, develops, manufactures and markets a broad range of linear and mixed signal integrated circuits. The Chief Executive Officer has been identified as the Chief Operating Decision Maker as defined by ASC No. 280, Disclosures about Segments Reporting ("ASC 280").

The Company has fifteen operating segments which aggregate into one reportable segment under ASC 280. Under ASC 280, two or more operating segments may be aggregated into a single operating segment for financial reporting purposes if aggregation is consistent with the objective and basic principles of ASC 280, if the segments have similar economic characteristics, and if the segments are similar in each of the following areas:

• the nature of products and services;

• the nature of the production processes;

• the type or class of customer for their products and services; and

• the methods used to distribute their products or provide their services.

The Company meets each of the aggregation criteria for the following reasons:

• the sale of analog and mixed signal integrated circuits is the primary source of revenue for each of the Company's fifteen operating segments,

• the integrated circuits sold by each of the Company's operating segments are manufactured using similar semiconductor manufacturing processes;

• the integrated circuits marketed by each of the Company's operating segments are sold to the same types of customers; and

• all of the Company's integrated circuits are sold through a centralized sales force and common wholesale distributors.

All of the Company's operating segments share similar economic characteristics as they have a similar long term business model. The causes for variation among the Company's operating segments are the same and include factors such as (i) life cycle and price and cost fluctuations, (ii) number of competitors, (iii) product differentiation and (iv) size of market opportunity. Additionally, each operating segment is subject to the overall cyclical nature of the semiconductor industry. The number and composition of employees and the amounts and types of tools and materials required are similar for each operating segment. Finally, even though the Company periodically reorganizes the Company's operating segments based upon changes in customers, end-markets or products, acquisitions, long-term growth strategies, and the experience and bandwidth of the senior executives in charge, the common financial goals for each operating segment remain constant.

Enterprise-wide information is provided in accordance with ASC 280. Geographical revenue information is based on customers' ship-to location. Long-lived assets consist of property, plant and equipment. Property, plant and equipment information is based on the physical location of the assets at the end of each fiscal year.

Net revenues from unaffiliated customers by geographic region were as follows:

	For the Year Ended
	June 25, 2011		June 26, 2010		June 27, 2009
	(in thousands)
United States	$	360,310	$	291,539	$	302,648
China	915,628		685,908		496,091
Japan	163,061		131,513		120,763
Korea	294,006		311,928		229,833
Rest of Asia	283,121		223,786		169,203
Europe	379,173		288,675		291,524
Rest of World	77,042		64,254		35,953
	$	2,472,341	$	1,997,603	$	1,646,015

65

MAXIM INTEGRATED PRODUCTS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Net long-lived assets by geographic region were as follows:

	Fiscal Year Ended
	June 25, 2011		June 26, 2010
	(in thousands)
United States	$	972,380	$	983,761
Philippines	204,581		216,738
Thailand	120,838		116,050
Rest of World	11,051		7,887
	$	1,308,850	$	1,324,436

NOTE 13: COMMITMENTS AND CONTINGENCIES

Stock Option Litigation

Beginning on or about May 22, 2006, several derivative actions were filed against certain current and former executive officers and directors of the Company alleging, among other things, wrongful conduct of back-dating stock options as well as security law violations, and named the Company as a nominal defendant against whom the plaintiffs sought no recovery.

The parties to the derivative litigation in the Delaware Court of Chancery entered into a stipulated settlement agreement, which was approved by the Delaware Court of Chancery on September 16, 2008. All derivative actions pending in the California Superior Court have since been dismissed, with prejudice. Net settlement proceeds of $18.9 million were received by the Company on September 10, 2009. The Company recognized an increase to additional paid in capital of $2.5 million related to excess gains while the remainder of the proceeds of $16.4 million was recorded as a reduction to Other operating (income) expenses, net.

On February 6, 2008, a putative class action complaint was filed against the Company and certain former officers and employees in the U.S. District Court for the Northern District of California alleging claims under the federal securities laws based on certain alleged misrepresentations and omissions in the Company's public disclosures concerning its stock option accounting practices.  On June 18, 2010, lead plaintiffs and the Company entered into a stipulation of settlement settling the action and providing for the payment of $173.0 million in cash by the Company. The Company made the payment in July, 2010. On September 29, 2010, the Court issued a Final Order and Judgment approving the settlement.

Other Legal Proceedings

In addition to the above proceedings, the Company is subject to other legal proceedings and claims that arise in the normal course of the Company's business. The Company does not believe that the ultimate outcome of such matters arising in the normal course of business will have a material adverse effect on the financial position, results of operations or cash flows of the Company.

Commitments

The Company leases certain of its facilities under various operating leases that expire at various dates through October 2025. The lease agreements generally include renewal provisions and require the Company to pay property taxes, insurance, and maintenance costs.

66

MAXIM INTEGRATED PRODUCTS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Future annual minimum payments for all commitments are as follows:

	Total		Less than 1 year		2-3 years		4-5 years		More than 5 years
	(Amounts in thousands)
Operating lease obligations (1)	$	44,489	$	12,808	$	15,478	$	8,005	$	8,198
Royalty obligations (2)	20,000		10,000		10,000		—		—
Long-term debt obligations (3)	300,000		—		300,000		—		—
Interest payments associated with long-term debt obligations (4)	20,441		10,350		10,091		—		—
Capital equipment and inventory related purchase obligations (5)	33,899		17,515		3,752		3,752		8,880
Total	$	418,829	$	50,673	$	339,321	$	11,757	$	17,078

(1) The Company leases some facilities under non-cancelable operating lease agreements that expire at various dates through 2025.

(2) Royalty obligations represent payments for licensed patents.

(3) Long-term debt represents amount due for the Company's 3.45% senior unsecured notes due 2013.

(4) Interest payments associated with the Company's 3.45% senior unsecured notes due 2013.

(5) Capital equipment purchase obligations represent commitments for purchase of property, plant and equipment. The Company orders some materials and supplies in advance or with minimum purchase quantities. The Company is obligated to pay for the materials and supplies when received.

Purchase orders for the purchase of the majority of our raw materials and other goods and services are not included in the table. Our purchase orders generally allow for cancellation without significant penalties. We do not have significant agreements for the purchase of raw materials or other goods specifying minimum quantities or set prices that exceed our expected short-term requirements.

Rental expense amounted to approximately $12.7 million, $8.2 million, and $7.7 million in fiscal years 2011, 2010 and 2009, respectively.

Potential Income Tax Liabilities Under Section 409A of the Internal Revenue Code and Other Payroll Taxes

In the past, a number of our outstanding stock option awards were granted at exercise prices below the fair market value of our stock on the appropriate accounting measurement date. Many of these options are potentially subject to option holder excise tax under Section 409A of the Internal Revenue Code (and, as applicable, similar excise taxes under state law or foreign law). In fiscal year 2008, we took action to cure certain options from exposure under Section 409A. However, there can be no assurance that such action cured all potential circumstances in which Section 409A would apply. Should it be determined that excise taxes under Section 409A were to apply and we decide to reimburse option holders for such taxes, our results of operations may be materially adversely affected. Also, we have determined that certain payroll taxes, interest and penalties may apply under various sections of the Internal Revenue Code, various state tax statutes, and tax statutes in various foreign jurisdictions. Maxim has reviewed these potential liabilities and accrued the estimated probable amount of the liability. There can be no assurance that our accruals covered all potential circumstances in which additional payroll taxes, interest and penalties would apply. Should it be found that additional payroll taxes, interest and penalties would apply, our results of operations may be materially adversely affected.

Indemnifications

The Company indemnifies certain customers, distributors, suppliers and subcontractors for attorney fees and damages and costs awarded against such parties in certain circumstances in which the Company's products are alleged to infringe third party intellectual property rights, including patents, registered trademarks or copyrights. The terms of the Company's indemnification obligations are generally perpetual from the effective date of the agreement. In certain cases, there are limits on and exceptions to the Company's potential liability for indemnification relating to intellectual property infringement claims.

67

MAXIM INTEGRATED PRODUCTS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Legal fees associated with indemnification obligations, defense and other related costs

Pursuant to the Company's charter documents and indemnification agreements, the Company has certain indemnification obligations to its officers and directors and certain former officers and directors. More specifically, we have separate written indemnification agreements with our current and former executive officers and directors. Pursuant to such obligations, the Company has incurred expenses related to legal fees and expenses advanced to certain former officers of the Company subject to civil charges by the SEC in connection with Maxim's historical stock option granting practices.  The Company expenses such amounts as incurred.

NOTE 14: COMPREHENSIVE INCOME

The changes in the components of OCI, net of taxes, were as follows:

	For the Year Ended
	June 25, 2011			June 26, 2010			June 27, 2009
	(in thousands)
Net income, as reported	$	489,009		$	125,139		$	10,455
Change in unrealized gains (losses) on investments, net of tax benefit (expense) of $(189) in 2011, $770 in 2010, and $(383) in 2009	331			(1,346		)	681
Change in unrealized gains (losses) on forward exchange contracts, net of tax benefit (expense) of $(1) in 2011, $85 in 2010, and $0 in 2009	—			(150		)	—
Deferred tax on unrealized exchange gain (loss) on intercompany receivables	(2,369		)	(1,893		)	552
Actuarial gain (loss) on post-retirement benefits, net of tax benefit (expense) of $(132) in 2011, $515 in 2010 and $2,153 in 2009	(289		)	(896		)	(3,762		)
Total comprehensive income	$	486,682		$	120,854		$	7,926

The components of Accumulated Other Comprehensive Loss, were as follows:

	June 25, 2011			June 26, 2010
	(in thousands)
Deferred tax on unrealized exchange loss on long-term intercompany receivables	$	(8,081	)	$	(5,712	)
Unrealized components of post-retirement benefits	(4,841		)	(4,552		)
Cumulative translation adjustment	(1,527		)	(1,527		)
Net unrealized loss on cash flow hedges	(150		)	(150		)
Net unrealized gain on available-for-sale securities	331			—
Accumulated Other Comprehensive Loss	$	(14,268	)	$	(11,941	)

NOTE 15: COMMON STOCK REPURCHASES

In October 2008, the Board of Directors authorized the Company to repurchase up to $750 million of the Company's common stock from time to time at the discretion of the Company's management. This stock repurchase authorization has no expiration date. All prior authorizations by the Company's Board of Directors for the repurchase of common stock were canceled and superseded by this authorization.

During fiscal year 2011 and fiscal year 2010, the Company repurchased approximately 10.9 million, and 10.3 million shares of its common stock for $231.0 million and $190.9 million, respectively. As of June 25, 2011, the Company had remaining authorization of $93.8 million for future share repurchases. The number of shares to be repurchased and the timing of such repurchases will be based on several factors, including the price of the Company's common stock and general market and business conditions.

68

MAXIM INTEGRATED PRODUCTS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

NOTE 16: INCOME TAXES

The provision for income taxes consisted of the following:

	For the Year Ended
	June 25, 2011		June 26, 2010			June 27, 2009
	(in thousands)
Federal
Current	$	44,579	$	151,786		$	30,237
Deferred	118,351		12,340			(7,447		)
State
Current	781		4,092			(2,056		)
Deferred	4,204		(1,464		)	(681		)
Foreign
Current	2,810		14,345			2,995
Deferred	1,937		(6,175		)	1,116
	$	172,662	$	174,924		$	24,164

Pretax income (loss) from the Company's foreign subsidiaries was approximately $285.0 million, $(95.5) million and $(63.3) million for fiscal years ended June 25, 2011, June 26, 2010 and June 27, 2009, respectively.

The Company has tax holidays with respect to certain operations in Thailand and the Philippines. The Thailand and Philippines tax holidays will expire at various dates between the fiscal years 2012 and 2019. The impact of the tax holidays on net income was not material for fiscal years 2011, 2010, and 2009.

As of June 25, 2011, the Company's foreign subsidiaries have accumulated undistributed earnings of approximately $123.8 million that are intended to be indefinitely reinvested outside the U.S. and, accordingly, no provision for U.S. federal and state tax has been made for the distribution of these earnings. At June 25, 2011 the amount of the unrecognized deferred tax liability on the indefinitely reinvested earnings was $39.9 million.

The provision for income taxes differs from the amount computed by applying the statutory rate as follows:

	For the Year Ended
	June 25, 2011		June 26, 2010		June 27, 2009
Federal statutory rate	35.0	%	35.0	%	35.0	%
State tax, net of federal benefit	0.7		0.4		(10.8	)
General business credits	(1.5	)	(1.2	)	(25.6	)
Domestic production deduction benefit	(0.1	)	(2.1	)	(16.1	)
Foreign earnings and losses taxed or benefitted at different rates	(4.6	)	21.0		76.5
Stock-based compensation	1.3		3.0		8.4
Acquired in process R&D	—		—		3.9
Executive compensation	0.1		0.1		(11.2	)
Release of unrecognized tax benefits	(4.1	)	—		—
Interest accrual for unrecognized tax benefits	(1.6	)	0.9		9.9
Other	0.9		1.2		(0.2	)
Income tax rate	26.1	%	58.3	%	69.8	%

Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The components of the Company's deferred tax assets and liabilities are as follows:

69

MAXIM INTEGRATED PRODUCTS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

	For the Year Ended
	June 25, 2011			June 26, 2010
	(in thousands)
Deferred tax assets:
Inventory valuation and reserves	$	11,768		$	66,087
Distributor related accruals and sales return and allowance accruals	21,334			14,168
Deferred revenue	2,233			3,187
Accrued compensation	56,467			47,500
Stock-based compensation	73,295			84,225
Net operating loss carryovers	20,827			31,450
Tax credit carryovers	43,285			46,025
Other reserves and accruals not currently deductible for tax purposes	10,608			75,782
Other	8,940			18,437
Total deferred tax assets	248,757			386,861
Deferred tax liabilities:
Fixed assets cost recovery, net	(257,647		)	(240,463		)
Other	(12,168		)	(10,524		)
Net deferred tax assets /(liabilities) before valuation allowance	(21,058		)	135,874
Valuation allowance	(44,562		)	(47,006		)
Net deferred tax assets/(liabilities)	$	(65,620	)	$	88,868

The valuation allowance decreased by $2.4 million in fiscal year 2011 primarily due to benefits realized for state research tax credit carryforwards. $37.4 million of the valuation allowance is attributable to the tax benefits of income tax deductions generated by the exercise of stock options that when realized, will be recorded as a credit to additional paid-in-capital.

As of June 25, 2011, the Company has $29.1 million of federal net operating loss carryforwards expiring at various dates between fiscal years 2024 and 2028, $57.7 million of state net operating loss carryforwards expiring at various dates through the fiscal years 2029, $22.5 million of foreign net operating losses with no expiration date, $8.3 million of state credit carryforwards expiring at various dates between fiscal years 2012 and 2026 and $62.9 million of state credit carryforwards with no expiration date.

The Company classifies unrecognized tax benefits as (i) a current liability to the extent that payment is anticipated within one year; (ii) a non current liability to the extent that payment is not anticipated within one year; or (iii) as a reduction to deferred tax assets to the extent that the unrecognized tax benefit relates to deferred tax assets such as operating loss or tax credit carryforwards.

A reconciliation of the change in gross unrecognized tax benefits, excluding interest, penalties and the federal benefit for state unrecognized tax benefits, is as follows:

70

MAXIM INTEGRATED PRODUCTS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

	For the Year Ended
	June 25, 2011			June 26, 2010
	(in thousands)
Balance as of beginning of year	$	151,464		$	137,298
Tax positions related to current year:
Addition	59,345			31,491
Tax positions related to prior year:
Addition	7,935			5,696
Reduction	(21,399		)	(190		)
Settlements	(16,636		)	(22,831		)
Lapses in statutes of limitations	(63,296		)	—
Balance as of end of year	$	117,413		$	151,464

The total amount of gross unrecognized tax benefits as of June 25, 2011 that, if recognized, would affect the effective tax rate and additional paid in capital is $107.9 million and $9.5 million, respectively. During fiscal year 2011, $33.1 million of prior year unrecognized tax benefits were recognized, due to the lapse of the statute of limitations, and credited to additional paid in capital.

Consistent with prior years, the Company reports interest and penalties related to unrecognized tax benefits as a component of income tax expense. The gross amount of interest and penalties recognized in income tax expense during fiscal years ended June 25, 2011, June 26, 2010, and June 27, 2009 was $(17.1) million, $4.4 million and $5.5 million, respectively, and the total amount of interest and penalties accrued as of June 25, 2011, June 26, 2010, and June 27, 2009 was $3.3 million, $20.4 million, and $21.8 million, respectively. The fiscal year 2011 interest and penalty net benefit of $17.1 million is primarily due to a $19.5 million reversal of prior year interest and penalties due to the expiration of the statute of limitations.

Management estimates that it is reasonably possible that the liability for gross unrecognized tax benefits, including accrued interest and penalties, could decrease within the next 12 months by $3.4 million. Such changes could occur based on the expiration of various statutes of limitations and the possible conclusion of ongoing tax audits.

During the second quarter of fiscal year 2011 the Internal Revenue Service ("IRS") completed its examination of the Company's federal corporate income tax returns for the fiscal years 2007- 2008 and issued a Revenue Agents Report ("RAR"). The Company agreed with the RAR findings and made a payment of $0.8 million that reduced the Company's liability for unrecognized tax benefits. During the fourth quarter of fiscal year 2011, an examination of the Company's California corporate income tax returns for the fiscal years 2006 - 2007 was completed. The Company agreed with the examination results, which reduced California research tax credit carryforwards and unrecognized tax benefits by $14.5 million.

In the first quarter of fiscal year 2012 the IRS intends to commence an examination of the Company's federal corporate income tax returns for the fiscal years 2009 and 2010. Management believes that it has adequately provided for any adjustments that may result from the IRS examination, however, the outcome of tax examinations cannot be predicted with certainty.

A summary of the fiscal tax years that remain subject to examination, as of June 25, 2011, for the Company's major tax jurisdictions are:

United States - Federal	2008 - forward
United States - Various States	2007 - forward
Japan	2006 - forward
Philippines	2008 - forward
Thailand	2009 - forward
United Kingdom	2008 - forward

71

MAXIM INTEGRATED PRODUCTS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

NOTE 17: BENEFITS

Defined contribution plan:

Starting January 1, 2011, Maxim reinstated its 401(k) employer matching contribution for U.S. employees. U.S. employees are automatically enrolled in the plan when they meet eligibility requirements, unless they decline participation.  Under the terms of the plan Maxim matches 100% of the employee contributions up to 3% of employee eligible compensation and 50% of additional employee contributions up to 5% of employee eligible compensation,up to the IRS Annual Compensation Limits. Total defined contribution expense was $6.0 million in fiscal 2011.

Non-U.S. Pension Benefits

We provide defined-benefit pension plans in certain countries. Consistent with the requirements of local law, we deposit funds for certain plans with insurance companies, with third-party trustees, or into government-managed accounts, and/or accrue for the unfunded portion of the obligation.

Former CEO Retirement Benefits

The Company's former CEO, John F. Gifford, now deceased, resigned in fiscal year 2007. As part of his resignation, he was provided with certain retirement benefits which included office space, administrative assistance, and health benefits. In accordance with ASC 712, the Company recorded a charge for the net present value of these benefits of $3.1 million in fiscal year 2007. During the fiscal year ended June 27, 2009, the Company reversed $2.4 million of accrued retirement benefits as a change in estimate as a result of the death of Mr. Gifford.

Post-Employment Benefits

The Company maintained an outstanding obligation associated with certain former Maxim employees to provide post-employment medical benefits. The total amount of this obligation was $4.8 million and $5.6 million and included in Other liabilities in the Consolidated Balance Sheet as of June 25, 2011 and June 26, 2010, respectively.

Post-Retirement Benefits

As a result of the Company's 2001 acquisition of Dallas Semiconductor, the Company assumed the obligation to continue medical coverage for certain former officers and directors. The Company accounted for the obligation under GAAP applicable to post-retirement benefits.

72

MAXIM INTEGRATED PRODUCTS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Medical Expense & Funded Status Reconciliation

	June 26 2010			Fiscal 2011 Expense		Current Year end			Estimated Fiscal 2012 Expense
	(in thousands, except percentages)
Accumulated Postretirement Benefit Obligation [APBO]:
Retirees and beneficiaries	$	(9,239	)			$	(9,989	)
Funded status	$	(9,239	)			$	(9,989	)
Actuarial loss						$	521
Amounts Recognized in Accumulated Other Comprehensive Income:
Net actuarial loss	$	7,327				$	7,484
Total	$	7,327				$	7,484
Net Periodic Postretirement Benefit Cost/(Income):
Interest cost				471					500
Amortization:
Net actuarial loss (1)				364					388
Total net periodic postretirement benefit cost				$	835				$	888
Employer contributions				$	241				$	388
Economic Assumptions:
Discount rate	5.2%					5.1%
Medical trend	10.0% in 2011, declining to 5% at the rate of 0.5%/yr.					9.5% in 2012, declining to 5% at the rate of 0.5%/yr.
Dental trend	5.0%					5.0%

(1) Unrecognized losses are amortized over an average remaining life expectancy of 16.7 years at June 25, 2011.

The following benefit payments are expected to be paid:

	Non-Pension Benefits
2012	$	388
2013	428
2014	469
2015	508
2016	546
Thereafter	7,650
	$	9,989

Dallas Semiconductor Split-Dollar Life Insurance

As a result of the Company's 2001 acquisition of Dallas Semiconductor, the Company assumed responsibility associated with

73

MAXIM INTEGRATED PRODUCTS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

certain split-dollar life insurance policies held by certain former Dallas Semiconductor officers and directors. The policies are owned by the individuals with the Company maintaining a limited collateral assignment on each policy. As a result of the adoption of ASC 715, Accounting for Compensation in retirement benefits, during the first quarter of fiscal year 2008 (effective July 1, 2007), the Company recognized a $14.1 million cumulative reduction to retained earnings. No corporate income tax benefit was netted against the charge to retained earnings because the liabilities being accrued are not deductible for corporate income tax purposes.

During the fourth quarter of 2009, the Company entered into contractual arrangements to settle certain of these split- dollar life insurance policies for cash consideration of $6.4 million. Pursuant to the arrangements the Company released rights to their limited collateral assignment on the policies and was relieved of its obligation to continue funding the policies.

The Company had $2.9 million and $2.7 million included in Other Assets as of June 25, 2011 and June 26, 2010, respectively, associated with the limited collateral assignment to the policies. The Company had a $4.4 million and $4.2 million obligation included in Other Liabilities as of June 25, 2011 and June 26, 2010, respectively, related to the anticipated continued funding associated with these policies.

NOTE 18: QUARTERLY FINANCIAL DATA (UNAUDITED)

	Quarter Ended
Fiscal Year 2011	6/25/2011			3/26/2011			12/25/2010			9/25/2010
	(In thousands, except percentages and per share data)
Net revenues	$	626,491		$	606,775		$	612,936		$	626,139
Cost of goods sold	235,666			234,125			232,661			239,925
Gross margin	$	390,825		$	372,650		$	380,275		$	386,214
Gross margin %	62.4		%	61.4		%	62.0		%	61.7		%
Operating income	$	177,922		$	163,995		$	151,999		$	179,123
% of net revenues	28.4		%	27.0		%	24.8		%	28.6		%
Net income	$	125,593		$	136,276		$	109,590		$	117,550
Earnings per share:
Basic	0.42			0.46			0.37			0.39
				.
Diluted	0.41			0.45			0.36			0.39
Shares used in the calculation of earnings per share:
Basic	295,751			296,511			296,550			298,216
Diluted	303,944			304,515			303,260			301,688
Dividends paid per share	$	0.21		$	0.21		$	0.21		$	0.21

The following table presents details of the total stock-based compensation expense that is included in the quarterly financial data above (in thousands):

	Quarter Ended
	6/25/2011		3/26/2011		12/25/2010		9/25/2010
Cost of goods sold	$	3,022	$	3,336	$	3,748	$	3,895
Research and development expenses	11,922		11,743		13,916		16,105
Selling, general and administrative expenses	6,464		6,149		6,858		7,139
Total	$	21,408	$	21,228	$	24,522	$	27,139

74

MAXIM INTEGRATED PRODUCTS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

	Quarter Ended
Fiscal Year 2010	6/26/2010			3/27/2010					12/26/2009			9/26/2009
	(In thousands, except percentages and per share data)
Net revenues	$	565,962		$	508,880				$	473,515		$	449,246
Cost of goods sold	225,014			200,177					181,727			197,619
Gross margin	$	340,948		$	308,703				$	291,788		$	251,627
Gross margin %	60.2		%	60.7		%			61.6		%	56.0		%
Operating income (loss)	$	141,083		$	(48,261	)	(1	)	$	109,129		$	90,099
% of net revenues	24.9		%	(9.5		)%			23.0		%	20.1		%
Net income (loss)	$	58,455		$	(33,903	)			$	58,635		$	41,952
Earnings (loss) per share:
Basic	$	0.19		$	(0.11	)			$	0.19		$	0.14
Diluted	$	0.19		$	(0.11	)			$	0.19		$	0.13
Shares used in the calculation of earnings (loss) per share:
Basic	302,188			304,518					305,324			306,276
Diluted	306,803			304,518					310,090			312,162
Dividends paid per share	$	0.20		$	0.20				$	0.20		$	0.20

(1) Includes $173.0 million litigation settlement expense included in other operating expenses, net in the Consolidated Statement of Income.

The following table presents details of the total stock-based compensation expense that is included in the quarterly financial date above (in thousands):

	Quarter Ended
	6/26/2010		3/27/2010		12/26/2009		9/26/2009
Cost of goods sold	$	3,423	$	1,071	$	5,265	$	5,461
Research and development expenses	13,983		8,691		14,650		16,741
Selling, general and administrative expenses	7,442		5,517		7,018		4,263
Total	$	24,848	$	15,279	$	26,933	$	26,465

75

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Board of Directors and Stockholders of

Maxim Integrated Products, Inc.

Sunnyvale, CA

We have audited the accompanying consolidated balance sheets of Maxim Integrated Products, Inc. and subsidiaries (the "Company") as of June 25, 2011 and June 26, 2010, and the related consolidated statements of income, stockholders' equity, and cash flows for each of the three years in the period ended June 25, 2011. Our audits also included the financial statement schedule listed in the Index at Item 15. These financial statements and financial statement schedules are the responsibility of the Company's management. Our responsibility is to express an opinion on the financial statements and financial statement schedule based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

In our opinion, such consolidated financial statements present fairly, in all material respects, the financial position of Maxim Integrated Products, Inc. and subsidiaries at June 25, 2011 and June 26, 2010, and the results of their operations and their cash flows for each of the three years in the period ended June 25, 2011, in conformity with accounting principles generally accepted in the United States of America. Also, in our opinion, such financial statement schedule, when considered in relation to the basic consolidated financial statements taken as a whole, presents fairly, in all material respects, the information set forth therein.

We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the Company's internal control over financial reporting as of June 25, 2011, based on the criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission and our report dated August 5, 2011 expressed an unqualified opinion on the Company's internal control over financial reporting.

DELOITTE & TOUCHE LLP

San Jose, California

August 5, 2011

76

MAXIM INTEGRATED PRODUCTS, INC.

SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS

	Balance at Beginning of Period		Additions (Deductions) Charged (Credited) to Costs and Expenses			Deductions (1)		Balance at End of Period
	(In thousands)
Doubtful accounts
Year ended June 25, 2011	$	2,446	$	(362	)	$	379	$	1,705
Year ended June 26, 2010	$	2,831	$	457		$	842	$	2,446
Year ended June 27, 2009	$	3,174	$	(9	)	$	334	$	2,831
	Balance at Beginning of Period		Additions (Deductions) Charged (Credited) to Costs and Expenses			Deductions		Balance at End of Period
	(In thousands)
Returns and Allowances
Year ended June 25, 2011	$	14,992	$	74,456		$	73,456	$	15,992
Year ended June 26, 2010	$	10,332	$	67,505		$	62,845	$	14,992
Year ended June 27, 2009	$	12,054	$	45,220		$	46,942	$	10,332

(1) Uncollectible accounts written off.

77

SIGNATURE

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.    

August 5, 2011	MAXIM INTEGRATED PRODUCTS, INC.
	By:/s/ Bruce Kiddoo
	Bruce Kiddoo
	Senior Vice President, Chief Financial Officer

August 5, 2011	MAXIM INTEGRATED PRODUCTS, INC.
	By:/s/ David A. Caron
	David A. Caron
	Vice President and Principal Accounting Officer (For the Registrant, as Principal Accounting Officer)

78

POWER OF ATTORNEY

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints each of Tunc Doluca and Bruce Kiddoo as his true and lawful attorneys-in-fact and agents, with full power of substitution and re-substitution, for him and in his name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Annual Report on Form 10-K, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith and about the premises, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, or their or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, the report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

Signature	Title	Date
/s/ Tunc Doluca	President and Chief Executive Officer	August 5, 2011
Tunc Doluca	(Principal Executive Officer)
/s/ James R. Bergman	Director	August 5, 2011
James R. Bergman
/s/ Joseph R. Bronson	Director	August 5, 2011
Joseph R. Bronson
/s/ Robert E. Grady	Director	August 5, 2011
Robert E. Grady
/s/ B. Kipling Hagopian	Director and Chairman of the Board	August 5, 2011
B. Kipling Hagopian
/s/ William D. Watkins	Director	August 5, 2011
William D. Watkins
/s/ A.R. Wazzan	Director	August 5, 2011
A.R. Wazzan

79

CORPORATE DATA AND STOCKHOLDER INFORMATION

Independent Registered Public Accounting Firm

Deloitte & Touche LLP

San Jose, California

Registrar/Transfer Agent

Computershare

Canton, Massachusetts

Corporate Headquarters

120 San Gabriel Drive

Sunnyvale, California 94086

(408) 737-7600

Stock Listing

At July 31, 2011, there were 912stockholders of record of the Company's common stock as reported by Computershare. Maxim common stock is traded on the Nasdaq Global Select Market under the symbol "MXIM".

80

Exhibit
Number	Description
3.1 (1)	Restated Certificate of Incorporation of the Company
3.3 (2)	Amendments to Restated Certificate of Incorporation of the Company
3.4 (3)	Amended and Restated Bylaws of the Company, as amended
4.1	Reference is made to Exhibits 3.1, 3.3, and 3.4
10.8 (5)	The Company's Forms of Indemnity Agreement(A)
10.11 (1)	The Company's Incentive Stock Option Plan, as amended(A)
10.12 (6)	The Company's 1987 Supplemental Stock Option Plan, as amended(A)
10.13 (6)	The Company's Supplemental Nonemployee Stock Option Plan, as amended(A)
10.15 (6)	The Company's 1988 Nonemployee Director Stock Option Plan, as amended(A)
10.16 (4)	The Company's 1996 Stock Incentive Plan, as amended and restated(A)
10.17 (7)	Dallas Semiconductor Corporation - 1993 Officer and Director Stock Option Plan, as amended, together with forms of stock option agreements thereunder(A)
10.18 (7)	Dallas Semiconductor Corporation Amended 1987 Stock Option Plan, together with forms of stock option agreements thereunder(A)
10.21 (7)	Form of Shareholder Agreements between Dallas Semiconductor Corporation and employee stockholders, as amended(A)
10.26 (7)	Assumption Agreement, dated April 11, 2001, relating to Dallas Semiconductor Corporation Executives Retiree Medical Plan(A)
10.27 (7)	Assumption Agreement, dated April 11, 2001, relating to Dallas Semiconductor Corporation stock options(A)
10.28 (7)	Dallas Semiconductor Corporation Executives Retiree Medical Plan(A)
10.29 (7)	Form of Indemnification Agreement between Dallas Semiconductor Corporation and its directors and officers(A)

81

10.30 (13)	Form of Non-Statutory Option Agreement, as amended and restated, under the Company's 1996 Stock Incentive Plan, for U.S. Option Optionees
10.31 (13)	Form of Restricted Stock Unit Agreement under the Company's 1996 Stock Incentive Plan, for U.S. Holders
10.32 (8)	Employment Agreement between the Company and Tunc Doluca dated as of September 30, 1993(A)
10.33 (8)	Employment Agreement between the Company and Vijay Ullal dated as of April 1, 1995(A)
10.34 (8)	Employment Agreement between the Company and Pirooz Parvarandeh dated as of November 1, 1994(A)
10.40 (9)	Employment Letter Agreement between the Company and Bruce Kiddoo dated as of August 6, 2007(A)
10.41 (3)	Form of Non-Statutory Option Agreement, as amended and restated, under the Company's 1996 Stock Incentive Plan, for Non-U.S. Option Optionees
10.42 (3)	Form of Restricted Stock Unit Agreement under the Company's 1996 Stock Incentive Plan, for Non-U.S. Holders
10.43 (10)	The Company's 2008 Employee Stock Purchase Plan, as amended(A)
10.44 (11)	Release of Claims and Vesting Agreement for Officer Goodwill Payment(A)
10.45 (12)	Amendment to Dallas Semiconductor Corporation Executives Retiree Medical Plan(A)
10.46 (14)	Agreement and Plan of Merger dated April 12, 2010, relating to the acquisition of Teridian Semiconductor Corp. by the Company
10.47 (15)	Underwriting Agreement, dated June 10, 2010, between the Company and J.P. Morgan Securities Inc. and Goldman, Sachs & Co.
10.48 (16)	Supplemental Indenture, dated as of June 17, 2010, between the Company and Wells Fargo Bank, National Association, as trustee
10.49 (17)	Change In Control Employee Severance Plan for U.S. Based Employees
10.50 (17)	Change In Control Employee Severance Plan for Non-U.S. Based Employees
10.51 (17)	Equity Award Policy Acceleration Of Vesting In The Event of A Change In Control For Employees Based Outside The U.S.
12.1	Statement of Ratio of Income to Fixed ChargesPDF provided as a courtesy
14 (17)	Code of Business Conduct and Ethics
21.1	Subsidiaries of the CompanyPDF provided as a courtesy
23.1	Consent of Deloitte & Touche LLP, Independent Registered Public Accounting FirmPDF provided as a courtesy
24.1	Power of Attorney (see page 81)

82

31.1	Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002PDF provided as a courtesy
31.2	Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002PDF provided as a courtesy
32.1	Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002PDF provided as a courtesy
32.2	Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002PDF provided as a courtesy

_________________

(A) Management contract or compensatory plan or arrangement.

_________________

(1)	Incorporated by reference to the Company's Annual Report on Form 10-K for the year ended June 30, 1995.
(2)	Incorporated by reference to the Company's Annual Report on Form 10-K for the year ended June 30, 1997, to the Company's Annual Report on Form 10-K for the year ended June 30, 1998, to the Company's Quarterly Report on Form 10-Q for the quarter ended December 25, 1999, and to the Company's Quarterly Report on Form 10-Q for the quarter ended December 30, 2000.
(3)	Incorporated by reference to the Company's Quarterly Report on Form 10-Q for the quarter ended September 27, 2008.
(4)	Incorporated by reference to the Company's Period Report on Form 8-K filed on November 24, 2009.
(5)	Incorporated by reference to the Company's Registration Statement on Form S-1 No. 33-19561 and to the Company's Annual Report on Form 10-K for the year ended June 25, 2005.
(6)	Incorporated by reference to the Company's Annual Report on Form 10-K for the year ended June 27, 1998.
(7)	Incorporated by reference to the Company's Annual Report on Form 10-K for the year ended June 30, 2001.
(8)	Incorporated by reference to the Company's Annual Report on Form 10-K for the year ended June 24, 2006.
(9)	Incorporated by reference to the Company's Quarterly Report on Form 10-Q for the quarter ended September 29, 2007.
(10)	Incorporated by reference as Appendix A to the Company's Definitive Proxy Statement on Schedule 14A filed on October 26, 2009.
(11)	Incorporated by reference to the Company's Quarterly Report on Form 10-Q for the quarter ended March 28, 2009.
(12)	Incorporated by reference to the Company's Annual Report on Form 10-K for the year ended June 27, 2009.
(13)	Incorporated by reference to the Company's Quarterly Report on Form 10-Q for the quarter ended September 26, 2009.
(14)	Incoporated by reference to the Company's Period Report on Form 8-K filed on April 14, 2010.
(15)	Incorporated by reference to the Company's Period Report on Form 8-K filed on June 16, 2010.
(16)	Incorporated by reference to the Company's Period Report on Form 8-K filed on June 18, 2010.
(17)	Incorporated by reference to the Company's Annual Report on Form 10-K for the year ended June 26, 2010.

83

EX-12.1

EXHIBIT 12.1

MAXIM INTEGRATED PRODUCTS, INC.

Statement of Ratio Of Income To Fixed Charges

(Dollar amounts in millions)

	Years ended
	June 25 2011		June 26 2010		June 27 2009		June 28 2008		June 30 2007
Income before provision for income taxes	$	661.7	$	300.1	$	34.6	$	482.8	$	413.7
Fixed Charges:
Interest portion of rental expense	$	0.6	$	0.4	$	0.4	$	0.3	$	0.2
Interest expense	11.1		0.4		0.8		0.4		0.9
Total fixed charges	$	11.7	$	0.8	$	1.2	$	0.7	$	1.1
Ratio of income to fixed charges	57x		371x		30x		697x		383x

EX-21.1

EXHIBIT 21.1

SUBSIDIARIES OF THE COMPANY

Name of Subsidiary	Jurisdiction of Incorporation
Maxim Integrated Products UK Limited	United Kingdom
Maxim Integrated Products GmbH	Germany
Maxim Gesellschaft fur elektronische Baustine GmbH	Germany
Maxim France SARL	France
Maxim Integrated Products Netherlands B.V.	Netherlands
Maxim Integrated Products GmbH	Austria
Maxim Integrated Products Holding Limited	Ireland
Maxim Integrated Products International Limited	Ireland
Maxim International Products International Sales Limited	Ireland
Maxim Overseas Technology SARL	Luxembourg
Maxim Japan Co., Ltd.	Japan
Maxim Integrated Products Korea Jusik Hoesa	Korea
Maxim Phil. Assembly Corporation	Philippines
Maxim Phil. Operating Corporation	Philippines
Maxim Phil. Holding Corporation	Philippines
Maxim Phil. Land Corporation *	Philippines
* This Subsidiary is 40% owned by the Registrant.
Maxim (I.P) Enterprise Solutions Corporation	Philippines
Maxim Integrated Products Switzerland AG	Switzerland
Maxim Integrated Products (Thailand) Co., Ltd.	Thailand

1

Maxim India Integrated Circuit Design Private Limited	India
Maxim Mikroelektronik Tasarim ve Gelistirme Ltd. Sti	Turkey
Maxim Nordic ApS	Denmark
Maxim Dallas/Direct, Inc.	Delaware
Maxim International Holding, Inc.	Delaware
L&L Engineering, LLC	New Hampshire
Maxim Technology Ltd.	Cayman Islands
Maxim Holding Company Ltd.	Cayman Islands
Dallas Semiconductor Corporation (Taiwan)	Delaware
Dallas Semiconductor Philippines, Inc.	Philippines
Maxim Integrated Products Asia Limited	Hong Kong
Chartec Laboratories A/S	Denmark
Chartec Laboratories Holding ApS	Denmark
Maxim Dallas (Shanghai) Semiconductor Trading Co. Ltd.	China
Mobilygen Corporation	California
Innova Card	France
Teridian Semiconductor Holding Corp.	Delaware
Teridian Semiconductor Intermediate Holdings Corp.	Delaware
Teridian Semiconductor Corp.	California
Phyworks Limited	United Kingdom
Phyworks Inc.	Delaware
Maxim Integrated products India Sales Pvt Ltd.	India
Maxim Integrated Products International Sales Japan GK	Japan
IPR, Limited	Cayman Islands
Calvatec Limited	Scotland

2

EX-23.1

EXHIBIT 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in Registration Statement No. 333-57849, 333-88535, 333-58772, 333-103163, 333-122559, 333-132888, 333-157416, 333-164640, and 333-171824 on Form S-8, and Registration Statement No. 333-167435 on Form S-3 of our report dated August 5, 2011, relating to the consolidated financial statements and financial statement schedule of Maxim integrated Products, Inc. and its subsidiaries (collectively the “Company”), and our report dated August 5, 2011 relating to the effectiveness of Company's internal control over financial reporting, appearing in this Annual Report on Form 10-K of the Company for the year ended June 25, 2011.

DELOITTE & TOUCHE LLP

San Jose, California

August 5, 2011

EX-31.1

Exhibit 31.1

CERTIFICATION

I, Tunc Doluca, certify that:

1. I have reviewed this Annual Report on Form 10-K of Maxim Integrated Products, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15 (e) and 15d-15 (e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f))for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date:	August 5, 2011	/s/Tunc Doluca
		Tunc Doluca
		President and Chief Executive Officer

EX-31.2

Exhibit 31.2

CERTIFICATION

I, Bruce E Kiddoo, certify that:

1. I have reviewed this Annual Report on Form 10-K of Maxim Integrated Products, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15 (e) and 15d-15 (e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f))for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date:	August 5, 2011	/s/Bruce E. Kiddoo
		Bruce E. Kiddoo
		Senior Vice President and Chief Financial Officer

EX-32.1

Exhibit 32.1

CERTIFICATE OF CHIEF EXECUTIVE OFFICER

In connection with the periodic report of Maxim Integrated Products, Inc. (the "Company") on Form 10-K for the period ended June 25, 2011 as filed with the Securities and Exchange Commission (the "Report"), I, Tunc Doluca, Chief Executive Officer of the Company, hereby certify as of the date hereof, solely for purposes of Title 18, Chapter 63, Section 1350 of the United States Code, that to the best of my knowledge:

1. the Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, and

2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated.

This Certification has not been, and shall not be deemed, "filed" with the Securities and Exchange Commission.

Date: August 5, 2011

By:	/s/Tunc Doluca
	Tunc Doluca President and Chief Executive Officer

This certification shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended or the Securities Exchange Act of 1934, as amended.

EX-32.2

Exhibit 32.2

CERTIFICATE OF CHIEF FINANCIAL OFFICER

In connection with the periodic report of Maxim Integrated Products, Inc. (the "Company") on Form 10-K for the period ended June 25, 2011 as filed with the Securities and Exchange Commission (the "Report"), I, Bruce E. Kiddoo, Chief Financial Officer of the Company, hereby certify as of the date hereof, solely for purposes of Title 18, Chapter 63, Section 1350 of the United States Code, that to the best of my knowledge:

1. the Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, and

2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated.

This Certification has not been, and shall not be deemed, "filed" with the Securities and Exchange Commission.

Date: August 5, 2011

By:	/s/Bruce E. Kiddoo
	Bruce E. Kiddoo Senior Vice President and Chief Financial Officer

This certification shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended or the Securities Exchange Act of 1934, as amended.

XML



Financial Instruments, Changes in Accumulated Other Comprehensive Income (Loss) (Details) (USD $) In Thousands	12 Months Ended
	Jun. 25, 2011	Jun. 26, 2010	Jun. 27, 2009
Accumulated other comprehensive income (loss) related to derivative instruments
Beginning balance	$ (11,941)
Amount recorded in other comprehensive loss	0	(150)	0
Ending balance	(14,268)	(11,941)
Estimated net accumulated other comprehensive loss, net of taxes, to be reclassified to earings in the next twelve months	(234)
Designated as Hedging Instrument [Member]
Accumulated other comprehensive income (loss) related to derivative instruments
Beginning balance	(235)	0
Loss reclassified to income	514	0
Amount recorded in other comprehensive loss	(513)	(235)
Ending balance	$ (234)	$ (235)

XML



Consolidated Balance Sheets (Parenthetical) (USD $) In Thousands, except Per Share data	Jun. 25, 2011	Jun. 26, 2010
Allowance for doubtful accounts	$ 17,697	$ 17,438
Stockholders' equity:
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	2,000	2,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	960,000	960,000
Common stock, shares issued	295,780	300,348
Common stock, shares outstanding	295,780	300,348

XML



Consolidated Statements of Income (USD $) In Thousands, except Per Share data	12 Months Ended
	Jun. 25, 2011		Jun. 26, 2010		Jun. 27, 2009
Net revenues	$ 2,472,341		$ 1,997,603		$ 1,646,015
Cost of goods sold	942,377	[1]	804,537	[1]	797,138	[1]
Gross margin	1,529,964		1,193,066		848,877
Operating expenses:
Research and development	525,308	[1]	474,652	[1]	520,228	[1]
Selling, general and administrative	292,494	[1]	242,144	[1]	199,151	[1]
Intangible asset amortization	18,752		10,477		6,019
In process research & development	0		0		3,900
Impairment of long-lived assets	0		8,291		51,112
Severance and restructuring expenses	1,247		(699)		28,124
Other operating expenses, net	19,124		166,151		22,965
Total operating expenses	856,925		901,016		831,499
Operating income	673,039		292,050		17,378
Interest (expense) income and other, net	(11,368)		8,013		17,241
Income before provision for income taxes	661,671		300,063		34,619
Provision for income taxes	172,662		174,924		24,164
Net income	489,009		125,139		10,455
Earnings per share:
Basic net income per share	$ 1.65		$ 0.41		$ 0.03
Diluted net income per share	$ 1.61		$ 0.4		$ 0.03
Shares used in the calculation of earnings per share:
Basic	296,755		304,579		310,805
Diluted	303,377		310,016		311,479
Dividends paid per share	$ 0.84		$ 0.8		$ 0.8
Stock-based compensation charges:
Stock-based compensation expense	94,297		93,525		196,108
Cost of goods sold [Member]
Stock-based compensation charges:
Stock-based compensation expense	14,001		15,220		57,100
Research and development [Member]
Stock-based compensation charges:
Stock-based compensation expense	53,686		54,065		100,830
Selling, general and administrative [Member]
Stock-based compensation charges:
Stock-based compensation expense	$ 26,610		$ 24,240		$ 38,178

[1] Includes stock-based compensation charges as follows:      Cost of goods sold$14,001 $15,220 $57,100     Research and development$53,686 $54,065 $100,830     Selling, general and administrative$26,610 $24,240 $38,178

XML



Comprehensive Income (Detail 1) (USD $) In Thousands	12 Months Ended
	Jun. 25, 2011	Jun. 26, 2010	Jun. 27, 2009
Change in unrealized gains (losses) on investments, tax benefit (expense)	$ (189)	$ 770	$ (383)
Change in unrealized gains (losses) on forward exchange contracts, tax benefit (expense)	(1)	85	0
Actuarial loss on post-retirement benefits, tax benefit (expense)	$ (132)	$ 515	$ 2,153

XML



Financial Instruments, Long-term Debt (Details) (USD $)	12 Months Ended
	Jun. 25, 2011	Jun. 26, 2010
Debt Instrument [Line Items]
Principal amount of public offering of the Notes	$ 300,000,000
Stated interest rate of the Notes	3.45%
Effective interest rate of the Notes		3.49%
Interest expense relating to the Notes	10,400,000	300,000
Estimated fair value of long-term debt	$ 311,000,000

XML



Benefits

12 Months Ended

Jun. 25, 2011

Compensation Related Costs [Abstract]

Benefits [Text Block]

BENEFITS

Defined contribution plan:

Starting January 1, 2011, Maxim reinstated its 401(k) employer matching contribution for U.S. employees. U.S. employees are automatically enrolled in the plan when they meet eligibility requirements, unless they decline participation.  Under the terms of the plan Maxim matches 100% of the employee contributions up to 3% of employee eligible compensation and 50% of additional employee contributions up to 5% of employee eligible compensation,up to the IRS Annual Compensation Limits. Total defined contribution expense was $6.0 million in fiscal 2011.

Non-U.S. Pension Benefits

We provide defined-benefit pension plans in certain countries. Consistent with the requirements of local law, we deposit funds for certain plans with insurance companies, with third-party trustees, or into government-managed accounts, and/or accrue for the unfunded portion of the obligation.

Former CEO Retirement Benefits

The Company's former CEO, John F. Gifford, now deceased, resigned in fiscal year 2007. As part of his resignation, he was provided with certain retirement benefits which included office space, administrative assistance, and health benefits. In accordance with ASC 712, the Company recorded a charge for the net present value of these benefits of $3.1 million in fiscal year 2007. During the fiscal year ended June 27, 2009, the Company reversed $2.4 million of accrued retirement benefits as a change in estimate as a result of the death of Mr. Gifford.

Post-Employment Benefits

The Company maintained an outstanding obligation associated with certain former Maxim employees to provide post-employment medical benefits. The total amount of this obligation was $4.8 million and $5.6 million and included in Other liabilities in the Consolidated Balance Sheet as of June 25, 2011 and June 26, 2010, respectively.

Post-Retirement Benefits

As a result of the Company's 2001 acquisition of Dallas Semiconductor, the Company assumed the obligation to continue medical coverage for certain former officers and directors. The Company accounted for the obligation under GAAP applicable to post-retirement benefits.

Medical Expense & Funded Status Reconciliation

	June 26 2010			Fiscal 2011 Expense		Current Year end			Estimated Fiscal 2012 Expense
	(in thousands, except percentages)
Accumulated Postretirement Benefit Obligation [APBO]:
Retirees and beneficiaries	$	(9,239	)			$	(9,989	)
Funded status	$	(9,239	)			$	(9,989	)
Actuarial loss						$	521
Amounts Recognized in Accumulated Other Comprehensive Income:
Net actuarial loss	$	7,327				$	7,484
Total	$	7,327				$	7,484
Net Periodic Postretirement Benefit Cost/(Income):
Interest cost				471					500
Amortization:
Net actuarial loss (1)				364					388
Total net periodic postretirement benefit cost				$	835				$	888
Employer contributions				$	241				$	388
Economic Assumptions:
Discount rate	5.2%					5.1%
Medical trend	10.0% in 2011, declining to 5% at the rate of 0.5%/yr.					9.5% in 2012, declining to 5% at the rate of 0.5%/yr.
Dental trend	5.0%					5.0%

(1) Unrecognized losses are amortized over an average remaining life expectancy of 16.7 years at June 25, 2011.

The following benefit payments are expected to be paid:

	Non-Pension Benefits
2012	$	388
2013	428
2014	469
2015	508
2016	546
Thereafter	7,650
	$	9,989

Dallas Semiconductor Split-Dollar Life Insurance

As a result of the Company's 2001 acquisition of Dallas Semiconductor, the Company assumed responsibility associated with certain split-dollar life insurance policies held by certain former Dallas Semiconductor officers and directors. The policies are owned by the individuals with the Company maintaining a limited collateral assignment on each policy. As a result of the adoption of ASC 715, Accounting for Compensation in retirement benefits, during the first quarter of fiscal year 2008 (effective July 1, 2007), the Company recognized a $14.1 million cumulative reduction to retained earnings. No corporate income tax benefit was netted against the charge to retained earnings because the liabilities being accrued are not deductible for corporate income tax purposes.

During the fourth quarter of 2009, the Company entered into contractual arrangements to settle certain of these split- dollar life insurance policies for cash consideration of $6.4 million. Pursuant to the arrangements the Company released rights to their limited collateral assignment on the policies and was relieved of its obligation to continue funding the policies.

The Company had $2.9 million and $2.7 million included in Other Assets as of June 25, 2011 and June 26, 2010, respectively, associated with the limited collateral assignment to the policies. The Company had a $4.4 million and $4.2 million obligation included in Other Liabilities as of June 25, 2011 and June 26, 2010, respectively, related to the anticipated continued funding associated with these policies.

XML



Schedule II - Valuation and Allowance (Details) (USD $) In Thousands	12 Months Ended
	Jun. 25, 2011		Jun. 26, 2010		Jun. 27, 2009
Allowance for Doubtful Accounts, Current [Member]
Movement in Valuation Allowances and Reserves [Roll Forward]
Valuation Allowances and Reserves, Balance at Beginning of Period	$ 2,446		$ 2,831		$ 3,174
Valuation Allowances and Reserves, Charged (Credited) to Cost and Expense	(362)		457		(9)
Valuation Allowances and Reserves, Deductions	379	[1]	842	[1]	334	[1]
Valuation Allowances and Reserves, Balance at End of Period	1,705		2,446		2,831
Allowance for Sales Returns [Member]
Movement in Valuation Allowances and Reserves [Roll Forward]
Valuation Allowances and Reserves, Balance at Beginning of Period	14,992		10,332		12,054
Valuation Allowances and Reserves, Charged (Credited) to Cost and Expense	74,456		67,505		45,220
Valuation Allowances and Reserves, Deductions	73,456		62,845		46,942
Valuation Allowances and Reserves, Balance at End of Period	$ 15,992		$ 14,992		$ 10,332

[1] Uncollectible accounts written off.

XML



Document and Entity Information (USD $)	12 Months Ended
	Jun. 25, 2011	Jul. 31, 2011	Dec. 25, 2010
Document Information [Line Items]
Entity Registrant Name	MAXIM INTEGRATED PRODUCTS INC
Entity Central Index Key	0000743316
Trading Symbol	MXIM
Document Type	10-K
Amendment Flag	false
Document Period End Date	Jun. 25, 2011
Document Fiscal Year Focus	2011
Document Fiscal Period Focus	Q4
Current Fiscal Year End Date	--06-25
Entity Current Reporting Status	Yes
Entity Well Known Seasoned Issuer	No
Entity Voluntary Filer	No
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		294,814,489
Entity Public Float			$ 3,559,148,668

XML



Financial Instruments, Short-term Investments (Details) (USD $) In Thousands	12 Months Ended
	Jun. 25, 2011	Jun. 26, 2010	Jun. 27, 2009
Available-for-sale Securities [Abstract]
Amortized Cost	$ 49,826	$ 0
Gross Unrealized Gains	520	0
Gross Unrealized Loss	0	0
Estimated Fair Value	50,346	0
Impairment charges on available for sale securities	0	0	0
Due February 26, 2013, Amortized Cost	49,826
Due February 26, 2013, Estimated Fair Value	50,346
Interest (expense) income and other, net	(11,368)	8,013	17,241
Government agency securities [Member]
Available-for-sale Securities [Abstract]
Amortized Cost	49,826
Gross Unrealized Gains	520
Gross Unrealized Loss	0
Estimated Fair Value	$ 50,346

XML



Summary of Significant Accounting Policies (Policies)

12 Months Ended

Jun. 25, 2011

Accounting Policies [Abstract]

Fiscal Year [Policy Text Block]

The Company has a 52-to-53-week fiscal year that ends on the last Saturday of June. Accordingly, every fifth or sixth year will be a 53-week fiscal year. Fiscal years 2011, 2010 and 2009 were 52-week fiscal years. Fiscal year 2012 will be a 53-week fiscal year.

Use of Estimates [Policy Text Block]

The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Such estimates relate to the useful lives and fair value of fixed assets, valuation allowance for deferred tax assets, reserves relating to uncertain tax positions, allowances for doubtful accounts, customer returns and allowances, inventory valuation, reserves relating to litigation matters, assumptions about the fair value of reporting units, accrued liabilities and reserves and assumptions related to the calculation of stock-based compensation. The Company bases its estimates and judgments on its historical experience, knowledge of current conditions and its beliefs of what could occur in the future, given available information. Actual results may differ from those estimates, and such differences may be material to the financial statements.

Basis of Presentation [Policy Text Block]

The consolidated financial statements include the accounts of the Company and all of its majority-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. The condition for control of entities is the ownership of a majority voting interest and ability to otherwise exercise control over the entity.

Cash Equivalents and Short Term Investments [Policy Text Block]

The Company considers all highly liquid financial instruments purchased with an original maturity of three months or less at the date of purchase to be cash equivalents. Cash and cash equivalents consist of demand accounts and money market funds. Short-term investments consist primarily of U.S. Agency debt securities with original maturities beyond three months at the date of purchase.

The Company's short-term investments are considered available-for-sale. Such securities are carried at fair market value based on market quotes. Unrealized gains and losses, net of tax, on securities in this category are reported as a separate component of stockholders' equity. Realized gains and losses on sales of investment securities are determined based on the specific identification method and are included in "Interest (expense) income and other, net" in the Consolidated Statements of Income.

Derivative Instruments [Policy Text Block]

The Company generates revenues in various global markets based on orders obtained in non-U.S. currencies, primarily the Japanese Yen, the British Pound and the Euro. Maxim incurs expenditures denominated in non-US currencies, principally Philippine Pesos and Thailand Baht associated with the Company's manufacturing activities in the Philippines and Thailand, respectively. Maxim is exposed to fluctuations in foreign currency exchange rates primarily on orders and accounts receivable from sales in these foreign currencies and cash flows for expenditures in these foreign currencies. Maxim has established risk management strategies designed to reduce the impact of volatility of future cash flows caused by changes in the exchange rates for these currencies. These strategies reduce, but do not entirely eliminate, the impact of currency exchange rates movements.

Currency forward contracts are used to offset the currency risk of non-U.S. dollar-denominated assets and liabilities. The Company typically enters into currency forward contracts quarterly to hedge exposures associated with its expenditures denominated in Philippine Pesos and Thailand Baht. The Company enters into contracts each quarter for its accounts receivable and backlog denominated in Japanese Yen, British Pound and Euro. Changes in fair value of the underlying assets and liabilities are generally offset by the changes in fair value of the related currency forward contract.

The Company uses currency forward contracts to hedge exposure to variability in anticipated non-U.S. dollar denominated cash flows. These contracts are designated as cash flow hedges and recorded on the Consolidated Balance Sheets at their fair market value. The maturities of these instruments are generally less than 6 months. For derivative instruments that are designated and qualify as cash flow hedges, the effective portion of the gain or loss on the derivative is reported as a component of accumulated other comprehensive income (loss) and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings.  For derivative instruments that are not designated as hedging instruments gains and losses are recognized in "interest (expense) income and other, net" in the Consolidated Statements of Income.

Fair Value of Financial Instruments [Policy Text Block]

Maxim measures certain financial assets and liabilities at fair value based on the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants. See Note 5 for a further discussion on fair value of financial instruments.

Inventories [Policy Text Block]

Inventories are stated at the lower of (i) standard cost, which approximates actual cost on a first-in-first-out basis, or (ii) market value. Because of the cyclical nature of the market, inventory levels, obsolescence of technology, and product life cycles, the Company generally writes down inventories to net realizable value based on 12 months forecasted product demand.

Property, Plant and Equipment [Policy Text Block]

Property, plant and equipment are stated at cost. Depreciation is primarily computed on the straight-line method over the estimated useful lives of the assets, which range from 2 to 15 years for machinery and equipment and up to 40 years for buildings and building improvements. Leasehold improvements are amortized over the lesser of their useful lives or the remaining term of the related lease. When assets are retired or otherwise disposed of, the cost and accumulated depreciation or amortization is removed from the accounts and any resulting gain or loss is reflected in operating expense in the Consolidated Statements of Income in the period recognized.

The Company evaluates the recoverability of property, plant and equipment in accordance with Accounting Standards Codification ("ASC") No. 360, Accounting for the Property, Plant, and Equipment. ("ASC No. 360"). The Company performs periodic reviews to determine whether facts and circumstances exist that would indicate that the carrying amounts of property, plant and equipment exceeds their fair values. If facts and circumstances indicate that the carrying amount of property, plant and equipment might not be fully recoverable, projected undiscounted net cash flows associated with the related asset or group of assets over their estimated remaining useful lives are compared against their respective carrying amounts. In the event that the projected undiscounted cash flows are not sufficient to recover the carrying value of the assets, the assets are written down to their estimated fair values. All long-lived assets to be disposed of are reported at the lower of carrying amount or fair market value, less expected selling costs.

Intangible Assets and Goodwill [Policy Text Block]

The Company accounts for intangible assets in accordance with ASC No. 360. The Company reviews goodwill and purchased intangible assets with indefinite lives for impairment annually and whenever events or changes in circumstances indicate the carrying value of an asset may not be recoverable, such as when reductions in demand or significant economic slowdowns in the semiconductor industry are present. Reviews are performed to determine whether the carrying value of an asset is impaired, based on comparisons to undiscounted expected future cash flows. If this comparison indicates that there is impairment, the impaired asset is written down to fair value, which is typically calculated using: (i) quoted market prices or (ii) discounted expected future cash flows utilizing a discount rate consistent with the guidance provided in FASB Concepts Statement No. 7, Using Cash Flow Information and Present Value in Accounting Measurements. Impairment is based on the excess of the carrying amount over the fair value of those assets.

Goodwill is recorded as the difference, if any, between the aggregate consideration paid for an acquisition and the fair value of the net tangible and intangible assets acquired. In accordance with ASC No. 350, Intangibles-Goodwill and Other, ("ASC 350"), the Company tests goodwill for impairment at the reporting unit level (operating segment or one level below an operating segment) on an annual basis in the first quarter or more frequently if the Company believes indicators of impairment exist. The performance of the test involves a two-step process. The first step of the impairment test involves comparing the fair values of the applicable reporting units with their aggregate carrying values, including goodwill. The Company generally determines the fair value of the Company's reporting units using the income approach methodology of valuation that includes the discounted cash flow method as well as other generally accepted valuation methodologies. If the carrying amount of a reporting unit exceeds the reporting unit's fair value, the Company performs the second step of the goodwill impairment test to determine the amount of impairment loss. The second step of the goodwill impairment test involves comparing the implied fair value of the affected reporting unit's goodwill with the carrying value of that goodwill.

Product Warranty [Policy Text Block]

The Company warrants its products to its customers generally for one year from the date of shipment, but in certain cases for longer periods. In certain other cases, the Company's product warranty may include significant financial responsibility beyond the cost of replacing the product. If there is a material increase in the rate of customer claims or the Company's estimates of probable losses relating to specifically identified warranty exposures are inaccurate, the Company may record a charge against future cost of sales. Warranty expense has historically been immaterial to the Company's financial statements.

Self-Insurance Accruals [Policy Text Block]

The Company is self-insured with respect to defective product claims, employment practice claims, property and casualty and general liability. The Company's workers' compensation insurance has a $1.0 million deductible per case. Accruals are primarily based on the estimated, undiscounted cost of claims, which includes incurred-but-not-reported claims. Amounts accrued for defective product claims, employment practice claims, workers' compensation claims, property and casualty and general liability of $4.7 million and $4.4 million are included in accrued expenses as of June 25, 2011 and June 26, 2010, respectively.

In addition to the above, the Company is primarily self-insured with respect to healthcare benefits for most of its domestic employees. Accruals are primarily based on estimated incurred-but-not-reported claims. Amounts accrued for employee healthcare claims of $5.9 million and $5.6 million are included in accrued salary and related expenses as of June 25, 2011 and June 26, 2010, respectively.

Retirement Benefits [Policy Text Block]

The Company periodically provides medical benefits to former employees pursuant to retirement agreements and other post-employment arrangements. The Company accounts for medical benefits to individuals pursuant to a documented plan under ASC No. 715, Compensation- Retirement Benefits, while one-off employment arrangements are treated as post-employment benefits recognized when the liability is incurred and the amount is estimable under ASC No. 712, Compensation-Nonretirement Postemployment Benefits, an amendment of ASC No. 715 ("ASC 712").

Income Taxes [Policy Text Block]

The Company accounts for income taxes using an asset and liability approach as prescribed in ASC 740, Income Taxes.  The Company records the amount of taxes payable or refundable for the current and prior years and deferred tax assets and liabilities for the future tax consequences of events that have been recognized in the Company's financial statements or tax returns.  A valuation allowance is recorded to reduce deferred tax assets when it is more likely than not that a tax benefit will not be realized.

ASC 740-10 prescribes a recognition threshold and measurement framework for the financial statement reporting and disclosure of an income tax position taken or expected to be taken on a tax return. Under ASC 740-10, a tax position is recognized in the financial statements when it is more-likely-than-not, based on the technical merits, that the position will be sustained upon examination, including resolution of any related appeals or litigation processes. A tax position that meets the recognition threshold is then measured to determine the largest amount of the benefit that has a greater than 50% likelihood of being realized upon settlement.

The calculation of tax liabilities involves significant judgment in estimating the impact of uncertainties in the application of complex tax laws across multiple tax jurisdictions. Although ASC 740-10 provides clarification on the accounting for uncertainty in income taxes recognized in the financial statements, the threshold and measurement attributes will continue to require significant judgment by management. Resolution of these uncertainties in a manner inconsistent with the Company's expectations could have a material impact on the Company's results of operations.

Revenue Recognition [Policy Text Block]

The Company recognizes revenue for sales to direct customers and sales to distributors upon shipment, provided that persuasive evidence of a sales arrangement exists, the price is fixed or determinable, title and risk of loss has transferred, collectability of the resulting receivable is reasonably assured, there are no customer acceptance requirements and we do not have any significant post-shipment obligations. The Company estimates returns for sales to direct customers and international distributors based on historical returns rates applied against current period gross revenues. Specific customer returns and allowances are considered within this estimate.

Sales to certain distributors are made pursuant to agreements allowing for the possibility of certain sales price rebates and for non-warranty product return privileges. The non-warranty product return privileges include allowing certain U.S. distributors to return a small portion of our products in their inventory based on their previous 90 days of purchases. Given the uncertainties associated with the levels of non-warranty product returns and sales price rebates that could be issued to U.S. distributors, the Company defers recognition of such revenue and related cost of goods sold until the product is sold by the U.S. distributors to their end-customers. Accounts receivable from direct customers, domestic distributors and international distributors are recognized and inventory is relieved upon shipment as title to inventories generally transfers upon shipment at which point the Company has a legally enforceable right to collection under normal terms. Accounts receivable related to consigned inventory is recognized when the customer takes title of such inventory from its consigned location at which point inventory is relieved, title transfers, and the Company has a legally enforceable right to collection under the terms of our agreement with the related customers.

Revenue Recognition, Sales Returns [Policy Text Block]

The Company estimates potential future returns and sales allowances related to current period product revenue.  Management analyzes historical returns, changes in customer demand and acceptance of products when evaluating the adequacy of returns and sales allowances.  Estimates made by the Company may differ from actual returns and sales allowances.  These differences may materially impact reported revenue and amounts ultimately collected on accounts receivable. Historically, such differences have not been material.

Research and Development Costs [Policy Text Block]

Research and development costs are expensed as incurred. Such costs consist primarily of expenditures for labor and benefits, masks, prototype wafers and depreciation.

Advertising [Policy Text Block]

Advertising costs are expensed as incurred and included in selling, general and administrative expenses in the Consolidated Statements of Income.

Shipping Cost [Policy Text Block]

Shipping costs billed to customers are included in net revenues and the related shipping costs are included in cost of goods sold.

Share-based Compensation [Policy Text Block]

Stock-based compensation cost is measured at the grant date, based on the fair value of the awards ultimately expected to vest and is recognized as an expense, on a straight-line basis, over the requisite service period. The Company uses the Black-Scholes valuation model to measure the fair value of its stock-based awards utilizing various inputs with respect to expected holding period, risk-free interest rates, stock price volatility and dividend yield.

ASC 718 also requires forfeitures to be estimated at the time of grant and revised if necessary in subsequent periods if actual forfeitures or vesting differ from those estimates. Such revisions could have a material effect on the Company's operating results. The assumptions the Company uses in the valuation model are based on subjective future expectations combined with management judgment. If any of the assumptions used in the Black-Scholes model changes, stock-based compensation for future awards may differ materially compared to the awards granted previously.

Restructuring [Policy Text Block]

Post-employment benefits accrued for workforce reductions related to restructuring activities in the United States are accounted for under ASC 712. A liability for post-employment benefits is recorded when payment is probable, the amount is reasonably estimable, and the obligation relates to rights that have vested or accumulated. In accordance with ASC No. 420, Exit or Disposal Cost Obligations ("ASC 420"), generally costs associated with restructuring activities initiated outside the United States have been recognized when they are incurred.

The Company continually evaluates the adequacy of the remaining liabilities under its restructuring initiatives. Although the Company believes that these estimates accurately reflect the costs of its restructuring plans, actual results may differ, thereby requiring the Company to record additional provisions or reverse a portion of such provisions.

Foreign Currency Translations and Remeasurement [Policy Text Block]

The U.S. dollar is the functional currency for the Company's foreign operations. Using the U.S. dollar as the functional currency, monetary assets and liabilities are remeasured at the year-end exchange rates. Certain non-monetary assets and liabilities are remeasured using historical rates. Statements of Income are remeasured at the average exchange rates during the year.

Earnings Per Share [Policy Text Block]

Basic earnings per share are computed using the weighted average number of common shares outstanding during the period. Diluted earnings per share incorporate the potentially dilutive incremental shares issuable upon the assumed exercise of stock options, the assumed vesting of outstanding restricted stock units, and the assumed issuance of common stock under the stock purchase plan. The number of incremental shares from the assumed issuance of stock options is calculated by applying the treasury stock method. See Note 7 "Earnings Per Share" of these Notes to the Consolidated Financial Statements.

Litigation and Contingencies [Policy Text Block]

From time to time, the Company receives notices that its products or manufacturing processes may be infringing the patent or intellectual property rights of others, notices of stockholder litigation or other lawsuits or claims against the Company. The Company periodically assesses each matter in order to determine if a contingent liability in accordance with ASC 450, should be recorded. In making this determination, management may, depending on the nature of the matter, consult with internal and external legal counsel and technical experts. The Company expenses legal fees associated with consultations and defense of lawsuits as incurred. Based on the information obtained combined with management's judgment regarding all the facts and circumstances of each matter, the Company determines whether a contingent loss is probable and whether the amount of such loss can be estimated. Should a loss be probable and estimable, the Company records a contingent loss in accordance with ASC 450. In determining the amount of a contingent loss, the Company takes into consideration advice received from experts in the specific matter, current status of legal proceedings, settlement negotiations which may be ongoing, prior case history and other factors. Should the judgments and estimates made by management be incorrect, the Company may need to record additional contingent losses that could materially adversely impact its results of operations. Alternatively, if the judgments and estimates made by management are incorrect and a particular contingent loss does not occur, the contingent loss recorded would be reversed thereby favorably impacting the Company's results of operations.

Pursuant to the Company's charter documents and indemnification agreements, the Company has certain indemnification obligations to its officers and directors, and certain former officers and directors. More specifically, the Company has separate written indemnification agreements with its current and former executive officers and directors. Pursuant to such obligations, the Company has incurred substantial expenses related to legal fees and expenses to certain former officers of the Company subject to civil charges by the SEC in connection with Maxim's historical stock option granting practices. The Company has also incurred substantial expenses related to legal fees and expenses advanced to certain current and former officers and directors who were defendants in the civil actions described above. The Company expenses such amounts as incurred.

Concentration of Credit Risk [Policy Text Block]

The Company maintains cash, cash equivalents, and short-term investments with various high credit quality financial institutions, limits the amount of credit exposure to any one financial institution or instrument, and is exposed to credit risk in the event of default by these institutions to the extent of amounts recorded at the balance sheet date. To date, the Company has not incurred losses related to these investments.

Concentration of Other Risks [Policy Text Block]

The semiconductor industry is characterized by rapid technological change, competitive pricing pressures, and cyclical market patterns. The Company's results of operations are affected by a wide variety of factors, including general economic conditions, both in the United States and abroad; economic conditions specific to the semiconductor industry and to the analog and mixed signal portion of that industry; demand for the Company's products; the timely introduction of new products; implementation of new manufacturing technologies; manufacturing capacity; the ability to manufacture efficiently; the availability of materials, supplies, machinery and equipment; competition; the ability to safeguard patents and intellectual property in a rapidly evolving market; and reliance on assembly and, to a small extent, wafer fabrication subcontractors and on independent distributors and sales representatives. As a result, the Company may experience substantial period-to-period fluctuations in future operating results due to the factors mentioned above or other factors.

Recently Issued Accounting Pronouncements [Text Block]

In June 2011, the FASB issued Accounting Standards Update (“ASU”) relating to Comprehensive Income (Topic 220)-Presentation of Comprehensive Income (ASU 2011-05), to require an entity to present the total of comprehensive income, the components of net income, and the components of other comprehensive income either in a single continuous statement of comprehensive income or in two separate but consecutive statements. The ASU is effective for us in our third quarter of fiscal 2012 and should be applied retrospectively. The Company is currently evaluating the impact of its pending adoption of ASU 2011-05 on its consolidated financial statements.

In May 2011, the FASB issued ASU No. 2011-04, Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and International Financial Reporting Standards (Topic 820)-Fair Value Measurement (ASU 2011-04), to provide a consistent definition of fair value and ensure that the fair value measurement and disclosure requirements are similar between U.S. GAAP and International Financial Reporting Standards. ASU 2011-04 changes certain fair value measurement principles and enhances the disclosure requirements particularly for level 3 fair value measurements. ASU 2011-04 is effective for us in our first quarter of fiscal 2013 and should be applied prospectively. The Company is currently evaluating the impact of its pending adoption of ASU 2011-04 on its consolidated financial statements.

XML



Fair Value Measurements (Details) (USD $) In Thousands	Jun. 25, 2011		Jun. 26, 2010
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Available-for-sale securities, fair value disclosure	$ 50,346		$ 0
Fair Value, Measurements, Recurring [Member] | Money market funds [Member] | Total [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and cash equivalents, fair value disclosure	606,637	[1]	637,355	[1]
Fair Value, Measurements, Recurring [Member] | Money market funds [Member] | Fari Value Measurements Using Level 1 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and cash equivalents, fair value disclosure	603,180	[1]	634,358	[1]
Fair Value, Measurements, Recurring [Member] | Money market funds [Member] | Fair Value Measurements Using Level 2 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and cash equivalents, fair value disclosure	3,457	[1]	2,997	[1]
Fair Value, Measurements, Recurring [Member] | Money market funds [Member] | Fair Value Measurements Using Level 3 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and cash equivalents, fair value disclosure	0	[1]	0	[1]
Fair Value, Measurements, Recurring [Member] | Government agency securities [Member] | Total [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Available-for-sale securities, fair value disclosure	50,346	[2]	0	[2]
Fair Value, Measurements, Recurring [Member] | Government agency securities [Member] | Fari Value Measurements Using Level 1 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Available-for-sale securities, fair value disclosure	0	[2]	0	[2]
Fair Value, Measurements, Recurring [Member] | Government agency securities [Member] | Fair Value Measurements Using Level 2 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Available-for-sale securities, fair value disclosure	50,346	[2]	0	[2]
Fair Value, Measurements, Recurring [Member] | Government agency securities [Member] | Fair Value Measurements Using Level 3 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Available-for-sale securities, fair value disclosure	0	[2]	0	[2]
Fair Value, Measurements, Recurring [Member] | Foreign currency forward contracts [Member] | Total [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Foreign currency contract, asset, fair value disclosure	326		18
Foreign currency contract, liability, fair value disclosure	309		851
Fair Value, Measurements, Recurring [Member] | Foreign currency forward contracts [Member] | Fari Value Measurements Using Level 1 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Foreign currency contract, asset, fair value disclosure	0		0
Foreign currency contract, liability, fair value disclosure	0		0
Fair Value, Measurements, Recurring [Member] | Foreign currency forward contracts [Member] | Fair Value Measurements Using Level 2 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Foreign currency contract, asset, fair value disclosure	326		18
Foreign currency contract, liability, fair value disclosure	309		851
Fair Value, Measurements, Recurring [Member] | Foreign currency forward contracts [Member] | Fair Value Measurements Using Level 3 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Foreign currency contract, asset, fair value disclosure	0		0
Foreign currency contract, liability, fair value disclosure	0		0
Fair Value, Measurements, Recurring [Member] | Total [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets, fair value disclosure	657,309		637,373
Liabilities, fair value disclosure	309		851
Fair Value, Measurements, Recurring [Member] | Fari Value Measurements Using Level 1 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets, fair value disclosure	603,180		634,358
Liabilities, fair value disclosure	0		0
Fair Value, Measurements, Recurring [Member] | Fair Value Measurements Using Level 2 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets, fair value disclosure	54,129		3,015
Liabilities, fair value disclosure	309		851
Fair Value, Measurements, Recurring [Member] | Fair Value Measurements Using Level 3 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets, fair value disclosure	0		0
Liabilities, fair value disclosure	0		0
Fair Value, Measurements, Nonrecurring [Member] | Total [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets, fair value disclosure	0		0
Liabilities, fair value disclosure	$ 0		$ 0

[1] Included in Cash and cash equivalents in the accompanying Consolidated Balance Sheets.

[2] Included in Short-term investments in the accompanying Consolidated Balance Sheets.

XML



Income Taxes Tax Examination (Details) (USD $) In Millions	12 Months Ended
	Jun. 25, 2011
Income Tax Examination [Line Items]
Tax payment to decrease uncertain tax positions liability	$ 0.8
United States [Member] | Internal Revenue Service (IRS) [Member]
Income Tax Examination [Line Items]
Income tax years under examination	2008 - forward
United States [Member] | State and Local Jurisdiction [Member]
Income Tax Examination [Line Items]
Income tax years under examination	2007 - forward
Japan [Member] | Foreign Country [Member]
Income Tax Examination [Line Items]
Income tax years under examination	2006 - forward
Philippines [Member] | Foreign Country [Member]
Income Tax Examination [Line Items]
Income tax years under examination	2008 - forward
Thailand [Member] | Foreign Country [Member]
Income Tax Examination [Line Items]
Income tax years under examination	2009 - forward
Foreign Country [Member] | United Kingdom [Member]
Income Tax Examination [Line Items]
Income tax years under examination	2008 - forward

XML



Stock-Based Compensation

12 Months Ended

Jun. 25, 2011

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Stock-Based Compensation [Text Block]

STOCK-BASED COMPENSATION

At June 25, 2011, the Company had five stock option plans and one employee stock purchase plan, including the Company's 1996 Stock Incentive Plan (the "1996 Plan"), 1993 Officer and Director Stock Option Plan, 1987 Stock Option Plan, 1987 Supplemental Stock Option Plan, Supplemental Non-employee Stock Option Plan and 2008 Employee Stock Purchase Plan ("2008 ESPP").

The following tables present stock-based compensation expense by type of award and resulting tax effect included in the Consolidated Statements of Income for fiscal year 2011, 2010, and 2009:

	For the Year Ended
	June 25, 2011		June 26, 2010		June 27, 2009
	(in thousands)
Cost of goods sold
Stock options	$	2,625	$	3,330	$	33,380
Restricted stock units	9,820		10,825		23,350
Employee stock purchase plan	1,556		1,065		370
	14,001		15,220		57,100
Research and development expense
Stock options	11,325		15,085		38,237
Restricted stock units	36,925		33,834		61,151
Employee stock purchase plan	5,436		5,146		1,442
	53,686		54,065		100,830
Selling, general and administrative expense
Stock options	6,120		8,130		21,390
Restricted stock units	18,944		15,056		16,665
Employee stock purchase plan	1,546		1,054		123
	26,610		24,240		38,178
Total stock-based compensation expense
Stock options	20,070		26,545		93,007
Restricted stock units	65,689		59,715		101,166
Employee stock purchase plan	8,538		7,265		1,935
Pre-tax stock-based compensation expense	94,297		93,525		196,108
Less: Income tax effect	25,457		25,041		67,430
Net stock-based compensation expense	$	68,840	$	68,484	$	128,678

Modifications and Settlements

Tender Offer

In November 2008, the Company offered to purchase from employees up to 52.8 million shares underlying certain outstanding stock options for cash payments for the total potential cash consideration of $22.4 million. The amount of the cash payment was determined based on the Black-Scholes value of the eligible options utilizing the average stock price over the 20 trading days period preceding the date of the offer.

In December 2008, upon the closing of the offer, a total of 31.9 million shares underlying the eligible options had been tendered requiring the Company to remit an aggregate payment totaling $13.6 million. The Company accounted for the offer as a settlement under ASC Topic-718 Stock Based Compensation ("ASC 718"), which resulted in the recognition of $75.9 million in stock-based compensation expenses consisting of $8.7 million inadditional expense from settlements above fair value and $67.2 million associated with the unamortized compensation expense on the previously unvested tendered options. Settlement of the tendered options reduced deferred tax assets by $129.4 million, generated a tax benefit of $4.7 million, and resulted in a $124.7 million charge to additional paid in capital for the difference between the deferred tax assets and tax benefits associated with the tendered options.

The $75.9 million expense recognized in connection with the tender offer in the second quarter of fiscal year 2009 included the final true-up for $31.9 million tendered options, therefore, the Company also recorded in the same period a reversal of stock based compensation of $52.2 million related to the true-up for previously forfeited options.

Officer Option Repurchase

In December 2008, the Company repurchased 6.2 million outstanding stock options from officers for $1.8 million payable in installments over the greater of two years or the remaining vesting period associated with the options prior to their repurchase. The Company accounted for the repurchase as a modification under ASC 718 resulting in incremental compensation of $1.1 million which will be recognized over the payment period.

2009 Goodwill Program

In January 2009, the Company approved a program ("Goodwill Program") wherein non-officer employees holding options that were outstanding as of November 1, 2008 and which reached or will reach their contractual 10-year expiration term between November 2008 and December 2009 would be eligible for a payment in the form of cash or restricted stock units ("RSUs"). Payments exceeding $5,000 would be settled in restricted stock units that vest over three quarters and are contingent upon continued employment, while amounts below $5,000 would be settled in cash in a lump sum payment. The program was extended to officers in May 2009 except that payments exceeding $5,000 to officers were settled in restricted stock units vesting over six quarters.

The Company recorded a liability for the options settling in cash under the Goodwill Program. Options associated with payments being made in the form of restricted stock units under the Goodwill Program, which contain market and service conditions, are accounted for under the provisions of ASC 718. The Company recognized $0.2 million, and $5.4 million in stock based compensation expense related to this program during fiscal year 2011 and fiscal year 2010, respectively.

Share-Based Compensation and Other Adjustments resulting from the Blackout Period

On September 8, 2006, the SEC was notified that the Company would delay filing its Annual Report on Form 10K for the fiscal year ended June 24, 2006 as a result of the ongoing investigation into the Company's historical stock option granting practices. As a result of such delay, the Company suspended the issuance of shares upon exercise of stock options, vesting of RSUs and purchases of stock under the 1987 Employee Stock Participation Plan, as amended ("1987 ESPP") until the Company became current with all of its required SEC filings and its registration statements on Form S-8 became effective ("Blackout Period"). The Company instituted multiple programs in an attempt to compensate employees during the Blackout Period, as described below. The Company became current in its SEC filings, and its registration statements on Form S-8 became effective on September 30, 2008.

RSU Loan Program

In October 2006, the Company offered certain domestic employees an opportunity to receive cash in the form of a non-recourse loan ("RSU Loan") for common stock that they would have otherwise been able to receive in settlement for RSUs that vested during the Blackout Period. The program was not offered to executive officers or members of the Company's Board of Directors. Employees accepting the offer were also entitled to additional shares of common stock if the Company's stock price appreciated between the vesting date and the settlement date at the end of the Blackout Period. Employees foregoing the loan received shares of common stock at the conclusion of the Blackout Period. The Company also offered to cash-settle RSUs vesting during the Blackout Period held by foreign employees. The aforementioned loan offers were considered modifications of the RSUs triggering a change in the classification from equity to liability for all eligible awards vesting during the Blackout Period. The Company recorded a reclassification from additional paid-in-capital to accrued salary and related expenses of $19.4 million on the modification date and incremental compensation expense of $2.2 million from the modifications. Vesting of eligible awards and changes in stock price resulted in additional reclassifications from additional paid-in-capital to accrued salary and related expenses and additional compensation expenses in periods in which they occurred. The Company recorded $6.8 million and $50.2 million in stock based compensation expense in fiscal year 2009, and 2008, respectively. During fiscal years 2009 and 2008, the Company made cash payments of $35.6 million and $25.3 million pursuant to the RSU Loan program and $1.9 million and $4.3 million to cash-settle restricted stock units held by employees located outside the United States.

Extension of Options that Would Have Expired after Reaching 10-Year Contractual Term and Cash-Settlements of Expired Options

In September 2006, the Company approved the extension of the terms of vested stock options that would have expired during the Blackout Period as a result of the expiration of the 10-year contractual term. The extension was considered a modification under ASC 718. The incremental compensation expense of the modification was equal to the fair value of the option at the modification date after the extension compared to the fair value of the option prior to modification. The Company recognized additional compensation expense totaling $118.9 million for 8.3 million options in the three months ended September 23, 2006. The stock-based compensation expense adjustment was based on modified vested options held by employees that expired during the period from September 22, 2006 through the end of the Blackout Period.

In September 2007, as a result of changes in NASDAQ regulations, the Company decided to cash-settle substantially all options expiring during the Blackout Period ("goodwill payment") based on the price at which 10% of the daily close prices of the Company's common stock fall above this price for trading days from August 7, 2006 (the date on which the Company initiated a trading suspension on officers and other individuals) through the expiration date of the option. The cash payment is subject to the option holder executing a release of all claims relating to the option. The goodwill payment modification changed the classification of the associated awards from equity to liability instruments. The modification resulted in a reclassification from additional paid-in capital to accrued salary and related expenses of $126.8 million and incremental compensation expenses of $27.5 million. At the end of each period, the Company recognized changes in fair value of the options in its Consolidated Statements of Operations in the period of change until the options were settled.

On September 26, 2008, the Company offered certain employees, including certain officers of the Company, holding vested stock options that expired due to reaching their maximum 10-year terms in October 2008, certain cash goodwill payments contingent upon employee acceptance and signing of a release of claims related to the option. The Company cash-settled options to purchase 1.1 million option shares that expired in October 2008, with employees that accepted the offer. The cash-settlement resulted in a reduction of additional paid-in-capital of $0.3 million for the fair value of the underlying options on the settlement dates and incremental compensation expense of $4.3 million during the year ended June 26, 2010.

Fair Value

The fair value of share-based awards granted to employees under the Company's 1996 Plan and 2008 ESPP is estimated on the date of grant using the Black-Scholes option valuation model. Expected volatilities are based on the implied volatilities from traded options of the Company's common stock before the Company's common stock was delisted from NASDAQ on October 2, 2007. Subsequent to the Company's delisting, the Company began analyzing its expected volatilities based on historical volatilities from its traded common stock over a period equal to the expected term. The Company analyzed historical exercise patterns of relatively homogeneous groups of employees to estimate the expected holding period for options granted through December 29, 2008. Subsequent to the end of the second quarter of 2009, the Company began utilizing the simplified method under ASC-718, to estimate expected holding periods. This change was attributable to the significant impact resulting from the completion of the tender offer and the Company reducing the contractual term associated with new option grants from ten years to seven years. The risk-free interest rate is based on the U.S. Treasury yield. The Company determines the dividend yield by dividing the annualized dividends per share by the prior quarter's average stock price. The result is analyzed by the Company to decide whether it represents expected future dividend yield. As required by ASC 718, the Company also estimates forfeitures at the time of grant and makes revisions if the estimates change or the actual forfeitures differ from those estimates.

The fair value of each award granted in fiscal years 2011, 2010 and 2009 has been estimated at the date of grant using the Black-Scholes option valuation model and the following weighted-average assumptions:

	Stock Option Plan For the Year Ended
	June 25, 2011		June 26, 2010		June 27, 2009
Expected holding period (in years)	5.2		5.2		6.3
Risk-free interest rate	1.7	%	2.3	%	3.0	%
Expected stock price volatility	37.1	%	38.0	%	39.0	%
Dividend yield	4.2	%	4.5	%	4.1	%
	ESP Plan For the Year Ended
	June 25, 2011		June 26, 2010		June 27, 2009
Expected holding period (in years)	0.5		0.7		1.0
Risk-free interest rate	0.1	%	0.3	%	4.0	%
Expected stock price volatility	24.7	%	35.0	%	57.0	%
Dividend yield	3.3	%	4.4	%	6.1	%

The weighted-average fair value of stock options granted was $4.02, $4.23 and $3.61 per share for fiscal years 2011, 2010 and 2009, respectively. The weighted-average fair value of RSUs granted was $16.61, $16.20 and $11.91 per share for fiscal years 2011, 2010 and 2009, respe

Stock Option Plans

1996 Stock Incentive Plan

The Company's 1996 Plan, which was previously approved by the Company's stockholders, permits the grant of up to 113.1 million shares. The 1996 Plan provides for the grant of stock options, restricted stock units and restricted stock. To date, the Company has only issued stock options and restricted stock units. Under the 1996 Plan, the exercise price for all stock options will not be less than the fair market value of the Company's common stock on the date of grant. Options granted under the 1996 Plan, as well as under the Company's other stock plans described above, generally vest over a period of up to five years and expire from five to ten years from the date of the grant or such shorter term as may be provided in the agreement.

At June 25, 2011, the Company had 15.5 million shares of its common stock available for issuance to employees and other option recipients under its 1996 Stock Incentive Plan, 1993 Officer and Director Stock Option Plan, 1987 Stock Option Plan, 1987 Supplemental Stock Option Plan, and Supplemental Non-employee Stock Option Plan.

The following table summarizes stock options outstanding, exercisable and vested and expected to vest as of June 25, 2011:

	Options			Weighted Average Remaining Contractual Term (In Years)	Aggregate Intrinsic Value (1)
	Number of Shares		Weighted Average Exercise Price
Balance at June 28, 2008	76,906,882		35.59
Options Granted	8,309,163		13.06
Options Exercised	(2,377	)	11.39
Options Cancelled	(55,613,752	)	35.89
Balance at June 27, 2009	29,599,916		28.83
Options Granted	3,671,459		18.08
Options Exercised	(47,327	)	12.86
Options Cancelled	(4,061,541	)	32.38
Balance at June 26, 2010	29,162,507		27.05
Options Granted	3,559,132		17.61
Options Exercised	(1,460,652	)	17.22
Options Cancelled	(2,928,501	)	33.67
Balance at June 25, 2011	28,332,486		25.62	3.7	$	119,500,252
Exercisable at June 25, 2011	16,468,585		$32.33	2.7	$	25,036,590
Vested and expected to vest, June 25, 2011	27,345,574		$25.93	3.7	$	112,428,729

(1) Aggregate intrinsic value represents the difference between the exercise price and the closing price per share of the Company's common stock on June 24, 2011, the last business day preceding the fiscal year end, multiplied by the number of options outstanding, exercisable or vested and expected to vest as of June 25, 2011.

The following table summarizes information about stock options that were outstanding and exercisable at June 25, 2011:

	Outstanding Options			Options Exercisable
Range of Exercise Prices	Number Outstanding at June 25, 2011	Weighted Average Remaining Contractual Term (In years)	Weighted Average Exercise Price	Number Exercisable at June 25, 2011	Weighted Average Exercise Price
$12.00 - $18.04	9,496,988	5.03	$14.10	1,731,327	$12.95
$18.11 - $27.45	6,428,859	4.19	20.49	2,603,082	22.40
$28.52 - $43.00	10,614,912	2.52	35.57	10,357,209	35.69
$49.95 - $52.33	1,791,727	1.93	46.12	1,776,967	46.12
	28,332,486			16,468,585

During fiscal year 2011, the Company granted approximately 3.6 million stock options from its 1996 Plan with an estimated total grant date fair value of $14.3 million. The weighted average grant date fair values of stock options granted during fiscal years 2011, 2010 and 2009 were $4.02, $4.23 and $3.61, respectively. The total intrinsic value of options exercised during fiscal year 2011 was $11.8 million and insignificant in fiscal years 2010 and 2009, respectively. The total fair value of options vested during fiscal year 2011 was $23.0 million and insignificant in fiscal years 2010 and 2009, respectively. As of June 25, 2011, there was $33.2 million of total unrecognized compensation costs related to 11.9 million unvested stock options expected to be recognized over a weighted average period of approximately 2.5 years.

Restricted Stock Units

Restricted stock units ("RSUs") generally vest on a quarterly basis over a service period of up to five years from the grant date. The restricted stock units represent a promise by the Company to the employees to issue shares of its common stock in the future, provided the vesting criteria are satisfied. RSUs granted reduce the total number of shares available for issuance under the 1996 Plan by a factor of two. To the extent RSUs are returned back to the 1996 Plan, for example, due to cancellations, such RSUs would increase the number of shares available to grant by a factor of two.

The following table summarizes outstanding and expected to vest RSUs as of June 25, 2011 and their activity during fiscal year 2011, 2010 and 2009:

	Number of Shares		Weighted Average Remaining Contractual Term (In Years)	Aggregate Intrinsic Value (1)
Balance at June 28, 2008	10,266,201
Restricted stock units granted	10,738,846
Restricted stock units released	(8,160,302	)
Restricted stock units cancelled	(977,416	)
Balance at June 27, 2009	11,867,329
Restricted stock units granted	4,259,756
Restricted stock units released	(4,813,738	)
Restricted stock units cancelled	(737,930	)
Balance at June 26, 2010	10,575,417
Restricted stock units granted	4,171,372
Restricted stock units released	(3,922,768	)
Restricted stock units cancelled	(823,283	)
Balance at June 25, 2011	10,000,738		2.5	239,894,343
Expected to vest at June 25, 2011	8,897,935		2.4	213,906,362

(1) Aggregate intrinsic value for RSUs represents the closing price per share of the Company's common stock on June 24, 2011, the last business day preceding the fiscal year end, multiplied by the number of RSUs outstanding, or expected to vest as of June 25, 2011.

The Company withheld shares worth $8.9 million related to employee withholding taxes based on the value of the RSUs on their vesting date as determined by the Company's closing stock price during the year ended June 25, 2011. The total payments for the employees' tax obligations to the taxing authorities are reflected as financing activities within the Consolidated Statements of Cash Flows.

The weighted average grant-date fair value of RSUs granted during fiscal years 2011, 2010 and 2009 was $16.61, $16.20 and $11.91, respectively. As of June 25, 2011, there was $122.8 million of unrecognized compensation cost related to 10.0 million unvested RSUs, which is expected to be recognized over a weighted average period of approximately 2.5 years.

2008 Employee Stock Purchase Plan

In December 2008, stockholders of the Company approved the creation of the 2008 Employee Stock Purchase Plan ("2008 ESPP"). Under the 2008 ESPP, the Company has reserved to date 8.0 million shares of its common stock for future issuance. The 2008 ESPP permits two purchases over a twelve month offer period. Pursuant to the terms of the 2008 ESPP, eligible employees may elect withholdings of up to 25% of eligible compensation to purchase shares of common stock at the lower of (i) 85% of the fair market value of the shares on the offer date or (ii) 85% of the fair market value of the shares on the purchase date. The 2008 ESPP does not permit employees to buy more than $25,000 worth of stock annually or 1,600 shares during an offer period.

The Company issued 1.7 million shares of its common stock for total consideration of $29.0 million related to the ESPP plan during the fiscal year ended June 25, 2011. As of June 25, 2011, the Company has remaining 4.0 million shares of its common stock reserved and available for future issuance under the 2008 ESPP.

XML



Balance Sheet Components (Tables)

12 Months Ended

Jun. 25, 2011

Balance Sheet Related Disclosures [Abstract]

Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]

Accounts receivables, net consist of:

	June 25, 2011			June 26, 2010
	(in thousands)
Accounts receivable	$	315,329		$	356,760
Returns and allowances	(17,697		)	(17,438		)
	$	297,632		$	339,322

Schedule of Inventory, Current [Table Text Block]

The components of inventories consist of:

	June 25, 2011		June 26, 2010
Inventory:	(In thousands)
Raw materials	$	18,419	$	16,747
Work-in-process	162,245		140,497
Finished goods	57,264		48,796
	$	237,928	$	206,040

Property, Plant and Equipment [Table Text Block]

Property, plant and equipment, net consist of:

	June 25, 2011			June 26, 2010
Property and equipment:	(In thousands)
Land	$	86,257		$	87,237
Buildings and building improvements	313,642			341,734
Machinery and equipment	1,978,827			1,872,349
	2,378,726			2,301,320
Less accumulated depreciation	(1,069,876		)	(976,884		)
	$	1,308,850		$	1,324,436

XML



Summary of Significant Accounting Policies Self-Insurance Accrual (Details) (USD $) In Thousands	12 Months Ended
	Jun. 25, 2011	Jun. 25, 2011 Defective Product, Employment Practice, Property and Casualty, and General Liability Claims [Member]	Jun. 26, 2010 Defective Product, Employment Practice, Property and Casualty, and General Liability Claims [Member]	Jun. 25, 2011 Employee Healthcare Claims [Member]	Jun. 26, 2010 Employee Healthcare Claims [Member]
Workers' compensation deductible per case	$ 1,000
Amounts accrued for self insurance		$ 4,669	$ 4,394	$ 5,919	$ 5,630

XML



Income Taxes (Tables)

12 Months Ended

Jun. 25, 2011

Income Tax Disclosure [Abstract]

Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]

The provision for income taxes consisted of the following:

	For the Year Ended
	June 25, 2011		June 26, 2010			June 27, 2009
	(in thousands)
Federal
Current	$	44,579	$	151,786		$	30,237
Deferred	118,351		12,340			(7,447		)
State
Current	781		4,092			(2,056		)
Deferred	4,204		(1,464		)	(681		)
Foreign
Current	2,810		14,345			2,995
Deferred	1,937		(6,175		)	1,116
	$	172,662	$	174,924		$	24,164

Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]

The provision for income taxes differs from the amount computed by applying the statutory rate as follows:

	For the Year Ended
	June 25, 2011		June 26, 2010		June 27, 2009
Federal statutory rate	35.0	%	35.0	%	35.0	%
State tax, net of federal benefit	0.7		0.4		(10.8	)
General business credits	(1.5	)	(1.2	)	(25.6	)
Domestic production deduction benefit	(0.1	)	(2.1	)	(16.1	)
Foreign earnings and losses taxed or benefitted at different rates	(4.6	)	21.0		76.5
Stock-based compensation	1.3		3.0		8.4
Acquired in process R&D	—		—		3.9
Executive compensation	0.1		0.1		(11.2	)
Release of unrecognized tax benefits	(4.1	)	—		—
Interest accrual for unrecognized tax benefits	(1.6	)	0.9		9.9
Other	0.9		1.2		(0.2	)
Income tax rate	26.1	%	58.3	%	69.8	%

Schedule of Deferred Tax Assets and Liabilities [Table Text Block]

The components of the Company's deferred tax assets and liabilities are as follows:

	For the Year Ended
	June 25, 2011			June 26, 2010
	(in thousands)
Deferred tax assets:
Inventory valuation and reserves	$	11,768		$	66,087
Distributor related accruals and sales return and allowance accruals	21,334			14,168
Deferred revenue	2,233			3,187
Accrued compensation	56,467			47,500
Stock-based compensation	73,295			84,225
Net operating loss carryovers	20,827			31,450
Tax credit carryovers	43,285			46,025
Other reserves and accruals not currently deductible for tax purposes	10,608			75,782
Other	8,940			18,437
Total deferred tax assets	248,757			386,861
Deferred tax liabilities:
Fixed assets cost recovery, net	(257,647		)	(240,463		)
Other	(12,168		)	(10,524		)
Net deferred tax assets /(liabilities) before valuation allowance	(21,058		)	135,874
Valuation allowance	(44,562		)	(47,006		)
Net deferred tax assets/(liabilities)	$	(65,620	)	$	88,868

Summary of Income Tax Contingencies [Table Text Block]

A reconciliation of the change in gross unrecognized tax benefits, excluding interest, penalties and the federal benefit for state unrecognized tax benefits, is as follows:

	For the Year Ended
	June 25, 2011			June 26, 2010
	(in thousands)
Balance as of beginning of year	$	151,464		$	137,298
Tax positions related to current year:
Addition	59,345			31,491
Tax positions related to prior year:
Addition	7,935			5,696
Reduction	(21,399		)	(190		)
Settlements	(16,636		)	(22,831		)
Lapses in statutes of limitations	(63,296		)	—
Balance as of end of year	$	117,413		$	151,464

Summary of Income Tax Examinations [Table Text Block]

A summary of the fiscal tax years that remain subject to examination, as of June 25, 2011, for the Company's major tax jurisdictions are:

United States - Federal	2008 - forward
United States - Various States	2007 - forward
Japan	2006 - forward
Philippines	2008 - forward
Thailand	2009 - forward
United Kingdom	2008 - forward

XML



Schedule II - Valuation and Allowance

12 Months Ended

Jun. 25, 2011

Valuation and Qualifying Accounts [Abstract]

Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]

VALUATION AND QUALIFYING ACCOUNTS

	Balance at Beginning of Period		Additions (Deductions) Charged (Credited) to Costs and Expenses			Deductions (1)		Balance at End of Period
	(In thousands)
Doubtful accounts
Year ended June 25, 2011	$	2,446	$	(362	)	$	379	$	1,705
Year ended June 26, 2010	$	2,831	$	457		$	842	$	2,446
Year ended June 27, 2009	$	3,174	$	(9	)	$	334	$	2,831
	Balance at Beginning of Period		Additions (Deductions) Charged (Credited) to Costs and Expenses			Deductions		Balance at End of Period
	(In thousands)
Returns and Allowances
Year ended June 25, 2011	$	14,992	$	74,456		$	73,456	$	15,992
Year ended June 26, 2010	$	10,332	$	67,505		$	62,845	$	14,992
Year ended June 27, 2009	$	12,054	$	45,220		$	46,942	$	10,332

(1) Uncollectible accounts written off.

XML



Restructuring Activities

12 Months Ended

Jun. 25, 2011

Restructuring and Related Activities [Abstract]

Restructuring Activities [Text Block]

RESTRUCTURING ACTIVITIES

Significant FY'10 Activities

Ireland Sales Operations Restructuring

In fiscal year 2010, the Company recorded approximately $3.0 million in restructuring costs associated with the reorganization of its international sales operations to Ireland.

Shutdown of Dallas Wafer Fabrication Facility

In fiscal year 2010, the Company recorded approximately $1.6 million in restructuring costs associated with the closure of the Dallas, Texas wafer manufacturing facility. These costs consisted of decommissioning of equipment at the facility and estimated severance and benefits associated with employees of the facility.

Change in Estimate

During fiscal year 2010, the Company recognized reversals of expense of approximately $5.3 million related to reductions in estimated benefits costs compared to amounts originally estimated.

Significant FY'09 Activities

San Jose Fab Rampdown

In fiscal year 2009, the Company continued its transfer of wafer manufacturing production from its San Jose, California wafer manufacturing facility to Epson's Sakata, Japan facility. In connection with the resulting termination of 78 employees, the Company recorded and paid approximately $2.1 million in severance and benefit arrangements.

Dallas Fab Closure

In fiscal year 2009, the Company recorded approximately $3.1 million in severance and benefit expenses in connection with the closure of the Dallas, Texas wafer manufacturing facility during the fourth quarter of fiscal year 2009.

Test Operation Cost Reduction

The Company continued its cost reduction efforts within the test operations function during fiscal year 2009 resulting in the recording of $3.4 million in severance and benefit expenses in connection with the involuntary termination of approximately 95 employees.

Cost Reduction of Business Units

In order to improve operational and selling efficiency, the Company reviewed its relative long term goals and decided to reduce development efforts in certain product lines and increase investment in others. During the second quarter of fiscal year 2009, the Company consolidated several product lines in business units which resulted in the termination of approximately 128 employees in the United States and total costs of approximately $6.1 million, consisting principally of severance and benefit payments.

The Company terminated certain international employees in certain business units during the third quarter of fiscal year 2009 and recognized an additional $0.6 million consisting principally of severance and benefit payments.

Cost Reduction of Selling, General and Administrative Groups

The Company also previously announced the decision to consolidate certain selling, general and administrative functions throughout the world, which resulted in the termination of approximately 44 employees and total costs consisting principally of severance and benefit payments of approximately $1.7 million in fiscal year 2009.

Cost Reduction in Domestic Manufacturing & Support Functions

During the third quarter of fiscal year 2009, as a result of the continued global economic weakness, the Company announced restructuring programs primarily in the manufacturing and support functions. These activities resulted in the eventual termination of approximately 382 employees (189 fab employees and 193 other employees in the US) between March and April 2009 and total costs of approximately $11.3 million, consisting principally of severance and medical benefit costs. These costs are included in restructuring expenses in the Consolidated Statements of Income.

Lease Restructuring

In addition to the Company's severance activities, the Company also decided to vacate certain leased offices in Greensboro, North Carolina, Santa Clara, California, Irving, Texas, and Swindon, United Kingdom, which resulted in a lease impairment of approximately $0.5 million during fiscal year 2009.

Change in Estimate

During fiscal year 2009 the Company recognized reversals of expense of approximately $4.6 million related to reductions in estimated benefits costs compared to amounts originally estimated.

Activity and liability balances related to the restructuring activity for fiscal year 2010 and fiscal year 2011 follows:

	Severance and Benefits
	(in thousands)
Balance at June 27, 2009	$	7,694
Restructuring accrual	4,558
Cash payments	(6,247		)
Changes in estimates	(5,257		)
Balance at June 26, 2010	$	748
Restructuring accrual	3,007
Cash payments	(3,640		)
Balance at June 25, 2011	$	115

The Company has included this amount in accrued salary and related expenses in the Consolidated Balance Sheets.

XML



Summary of Significant Accounting Policies

12 Months Ended

Jun. 25, 2011

Accounting Policies [Abstract]

Summary of Significant Accounting Policies [Text Block]

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Fiscal Year

The Company has a 52-to-53-week fiscal year that ends on the last Saturday of June. Accordingly, every fifth or sixth year will be a 53-week fiscal year. Fiscal years 2011, 2010 and 2009 were 52-week fiscal years. Fiscal year 2012 will be a 53-week fiscal year.

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Such estimates relate to the useful lives and fair value of fixed assets, valuation allowance for deferred tax assets, reserves relating to uncertain tax positions, allowances for doubtful accounts, customer returns and allowances, inventory valuation, reserves relating to litigation matters, assumptions about the fair value of reporting units, accrued liabilities and reserves and assumptions related to the calculation of stock-based compensation. The Company bases its estimates and judgments on its historical experience, knowledge of current conditions and its beliefs of what could occur in the future, given available information. Actual results may differ from those estimates, and such differences may be material to the financial statements.

Basis of Presentation

The consolidated financial statements include the accounts of the Company and all of its majority-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. The condition for control of entities is the ownership of a majority voting interest and ability to otherwise exercise control over the entity.

Cash Equivalents and Short-term Investments

The Company considers all highly liquid financial instruments purchased with an original maturity of three months or less at the date of purchase to be cash equivalents. Cash and cash equivalents consist of demand accounts and money market funds. Short-term investments consist primarily of U.S. Agency debt securities with original maturities beyond three months at the date of purchase.

The Company's short-term investments are considered available-for-sale. Such securities are carried at fair market value based on market quotes. Unrealized gains and losses, net of tax, on securities in this category are reported as a separate component of stockholders' equity. Realized gains and losses on sales of investment securities are determined based on the specific identification method and are included in "Interest (expense) income and other, net" in the Consolidated Statements of Income.

Derivative Instruments

The Company generates revenues in various global markets based on orders obtained in non-U.S. currencies, primarily the Japanese Yen, the British Pound and the Euro. Maxim incurs expenditures denominated in non-US currencies, principally Philippine Pesos and Thailand Baht associated with the Company's manufacturing activities in the Philippines and Thailand, respectively. Maxim is exposed to fluctuations in foreign currency exchange rates primarily on orders and accounts receivable from sales in these foreign currencies and cash flows for expenditures in these foreign currencies. Maxim has established risk management strategies designed to reduce the impact of volatility of future cash flows caused by changes in the exchange rates for these currencies. These strategies reduce, but do not entirely eliminate, the impact of currency exchange rates movements.

Currency forward contracts are used to offset the currency risk of non-U.S. dollar-denominated assets and liabilities. The Company typically enters into currency forward contracts quarterly to hedge exposures associated with its expenditures denominated in Philippine Pesos and Thailand Baht. The Company enters into contracts each quarter for its accounts receivable and backlog denominated in Japanese Yen, British Pound and Euro. Changes in fair value of the underlying assets and liabilities are generally offset by the changes in fair value of the related currency forward contract.

The Company uses currency forward contracts to hedge exposure to variability in anticipated non-U.S. dollar denominated cash flows. These contracts are designated as cash flow hedges and recorded on the Consolidated Balance Sheets at their fair market value. The maturities of these instruments are generally less than 6 months. For derivative instruments that are designated and qualify as cash flow hedges, the effective portion of the gain or loss on the derivative is reported as a component of accumulated other comprehensive income (loss) and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings.  For derivative instruments that are not designated as hedging instruments gains and losses are recognized in "interest (expense) income and other, net" in the Consolidated Statements of Income.

Fair Value of Financial Instruments

Maxim measures certain financial assets and liabilities at fair value based on the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants. See Note 5 for a further discussion on fair value of financial instruments.

Inventories

Inventories are stated at the lower of (i) standard cost, which approximates actual cost on a first-in-first-out basis, or (ii) market value. Because of the cyclical nature of the market, inventory levels, obsolescence of technology, and product life cycles, the Company generally writes down inventories to net realizable value based on 12 months forecasted product demand.

Property, Plant and Equipment

Property, plant and equipment are stated at cost. Depreciation is primarily computed on the straight-line method over the estimated useful lives of the assets, which range from 2 to 15 years for machinery and equipment and up to 40 years for buildings and building improvements. Leasehold improvements are amortized over the lesser of their useful lives or the remaining term of the related lease. When assets are retired or otherwise disposed of, the cost and accumulated depreciation or amortization is removed from the accounts and any resulting gain or loss is reflected in operating expense in the Consolidated Statements of Income in the period recognized.

The Company evaluates the recoverability of property, plant and equipment in accordance with Accounting Standards Codification ("ASC") No. 360, Accounting for the Property, Plant, and Equipment. ("ASC No. 360"). The Company performs periodic reviews to determine whether facts and circumstances exist that would indicate that the carrying amounts of property, plant and equipment exceeds their fair values. If facts and circumstances indicate that the carrying amount of property, plant and equipment might not be fully recoverable, projected undiscounted net cash flows associated with the related asset or group of assets over their estimated remaining useful lives are compared against their respective carrying amounts. In the event that the projected undiscounted cash flows are not sufficient to recover the carrying value of the assets, the assets are written down to their estimated fair values. All long-lived assets to be disposed of are reported at the lower of carrying amount or fair market value, less expected selling costs.

Intangible Assets and Goodwill

The Company accounts for intangible assets in accordance with ASC No. 360. The Company reviews goodwill and purchased intangible assets with indefinite lives for impairment annually and whenever events or changes in circumstances indicate the carrying value of an asset may not be recoverable, such as when reductions in demand or significant economic slowdowns in the semiconductor industry are present. Reviews are performed to determine whether the carrying value of an asset is impaired, based on comparisons to undiscounted expected future cash flows. If this comparison indicates that there is impairment, the impaired asset is written down to fair value, which is typically calculated using: (i) quoted market prices or (ii) discounted expected future cash flows utilizing a discount rate consistent with the guidance provided in FASB Concepts Statement No. 7, Using Cash Flow Information and Present Value in Accounting Measurements. Impairment is based on the excess of the carrying amount over the fair value of those assets.

Goodwill is recorded as the difference, if any, between the aggregate consideration paid for an acquisition and the fair value of the net tangible and intangible assets acquired. In accordance with ASC No. 350, Intangibles-Goodwill and Other, ("ASC 350"), the Company tests goodwill for impairment at the reporting unit level (operating segment or one level below an operating segment) on an annual basis in the first quarter or more frequently if the Company believes indicators of impairment exist. The performance of the test involves a two-step process. The first step of the impairment test involves comparing the fair values of the applicable reporting units with their aggregate carrying values, including goodwill. The Company generally determines the fair value of the Company's reporting units using the income approach methodology of valuation that includes the discounted cash flow method as well as other generally accepted valuation methodologies. If the carrying amount of a reporting unit exceeds the reporting unit's fair value, the Company performs the second step of the goodwill impairment test to determine the amount of impairment loss. The second step of the goodwill impairment test involves comparing the implied fair value of the affected reporting unit's goodwill with the carrying value of that goodwill. No impairment charges were recorded associated with our goodwill and intangible assets during fiscal years 2011, 2010, and 2009, respectively.

Product Warranty

The Company warrants its products to its customers generally for one year from the date of shipment, but in certain cases for longer periods. In certain other cases, the Company's product warranty may include significant financial responsibility beyond the cost of replacing the product. If there is a material increase in the rate of customer claims or the Company's estimates of probable losses relating to specifically identified warranty exposures are inaccurate, the Company may record a charge against future cost of sales. Warranty expense has historically been immaterial to the Company's financial statements.

Self-Insurance Accruals

The Company is self-insured with respect to defective product claims, employment practice claims, property and casualty and general liability. The Company's workers' compensation insurance has a $1.0 million deductible per case. Accruals are primarily based on the estimated, undiscounted cost of claims, which includes incurred-but-not-reported claims. Amounts accrued for defective product claims, employment practice claims, workers' compensation claims, property and casualty and general liability of $4.7 million and $4.4 million are included in accrued expenses as of June 25, 2011 and June 26, 2010, respectively.

In addition to the above, the Company is primarily self-insured with respect to healthcare benefits for most of its domestic employees. Accruals are primarily based on estimated incurred-but-not-reported claims. Amounts accrued for employee healthcare claims of $5.9 million and $5.6 million are included in accrued salary and related expenses as of June 25, 2011 and June 26, 2010, respectively.

Retirement Benefits

The Company periodically provides medical benefits to former employees pursuant to retirement agreements and other post-employment arrangements. The Company accounts for medical benefits to individuals pursuant to a documented plan under ASC No. 715, Compensation- Retirement Benefits, while one-off employment arrangements are treated as post-employment benefits recognized when the liability is incurred and the amount is estimable under ASC No. 712, Compensation-Nonretirement Postemployment Benefits, an amendment of ASC No. 715 ("ASC 712").

Income Taxes

The Company accounts for income taxes using an asset and liability approach as prescribed in ASC 740, Income Taxes.  The Company records the amount of taxes payable or refundable for the current and prior years and deferred tax assets and liabilities for the future tax consequences of events that have been recognized in the Company's financial statements or tax returns.  A valuation allowance is recorded to reduce deferred tax assets when it is more likely than not that a tax benefit will not be realized.

ASC 740-10 prescribes a recognition threshold and measurement framework for the financial statement reporting and disclosure of an income tax position taken or expected to be taken on a tax return. Under ASC 740-10, a tax position is recognized in the financial statements when it is more-likely-than-not, based on the technical merits, that the position will be sustained upon examination, including resolution of any related appeals or litigation processes. A tax position that meets the recognition threshold is then measured to determine the largest amount of the benefit that has a greater than 50% likelihood of being realized upon settlement.

The calculation of tax liabilities involves significant judgment in estimating the impact of uncertainties in the application of complex tax laws across multiple tax jurisdictions. Although ASC 740-10 provides clarification on the accounting for uncertainty in income taxes recognized in the financial statements, the threshold and measurement attributes will continue to require significant judgment by management. Resolution of these uncertainties in a manner inconsistent with the Company's expectations could have a material impact on the Company's results of operations.

Revenue Recognition

The Company recognizes revenue for sales to direct customers and sales to distributors upon shipment, provided that persuasive evidence of a sales arrangement exists, the price is fixed or determinable, title and risk of loss has transferred, collectability of the resulting receivable is reasonably assured, there are no customer acceptance requirements and we do not have any significant post-shipment obligations. The Company estimates returns for sales to direct customers and international distributors based on historical returns rates applied against current period gross revenues. Specific customer returns and allowances are considered within this estimate.

Sales to certain distributors are made pursuant to agreements allowing for the possibility of certain sales price rebates and for non-warranty product return privileges. The non-warranty product return privileges include allowing certain U.S. distributors to return a small portion of our products in their inventory based on their previous 90 days of purchases. Given the uncertainties associated with the levels of non-warranty product returns and sales price rebates that could be issued to U.S. distributors, the Company defers recognition of such revenue and related cost of goods sold until the product is sold by the U.S. distributors to their end-customers. Accounts receivable from direct customers, domestic distributors and international distributors are recognized and inventory is relieved upon shipment as title to inventories generally transfers upon shipment at which point the Company has a legally enforceable right to collection under normal terms. Accounts receivable related to consigned inventory is recognized when the customer takes title of such inventory from its consigned location at which point inventory is relieved, title transfers, and the Company has a legally enforceable right to collection under the terms of our agreement with the related customers.

The Company estimates potential future returns and sales allowances related to current period product revenue.  Management analyzes historical returns, changes in customer demand and acceptance of products when evaluating the adequacy of returns and sales allowances.  Estimates made by the Company may differ from actual returns and sales allowances.  These differences may materially impact reported revenue and amounts ultimately collected on accounts receivable. Historically, such differences have not been material. At June 25, 2011 and June 26, 2010, the Company had $16.0 million and $15.0 million reserved for returns and allowances against accounts receivable, respectively. During fiscal years 2011 and 2010, the Company recorded $74.5 million and $67.5 million for estimated returns and allowances against revenues, respectively. These amounts were offset by $73.5 million and $62.8 million actual returns and allowances given during fiscal years 2011 and 2010, respectively.

Research and Development Costs

Research and development costs are expensed as incurred. Such costs consist primarily of expenditures for labor and benefits, masks, prototype wafers and depreciation.

Advertising

Advertising costs are expensed as incurred and included in selling, general and administrative expenses in the Consolidated Statements of Income. Advertising expenses were immaterial in fiscal years 2011, 2010, and 2009, respectively.

Shipping Costs

Shipping costs billed to customers are included in net revenues and the related shipping costs are included in cost of goods sold.

Stock-Based Compensation

Stock-based compensation cost is measured at the grant date, based on the fair value of the awards ultimately expected to vest and is recognized as an expense, on a straight-line basis, over the requisite service period. The Company uses the Black-Scholes valuation model to measure the fair value of its stock-based awards utilizing various inputs with respect to expected holding period, risk-free interest rates, stock price volatility and dividend yield.

ASC 718 also requires forfeitures to be estimated at the time of grant and revised if necessary in subsequent periods if actual forfeitures or vesting differ from those estimates. Such revisions could have a material effect on the Company's operating results. The assumptions the Company uses in the valuation model are based on subjective future expectations combined with management judgment. If any of the assumptions used in the Black-Scholes model changes, stock-based compensation for future awards may differ materially compared to the awards granted previously.

Restructuring

Post-employment benefits accrued for workforce reductions related to restructuring activities in the United States are accounted for under ASC 712. A liability for post-employment benefits is recorded when payment is probable, the amount is reasonably estimable, and the obligation relates to rights that have vested or accumulated. In accordance with ASC No. 420, Exit or Disposal Cost Obligations ("ASC 420"), generally costs associated with restructuring activities initiated outside the United States have been recognized when they are incurred.

The Company continually evaluates the adequacy of the remaining liabilities under its restructuring initiatives. Although the Company believes that these estimates accurately reflect the costs of its restructuring plans, actual results may differ, thereby requiring the Company to record additional provisions or reverse a portion of such provisions.

Foreign Currency Translation and Remeasurement

The U.S. dollar is the functional currency for the Company's foreign operations. Using the U.S. dollar as the functional currency, monetary assets and liabilities are remeasured at the year-end exchange rates. Certain non-monetary assets and liabilities are remeasured using historical rates. Statements of Income are remeasured at the average exchange rates during the year.

Earnings Per Share

Basic earnings per share are computed using the weighted average number of common shares outstanding during the period. Diluted earnings per share incorporate the potentially dilutive incremental shares issuable upon the assumed exercise of stock options, the assumed vesting of outstanding restricted stock units, and the assumed issuance of common stock under the stock purchase plan. The number of incremental shares from the assumed issuance of stock options is calculated by applying the treasury stock method. See Note 7 "Earnings Per Share" of these Notes to the Consolidated Financial Statements.

Litigation and Contingencies

From time to time, the Company receives notices that its products or manufacturing processes may be infringing the patent or intellectual property rights of others, notices of stockholder litigation or other lawsuits or claims against the Company. The Company periodically assesses each matter in order to determine if a contingent liability in accordance with ASC 450, should be recorded. In making this determination, management may, depending on the nature of the matter, consult with internal and external legal counsel and technical experts. The Company expenses legal fees associated with consultations and defense of lawsuits as incurred. Based on the information obtained combined with management's judgment regarding all the facts and circumstances of each matter, the Company determines whether a contingent loss is probable and whether the amount of such loss can be estimated. Should a loss be probable and estimable, the Company records a contingent loss in accordance with ASC 450. In determining the amount of a contingent loss, the Company takes into consideration advice received from experts in the specific matter, current status of legal proceedings, settlement negotiations which may be ongoing, prior case history and other factors. Should the judgments and estimates made by management be incorrect, the Company may need to record additional contingent losses that could materially adversely impact its results of operations. Alternatively, if the judgments and estimates made by management are incorrect and a particular contingent loss does not occur, the contingent loss recorded would be reversed thereby favorably impacting the Company's results of operations.

Pursuant to the Company's charter documents and indemnification agreements, the Company has certain indemnification obligations to its officers and directors, and certain former officers and directors. More specifically, the Company has separate written indemnification agreements with its current and former executive officers and directors. Pursuant to such obligations, the Company has incurred substantial expenses related to legal fees and expenses to certain former officers of the Company subject to civil charges by the SEC in connection with Maxim's historical stock option granting practices. The Company has also incurred substantial expenses related to legal fees and expenses advanced to certain current and former officers and directors who were defendants in the civil actions described above. The Company expenses such amounts as incurred.

Concentration of Credit Risk

Due to the Company's credit evaluation and collection process, bad debt expenses have not been significant. Credit risk with respect to trade receivables is limited because a large number of geographically diverse customers make up the Company's customer base, thus spreading the credit risk. The company derived approximately 30% of our fiscal 2011 revenue from sales made through distributors. Our primary distributor is Avnet Electronics. Avnet, like our other distributors are not end customers, but rather serve as a channel of sale to many end users of the Company's products. Avnet accounted for 14% and 12% of revenues in fiscal years 2011 and 2010, respectively, and 11% and 10% of accounts receivable in fiscal years 2011 and 2010, respectively. Samsung, our largest single customer, excluding distributors, accounted for approximately 12% and 12% of net revenues in fiscal year 2011 and 2010, respectively, and 18% and 13% of accounts receivable as of June 25, 2011 and June 26, 2010, respectively. No other single customer accounted for more than 10% of revenue or receivables in fiscal years 2011, 2010 and 2009.

The Company maintains cash, cash equivalents, and short-term investments with various high credit quality financial institutions, limits the amount of credit exposure to any one financial institution or instrument, and is exposed to credit risk in the event of default by these institutions to the extent of amounts recorded at the balance sheet date. To date, the Company has not incurred losses related to these investments.

Concentration of Other Risks

The semiconductor industry is characterized by rapid technological change, competitive pricing pressures, and cyclical market patterns. The Company's results of operations are affected by a wide variety of factors, including general economic conditions, both in the United States and abroad; economic conditions specific to the semiconductor industry and to the analog and mixed signal portion of that industry; demand for the Company's products; the timely introduction of new products; implementation of new manufacturing technologies; manufacturing capacity; the ability to manufacture efficiently; the availability of materials, supplies, machinery and equipment; competition; the ability to safeguard patents and intellectual property in a rapidly evolving market; and reliance on assembly and, to a small extent, wafer fabrication subcontractors and on independent distributors and sales representatives. As a result, the Company may experience substantial period-to-period fluctuations in future operating results due to the factors mentioned above or other factors.

Recently Issued Accounting Pronouncements

In June 2011, the FASB issued Accounting Standards Update (“ASU”) relating to Comprehensive Income (Topic 220)-Presentation of Comprehensive Income (ASU 2011-05), to require an entity to present the total of comprehensive income, the components of net income, and the components of other comprehensive income either in a single continuous statement of comprehensive income or in two separate but consecutive statements. The ASU is effective for us in our third quarter of fiscal 2012 and should be applied retrospectively. The Company is currently evaluating the impact of its pending adoption of ASU 2011-05 on its consolidated financial statements.

In May 2011, the FASB issued ASU No. 2011-04, Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and International Financial Reporting Standards (Topic 820)-Fair Value Measurement (ASU 2011-04), to provide a consistent definition of fair value and ensure that the fair value measurement and disclosure requirements are similar between U.S. GAAP and International Financial Reporting Standards. ASU 2011-04 changes certain fair value measurement principles and enhances the disclosure requirements particularly for level 3 fair value measurements. ASU 2011-04 is effective for us in our first quarter of fiscal 2013 and should be applied prospectively. The Company is currently evaluating the impact of its pending adoption of ASU 2011-04 on its consolidated financial statements.

XML



Segment Information (Tables)

12 Months Ended

Jun. 25, 2011

Segment Reporting [Abstract]

Schedule of Revenue from External Customers by Geographical Areas [Table Text Block]

Net revenues from unaffiliated customers by geographic region were as follows:

	For the Year Ended
	June 25, 2011		June 26, 2010		June 27, 2009
	(in thousands)
United States	$	360,310	$	291,539	$	302,648
China	915,628		685,908		496,091
Japan	163,061		131,513		120,763
Korea	294,006		311,928		229,833
Rest of Asia	283,121		223,786		169,203
Europe	379,173		288,675		291,524
Rest of World	77,042		64,254		35,953
	$	2,472,341	$	1,997,603	$	1,646,015

Schedule of Long Lived Assets by Geographical Areas [Table Text Block]

Net long-lived assets by geographic region were as follows:

	Fiscal Year Ended
	June 25, 2011		June 26, 2010
	(in thousands)
United States	$	972,380	$	983,761
Philippines	204,581		216,738
Thailand	120,838		116,050
Rest of World	11,051		7,887
	$	1,308,850	$	1,324,436

XML



Goodwill and Intangible Assets

12 Months Ended

Jun. 25, 2011

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill and Intangible Assets [Text Block]

GOODWILL AND INTANGIBLE ASSETS

Goodwill

The Company classifies goodwill and acquired intangible assets within other assets in the Consolidated Balance Sheets. The Company's carrying value of goodwill was $265.1 million and $226.2 million at June 25, 2011 and June 26, 2010, respectively.

	Goodwill
Balance at June 26, 2010	$	226,223
Acquisition	42,564
Adjustments	(3,662		)
Balance at June 25, 2011	$	265,125

Intangible Assets

The useful lives of the significant definite lived intangible assets are as follows:

Asset	Life
Intellectual Property	5-10 years
Customer Relationships	5-10 years
Tradename	3 years
Backlog	1 year

Intangible assets consisted of the following:

	June 25, 2011						June 26, 2010
	Original Cost		Accumulated Amortization		Net		Original Cost		Accumulated Amortization		Net
	(in thousands)
Intellectual property	$	195,912	$	64,996	$	130,916	$	145,262	$	33,305	$	111,957
Customer relationships	88,630		24,915		63,715		87,030		11,745		75,285
Backlog	6,400		5,687		713		4,500		2,350		2,150
Tradename	1,700		981		719		1,400		264		1,136
Total amortizable purchased intangible assets	292,642		96,579		196,063		238,192		47,664		190,528
IPR&D	8,200		—		8,200		4,200		—		4,200
Total purchased intangible assets	$	300,842	$	96,579	$	204,263	$	242,392	$	47,664	$	194,728

The following table presents the amortization expense of intangible assets and its presentation in the Consolidated Statements of Income:

	For the Year Ended
	June 25, 2011		June 26, 2010		June 27, 2009
	(in thousands)
Cost of goods sold	$	30,164	$	10,999	$	8,024
Intangible Asset Amortization	18,752		10,477		6,019
Total Intangible Asset Amortization Expenses	$	48,916	$	21,476	$	14,043

The following table represents the estimated future amortization expense of intangible assets as of the end of fiscal year 2011:
Fiscal Year	Amount
	(in thousands)
2012	$	46,853
2013	42,022
2014	35,439
2015	33,131
2016	21,011
Thereafter	17,607
Total intangible assets	$	196,063

XML



Commitments and Contingencies

12 Months Ended

Jun. 25, 2011

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies [Text Block]

COMMITMENTS AND CONTINGENCIES

Stock Option Litigation

Beginning on or about May 22, 2006, several derivative actions were filed against certain current and former executive officers and directors of the Company alleging, among other things, wrongful conduct of back-dating stock options as well as security law violations, and named the Company as a nominal defendant against whom the plaintiffs sought no recovery.

The parties to the derivative litigation in the Delaware Court of Chancery entered into a stipulated settlement agreement, which was approved by the Delaware Court of Chancery on September 16, 2008. All derivative actions pending in the California Superior Court have since been dismissed, with prejudice. Net settlement proceeds of $18.9 million were received by the Company on September 10, 2009. The Company recognized an increase to additional paid in capital of $2.5 million related to excess gains while the remainder of the proceeds of $16.4 million was recorded as a reduction to Other operating (income) expenses, net.

On February 6, 2008, a putative class action complaint was filed against the Company and certain former officers and employees in the U.S. District Court for the Northern District of California alleging claims under the federal securities laws based on certain alleged misrepresentations and omissions in the Company's public disclosures concerning its stock option accounting practices.  On June 18, 2010, lead plaintiffs and the Company entered into a stipulation of settlement settling the action and providing for the payment of $173.0 million in cash by the Company. The Company made the payment in July, 2010. On September 29, 2010, the Court issued a Final Order and Judgment approving the settlement.

Other Legal Proceedings

In addition to the above proceedings, the Company is subject to other legal proceedings and claims that arise in the normal course of the Company's business. The Company does not believe that the ultimate outcome of such matters arising in the normal course of business will have a material adverse effect on the financial position, results of operations or cash flows of the Company.

Commitments

The Company leases certain of its facilities under various operating leases that expire at various dates through October 2025. The lease agreements generally include renewal provisions and require the Company to pay property taxes, insurance, and maintenance costs.

Future annual minimum payments for all commitments are as follows:

	Total		Less than 1 year		2-3 years		4-5 years		More than 5 years
	(Amounts in thousands)
Operating lease obligations (1)	$	44,489	$	12,808	$	15,478	$	8,005	$	8,198
Royalty obligations (2)	20,000		10,000		10,000		—		—
Long-term debt obligations (3)	300,000		—		300,000		—		—
Interest payments associated with long-term debt obligations (4)	20,441		10,350		10,091		—		—
Capital equipment and inventory related purchase obligations (5)	33,899		17,515		3,752		3,752		8,880
Total	$	418,829	$	50,673	$	339,321	$	11,757	$	17,078

(1) The Company leases some facilities under non-cancelable operating lease agreements that expire at various dates through 2025.

(2) Royalty obligations represent payments for licensed patents.

(3) Long-term debt represents amount due for the Company's 3.45% senior unsecured notes due 2013.

(4) Interest payments associated with the Company's 3.45% senior unsecured notes due 2013.

(5) Capital equipment purchase obligations represent commitments for purchase of property, plant and equipment. The Company orders some materials and supplies in advance or with minimum purchase quantities. The Company is obligated to pay for the materials and supplies when received.

Purchase orders for the purchase of the majority of our raw materials and other goods and services are not included in the table. Our purchase orders generally allow for cancellation without significant penalties. We do not have significant agreements for the purchase of raw materials or other goods specifying minimum quantities or set prices that exceed our expected short-term requirements.

Rental expense amounted to approximately $12.7 million, $8.2 million, and $7.7 million in fiscal years 2011, 2010 and 2009, respectively.

Potential Income Tax Liabilities Under Section 409A of the Internal Revenue Code and Other Payroll Taxes

In the past, a number of our outstanding stock option awards were granted at exercise prices below the fair market value of our stock on the appropriate accounting measurement date. Many of these options are potentially subject to option holder excise tax under Section 409A of the Internal Revenue Code (and, as applicable, similar excise taxes under state law or foreign law). In fiscal year 2008, we took action to cure certain options from exposure under Section 409A. However, there can be no assurance that such action cured all potential circumstances in which Section 409A would apply. Should it be determined that excise taxes under Section 409A were to apply and we decide to reimburse option holders for such taxes, our results of operations may be materially adversely affected. Also, we have determined that certain payroll taxes, interest and penalties may apply under various sections of the Internal Revenue Code, various state tax statutes, and tax statutes in various foreign jurisdictions. Maxim has reviewed these potential liabilities and accrued the estimated probable amount of the liability. There can be no assurance that our accruals covered all potential circumstances in which additional payroll taxes, interest and penalties would apply. Should it be found that additional payroll taxes, interest and penalties would apply, our results of operations may be materially adversely affected.

Indemnifications

The Company indemnifies certain customers, distributors, suppliers and subcontractors for attorney fees and damages and costs awarded against such parties in certain circumstances in which the Company's products are alleged to infringe third party intellectual property rights, including patents, registered trademarks or copyrights. The terms of the Company's indemnification obligations are generally perpetual from the effective date of the agreement. In certain cases, there are limits on and exceptions to the Company's potential liability for indemnification relating to intellectual property infringement claims.

Legal fees associated with indemnification obligations, defense and other related costs

Pursuant to the Company's charter documents and indemnification agreements, the Company has certain indemnification obligations to its officers and directors and certain former officers and directors. More specifically, we have separate written indemnification agreements with our current and former executive officers and directors. Pursuant to such obligations, the Company has incurred expenses related to legal fees and expenses advanced to certain former officers of the Company subject to civil charges by the SEC in connection with Maxim's historical stock option granting practices.  The Company expenses such amounts as incurred.

XML



Income Taxes (Details) (USD $)	12 Months Ended
	Jun. 25, 2011	Jun. 26, 2010	Jun. 27, 2009
Federal
Current	$ 44,579,000	$ 151,786,000	$ 30,237,000
Deferred	118,351,000	12,340,000	(7,447,000)
State
Current	781,000	4,092,000	(2,056,000)
Deferred	4,204,000	(1,464,000)	(681,000)
Foreign
Current	2,810,000	14,345,000	2,995,000
Deferred	1,937,000	(6,175,000)	1,116,000
Total income tax expense (benefit)	172,662,000	174,924,000	24,164,000
Pretax income (loss) from foreign subsidiaries	285,000,000	(95,500,000)	(63,300,000)
Indefinitely reinvested earnings from foreign subsidiaries	123,800,000
Investments in Foreign Subsidiaries and Foreign Corporate Joint Ventures that are Essentially Permanent in Duration [Member]
Foreign
Unrecognized deferred tax liability on indefinitely reinvested earnings		$ 39,900,000

XML



Acquisitions

12 Months Ended

Jun. 25, 2011

Acquisition [Abstract]

Acquisitions [Text Block]

ACQUISITIONS

Acquisitions in fiscal 2011

The purchase price allocation for acquisitions completed in fiscal year 2011 are set forth in the table below and reflects various preliminary fair value estimates and analysis, including preliminary work performed by third-party valuation specialists, which are subject to change within the measurement period as valuations are finalized.

Pro forma results of operations for these acquisitions have not been presented because they are not material to Maxim's consolidated results of operations, either individually or in the aggregate. Goodwill, which represents the excess of the purchase price over the net tangible and intangible assets acquired, is not deductible for tax purposes.

Aggregate purchase price allocation for Maxim's fiscal 2011 acquisitions:

	In millions
Net tangible assets	$	(11.5	)
Amortizable intangible assets	52.6
In-process research and development ("IPR&D")	6.0
Goodwill(1)	42.6
Total purchase price (1)	$	89.7

(1) Includes $8.8 million of contingent consideration relating to the Calvatec acquisition.

CALVATEC

On May 31, 2011, the Company acquired Calvatec Ltd, based in Edinburgh, Scotland. Calvatec is a developer of highly integrated, analog, mixed-signal solutions, as well as design methods and flows for analog system-on-a-chip (SoCs). The total cash consideration associated with the acquisition was $8.2 million. The acquired assets included cash of $0.4 million. Maxim also recorded $8.8 million, representing the fair value of contingent consideration that would be payable in the future should Calvatec meets certain specified project milestones. Total contingent consideration that could be paid out under the agreement amounts to $12.5 million.

PHYWORKS

On September 7, 2010, the Company acquired Phyworks Limited. (“Phyworks”), a developer of high-speed communications integrated circuits. The total cash consideration associated with the acquisition was $76.0 million. The acquired assets included cash of $4.6 million, accounts receivable of $1.2 million, inventories of $2.9 million, $0.1 million in prepaid expenses and other current assets, and $0.4 million in fixed assets. The Company preliminarily allocated $1.9 million to customer order backlog, $47.1 million to Intellectual Property, $5.8 million to in-process research and development (“IPR&D”), $1.6 million to customer relationships, $0.3 million to tradename, and $26.1 million to goodwill. The Company also assumed $3.8 million in accounts payable and accrued liabilities and $12.2 million in deferred tax liabilities. We have included the financial results of Phyworks in our consolidated financial statements from the date of acquisition. The Company expects that none of the goodwill will be deductible for tax purposes.

Subsequent acquisition

SENSORDYNAMICS

On July 18, 2011, the Company acquired SensorDynamics, a semiconductor company that develops proprietary sensor and microelectromechanical ("MEMS") solutions. SensorDynamics is based in Lebring, near Graz, Austria. The total cash consideration associated with the acquisition was approximately $130.0 million plus the assumption of approximately $34.0 million in debt. The Company is in the process of preparing the preliminary purchase price allocation. Given the timing of the acquisition, further details to support these estimates are not yet available.

Acquisitions in prior years

TERIDIAN

On May 11, 2010, the Company completed its purchase of Teridian Semiconductor, Inc. (“Teridian”), a fabless mixed-signal semiconductor company focused on electricity metering and energy measurement for the smart grid. The total cash consideration associated with the acquisition was $314.9 million. The acquired assets included cash of $2.1 million, accounts receivable of $7.3 million, inventories of $14.0 million, $2.7 million in prepaid expenses and other current assets, $2.1 million in fixed assets, $4.3 million in customer order backlog, $85.6 million in Intellectual Property, $3.1 million of in process research and development, $44.7 million in customer relationships, $1.0 million in tradename, $13.8 million in deferred tax assets and $196.6 million in goodwill. The Company also assumed $14.1 million in accounts payable and accrued liabilities and $48.3 million in deferred tax liabilities. The company expects that none of the goodwill will be deductible for tax purposes.

ZILOG

On February 18, 2009, the Company acquired the remote and secure product lines of Zilog Corporation, a publicly traded, fabless semiconductor company. The total cash consideration associated with the acquisition was $22.6 million consisting of $21.7 million in cash and $0.9 million in direct legal costs associated with the acquisition. The acquired assets included inventories of $2.9 million, $0.5 million in customer order backlog, $12.9 million in customer relationships, and $6.3 million in goodwill. The Company expects that all of the goodwill will be deductible for tax purposes.

INNOVA CARD

On December 29, 2008, the Company acquired Innova Card, a privately held, fabless semiconductor company focusing on advanced secure microcontroller technology for financial terminals. The total consideration associated with the acquisition was $13.5 million (including $8.1 million remitted to Innova Card equity shareholders upon close of the acquisition, $1.1 million to repay Innova Card debt, $3.8 million in future payments, and $0.5 million for legal and related acquisition costs). The acquired assets and liabilities included net working capital of $0.6 million, $0.2 million in fixed assets and other assets, $0.2 million in customer order backlog, $5.3 million in intellectual property, $3.0 million in customer relationships, and $4.2 million in goodwill.

During the fourth quarter of 2009, the Company remitted an additional $1.1 million to shareholders of Innova Card for additional working capital received pursuant to the agreement. The additional payment resulted in a corresponding increase in goodwill associated with the acquisition. The Company expects that none of the goodwill will be deductible for tax purposes.

MOBILYGEN

On October 27, 2008, the Company acquired Mobilygen Corporation ("Mobilygen"), a privately held, fabless semiconductor company with technology in H.264 video compression. The total consideration associated with the acquisition was $33.5 million consisting of $33.0 million cash and $0.5 million in direct legal costs associated with the acquisition. A portion of the cash consideration paid by the Company was used to retire all outstanding indebtedness of Mobilygen.

The Company allocated the acquisition cost to assets acquired and liabilities assumed based on their estimated fair values at the date of acquisition. The acquired assets included $1.5 million in tangible assets, $7.8 million of net deferred tax assets, $0.2 million in customer order backlog, $14.7 million in intellectual property, $4.2 million in customer relationships, $0.4 million in trademark and $2.2 million in goodwill. The Company recognized $3.9 million of research and development expense during the fiscal year 2009 in connection with this acquisition. In addition, the Company assumed $4.2 million of liabilities including $2.7 million in debt, which the Company paid off immediately after the acquisition was consummated.

The Company expects that none of the goodwill will be deductible for tax purposes.

XML



Goodwill and Intangible Assets (Tables)

12 Months Ended

Jun. 25, 2011

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of goodwill [Table Text Block]

	Goodwill
Balance at June 26, 2010	$	226,223
Acquisition	42,564
Adjustments	(3,662		)
Balance at June 25, 2011	$	265,125

Useful lives of definite lived intangible assets [Table Text Block]

The useful lives of the significant definite lived intangible assets are as follows:

Asset	Life
Intellectual Property	5-10 years
Customer Relationships	5-10 years
Tradename	3 years
Backlog	1 year

Schedule of intangible assets [Table Text Block]

Intangible assets consisted of the following:

	June 25, 2011						June 26, 2010
	Original Cost		Accumulated Amortization		Net		Original Cost		Accumulated Amortization		Net
	(in thousands)
Intellectual property	$	195,912	$	64,996	$	130,916	$	145,262	$	33,305	$	111,957
Customer relationships	88,630		24,915		63,715		87,030		11,745		75,285
Backlog	6,400		5,687		713		4,500		2,350		2,150
Tradename	1,700		981		719		1,400		264		1,136
Total amortizable purchased intangible assets	292,642		96,579		196,063		238,192		47,664		190,528
IPR&D	8,200		—		8,200		4,200		—		4,200
Total purchased intangible assets	$	300,842	$	96,579	$	204,263	$	242,392	$	47,664	$	194,728

Allocated amortization expense of intangible assets [Table Text Block]

The following table presents the amortization expense of intangible assets and its presentation in the Consolidated Statements of Income:

	For the Year Ended
	June 25, 2011		June 26, 2010		June 27, 2009
	(in thousands)
Cost of goods sold	$	30,164	$	10,999	$	8,024
Intangible Asset Amortization	18,752		10,477		6,019
Total Intangible Asset Amortization Expenses	$	48,916	$	21,476	$	14,043

Estimated future amortization expense of intangible assets [Table Text Block]

The following table represents the estimated future amortization expense of intangible assets as of the end of fiscal year 2011:
Fiscal Year	Amount
	(in thousands)
2012	$	46,853
2013	42,022
2014	35,439
2015	33,131
2016	21,011
Thereafter	17,607
Total intangible assets	$	196,063

XML



Earnings Per Share

12 Months Ended

Jun. 25, 2011

Earnings Per Share [Abstract]

Earnings Per Share [Text Block]

EARNINGS PER SHARE

Basic earnings per share are computed using the weighted average number of common shares outstanding during the period. For purposes of computing basic earnings per share, the weighted average number of outstanding shares of common stock excludes unvested RSUs. Diluted earnings per share incorporates the incremental dilutive shares issuable upon the assumed exercise of stock options, assumed release of unvested RSUs and assumed issuance of common stock under the employee stock purchase plans using the treasury stock method. As discussed in Note 6 herein, the Company cash-settled options that expired (reached the ten year contractual term) during the Blackout Period and cash-settled vested RSUs. These options and RSUs are considered liability instruments under ASC 718 and as such are excluded from the diluted earnings per share calculation.

The following table sets forth the computation of basic and diluted earnings per share:

	For the Year Ended
	June 25, 2011		June 26, 2010		June 27, 2009
	(In thousands, except per share data)
Numerator for basic earnings per share and diluted earnings
per share
Net income	$	489,009	$	125,139	$	10,455
Denominator for basic earnings per share	296,755		304,579		310,805
Effect of dilutive securities:
Stock options, RSUs, and ESPP	6,622		5,437		674
Denominator for diluted earnings per share	303,377		310,016		311,479
Earnings per share:
Basic	$	1.65	$	0.41	$	0.03
Diluted	$	1.61	$	0.40	$	0.03

Approximately 14.9 million, 21.1 million, and 29.6 million of the Company's stock awards were excluded from the calculation of diluted earnings per share for fiscal years 2011, 2010, and 2009, respectively. These options were excluded, as they were antidilutive. However, such options could be dilutive in the future.

XML



Financial Instruments, Volume of Derivative Activity (Details) (USD $) In Thousands	Jun. 25, 2011	Jun. 26, 2010
Derivative [Line Items]
Notional amount of foreign currency forward contracts, by net currency purchase (sell)	$ 6,121	$ (30,406)
Euro
Derivative [Line Items]
Notional amount of foreign currency forward contracts, by net currency purchase (sell)	1,542	(17,874)
Japanese Yen
Derivative [Line Items]
Notional amount of foreign currency forward contracts, by net currency purchase (sell)	(5,156)	(17,923)
British Pound
Derivative [Line Items]
Notional amount of foreign currency forward contracts, by net currency purchase (sell)	(10,928)	(3,512)
Philippine Peso
Derivative [Line Items]
Notional amount of foreign currency forward contracts, by net currency purchase (sell)	17,140	6,576
Thai Bhat
Derivative [Line Items]
Notional amount of foreign currency forward contracts, by net currency purchase (sell)	$ 3,523	$ 2,327

XML



Consolidated Statements of Cash Flows (USD $) In Thousands	12 Months Ended
	Jun. 25, 2011	Jun. 26, 2010	Jun. 27, 2009
Cash flows from operating activities:
Net income	$ 489,009	$ 125,139	$ 10,455
Adjustments to reconcile net income to net cash provided by operating activities:
Stock-based compensation	94,297	93,525	196,108
Depreciation and amortization	205,062	167,523	205,423
Deferred taxes	140,084	29,090	202,352
In process research & development	0	0	3,900
Loss from sale of property, plant and equipment	12,946	272	2,695
Loss (gain) from sale of equity investments	0	148	(529)
Tax benefit (shortfall) related to stock-based compensation	30,546	(15,748)	(216,835)
Excess tax benefit related to stock-based compensation	(12,869)	(7,005)	(670)
Impairment of long-lived assets	0	8,291	51,112
Changes in assets and liabilities:
Accounts receivable	43,256	(124,258)	65,288
Inventories	(29,435)	22,681	49,124
Other current assets	53,255	(79,319)	3,226
Accounts payable	(4,746)	41,191	(5,988)
Income taxes payable	(45,318)	17,384	15,545
Deferred income on shipments to distributors	11,102	9,020	(4,687)
Accrued liabilities- tender offer payments above settlement date fair value	0	0	(8,665)
Accrued liabilities - goodwill payments above settlement date fair value	(164)	(1,328)	(32,016)
Accrued liabilities - litigation settlement	(173,000)	173,000	0
All other accrued liabilities	47,429	31,347	(90,043)
Net cash provided by operating activities	861,454	490,953	445,795
Cash flows from investing activities:
Purchases of property, plant and equipment	(175,253)	(123,901)	(135,429)
Proceeds from sale of property, plant, and equipment	27,624	2,802	947
Acquisitions	(80,918)	(316,784)	(61,010)
Other non-current assets	0	(3,998)	873
Purchases of available-for-sale securities	(49,787)	0	(5,524)
Proceeds from sales/maturities of available-for-sale securities	0	200,233	8,426
Net cash used in investing activities	(278,334)	(241,648)	(191,717)
Cash flows from financing activities
Excess tax benefit from stock-based compensation plans	12,869	7,005	670
Mortgage liability	(3,237)	(40)	(40)
Equity settlements and payouts under the RSU loan program	26	(784)	(50,432)
Proceeds from derivative litigation settlement	0	2,460	0
Repayment of notes payable	(1,422)	0	(3,827)
Long-term debt, net of issuance costs	0	298,578	0
Issuance of common stock	24,830	(4,700)	(20,587)
Repurchase of common stock	(231,012)	(190,905)	(235,132)
Dividends paid	(249,145)	(243,755)	(248,501)
Net cash used in financing activities	(447,091)	(132,141)	(557,849)
Net increase (decrease) in cash and cash equivalents	136,029	117,164	(303,771)
Cash and cash equivalents:
Beginning of year	826,512	709,348	1,013,119
End of year	962,541	826,512	709,348
Supplemental disclosures of cash flow information:
Cash (refunded) paid, net during the year for income taxes	(15,529)	217,140	21,650
Cash paid for interest	10,264	0	0
Noncash financing and investing activities:
Accounts payable related to property, plant and equipment purchases	$ 22,841	$ 6,894	$ 15,712

XML



Balance Sheet Components

12 Months Ended

Jun. 25, 2011

Balance Sheet Related Disclosures [Abstract]

Balance Sheet Components [Text Block]

BALANCE SHEET COMPONENTS

Accounts receivables, net consist of:

	June 25, 2011			June 26, 2010
	(in thousands)
Accounts receivable	$	315,329		$	356,760
Returns and allowances	(17,697		)	(17,438		)
	$	297,632		$	339,322

The components of inventories consist of:

	June 25, 2011		June 26, 2010
Inventory:	(In thousands)
Raw materials	$	18,419	$	16,747
Work-in-process	162,245		140,497
Finished goods	57,264		48,796
	$	237,928	$	206,040

Property, plant and equipment, net consist of:

	June 25, 2011			June 26, 2010
Property and equipment:	(In thousands)
Land	$	86,257		$	87,237
Buildings and building improvements	313,642			341,734
Machinery and equipment	1,978,827			1,872,349
	2,378,726			2,301,320
Less accumulated depreciation	(1,069,876		)	(976,884		)
	$	1,308,850		$	1,324,436

The Company recorded $156.3 million, $146.1 million and $191.1 million of depreciation expense in fiscal years 2011, 2010 and 2009, respectively.

XML



Quarterly Financial Data (Unaudited) (Tables)

12 Months Ended

Jun. 25, 2011

Quarterly Financial Information Disclosure [Abstract]

Schedule of Quarterly Financial Information [Table Text Block]

	Quarter Ended
Fiscal Year 2011	6/25/2011			3/26/2011			12/25/2010			9/25/2010
	(In thousands, except percentages and per share data)
Net revenues	$	626,491		$	606,775		$	612,936		$	626,139
Cost of goods sold	235,666			234,125			232,661			239,925
Gross margin	$	390,825		$	372,650		$	380,275		$	386,214
Gross margin %	62.4		%	61.4		%	62.0		%	61.7		%
Operating income	$	177,922		$	163,995		$	151,999		$	179,123
% of net revenues	28.4		%	27.0		%	24.8		%	28.6		%
Net income	$	125,593		$	136,276		$	109,590		$	117,550
Earnings per share:
Basic	0.42			0.46			0.37			0.39
				.
Diluted	0.41			0.45			0.36			0.39
Shares used in the calculation of earnings per share:
Basic	295,751			296,511			296,550			298,216
Diluted	303,944			304,515			303,260			301,688
Dividends paid per share	$	0.21		$	0.21		$	0.21		$	0.21

The following table presents details of the total stock-based compensation expense that is included in the quarterly financial data above (in thousands):

	Quarter Ended
	6/25/2011		3/26/2011		12/25/2010		9/25/2010
Cost of goods sold	$	3,022	$	3,336	$	3,748	$	3,895
Research and development expenses	11,922		11,743		13,916		16,105
Selling, general and administrative expenses	6,464		6,149		6,858		7,139
Total	$	21,408	$	21,228	$	24,522	$	27,139

	Quarter Ended
Fiscal Year 2010	6/26/2010			3/27/2010					12/26/2009			9/26/2009
	(In thousands, except percentages and per share data)
Net revenues	$	565,962		$	508,880				$	473,515		$	449,246
Cost of goods sold	225,014			200,177					181,727			197,619
Gross margin	$	340,948		$	308,703				$	291,788		$	251,627
Gross margin %	60.2		%	60.7		%			61.6		%	56.0		%
Operating income (loss)	$	141,083		$	(48,261	)	(1	)	$	109,129		$	90,099
% of net revenues	24.9		%	(9.5		)%			23.0		%	20.1		%
Net income (loss)	$	58,455		$	(33,903	)			$	58,635		$	41,952
Earnings (loss) per share:
Basic	$	0.19		$	(0.11	)			$	0.19		$	0.14
Diluted	$	0.19		$	(0.11	)			$	0.19		$	0.13
Shares used in the calculation of earnings (loss) per share:
Basic	302,188			304,518					305,324			306,276
Diluted	306,803			304,518					310,090			312,162
Dividends paid per share	$	0.20		$	0.20				$	0.20		$	0.20

(1) Includes $173.0 million litigation settlement expense included in other operating expenses, net in the Consolidated Statement of Income.

The following table presents details of the total stock-based compensation expense that is included in the quarterly financial date above (in thousands):

	Quarter Ended
	6/26/2010		3/27/2010		12/26/2009		9/26/2009
Cost of goods sold	$	3,423	$	1,071	$	5,265	$	5,461
Research and development expenses	13,983		8,691		14,650		16,741
Selling, general and administrative expenses	7,442		5,517		7,018		4,263
Total	$	24,848	$	15,279	$	26,933	$	26,465

XML



Earnings Per Share (Tables)

12 Months Ended

Jun. 25, 2011

Earnings Per Share [Abstract]

Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]

The following table sets forth the computation of basic and diluted earnings per share:

	For the Year Ended
	June 25, 2011		June 26, 2010		June 27, 2009
	(In thousands, except per share data)
Numerator for basic earnings per share and diluted earnings
per share
Net income	$	489,009	$	125,139	$	10,455
Denominator for basic earnings per share	296,755		304,579		310,805
Effect of dilutive securities:
Stock options, RSUs, and ESPP	6,622		5,437		674
Denominator for diluted earnings per share	303,377		310,016		311,479
Earnings per share:
Basic	$	1.65	$	0.41	$	0.03
Diluted	$	1.61	$	0.40	$	0.03

XML



Stock-Based Compensation Restricted Stock Units (Details) (Restricted stock units [Member], USD $)	12 Months Ended
	Jun. 25, 2011 years		Jun. 26, 2010	Jun. 27, 2009
Restricted stock units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
RSUs requisite service period	up to five years
Each RSU to stock options factor	2
Outstanding and expected to vest RSUs [Roll Forward]
Restricted stock units outstanding, beginning	10,575,417		11,867,329	10,266,201
Restricted stock units granted	4,171,372		4,259,756	10,738,846
Restricted stock units released	(3,922,768)		(4,813,738)	(8,160,302)
Restricted stock units cancelled	(823,283)		(737,930)	(977,416)
Restricted stock units outstanding, ending	10,000,738		10,575,417	11,867,329
Restricted stock units outstanding, weighted average remaining contractual term (in years)	2.5
Restricted stock units outstanding, aggregate intrinsic value	$ 239,894,343	[1]
Restricted stock units expected to vest, number of shares	8,897,935
Restricted stock units expected to vest, weighted average remaining contractual term (in years)	2.4
Restricted stock units expected to vest, aggregate intrinsic value	$ 213,906,362	[1]
Restricted stock unit shares withheld for withholding tax	8,882,000,000
Restricted stock units granted, weighted average grant date fair value	$ 16.61		$ 16.20	$ 11.91
Unrecognized compensation costs related to unvested RSUs	$ 122,800,000
Weighted average period of recognition for unrecognized compensation costs	2.5

[1] Aggregate intrinsic value for RSUs represents the closing price per share of the Company's common stock on June 24, 2011, the last business day preceding the fiscal year end, multiplied by the number of RSUs outstanding, or expected to vest as of June 25, 2011.

XML



Earnings Per Share (Details) (USD $) In Thousands, except Share data	3 Months Ended								12 Months Ended
	Jun. 25, 2011	Mar. 26, 2011	Dec. 25, 2010	Sep. 25, 2010	Jun. 26, 2010	Mar. 27, 2010	Dec. 26, 2009	Sep. 26, 2009	Jun. 25, 2011	Jun. 26, 2010	Jun. 27, 2009
Numerator for basic earnings per share and diluted earnings per share
Net income	$ 125,593	$ 136,276	$ 109,590	$ 117,550	$ 58,455	$ (33,903)	$ 58,635	$ 41,952	$ 489,009	$ 125,139	$ 10,455
Denominator for basic earnings per share	295,751,000	296,511,000	296,550,000	298,216,000	302,188,000	304,518,000	305,324,000	306,276,000	296,755,000	304,579,000	310,805,000
Effect of dilutive securities
Stock options, RSUs, and ESPP									6,622,000	5,437,000	674,000
Denominator for diluted earnings per share	303,944,000	304,515,000	303,260,000	301,688,000	306,803,000	304,518,000	310,090,000	312,162,000	303,377,000	310,016,000	311,479,000
Earnings per share, Basic	$ 0.42	$ 0.46	$ 0.37	$ 0.39	$ 0.19	$ (0.11)	$ 0.19	$ 0.14	$ 1.65	$ 0.41	$ 0.03
Earnings per share, Diluted	$ 0.41	$ 0.45	$ 0.36	$ 0.39	$ 0.19	$ (0.11)	$ 0.19	$ 0.13	$ 1.61	$ 0.4	$ 0.03
Antidilutive securities excluded from computation of earnings per share, amount									14,900,000	21,100,000	29,600,000

XML



Financial Instruments, Income Statement Location (Details) (USD $) In Thousands	12 Months Ended
	Jun. 25, 2011	Jun. 26, 2010
Derivative Instruments, Gain (Loss) [Line Items]
Gain (Loss) Recognized in Income on Derivative Instrument	$ (1,893)	$ 1,444
Cash Flow Hedging [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Gain (Loss) Reclassified from Accumulated OCI into Income (Effective portion)	(514)	0
Cash Flow Hedging [Member] | Foreign Exchange Contract [Member] | Net Revenues [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Gain (Loss) Reclassified from Accumulated OCI into Income (Effective portion)	(1,152)	0
Cash Flow Hedging [Member] | Foreign Exchange Contract [Member] | Cost of goods sold [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Gain (Loss) Reclassified from Accumulated OCI into Income (Effective portion)	638	0
Interest and other (expense) income, net [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Gain (Loss) Recognized in Income on Derivative Instrument	$ (1,893)	$ 1,444

XML



Impairment of Long-Lived Assets (Details) (USD $) In Millions	3 Months Ended				3 Months Ended		3 Months Ended
	Sep. 26, 2009 End-of-Line Sorting and Testing Facilities [Member]	Dec. 27, 2008 End-of-Line Sorting and Testing Facilities [Member]	Jun. 26, 2010 End-of-Line Sorting and Testing Facilities [Member]	Jun. 27, 2009 End-of-Line Sorting and Testing Facilities [Member]	Sep. 26, 2009 Wafer Fabrication Facilit, Oregon [Member]	Jun. 26, 2010 Wafer Fabrication Facilit, Oregon [Member]	Sep. 27, 2008 Wafer Fabrication Facility, San Jose [Member]
Long Lived Assets Held-for-sale [Line Items]
Impairment of long-lived assets held for sale	$ 5.0	$ 43.8			$ 3.3		$ 7.3
Long-lived assets held for sale			$ 0.6	$ 3.6		$ 0.5

XML



Fair Value Measurements

12 Months Ended

Jun. 25, 2011

Fair Value Disclosures [Abstract]

Fair Value Measurements [Text Block]

FAIR VALUE MEASUREMENTS

The FASB established a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. This hierarchy requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Three levels of inputs that may be used to measure fair value are:

Level 1 - Quoted (unadjusted) prices in active markets for identical assets or liabilities.

The Company's Level 1 assets consist of certain money market funds.

Level 2 - Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the asset or liability.

The Company's Level 2 assets and liabilities consist of certain money market funds, government agency securities and foreign currency forward contracts.

Level 3 - Unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.

Assets and liabilities measured at fair value on a recurring basis were as follows:

	As of June 25, 2011								As of June 26, 2010
	Fair Value								Fair Value
	Measurements Using						Total		Measurements Using						Total
	Level 1		Level 2		Level 3		Balance		Level 1		Level 2		Level 3		Balance
	(in thousands)
Assets
Money market funds (1)	$	603,180	$	3,457	$	—	$	606,637	$	634,358	$	2,997	$	—	$	637,355
Government agency securities (2)	—		50,346		—		50,346		—		—		—		—
Foreign currency forward contracts	—		326		—		326		—		18		—		18
Total Assets	$	603,180	$	54,129	$	—	$	657,309	$	634,358	$	3,015	$	—	$	637,373
Liabilities
Foreign currency forward contracts	$	—	$	309	$	—	$	309	$	—	$	851	$	—	$	851
Total Liabilities	$	—	$	309	$	—	$	309	$	—	$	851	$	—	$	851

(1) Included in Cash and cash equivalents in the accompanying Consolidated Balance Sheets.

(2) Included in Short-term investments in the accompanying Consolidated Balance Sheets.

As of June 25, 2011 and June 26, 2010, none of the company's assets and liabilities were measured at fair value on a non-recurring basis.

XML



Income Taxes Unrecognized Tax Benefit (Details) (USD $)	12 Months Ended			3 Months Ended
	Jun. 25, 2011	Jun. 26, 2010	Jun. 27, 2009	Jun. 25, 2011 State and Local Jurisdiction [Member]	Jun. 25, 2011 State and Local Jurisdiction [Member] Research [Member]
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]
Beginning Balance	$ 151,464,000	$ 137,298,000
Additions related to current year tax positions	59,345,000	31,491,000
Additions related to prior year tax positions	7,935,000	5,696,000
Reductions related to prior year tax positions	(21,399,000)	(190,000)
Settlements	(16,636,000)	(22,831,000)		(14,500,000)
Lapses in statutes of limitations	(63,296,000)	0
Ending Balance	117,413,000	151,464,000	137,298,000
Unrecognized tax benefits that if recognzied would affect effective tax rate	107,900,000
Unrecognized tax benefits that if recognized would affect paid in capital	9,500,000
Unrecognized tax benefits reductions resulting from lapse of statute of limitations credited to additional paid in capital	33,100,000
Interest and penalties recognized in income tax expense	(17,100,000)	4,400,000	5,500,000
Reversal of prior year interest and penalties due to the expiration of the statute of limitations	19,500,000
Interest and penalties accrued	3,300,000	20,400,000	21,800,000
Period gross unrecognized tax benefits could decrease over	12 months
Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit	3,400,000
Reduction in California research tax credit carryforwards					$ (14,500,000)

XML



Summary of Significant Accounting Policies Property, Plant and Equipment (Details)	12 Months Ended
	Jun. 25, 2011 years
Machinery and Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment minimium useful life (in years)	2
Property, plant and equipment maximium useful life (in years)	15
Building and Building Improvements [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment maximium useful life (in years)	40

XML



Fair Value Measurements (Tables)

12 Months Ended

Jun. 25, 2011

Fair Value Disclosures [Abstract]

Fair Value, Measurement Inputs, Disclosure [Table Text Block]

Assets and liabilities measured at fair value on a recurring basis were as follows:

	As of June 25, 2011								As of June 26, 2010
	Fair Value								Fair Value
	Measurements Using						Total		Measurements Using						Total
	Level 1		Level 2		Level 3		Balance		Level 1		Level 2		Level 3		Balance
	(in thousands)
Assets
Money market funds (1)	$	603,180	$	3,457	$	—	$	606,637	$	634,358	$	2,997	$	—	$	637,355
Government agency securities (2)	—		50,346		—		50,346		—		—		—		—
Foreign currency forward contracts	—		326		—		326		—		18		—		18
Total Assets	$	603,180	$	54,129	$	—	$	657,309	$	634,358	$	3,015	$	—	$	637,373
Liabilities
Foreign currency forward contracts	$	—	$	309	$	—	$	309	$	—	$	851	$	—	$	851
Total Liabilities	$	—	$	309	$	—	$	309	$	—	$	851	$	—	$	851

(1) Included in Cash and cash equivalents in the accompanying Consolidated Balance Sheets.

(2) Included in Short-term investments in the accompanying Consolidated Balance Sheets.

XML



Restructuring Activities (Details) (USD $)	12 Months Ended								3 Months Ended			12 Months Ended	3 Months Ended
	Jun. 25, 2011	Jun. 26, 2010	Jun. 27, 2009	Jun. 26, 2010 Ireland Sales Operations Restructuring [Member]	Jun. 26, 2010 Shutdown of Dallas Wafer Fabrication Facility [Member]	Jun. 27, 2009 San Jose Fab Rampdown [Member]	Jun. 27, 2009 Dallas Fab Closure [Member]	Jun. 27, 2009 Test Operation Cost Reduction [Member]	Dec. 27, 2008 Cost Reduction of Business Units [Member]	Mar. 28, 2009 Cost Reduction of Business Units [Member] International Employees [Member]	Dec. 27, 2008 Cost Reduction of Business Units [Member] Domestic Employees [Member]	Jun. 27, 2009 Cost Reduction of Selling General and Administrative Groups [Member]	Mar. 28, 2009 Cost Reduction in Domestic Manufacturing and Support Functions [Member]	Mar. 28, 2009 Cost Reduction in Domestic Manufacturing and Support Functions [Member] Fab Employees [Member]	Mar. 28, 2009 Cost Reduction in Domestic Manufacturing and Support Functions [Member] Other Employees [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring charges	$ 1,247,000	$ (699,000)	$ 28,124,000
Number of positions eliminated						78		95	128			44	382	189	193
Severance and benefits costs						2,100,000	3,100,000	3,400,000		600,000	6,100,000	1,700,000	11,300,000
Restructuring Costs				3,000,000	1,600,000
Lease impairment costs			500,000
Restructuring Reserve [Roll Forward]
Balance	748,000	7,694,000
Restructuring accrual	3,007,000	4,558,000
Cash payments	(3,640,000)	(6,247,000)
Changes in estimates		(5,257,000)	(4,600,000)
Balance	$ 115,000	$ 748,000	$ 7,694,000

XML



Benefits (Details) (USD $)	12 Months Ended									12 Months Ended		3 Months Ended			3 Months Ended
	Jun. 25, 2011		Jun. 26, 2010	Jun. 30, 2012 Scenario, Forecast [Member]		Jun. 25, 2011 Scenario, Forecast [Member]	Jun. 25, 2011 Retirees and Beneficiaries [Member]	Jun. 26, 2010 Retirees and Beneficiaries [Member]	Jun. 25, 2011 Non-Pension Benefits [Member]	Jun. 27, 2009 Chief Executive Officer [Member]	Jun. 30, 2007 Chief Executive Officer [Member]	Jun. 27, 2009 Defined Benefit Postretirement Life Insurance [Member]	Jun. 25, 2011 Defined Benefit Postretirement Life Insurance [Member]	Jun. 26, 2010 Defined Benefit Postretirement Life Insurance [Member]	Sep. 29, 2007 EITF 06-4 [Member]
Defined contribution plan 401(k)
Employer matching percentage of employee contributions up to 3% of employee eligible compensation	100.00%
Maximum percentage of employee eligible compensation with 100% matching contributions by employer	3.00%
Employer matching percentage of additional employee contributions up to 5% of employee eligible compensation	50.00%
Maximum percentage of employee eligible compensation with 50% matching contributions by employer	5.00%
Defined contribution expense	$ 6,000,000
Postemployment benefits, period expense										(2,400,000)	3,100,000
Postemployment benefits obligation	4,800,000		5,600,000
Accumulated Postretirement Benefit Obligation [APBO]:
Retirees and beneficiaries							(9,989,000)	(9,239,000)
Funded status at end of year	(9,989,000)		(9,239,000)
Actuarial loss	521,000
Amounts Recognized in Accumulated Other Comprehensive Income:
Net actuarial loss	7,484,000		7,327,000
Amounts recognized in Accumulated Other Comprehensive Income	7,484,000		7,327,000
Net Periodic Postretirement Benefit Cost/(Income):
Interest cost	471,000			500,000
Amortization of net actuarial loss	364,000	[1]		388,000	[1]
Total net periodic postretirement benefit cost	835,000			888,000
Employer contributions, current period	241,000
Estimated employer contributions in next fiscal year						388,000
Economic Assumptions:
Benefit obligation, discount rate			5.20%			5.10%
Medical trend
Description of direction and pattern of change for assumed medical trend rate	9.5% in 2012, declining to 5% at the rate of 0.5%/yr.		10.0% in 2011, declining to 5% at the rate of 0.5%/yr.
Medical trend rate	9.50%		10.00%
Rate to which the cost trend rate is assumed to decline (the ultimate trend rate)	5.00%		5.00%
Annual rate of decrease assumed for future years	(0.50%)		(0.50%)
Dental Trend	5.00%		5.00%
Average remaining life expectancy	P16.7Y
Estimated future benefit payments
2012									388,000
2013									428,000
2014									469,000
2015									508,000
2016									546,000
Thereafter									7,650,000
Total									9,989,000
Cumulative reduction in retained earnings from adoption of ASC 715															14,100,000
Tax benefit from cumulative reduction in retained earnings from adoption of ASC 715															0
Contracted split-dollar life insurance policy settlement												6,400,000
Assets for plan benefits included in Other Assets													2,900,000	2,700,000
Obligations included in Other Liabilities													$ 4,400,000	$ 4,200,000

[1] Unrecognized losses are amortized over an average remaining life expectancy of 16.7 years at June 25, 2011.

XML



Goodwill and Intangible Assets, Intangible Assets (Details) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Jun. 25, 2011	Jun. 26, 2010	Jun. 27, 2009
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Original Cost	$ 292,642	$ 238,192
Accumulated Amortization	96,579	47,664
Net	196,063	190,528
IPR&D	8,200	4,200
Gross Intangible Assets	300,842	242,392
Total purchased intangible assets	204,263	194,728
Amortization expense of intangible assets, cost of goods sold	30,164	10,999	8,024
Intangible asset amortization	18,752	10,477	6,019
Total intangible asset amortization expenses	48,916	21,476	14,043
Future amortization expense [Abstract]
2012	46,853
2013	42,022
2014	35,439
2015	33,131
2016	21,011
Thereafter	17,607
Total future amortization expense of intangible assets	196,063
Intellectual property [Member]
Finite and Indefinite Lived Intangible Assets [Line Items]
Definite lived intangible assets, useful life, minimum	5
Definite lived intangible assets, useful life, maximum	10
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Original Cost	195,912	145,262
Accumulated Amortization	64,996	33,305
Net	130,916	111,957
Customer relationships [Member]
Finite and Indefinite Lived Intangible Assets [Line Items]
Definite lived intangible assets, useful life, minimum	5
Definite lived intangible assets, useful life, maximum	10
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Original Cost	88,630	87,030
Accumulated Amortization	24,915	11,745
Net	63,715	75,285
Backlog [Member]
Finite and Indefinite Lived Intangible Assets [Line Items]
Definite lived intangible assets, useful life	1
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Original Cost	6,400	4,500
Accumulated Amortization	5,687	2,350
Net	713	2,150
Tradename [Member]
Finite and Indefinite Lived Intangible Assets [Line Items]
Definite lived intangible assets, useful life	3
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Original Cost	1,700	1,400
Accumulated Amortization	981	264
Net	$ 719	$ 1,136

XML



Acquisitions (Tables)

12 Months Ended

Jun. 25, 2011

Acquisition [Abstract]

Schedule of Purchase Price Allocation [Table Text Block]

Aggregate purchase price allocation for Maxim's fiscal 2011 acquisitions:

	In millions
Net tangible assets	$	(11.5	)
Amortizable intangible assets	52.6
In-process research and development ("IPR&D")	6.0
Goodwill(1)	42.6
Total purchase price (1)	$	89.7

(1) Includes $8.8 million of contingent consideration relating to the Calvatec acquisition.

XML



Summary of Significant Accounting Policies (Details) (USD $) In Thousands	12 Months Ended
	Jun. 30, 2012	Jun. 25, 2011	Jun. 26, 2010	Jun. 27, 2009
Accounting Policies [Abstract]
Fiscal year duration range		52-to-53-week
Frequency of 53-week fiscal year		fifth or sixth year
Number of weeks in current fiscal year	P53W	P52W	P52W	P52W
Derivative remaining maturity		less than 6 months
Months of forecasted product demand used for inventory write-down valuation		12 months
Goodwill and intangible asset impairment		$ 0	$ 0	$ 0
Non-warranty product, return period from purchase date		90 days

XML



Stock-Based Compensation (Tables)

12 Months Ended

Jun. 25, 2011

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]

The following tables present stock-based compensation expense by type of award and resulting tax effect included in the Consolidated Statements of Income for fiscal year 2011, 2010, and 2009:

	For the Year Ended
	June 25, 2011		June 26, 2010		June 27, 2009
	(in thousands)
Cost of goods sold
Stock options	$	2,625	$	3,330	$	33,380
Restricted stock units	9,820		10,825		23,350
Employee stock purchase plan	1,556		1,065		370
	14,001		15,220		57,100
Research and development expense
Stock options	11,325		15,085		38,237
Restricted stock units	36,925		33,834		61,151
Employee stock purchase plan	5,436		5,146		1,442
	53,686		54,065		100,830
Selling, general and administrative expense
Stock options	6,120		8,130		21,390
Restricted stock units	18,944		15,056		16,665
Employee stock purchase plan	1,546		1,054		123
	26,610		24,240		38,178
Total stock-based compensation expense
Stock options	20,070		26,545		93,007
Restricted stock units	65,689		59,715		101,166
Employee stock purchase plan	8,538		7,265		1,935
Pre-tax stock-based compensation expense	94,297		93,525		196,108
Less: Income tax effect	25,457		25,041		67,430
Net stock-based compensation expense	$	68,840	$	68,484	$	128,678

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]

The fair value of each award granted in fiscal years 2011, 2010 and 2009 has been estimated at the date of grant using the Black-Scholes option valuation model and the following weighted-average assumptions:

	Stock Option Plan For the Year Ended
	June 25, 2011		June 26, 2010		June 27, 2009
Expected holding period (in years)	5.2		5.2		6.3
Risk-free interest rate	1.7	%	2.3	%	3.0	%
Expected stock price volatility	37.1	%	38.0	%	39.0	%
Dividend yield	4.2	%	4.5	%	4.1	%
	ESP Plan For the Year Ended
	June 25, 2011		June 26, 2010		June 27, 2009
Expected holding period (in years)	0.5		0.7		1.0
Risk-free interest rate	0.1	%	0.3	%	4.0	%
Expected stock price volatility	24.7	%	35.0	%	57.0	%
Dividend yield	3.3	%	4.4	%	6.1	%

Schedule of Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding [Table Text Block]

The following table summarizes stock options outstanding, exercisable and vested and expected to vest as of June 25, 2011:

	Options			Weighted Average Remaining Contractual Term (In Years)	Aggregate Intrinsic Value (1)
	Number of Shares		Weighted Average Exercise Price
Balance at June 28, 2008	76,906,882		35.59
Options Granted	8,309,163		13.06
Options Exercised	(2,377	)	11.39
Options Cancelled	(55,613,752	)	35.89
Balance at June 27, 2009	29,599,916		28.83
Options Granted	3,671,459		18.08
Options Exercised	(47,327	)	12.86
Options Cancelled	(4,061,541	)	32.38
Balance at June 26, 2010	29,162,507		27.05
Options Granted	3,559,132		17.61
Options Exercised	(1,460,652	)	17.22
Options Cancelled	(2,928,501	)	33.67
Balance at June 25, 2011	28,332,486		25.62	3.7	$	119,500,252
Exercisable at June 25, 2011	16,468,585		$32.33	2.7	$	25,036,590
Vested and expected to vest, June 25, 2011	27,345,574		$25.93	3.7	$	112,428,729

Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]

The following table summarizes information about stock options that were outstanding and exercisable at June 25, 2011:

	Outstanding Options			Options Exercisable
Range of Exercise Prices	Number Outstanding at June 25, 2011	Weighted Average Remaining Contractual Term (In years)	Weighted Average Exercise Price	Number Exercisable at June 25, 2011	Weighted Average Exercise Price
$12.00 - $18.04	9,496,988	5.03	$14.10	1,731,327	$12.95
$18.11 - $27.45	6,428,859	4.19	20.49	2,603,082	22.40
$28.52 - $43.00	10,614,912	2.52	35.57	10,357,209	35.69
$49.95 - $52.33	1,791,727	1.93	46.12	1,776,967	46.12
	28,332,486			16,468,585

Schedule of Share-based Compensation Arrangement by Share-based Payment Award, Restricted Stock Units, Vested and Expected to Vest [Table Text Block]

The following table summarizes outstanding and expected to vest RSUs as of June 25, 2011 and their activity during fiscal year 2011, 2010 and 2009:

	Number of Shares		Weighted Average Remaining Contractual Term (In Years)	Aggregate Intrinsic Value (1)
Balance at June 28, 2008	10,266,201
Restricted stock units granted	10,738,846
Restricted stock units released	(8,160,302	)
Restricted stock units cancelled	(977,416	)
Balance at June 27, 2009	11,867,329
Restricted stock units granted	4,259,756
Restricted stock units released	(4,813,738	)
Restricted stock units cancelled	(737,930	)
Balance at June 26, 2010	10,575,417
Restricted stock units granted	4,171,372
Restricted stock units released	(3,922,768	)
Restricted stock units cancelled	(823,283	)
Balance at June 25, 2011	10,000,738		2.5	239,894,343
Expected to vest at June 25, 2011	8,897,935		2.4	213,906,362

XML



Segment Information

12 Months Ended

Jun. 25, 2011

Segment Reporting [Abstract]

Segment Information [Text Block]

SEGMENT INFORMATION

The Company operates and tracks its results in one reportable segment. The Company designs, develops, manufactures and markets a broad range of linear and mixed signal integrated circuits. The Chief Executive Officer has been identified as the Chief Operating Decision Maker as defined by ASC No. 280, Disclosures about Segments Reporting ("ASC 280").

The Company has fifteen operating segments which aggregate into one reportable segment under ASC 280. Under ASC 280, two or more operating segments may be aggregated into a single operating segment for financial reporting purposes if aggregation is consistent with the objective and basic principles of ASC 280, if the segments have similar economic characteristics, and if the segments are similar in each of the following areas:

• the nature of products and services;

• the nature of the production processes;

• the type or class of customer for their products and services; and

• the methods used to distribute their products or provide their services.

The Company meets each of the aggregation criteria for the following reasons:

• the sale of analog and mixed signal integrated circuits is the primary source of revenue for each of the Company's fifteen operating segments,

• the integrated circuits sold by each of the Company's operating segments are manufactured using similar semiconductor manufacturing processes;

• the integrated circuits marketed by each of the Company's operating segments are sold to the same types of customers; and

• all of the Company's integrated circuits are sold through a centralized sales force and common wholesale distributors.

All of the Company's operating segments share similar economic characteristics as they have a similar long term business model. The causes for variation among the Company's operating segments are the same and include factors such as (i) life cycle and price and cost fluctuations, (ii) number of competitors, (iii) product differentiation and (iv) size of market opportunity. Additionally, each operating segment is subject to the overall cyclical nature of the semiconductor industry. The number and composition of employees and the amounts and types of tools and materials required are similar for each operating segment. Finally, even though the Company periodically reorganizes the Company's operating segments based upon changes in customers, end-markets or products, acquisitions, long-term growth strategies, and the experience and bandwidth of the senior executives in charge, the common financial goals for each operating segment remain constant.

Enterprise-wide information is provided in accordance with ASC 280. Geographical revenue information is based on customers' ship-to location. Long-lived assets consist of property, plant and equipment. Property, plant and equipment information is based on the physical location of the assets at the end of each fiscal year.

Net revenues from unaffiliated customers by geographic region were as follows:

	For the Year Ended
	June 25, 2011		June 26, 2010		June 27, 2009
	(in thousands)
United States	$	360,310	$	291,539	$	302,648
China	915,628		685,908		496,091
Japan	163,061		131,513		120,763
Korea	294,006		311,928		229,833
Rest of Asia	283,121		223,786		169,203
Europe	379,173		288,675		291,524
Rest of World	77,042		64,254		35,953
	$	2,472,341	$	1,997,603	$	1,646,015

Net long-lived assets by geographic region were as follows:

	Fiscal Year Ended
	June 25, 2011		June 26, 2010
	(in thousands)
United States	$	972,380	$	983,761
Philippines	204,581		216,738
Thailand	120,838		116,050
Rest of World	11,051		7,887
	$	1,308,850	$	1,324,436

XML



Stock-Based Compensation Stock Option Plans (Details) (USD $)	12 Months Ended
	Jun. 25, 2011 years		Jun. 26, 2010	Jun. 27, 2009	Jun. 28, 2008
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Options outstanding, beginning	29,162,507		29,599,916	76,906,882
Options Granted	3,559,132		3,671,459	8,309,163
Options Exercised	(1,460,652)		(47,327)	(2,377)	0
Options Cancelled	(2,928,501)		(4,061,541)	(55,613,752)
Options outstanding, ending	28,332,486		29,162,507	29,599,916	76,906,882
Options outstanding, weighted average exercise price, beginning	$ 27.05		$ 28.83	$ 35.59
Options granted, weighted average exercise price	$ 17.61		$ 18.08	$ 13.06
Options exercised, weighted average exercise price	$ 17.22		$ 12.86	$ 11.39
Options cancelled, weighted average exercise price	$ 33.67		$ 32.38	$ 35.89
Options outstanding, weighted average exercise price, ending	$ 25.62		$ 27.05	$ 28.83	$ 35.59
Options outstanding, weighted average remaining contractual term (in years)	3.7
Options outstanding, aggregate intrinsic value	$ 119,500,252	[1]
Options exercisable, number of shares	16,468,585
Options exercisable, weighted average exercise price	$ 32.33
Options exercisable, weighted average remaining contractual term (in years)	2.7
Options exercisable, aggregate intrinsic value	25,036,590	[1]
Options vested and expected to vest, number of shares	27,345,574
Options vested and expected to vest, weighted average exercise price	$ 25.93
Options vested and expected to vest, weighted average remaining contractual term (in years)	3.7
Options vested and expected to vest, aggregate intrinsic value	112,428,729	[1]
Options granted, estimated grant date fair value	14,300,000
Options exercised, total intrinsic value	11,838,616,000,000
Options vested, total fair value	22,982,147,000,000
Stock options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares authorized to grant under 1996 Plan	113,100,000
Options vesting period	up to five years
Options expiration term	five to ten years
Shares available for issuance	15,500,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Options granted, weighted average fair value of stock options	$ 4.02		$ 4.23	$ 3.61
Unrecognized compensation costs related to unvested stock options	33,200,000
Unvested stock options	11,863,000,000
Weighted average period of recognition for unrecognized compensation costs	2.5
Restricted stock units [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Unrecognized compensation costs related to unvested stock options	$ 122,800,000
Weighted average period of recognition for unrecognized compensation costs	2.5

[1] Aggregate intrinsic value represents the difference between the exercise price and the closing price per share of the Company's common stock on June 24, 2011, the last business day preceding the fiscal year end, multiplied by the number of options outstanding, exercisable or vested and expected to vest as of June 25, 2011.

XML



Income Taxes Effective Income Tax Rate Reconciliation (Details)	12 Months Ended
	Jun. 25, 2011	Jun. 26, 2010	Jun. 27, 2009
Effective Income Tax Rate, Continuing Operations, Tax Rate Reconciliation [Abstract]
Federal statutory rate	35.00%	35.00%	35.00%
State tax, net of federal benefit	0.70%	0.40%	(10.80%)
General business credits	(1.50%)	(1.20%)	(25.60%)
Domestic production deduction benefit	(0.10%)	(2.10%)	(16.10%)
Foreign earnings and losses taxed or benefitted at different rates	(4.60%)	21.00%	76.50%
Stock-based compensation	1.30%	3.00%	8.40%
Acquired in process R&D	0.00%	0.00%	3.90%
Executive compensation	0.10%	0.10%	(11.20%)
Release of unrecognized tax benefits	(4.10%)	0.00%	0.00%
Interest accrual for unrecognized tax benefits	(1.60%)	0.90%	9.90%
Other	0.90%	1.20%	(0.20%)
Income tax rate	26.10%	58.30%	69.80%

XML



Goodwill and Intangible Assets, Goodwill (Details) (USD $) In Thousands	12 Months Ended
	Jun. 25, 2011
Goodwill [Roll Forward]
Balance	$ 226,223
Acquisition	42,564
Adjustments	(3,662)
Balance	$ 265,125

XML



Financial Instruments

12 Months Ended

Jun. 25, 2011

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Financial Instruments [Text Block]

Financial Instruments

Short-term investments

Fair value as of June 25, 2011 were as follows:

	June 25, 2011
	Amortized Cost		Gross Unrealized Gain		Gross Unrealized Loss		Estimated Fair Value
	(in thousands)
Available‑for‑sale investments
Government agency securities	$	49,826	$	520	$	—	$	50,346
Total available‑for‑sale investments	$	49,826	$	520	$	—	$	50,346

Short-term investments as of June 26, 2010 ; none held.

Maxim did not recognize any impairment charges on such investments in fiscal years 2011, 2010 and 2009.

Contractual maturities of investments in available-for-sale debt securities at June 25, 2011 were as follows:

	June 25, 2011
	Amortized Cost		Estimated Fair Value
	(in thousands)
Due February 26, 2013	$	49,826	$	50,346
	$	49,826	$	50,346

The Company's interest (expense) income and other, net of $(11.4) million, $8.0 million and $17.2 million in fiscal years 2011, 2010 and 2009, respectively, include interest income and amortization and accretion of discounts and premiums, as well as realized gains and losses.

Gross gains and losses realized upon the sale of marketable securities were immaterial during fiscal years 2011, 2010 and 2009.

Derivative instruments and hedging activities

Foreign Currency Risk

The Company generates revenues in various global markets based on orders obtained in non-U.S. currencies, primarily the Japanese Yen, the Euro and the British Pound. Maxim incurs expenditures denominated in non-US currencies, principally Philippine Pesos and Thailand Baht associated with the Company's manufacturing activities in the Philippines and Thailand, respectively, and expenditures for sales offices and research and development activities undertaken outside of the U.S. Maxim is exposed to fluctuations in foreign currency exchange rates primarily on orders and accounts receivable from sales in these foreign currencies and cash flows for expenditures in these foreign currencies. Maxim has established risk management strategies designed to reduce the impact of volatility of future cash flows caused by changes in the exchange rates for these currencies. These strategies reduce, but do not entirely eliminate, the impact of currency exchange rates movements. Maxim does not use derivative financial instruments for speculative or trading purposes. The Company routinely hedges its exposures to certain foreign currencies with various financial institutions in an effort to minimize the impact of certain currency exchange rate fluctuations. If a financial counter party to any of the Company's hedging arrangements experiences financial difficulties or is otherwise unable to honor the terms of the foreign currency hedge, the Company may experience financial losses.

For derivative instruments that are designated and qualify as cash flow hedges under ASC No. 815- Derivatives and hedging, the effective portion of the gain or loss on the derivative is reported as a component of accumulated other comprehensive income (loss) and reclassified into earnings into the same financial statement line as the item being hedged, and in the same period or periods during which the hedged transaction affects earnings. Gains and losses on the derivative representing either hedge ineffectiveness or hedge components excluded from the assessment of effectiveness are recognized in interest and other (expense) income, net.

For derivative instruments that are not designated as hedging instruments under ASC No. 815, gains and losses are recognized in interest and other (expense) income, net. All derivatives are foreign currency forward contracts to hedge certain foreign currency denominated assets or liabilities. The gains and losses on these derivatives largely offset the changes in the fair value of the assets or liabilities being hedged.

Fair Value of Derivative Instruments in the Consolidated Balance Sheets

Maxim estimates the fair value of derivatives primarily based on pricing models using current market rates and records all derivatives on the balance sheet at fair value. The gross notional and fair value of derivative financial instruments in the Consolidated Balance Sheets were recorded as follows:

	As of June 25, 2011						As of June 26, 2010
	Gross Notional (1)		Other Current Assets		Accrued Expenses		Gross Notional (1)		Other Current Assets		Accrued Expenses
	(in thousands)
Derivatives designated as hedging instruments
Cash flow hedges:
Foreign exchange contracts	$	35,629	$	53	$	287	$	20,085	$	2	$	237
Derivatives not designated as hedging instruments
Foreign exchange contracts	26,342		273		22		32,281		16		614
Total derivatives	$	61,971	$	326	$	309	$	52,366	$	18	$	851

(1) Represents the face amounts of contracts that were outstanding as of June 25, 2011 and June 26, 2010, respectively.

Derivatives designated as hedging instruments

The following table provides the balances and changes in the accumulated other comprehensive income (loss) related to derivative instruments during the years ended June 25, 2011 and June 26, 2010.

	June 25, 2011			June 26, 2010
	(in thousands)
Beginning balance	$	(235	)	$	—
Loss reclassified to income	514			—
Amount recorded in other comprehensive loss	(513		)	(235		)
Ending balance	$	(234	)	$	(235	)

Maxim expects to reclassify an estimated net accumulated other comprehensive loss of $0.2 million, net of taxes, to earnings in the next twelve months along with the earnings effects of the related forecasted transactions in association with cash flow hedges.

The before-tax effect of cash flow derivative instruments for the years ended June 25, 2011 and June 26, 2010 was as follows:

	Gain (Loss) Reclassified from Accumulated OCI into Income (Effective portion)
		Year Ended
	Location	June 25, 2011			June 26, 2010
		(in thousands)
Cash Flow hedges:
Foreign exchange contracts	Net Revenues	$	(1,152	)	$	—
Foreign exchange contracts	Cost of goods sold	638			—
Total cash flow hedges		$	(514	)	$	—

The before-tax effect of cash flow derivative instruments not designated as hedging instruments on the Consolidated Statements of Income for the year ended June 25, 2011 and June 26, 2010 was as follows:

	Gain ( Loss) Recognized in Income on Derivative Instrument
		Years Ended
	Location	June 25, 2011			June 26, 2010
		(in thousands)
Foreign exchange contracts	Interest and other (expense) income, net	$	(1,893	)	$	1,444
Total		$	(1,893	)	$	1,444

Volume of Derivative Activity

Total net U.S. Dollar notional amounts for foreign currency forward contracts, presented by net currency purchase (sell), are as follows:

In United States Dollars	June 25, 2011			June 26, 2010
	(in thousands)
Euro	$	1,542		$	(17,874	)
Japanese Yen	(5,156		)	(17,923		)
British Pound	(10,928		)	(3,512		)
Philippine Peso	17,140			6,576
Thai Bhat	3,523			2,327
Total	$	6,121		$	(30,406	)

Long- term debt

On June 17, 2010, the Company completed a public offering of $300 million aggregate principal amount of the Company's 3.45% senior unsecured and unsubordinated notes (the "Notes") due on June 14, 2013, with an effective interest rate of 3.49%. Interest on the Notes is payable semi-annually in arrears on June 14 and December 14 of each year, commencing December 14, 2010. The Notes are governed by a base and supplemental indenture dated June 10, 2010 and June 17, 2010, respectively, between the Company and Wells Fargo Bank, National Association, as trustee. The Company accounts for the Notes based on their amortized cost. The discount and expenses are being amortized to Interest and other (expense) income, net over the life of the Notes. Interest expenses associated with the Notes was $10.4 million and $0.3 million in fiscal years 2011 and 2010 , respectively, and is recorded in Interest (expense) income and other, net in the Consolidated Statements of Income.

The estimated fair value of Maxim's long-term debt was approximately $311 million at June 25, 2011. The estimated fair value of the debt is based primarily on quoted market prices observed for comparable notes that were recently traded as of the Balance sheet date.

As of June 25, 2011, Maxim had the capacity to issue an unspecified amount of additional debt securities, common stock, preferred stock, warrants, rights and units under the 2010 Shelf Registration Statement.

Other Financial Instruments

For the balance of Maxim's financial instruments, cash equivalents, accounts receivable, accounts payable and other accrued liabilities, the carrying amounts approximate fair value due to their short maturities.

XML



Common Stock Repurchases

12 Months Ended

Jun. 25, 2011

Common Stock Repurchases [Abstract]

Common Stock Repurchases [Text Block]

COMMON STOCK REPURCHASES

In October 2008, the Board of Directors authorized the Company to repurchase up to $750 million of the Company's common stock from time to time at the discretion of the Company's management. This stock repurchase authorization has no expiration date. All prior authorizations by the Company's Board of Directors for the repurchase of common stock were canceled and superseded by this authorization.

During fiscal year 2011 and fiscal year 2010, the Company repurchased approximately 10.9 million, and 10.3 million shares of its common stock for $231.0 million and $190.9 million, respectively. As of June 25, 2011, the Company had remaining authorization of $93.8 million for future share repurchases. The number of shares to be repurchased and the timing of such repurchases will be based on several factors, including the price of the Company's common stock and general market and business conditions.

XML



Impairment of Long-Lived Assets, Dallas Wafer Fab Closure (Details) (USD $) In Millions	12 Months Ended
	Jun. 25, 2011	Jun. 26, 2010	Jun. 27, 2009
Change in Accounting Estimate [Line Items]
Additional depreciation expense recognized	$ 156.3	$ 146.1	$ 191.1
Service Life [Member] | Dallas Wafer Fab Closure [Member]
Change in Accounting Estimate [Line Items]
Additional depreciation expense recognized			$ 54.7

XML



Acquisitions (Details) (USD $)	12 Months Ended																			3 Months Ended					12 Months Ended
	Jun. 25, 2011		Jun. 26, 2010	Jun. 27, 2009	Jul. 18, 2011 Acquisition [Member] SensorDynamics [Member]	May 31, 2011 Calvatec [Member]	Sep. 07, 2010 Phyworks [Member]	Sep. 07, 2010 Phyworks [Member] Backlog [Member]	Sep. 07, 2010 Phyworks [Member] Intellectual property [Member]	Sep. 07, 2010 Phyworks [Member] Customer relationships [Member]	Sep. 07, 2010 Phyworks [Member] Tradename [Member]	May 11, 2010 Teridian [Member]	May 11, 2010 Teridian [Member] Backlog [Member]	May 11, 2010 Teridian [Member] Intellectual property [Member]	May 11, 2010 Teridian [Member] Customer relationships [Member]	May 11, 2010 Teridian [Member] Tradename [Member]	Feb. 18, 2009 Zilog [Member]	Feb. 18, 2009 Zilog [Member] Backlog [Member]	Feb. 18, 2009 Zilog [Member] Customer relationships [Member]	Jun. 27, 2009 Innova Card [Member]	Dec. 29, 2008 Innova Card [Member]	Dec. 29, 2008 Innova Card [Member] Backlog [Member]	Dec. 29, 2008 Innova Card [Member] Intellectual property [Member]	Dec. 29, 2008 Innova Card [Member] Customer relationships [Member]	Jun. 27, 2009 Mobilygen [Member]	Oct. 27, 2008 Mobilygen [Member]	Oct. 27, 2008 Mobilygen [Member] Backlog [Member]	Oct. 27, 2008 Mobilygen [Member] Intellectual property [Member]	Oct. 27, 2008 Mobilygen [Member] Customer relationships [Member]	Oct. 27, 2008 Mobilygen [Member] Tradename [Member]
Business Acquisition, Purchase Price Allocation [Abstract]
Net tangible assets acquired	$ (11,500,000)
Amortizable intangible assets acquired	52,600,000							1,900,000	47,100,000	1,600,000	300,000		4,300,000	85,600,000	44,700,000	1,000,000		500,000	12,900,000			200,000	5,300,000	3,000,000			200,000	14,700,000	4,200,000	400,000
In-process research and development acquired	6,000,000						5,800,000					3,100,000
Goodwill acquired	42,600,000	[1]					26,100,000					196,600,000					6,300,000				4,200,000					2,200,000
Total purchase price	89,700,000	[1]			130,000,000	8,200,000	76,000,000					314,900,000					22,600,000				13,500,000					33,500,000
Net working capital acquired																					600,000
Cash acquired						400,000	4,600,000					2,100,000
Accounts receivable acquired							1,200,000					7,300,000
Inventories acquired							2,900,000					14,000,000					2,900,000
Prepaid expenses and other current assets acquired							100,000					2,700,000
Fixed assets acquired							400,000					2,100,000									200,000
Tangible assets acquired																										1,500,000
Accounts payable and accrued liabilities acquired							3,800,000					14,100,000
Deferred tax assets acquired												13,800,000
Deferred tax liabilities acquired							12,200,000					48,300,000
Deferred tax assets (liabilities) acquired																										7,800,000
Liabilities assumed					34,000,000																					4,200,000
Long-term debt assumed																										2,700,000
Research and development expense recognized	0		0	3,900,000																					3,900,000
Business Acquisition, Cost of Acquired Entity [Abstract]
Cash paid																	21,700,000									33,000,000
Equity issued																					8,100,000
Debt repayment																					1,100,000
Future payments																					3,800,000
Legal and related acquisition costs																	900,000				500,000					500,000
Additional payment to shareholders for working capital																				1,100,000
Potential additional consideration in cash or stock						8,800,000
Business Acquisition, Contingent Consideration, Potential Cash Payment						12,500,000
Goodwill amount expected to be deductible for tax purposes							$ 0					$ 0					$ 6,300,000				$ 0					$ 0

[1] Includes $8.8 million of contingent consideration relating to the Calvatec acquisition.

XML



Benefits (Tables)

12 Months Ended

Jun. 25, 2011

Compensation Related Costs [Abstract]

Schedule of Net Funded Status [Table Text Block]

Medical Expense & Funded Status Reconciliation

	June 26 2010			Fiscal 2011 Expense		Current Year end			Estimated Fiscal 2012 Expense
	(in thousands, except percentages)
Accumulated Postretirement Benefit Obligation [APBO]:
Retirees and beneficiaries	$	(9,239	)			$	(9,989	)
Funded status	$	(9,239	)			$	(9,989	)
Actuarial loss						$	521
Amounts Recognized in Accumulated Other Comprehensive Income:
Net actuarial loss	$	7,327				$	7,484
Total	$	7,327				$	7,484
Net Periodic Postretirement Benefit Cost/(Income):
Interest cost				471					500
Amortization:
Net actuarial loss (1)				364					388
Total net periodic postretirement benefit cost				$	835				$	888
Employer contributions				$	241				$	388
Economic Assumptions:
Discount rate	5.2%					5.1%
Medical trend	10.0% in 2011, declining to 5% at the rate of 0.5%/yr.					9.5% in 2012, declining to 5% at the rate of 0.5%/yr.
Dental trend	5.0%					5.0%

(1) Unrecognized losses are amortized over an average remaining life expectancy of 16.7 years at June 25, 2011.

Schedule of Expected Benefit Payments [Table Text Block]

The following benefit payments are expected to be paid:

	Non-Pension Benefits
2012	$	388
2013	428
2014	469
2015	508
2016	546
Thereafter	7,650
	$	9,989

XML



Comprehensive Income (Details) (USD $) In Thousands	3 Months Ended								12 Months Ended
	Jun. 25, 2011	Mar. 26, 2011	Dec. 25, 2010	Sep. 25, 2010	Jun. 26, 2010	Mar. 27, 2010	Dec. 26, 2009	Sep. 26, 2009	Jun. 25, 2011	Jun. 26, 2010	Jun. 27, 2009
Changes in components of OCI, net of taxes
Net income	$ 125,593	$ 136,276	$ 109,590	$ 117,550	$ 58,455	$ (33,903)	$ 58,635	$ 41,952	$ 489,009	$ 125,139	$ 10,455
Change in unrealized gains (losses) on investments, net of tax benefits (expense) of $(189) 2011, $770 in 2010, and $(383) in 2009									331	(1,346)	681
Change in unrealized gains (losses) on forward exchange contracts, net of tax benefit (expense) of $(1) in 2011, $85 in 2010, and $0 in 2009									0	150	0
Deferred tax on unrealized exchange gain (loss) on intercompany receivables									(2,369)	(1,893)	552
Actuarial loss on post-retirement benefits, net of tax benefit (expense) of $(132) in 2011, $515 in 2010 and $2,153 in 2009									(289)	(896)	(3,762)
Total Comprehensive Income									486,682	120,854	7,926
Components of accumulated other comprehensive loss
Deferred Tax on Unrealized Exchange Gains on Long Term Intercompany Receivables	(8,081)				(5,712)				(8,081)	(5,712)
Unrealized components of post-retirement benefits	(4,841)				(4,552)				(4,841)	(4,552)
Cumulative translation adjustment	(1,527)				(1,527)				(1,527)	(1,527)
Net unrealized gain (loss) on cash flow hedges	(150)				(150)				(150)	(150)
Net unrealized gain on available-for-sale securities	331				0				331	0
Accumulated Other Comprehensive Loss	$ (14,268)				$ (11,941)				$ (14,268)	$ (11,941)

XML



Financial Instruments (Tables)

12 Months Ended

Jun. 25, 2011

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Available-for-sale investments [Table Text Block]

Fair value as of June 25, 2011 were as follows:

	June 25, 2011
	Amortized Cost		Gross Unrealized Gain		Gross Unrealized Loss		Estimated Fair Value
	(in thousands)
Available‑for‑sale investments
Government agency securities	$	49,826	$	520	$	—	$	50,346
Total available‑for‑sale investments	$	49,826	$	520	$	—	$	50,346

Contractual maturities of available-for-sale securities [Table Text Block]

Contractual maturities of investments in available-for-sale debt securities at June 25, 2011 were as follows:

	June 25, 2011
	Amortized Cost		Estimated Fair Value
	(in thousands)
Due February 26, 2013	$	49,826	$	50,346
	$	49,826	$	50,346

Schedule of derivative financial instruments in the Condensed Consolidated Balance Sheets [Table Text Block]

The gross notional and fair value of derivative financial instruments in the Consolidated Balance Sheets were recorded as follows:

	As of June 25, 2011						As of June 26, 2010
	Gross Notional (1)		Other Current Assets		Accrued Expenses		Gross Notional (1)		Other Current Assets		Accrued Expenses
	(in thousands)
Derivatives designated as hedging instruments
Cash flow hedges:
Foreign exchange contracts	$	35,629	$	53	$	287	$	20,085	$	2	$	237
Derivatives not designated as hedging instruments
Foreign exchange contracts	26,342		273		22		32,281		16		614
Total derivatives	$	61,971	$	326	$	309	$	52,366	$	18	$	851

(1) Represents the face amounts of contracts that were outstanding as of June 25, 2011 and June 26, 2010, respectively.

Changes in accumulated other comprehensive income (loss) related to derivative instruments [Table Text Block]

The following table provides the balances and changes in the accumulated other comprehensive income (loss) related to derivative instruments during the years ended June 25, 2011 and June 26, 2010.

	June 25, 2011			June 26, 2010
	(in thousands)
Beginning balance	$	(235	)	$	—
Loss reclassified to income	514			—
Amount recorded in other comprehensive loss	(513		)	(235		)
Ending balance	$	(234	)	$	(235	)

Before-tax effect of cash flow derivative instruments [Table Text Block]

The before-tax effect of cash flow derivative instruments for the years ended June 25, 2011 and June 26, 2010 was as follows:

	Gain (Loss) Reclassified from Accumulated OCI into Income (Effective portion)
		Year Ended
	Location	June 25, 2011			June 26, 2010
		(in thousands)
Cash Flow hedges:
Foreign exchange contracts	Net Revenues	$	(1,152	)	$	—
Foreign exchange contracts	Cost of goods sold	638			—
Total cash flow hedges		$	(514	)	$	—

Before-tax effect of derivative instruments not designated as hedging instruments on Condensed Consolidated Statements of Income [Table Text Block]

The before-tax effect of cash flow derivative instruments not designated as hedging instruments on the Consolidated Statements of Income for the year ended June 25, 2011 and June 26, 2010 was as follows:

	Gain ( Loss) Recognized in Income on Derivative Instrument
		Years Ended
	Location	June 25, 2011			June 26, 2010
		(in thousands)
Foreign exchange contracts	Interest and other (expense) income, net	$	(1,893	)	$	1,444
Total		$	(1,893	)	$	1,444

XML



Consolidated Statement of Stockholders' Equity (USD $) In Thousands, except Share data	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Accumulated Other Comprehensive Loss [Member]
Balance at Jun. 28, 2008	$ 3,147,811	$ 321	$ 251,478	$ 2,901,139	$ (5,127)
Balance, shares at Jun. 28, 2008		320,553,000
Components of comprehensive income:
Net income	10,455			10,455
Unrealized actuarial loss on post-retirement benefits, net of tax	(3,762)				(3,762)
Deferred tax on unrealized exchange (gain) loss on intercompany receivables	552				552
Unrealized gain on available-for-sale investments, net of tax	681				681
Unrealized loss on forward-exchange contracts, net of tax	0
Total Comprehensive Income	7,926
Repurchase of common stock, shares		(18,132,000)
Repurcahse of common stock, value	(235,132)	(18)	(174,172)	(60,942)
Common stock shares issued under stock plans net of shares withheld for employee taxes		3,598,000
Common stock value issued under stock plans net of shares withheld for employee taxes	(20,587)	3	(20,590)
Stock options exercised, shares	2,377
Stock based compensation	162,010		162,010
Tax (shortfall) benefit on settlement of equity instruments	(216,835)		(195,294)	(21,541)
Modification of equity instrument to liability	18,658		18,658
Modification of liability instruments to equity	16,431		16,431
Dividends paid	(248,501)			(248,501)
Balance at Jun. 27, 2009	2,594,465	306	21,205	2,580,610	(7,656)
Balance, shares at Jun. 27, 2009		306,019,000
Components of comprehensive income:
Net income	125,139			125,139
Unrealized actuarial loss on post-retirement benefits, net of tax	(896)				(896)
Deferred tax on unrealized exchange (gain) loss on intercompany receivables	(1,893)				(1,893)
Unrealized gain on available-for-sale investments, net of tax	(1,346)				(1,346)
Unrealized loss on forward-exchange contracts, net of tax	(150)				(150)
Total Comprehensive Income	120,854
Repurchase of common stock, shares	(10,283,000)	(10,303,000)
Repurcahse of common stock, value	(190,905)	(10)	(93,499)	(97,396)
Common stock shares issued under stock plans net of shares withheld for employee taxes		3,295,000
Common stock value issued under stock plans net of shares withheld for employee taxes	(29,472)	3	(29,475)
Stock options exercised, shares	47,327
Stock based compensation	90,440		90,440
Tax (shortfall) benefit on settlement of equity instruments	(15,748)		(15,748)
Derivative settlement, net of tax	3,512		3,512
Modification of equity instrument to liability	1,205		1,205
Common stock shares issued under Employee Stock Purchase Plan		1,837,000
Common stock value issued under Employee Stock Purchase Plan	24,772	2	24,770
Dividends paid	(243,755)			(243,755)
Balance at Jun. 26, 2010	2,352,958	301	0	2,364,598	(11,941)
Balance, shares at Jun. 26, 2010	300,348,000	300,848,000
Components of comprehensive income:
Net income	489,009			489,009
Unrealized actuarial loss on post-retirement benefits, net of tax	(289)				(289)
Deferred tax on unrealized exchange (gain) loss on intercompany receivables	(2,369)				(2,369)
Unrealized gain on available-for-sale investments, net of tax	331				331
Unrealized loss on forward-exchange contracts, net of tax	0
Total Comprehensive Income	486,682
Repurchase of common stock, shares	(10,880,000)	(10,880,000)
Repurcahse of common stock, value	(231,012)	(11)	(151,329)	(79,672)
Common stock shares issued under stock plans net of shares withheld for employee taxes		2,660,000
Common stock value issued under stock plans net of shares withheld for employee taxes	(28,836)	3	(28,839)
Stock options exercised, shares	1,460,652	1,461,000
Stock options exercised, value	24,830	1	24,829
Stock based compensation	93,623		93,623
Tax (shortfall) benefit on settlement of equity instruments	30,546		30,546
Modification of liability instruments to equity	2,350		2,350
Common stock shares issued under Employee Stock Purchase Plan		1,691,000
Common stock value issued under Employee Stock Purchase Plan	28,822	2	28,820
Dividends paid	(249,145)			(249,145)
Balance at Jun. 25, 2011	$ 2,510,818	$ 296	$ 0	$ 2,524,790	$ (14,268)
Balance, shares at Jun. 25, 2011	295,780,000	295,780,000

XML



Income Taxes

12 Months Ended

Jun. 25, 2011

Income Tax Disclosure [Abstract]

Income Taxes [Text Block]

INCOME TAXES

The provision for income taxes consisted of the following:

	For the Year Ended
	June 25, 2011		June 26, 2010			June 27, 2009
	(in thousands)
Federal
Current	$	44,579	$	151,786		$	30,237
Deferred	118,351		12,340			(7,447		)
State
Current	781		4,092			(2,056		)
Deferred	4,204		(1,464		)	(681		)
Foreign
Current	2,810		14,345			2,995
Deferred	1,937		(6,175		)	1,116
	$	172,662	$	174,924		$	24,164

Pretax income (loss) from the Company's foreign subsidiaries was approximately $285.0 million, $(95.5) million and $(63.3) million for fiscal years ended June 25, 2011, June 26, 2010 and June 27, 2009, respectively.

The Company has tax holidays with respect to certain operations in Thailand and the Philippines. The Thailand and Philippines tax holidays will expire at various dates between the fiscal years 2012 and 2019. The impact of the tax holidays on net income was not material for fiscal years 2011, 2010, and 2009.

As of June 25, 2011, the Company's foreign subsidiaries have accumulated undistributed earnings of approximately $123.8 million that are intended to be indefinitely reinvested outside the U.S. and, accordingly, no provision for U.S. federal and state tax has been made for the distribution of these earnings. At June 25, 2011 the amount of the unrecognized deferred tax liability on the indefinitely reinvested earnings was $39.9 million.

The provision for income taxes differs from the amount computed by applying the statutory rate as follows:

	For the Year Ended
	June 25, 2011		June 26, 2010		June 27, 2009
Federal statutory rate	35.0	%	35.0	%	35.0	%
State tax, net of federal benefit	0.7		0.4		(10.8	)
General business credits	(1.5	)	(1.2	)	(25.6	)
Domestic production deduction benefit	(0.1	)	(2.1	)	(16.1	)
Foreign earnings and losses taxed or benefitted at different rates	(4.6	)	21.0		76.5
Stock-based compensation	1.3		3.0		8.4
Acquired in process R&D	—		—		3.9
Executive compensation	0.1		0.1		(11.2	)
Release of unrecognized tax benefits	(4.1	)	—		—
Interest accrual for unrecognized tax benefits	(1.6	)	0.9		9.9
Other	0.9		1.2		(0.2	)
Income tax rate	26.1	%	58.3	%	69.8	%

Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The components of the Company's deferred tax assets and liabilities are as follows:

	For the Year Ended
	June 25, 2011			June 26, 2010
	(in thousands)
Deferred tax assets:
Inventory valuation and reserves	$	11,768		$	66,087
Distributor related accruals and sales return and allowance accruals	21,334			14,168
Deferred revenue	2,233			3,187
Accrued compensation	56,467			47,500
Stock-based compensation	73,295			84,225
Net operating loss carryovers	20,827			31,450
Tax credit carryovers	43,285			46,025
Other reserves and accruals not currently deductible for tax purposes	10,608			75,782
Other	8,940			18,437
Total deferred tax assets	248,757			386,861
Deferred tax liabilities:
Fixed assets cost recovery, net	(257,647		)	(240,463		)
Other	(12,168		)	(10,524		)
Net deferred tax assets /(liabilities) before valuation allowance	(21,058		)	135,874
Valuation allowance	(44,562		)	(47,006		)
Net deferred tax assets/(liabilities)	$	(65,620	)	$	88,868

The valuation allowance decreased by $2.4 million in fiscal year 2011 primarily due to benefits realized for state research tax credit carryforwards. $37.4 million of the valuation allowance is attributable to the tax benefits of income tax deductions generated by the exercise of stock options that when realized, will be recorded as a credit to additional paid-in-capital.

As of June 25, 2011, the Company has $29.1 million of federal net operating loss carryforwards expiring at various dates between fiscal years 2024 and 2028, $57.7 million of state net operating loss carryforwards expiring at various dates through the fiscal years 2029, $22.5 million of foreign net operating losses with no expiration date, $8.3 million of state credit carryforwards expiring at various dates between fiscal years 2012 and 2026 and $62.9 million of state credit carryforwards with no expiration date.

The Company classifies unrecognized tax benefits as (i) a current liability to the extent that payment is anticipated within one year; (ii) a non current liability to the extent that payment is not anticipated within one year; or (iii) as a reduction to deferred tax assets to the extent that the unrecognized tax benefit relates to deferred tax assets such as operating loss or tax credit carryforwards.

A reconciliation of the change in gross unrecognized tax benefits, excluding interest, penalties and the federal benefit for state unrecognized tax benefits, is as follows:

	For the Year Ended
	June 25, 2011			June 26, 2010
	(in thousands)
Balance as of beginning of year	$	151,464		$	137,298
Tax positions related to current year:
Addition	59,345			31,491
Tax positions related to prior year:
Addition	7,935			5,696
Reduction	(21,399		)	(190		)
Settlements	(16,636		)	(22,831		)
Lapses in statutes of limitations	(63,296		)	—
Balance as of end of year	$	117,413		$	151,464

The total amount of gross unrecognized tax benefits as of June 25, 2011 that, if recognized, would affect the effective tax rate and additional paid in capital is $107.9 million and $9.5 million, respectively. During fiscal year 2011, $33.1 million of prior year unrecognized tax benefits were recognized, due to the lapse of the statute of limitations, and credited to additional paid in capital.

Consistent with prior years, the Company reports interest and penalties related to unrecognized tax benefits as a component of income tax expense. The gross amount of interest and penalties recognized in income tax expense during fiscal years ended June 25, 2011, June 26, 2010, and June 27, 2009 was $(17.1) million, $4.4 million and $5.5 million, respectively, and the total amount of interest and penalties accrued as of June 25, 2011, June 26, 2010, and June 27, 2009 was $3.3 million, $20.4 million, and $21.8 million, respectively. The fiscal year 2011 interest and penalty net benefit of $17.1 million is primarily due to a $19.5 million reversal of prior year interest and penalties due to the expiration of the statute of limitations.

Management estimates that it is reasonably possible that the liability for gross unrecognized tax benefits, including accrued interest and penalties, could decrease within the next 12 months by $3.4 million. Such changes could occur based on the expiration of various statutes of limitations and the possible conclusion of ongoing tax audits.

During the second quarter of fiscal year 2011 the Internal Revenue Service ("IRS") completed its examination of the Company's federal corporate income tax returns for the fiscal years 2007- 2008 and issued a Revenue Agents Report ("RAR"). The Company agreed with the RAR findings and made a payment of $0.8 million that reduced the Company's liability for unrecognized tax benefits. During the fourth quarter of fiscal year 2011, an examination of the Company's California corporate income tax returns for the fiscal years 2006 - 2007 was completed. The Company agreed with the examination results, which reduced California research tax credit carryforwards and unrecognized tax benefits by $14.5 million.

In the first quarter of fiscal year 2012 the IRS intends to commence an examination of the Company's federal corporate income tax returns for the fiscal years 2009 and 2010. Management believes that it has adequately provided for any adjustments that may result from the IRS examination, however, the outcome of tax examinations cannot be predicted with certainty.

A summary of the fiscal tax years that remain subject to examination, as of June 25, 2011, for the Company's major tax jurisdictions are:

United States - Federal	2008 - forward
United States - Various States	2007 - forward
Japan	2006 - forward
Philippines	2008 - forward
Thailand	2009 - forward
United Kingdom	2008 - forward

XML



Summary of Significant Accounting Policies Revenue Recognition (Details) (Allowance for Sales Returns [Member], USD $) In Thousands	12 Months Ended
	Jun. 25, 2011	Jun. 26, 2010	Jun. 27, 2009	Jun. 28, 2008
Allowance for Sales Returns [Member]
Valuation and Qualifying Accounts Disclosure [Line Items]
Returns and allowances reserve	$ 15,992	$ 14,992	$ 10,332	$ 12,054
Estimated returns and allowances against revenues	74,456	67,505	45,220
Actual returns and allowances	$ 73,456	$ 62,845	$ 46,942

XML



Quarterly Financial Data (Unaudited)

12 Months Ended

Jun. 25, 2011

Quarterly Financial Information Disclosure [Abstract]

Quarterly Financial Data (Unaudited) [Text Block]

QUARTERLY FINANCIAL DATA (UNAUDITED)

	Quarter Ended
Fiscal Year 2011	6/25/2011			3/26/2011			12/25/2010			9/25/2010
	(In thousands, except percentages and per share data)
Net revenues	$	626,491		$	606,775		$	612,936		$	626,139
Cost of goods sold	235,666			234,125			232,661			239,925
Gross margin	$	390,825		$	372,650		$	380,275		$	386,214
Gross margin %	62.4		%	61.4		%	62.0		%	61.7		%
Operating income	$	177,922		$	163,995		$	151,999		$	179,123
% of net revenues	28.4		%	27.0		%	24.8		%	28.6		%
Net income	$	125,593		$	136,276		$	109,590		$	117,550
Earnings per share:
Basic	0.42			0.46			0.37			0.39
				.
Diluted	0.41			0.45			0.36			0.39
Shares used in the calculation of earnings per share:
Basic	295,751			296,511			296,550			298,216
Diluted	303,944			304,515			303,260			301,688
Dividends paid per share	$	0.21		$	0.21		$	0.21		$	0.21

The following table presents details of the total stock-based compensation expense that is included in the quarterly financial data above (in thousands):

	Quarter Ended
	6/25/2011		3/26/2011		12/25/2010		9/25/2010
Cost of goods sold	$	3,022	$	3,336	$	3,748	$	3,895
Research and development expenses	11,922		11,743		13,916		16,105
Selling, general and administrative expenses	6,464		6,149		6,858		7,139
Total	$	21,408	$	21,228	$	24,522	$	27,139

	Quarter Ended
Fiscal Year 2010	6/26/2010			3/27/2010					12/26/2009			9/26/2009
	(In thousands, except percentages and per share data)
Net revenues	$	565,962		$	508,880				$	473,515		$	449,246
Cost of goods sold	225,014			200,177					181,727			197,619
Gross margin	$	340,948		$	308,703				$	291,788		$	251,627
Gross margin %	60.2		%	60.7		%			61.6		%	56.0		%
Operating income (loss)	$	141,083		$	(48,261	)	(1	)	$	109,129		$	90,099
% of net revenues	24.9		%	(9.5		)%			23.0		%	20.1		%
Net income (loss)	$	58,455		$	(33,903	)			$	58,635		$	41,952
Earnings (loss) per share:
Basic	$	0.19		$	(0.11	)			$	0.19		$	0.14
Diluted	$	0.19		$	(0.11	)			$	0.19		$	0.13
Shares used in the calculation of earnings (loss) per share:
Basic	302,188			304,518					305,324			306,276
Diluted	306,803			304,518					310,090			312,162
Dividends paid per share	$	0.20		$	0.20				$	0.20		$	0.20

(1) Includes $173.0 million litigation settlement expense included in other operating expenses, net in the Consolidated Statement of Income.

The following table presents details of the total stock-based compensation expense that is included in the quarterly financial date above (in thousands):

	Quarter Ended
	6/26/2010		3/27/2010		12/26/2009		9/26/2009
Cost of goods sold	$	3,423	$	1,071	$	5,265	$	5,461
Research and development expenses	13,983		8,691		14,650		16,741
Selling, general and administrative expenses	7,442		5,517		7,018		4,263
Total	$	24,848	$	15,279	$	26,933	$	26,465

XML



Common Stock Repurchases (Details) (USD $) Share data in Thousands	1 Months Ended	12 Months Ended
	Oct. 31, 2008	Jun. 25, 2011	Jun. 26, 2010	Jun. 27, 2009
Common Stock Repurchases [Abstract]
Stock repurchase program, authorized amount	$ 750,000,000
Shares of common stock repurchased		10,880	10,283
Value of common stock repurchased		231,012,000	190,905,000	235,132,000
Stock repurchase program, remaining authorized amount		$ 93,800,000

XML



Commitments and Contingencies Stock Option Litigation (Details) (USD $)	12 Months Ended			3 Months Ended
	Jun. 25, 2011	Jun. 26, 2010	Jun. 27, 2009	Sep. 26, 2009 Positive Outcome of Litigation [Member]
Gain Contingencies [Line Items]
Proceeds from derivative litigation settlement	$ 0	$ 2,460,000	$ 0	$ 18,900,000
Adjustments to additional paid-in capital, derivative settlement		3,512,000		2,500,000
Gain (Loss) Related to Litigation Settlement				16,400,000
Payments for Legal Settlements	$ 173,000,000

XML



Nature of Operations

12 Months Ended

Jun. 25, 2011

Nature of Operations [Abstract]

Nature of Operations [Text Block]

NATURE OF OPERATIONS

Maxim Integrated Products, Inc. ("Maxim," the "Company," "we," "us" or "our"), incorporated in Delaware, designs, develops, manufactures, and markets a broad range of linear and mixed-signal integrated circuits, commonly referred to as analog circuits, for a large number of customers in diverse geographical locations. The Company also provides a range of high-frequency process technologies and capabilities for use in custom designs. The analog market is fragmented and characterized by diverse applications, a great number of product variations and, with respect to many circuit types, relatively long product life cycles. Maxim is a global company with manufacturing facilities in the United States, testing facilities in the Philippines and Thailand, and sales and circuit design offices throughout the world. Integrated circuit assembly is performed by foreign assembly subcontractors, located in the Philippines, Malaysia, Thailand, China, Taiwan, Singapore, Indonesia, South Korea and Japan, where wafers are separated into individual integrated circuits and assembled into a variety of packages. The major end-markets the Company's products are sold in are the communications, computing, consumer and industrial markets.

XML



Impairment of Long-Lived Assets

12 Months Ended

Jun. 25, 2011

Impairment of Long Lived Assets Disclosure [Abstract]

Impairment of Long-Lived Assets [Text Block]

IMPAIRMENT OF LONG-LIVED ASSETS

End-of-Line Sorting and Testing Facilities

During the first quarter of fiscal year 2010, the Company identified certain assets as excess or obsolete, primarily due to changes in certain manufacturing technology. In connection with these circumstances, the Company recorded a charge for the write-down of equipment to its estimated fair value. The total charge of $5.0 million was included in impairment of long-lived assets in the Company's Consolidated Statements of Income. The Company has ceased depreciation and classified these assets as held for sale based on its intentions to sell the assets and has included $0.6 million in other assets in the Consolidated Balance Sheet as of June 26, 2010.

During the second quarter of fiscal year 2009, the Company identified certain assets as excess as a result of reductions in demand for product tested and sorted on certain equipment. In connection with these circumstances, the Company incurred an asset impairment charge of $43.8 million which is included in impairment of long-lived assets in the Company's Consolidated Statements of Income. The Company has classified these assets as held for sale based on their intentions to sell the assets and has included $3.6 million in other assets in the Consolidated Balance Sheet as of June 27, 2009.

Wafer Fabrication Facility, Oregon

During the first quarter of fiscal year 2010, as a result of reduced future wafer output requirements associated with equipment utilizing certain process technologies, the Company recorded a write-down of equipment to be sold to the equipment's estimated fair value. This charge of $3.3 million was included in impairment of long-lived assets in the Company's Consolidated Statements of Income. The Company has ceased depreciation and classified these assets as held for sale based on its intentions to sell the assets and has included $0.5 million in other assets in the Consolidated Balance Sheet as of June 26, 2010.

Wafer Fabrication Facility, San Jose

During the first quarter of fiscal year 2009, the Company recorded a $7.3 million asset impairment charge as a result of transferring certain wafer manufacturing production from its San Jose, California, wafer manufacturing facility to an outsourced Japanese manufacturing facility, Epson's Sakata, Japan, facility, and reductions in demand and reduced future capacity requirements.

The Company reached its conclusions regarding the asset impairment after conducting evaluations of the recoverability of the related manufacturing assets in accordance with ASC No. 360, Accounting for Property, Plant, and Equipment. The fair value of the equipment was determined after consideration of equipment specifications, quoted market prices of similar equipment and management's perception of demand for the equipment. The Company applied present value techniques to estimate fair value for certain of the equipment which they believe has limited marketability.

Dallas Wafer Fab Closure

In connection with the closure of the Dallas facility, the Company evaluated the recoverability of the facilities' manufacturing assets and concluded that there was no impairment. The Company also reevaluated the useful lives and salvage values of the fixed assets used in this manufacturing facility based on the new period of intended use. As a result of this review, the Company changed its depreciable lives and salvage values and recognized additional depreciation expense of $54.7 million for fiscal year 2009 related to this change in accounting estimate.

XML



Stock-Based Compensation Fair Value of Options (Details) (USD $)	12 Months Ended
	Jun. 25, 2011 years plans	Jun. 26, 2010 years	Jun. 27, 2009 years
Stock options [Member]
Weighted-average Assumptions Used for Fair Value of Award Granted [Abstract]
Expected holding period (in years)	5.2	5.2	6.3
Risk-free interest rate	1.70%	2.30%	3.00%
Expected stock price volatility	37.10%	38.00%	39.00%
Dividend yield	4.20%	4.50%	4.10%
Options granted, weighted average fair value of stock options	$ 4.02	$ 4.23	$ 3.61
ESP Plan [Member]
Weighted-average Assumptions Used for Fair Value of Award Granted [Abstract]
Expected holding period (in years)	0.5	0.7	1
Risk-free interest rate	0.10%	0.30%	4.00%
Expected stock price volatility	24.70%	35.00%	57.00%
Dividend yield	3.30%	4.40%	6.10%
Restricted stock units [Member]
Weighted-average Assumptions Used for Fair Value of Award Granted [Abstract]
Restricted stock units granted, weighted average grant date fair value	$ 16.61	$ 16.20	$ 11.91

XML



Stock-Based Compensation Employee Stock Purchase Plan (Details) (USD $) In Thousands, except Share data, unless otherwise specified	12 Months Ended
	Jun. 25, 2011	Jun. 26, 2010
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Consideration for common stock issued	$ 28,822	$ 24,772
Stock options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares reserved for future issuance	15,500,000
ESP Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares reserved for future issuance	8,000,000
Number of purchases permitted per offer period	2
Offer period	12 months
Maximum percentage of withholding for eligible employees	25.00%
Percentage of fair market value shares can be purchased at	85.00%
Dollar limit of stock employees can purchase annually	25
Limit of shares employees can purchase annually	1,600
Common stock shares issued	1,700,000
Consideration for common stock issued	$ 29,000
Shares for future issuance	4,000,000

XML



Commitments and Contingencies Commitments (Details) (USD $)	12 Months Ended
	Jun. 25, 2011		Jun. 26, 2010	Jun. 27, 2009
Future Minimum Payments for Commitments [Line Items]
Payments for Legal Settlements	$ 173,000,000
Operating lease obligations	44,489,000	[1]
Royalty obligations	20,000,000	[2]
Long-term debt obligations	300,000,000	[3]
Interest payments associated with long-term debt obligations	20,441,000	[4]
Capital equipment and inventory related purchase obligations	33,899,000	[5]
Future minimum payments for all commitments	418,829,000
Stated interest rate of the Notes	3.45%
Rental expense	12,700,000		8,200,000	7,700,000
Less than 1 year [Member]
Future Minimum Payments for Commitments [Line Items]
Operating lease obligations	12,808,000	[1]
Royalty obligations	10,000,000	[2]
Long-term debt obligations	0	[3]
Interest payments associated with long-term debt obligations	10,350,000	[4]
Capital equipment and inventory related purchase obligations	17,515,000	[5]
Future minimum payments for all commitments	50,673,000
2-3 years [Member]
Future Minimum Payments for Commitments [Line Items]
Operating lease obligations	15,478,000	[1]
Royalty obligations	10,000,000	[2]
Long-term debt obligations	300,000,000	[3]
Interest payments associated with long-term debt obligations	10,091,000	[4]
Capital equipment and inventory related purchase obligations	3,752,000	[5]
Future minimum payments for all commitments	339,321,000
4-5 years [Member]
Future Minimum Payments for Commitments [Line Items]
Operating lease obligations	8,005,000	[1]
Royalty obligations	0	[2]
Long-term debt obligations	0	[3]
Interest payments associated with long-term debt obligations	0	[4]
Capital equipment and inventory related purchase obligations	3,752,000	[5]
Future minimum payments for all commitments	11,757,000
More than 5 years [Member]
Future Minimum Payments for Commitments [Line Items]
Operating lease obligations	8,198,000	[1]
Royalty obligations	0	[2]
Long-term debt obligations	0	[3]
Interest payments associated with long-term debt obligations	0	[4]
Capital equipment and inventory related purchase obligations	8,880,000	[5]
Future minimum payments for all commitments	$ 17,078,000

[1] The Company leases some facilities under non-cancelable operating lease agreements that expire at various dates through 2025.

[2] Royalty obligations represent payments for licensed patents.

[3] Long-term debt represents amount due for the Company's 3.45% senior unsecured notes due 2013.

[4] Interest payments associated with the Company's 3.45% senior unsecured notes due 2013.

[5] Capital equipment purchase obligations represent commitments for purchase of property, plant and equipment. The Company orders some materials and supplies in advance or with minimum purchase quantities. The Company is obligated to pay for the materials and supplies when received.

XML



Restructuring Activities (Tables)

12 Months Ended

Jun. 25, 2011

Restructuring and Related Activities [Abstract]

Schedule of Restructuring Reserve by Type of Cost [Table Text Block]

Activity and liability balances related to the restructuring activity for fiscal year 2010 and fiscal year 2011 follows:

	Severance and Benefits
	(in thousands)
Balance at June 27, 2009	$	7,694
Restructuring accrual	4,558
Cash payments	(6,247		)
Changes in estimates	(5,257		)
Balance at June 26, 2010	$	748
Restructuring accrual	3,007
Cash payments	(3,640		)
Balance at June 25, 2011	$	115

XML



Comprehensive Income

12 Months Ended

Jun. 25, 2011

Statement of Income and Comprehensive Income [Abstract]

Comprehensive Income [Text Block]

COMPREHENSIVE INCOME

The changes in the components of OCI, net of taxes, were as follows:

	For the Year Ended
	June 25, 2011			June 26, 2010			June 27, 2009
	(in thousands)
Net income, as reported	$	489,009		$	125,139		$	10,455
Change in unrealized gains (losses) on investments, net of tax benefit (expense) of $(189) in 2011, $770 in 2010, and $(383) in 2009	331			(1,346		)	681
Change in unrealized gains (losses) on forward exchange contracts, net of tax benefit (expense) of $(1) in 2011, $85 in 2010, and $0 in 2009	—			(150		)	—
Deferred tax on unrealized exchange gain (loss) on intercompany receivables	(2,369		)	(1,893		)	552
Actuarial gain (loss) on post-retirement benefits, net of tax benefit (expense) of $(132) in 2011, $515 in 2010 and $2,153 in 2009	(289		)	(896		)	(3,762		)
Total comprehensive income	$	486,682		$	120,854		$	7,926

The components of Accumulated Other Comprehensive Loss, were as follows:

	June 25, 2011			June 26, 2010
	(in thousands)
Deferred tax on unrealized exchange loss on long-term intercompany receivables	$	(8,081	)	$	(5,712	)
Unrealized components of post-retirement benefits	(4,841		)	(4,552		)
Cumulative translation adjustment	(1,527		)	(1,527		)
Net unrealized loss on cash flow hedges	(150		)	(150		)
Net unrealized gain on available-for-sale securities	331			—
Accumulated Other Comprehensive Loss	$	(14,268	)	$	(11,941	)

XML



Consolidated Balance Sheets (USD $) In Thousands	Jun. 25, 2011	Jun. 26, 2010
Current assets:
Cash and cash equivalents	$ 962,541	$ 826,512
Short-term investments	50,346	0
Total cash, cash equivalents and short-term investments	1,012,887	826,512
Accounts receivable, net of allowances of $17,697 in 2011 and $17,438 in 2010	297,632	339,322
Inventories	237,928	206,040
Deferred tax assets	113,427	217,017
Income tax refund receivable	483	83,813
Other current assets	65,495	33,909
Total current assets	1,727,852	1,706,613
Property, plant and equipment, net	1,308,850	1,324,436
Intangible assets, net	204,263	194,728
Goodwill	265,125	226,223
Other assets	21,653	30,325
TOTAL ASSETS	3,527,743	3,482,325
Current liabilities:
Accounts payable	110,153	107,797
Income taxes payable	3,912	13,053
Accrued salary and related expenses	215,627	175,858
Accrued expenses	47,767	37,030
Deferred income on shipments to distributors	36,881	25,779
Accrual for litigation settlement	0	173,000
Total current liabilities	414,340	532,517
Long term debt	300,000	300,000
Income taxes payable	96,099	132,400
Deferred tax liabilities	183,715	136,524
Other liabilities	22,771	27,926
Total liabilities	1,016,925	1,129,367
Commitments and contingencies (Note 13)
Stockholders' equity:
Preferred stock, $0.001 par value, Authorized: 2,000 shares, issued and outstanding: none	0	0
Common stock, $0.001 par value, Authorized: 960,000 shares, Issued and outstanding: 295,780 in 2011 and 300,848 in 2010	296	301
Additional paid-in capital	0	0
Retained earnings	2,524,790	2,364,598
Accumulated other comprehensive loss	(14,268)	(11,941)
Total stockholders' equity	2,510,818	2,352,958
TOTAL LIABILITIES & STOCKHOLDERS' EQUITY	$ 3,527,743	$ 3,482,325

XML



Commitments and Contingencies (Tables)

12 Months Ended

Jun. 25, 2011

Commitments and Contingencies Disclosure [Abstract]

Future Annual Minimum Payments Related to Commitments [Table Text Block]

Future annual minimum payments for all commitments are as follows:

	Total		Less than 1 year		2-3 years		4-5 years		More than 5 years
	(Amounts in thousands)
Operating lease obligations (1)	$	44,489	$	12,808	$	15,478	$	8,005	$	8,198
Royalty obligations (2)	20,000		10,000		10,000		—		—
Long-term debt obligations (3)	300,000		—		300,000		—		—
Interest payments associated with long-term debt obligations (4)	20,441		10,350		10,091		—		—
Capital equipment and inventory related purchase obligations (5)	33,899		17,515		3,752		3,752		8,880
Total	$	418,829	$	50,673	$	339,321	$	11,757	$	17,078

(1) The Company leases some facilities under non-cancelable operating lease agreements that expire at various dates through 2025.

(2) Royalty obligations represent payments for licensed patents.

(3) Long-term debt represents amount due for the Company's 3.45% senior unsecured notes due 2013.

(4) Interest payments associated with the Company's 3.45% senior unsecured notes due 2013.

(5) Capital equipment purchase obligations represent commitments for purchase of property, plant and equipment. The Company orders some materials and supplies in advance or with minimum purchase quantities. The Company is obligated to pay for the materials and supplies when received.

XML



Quarterly Financial Data (Unaudited) (Details) (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended									12 Months Ended
	Jun. 25, 2011	Mar. 26, 2011	Dec. 25, 2010	Sep. 25, 2010	Jun. 26, 2010	Mar. 27, 2010		Dec. 26, 2009	Sep. 26, 2009	Jun. 25, 2011		Jun. 26, 2010		Jun. 27, 2009
Litigation settlement expense						$ 173,000
Quarterly Financial Data [Abstract]
Net revenues	626,491	606,775	612,936	626,139	565,962	508,880		473,515	449,246	2,472,341		1,997,603		1,646,015
Cost of goods sold	235,666	234,125	232,661	239,925	225,014	200,177		181,727	197,619	942,377	[1]	804,537	[1]	797,138	[1]
Gross margin	390,825	372,650	380,275	386,214	340,948	308,703		291,788	251,627	1,529,964		1,193,066		848,877
Gross margin %	62.40%	61.40%	62.00%	61.70%	60.20%	60.70%		61.60%	56.00%
Operating income (loss)	177,922	163,995	151,999	179,123	141,083	(48,261)	[2]	109,129	90,099	673,039		292,050		17,378
% of net revenues	28.40%	27.00%	24.80%	28.60%	24.90%	(9.50%)		23.00%	20.10%
Net income	125,593	136,276	109,590	117,550	58,455	(33,903)		58,635	41,952	489,009		125,139		10,455
Earnings (loss) per share:
Basic net income per share	$ 0.42	$ 0.46	$ 0.37	$ 0.39	$ 0.19	$ (0.11)		$ 0.19	$ 0.14	$ 1.65		$ 0.41		$ 0.03
Diluted net income per share	$ 0.41	$ 0.45	$ 0.36	$ 0.39	$ 0.19	$ (0.11)		$ 0.19	$ 0.13	$ 1.61		$ 0.4		$ 0.03
Shares used in the calculation of earnings (loss) per share:
Basic	295,751	296,511	296,550	298,216	302,188	304,518		305,324	306,276	296,755		304,579		310,805
Diluted	303,944	304,515	303,260	301,688	306,803	304,518		310,090	312,162	303,377		310,016		311,479
Dividends paid per share	$ 0.21	$ 0.21	$ 0.21	$ 0.21	$ 0.2	$ 0.2		$ 0.2	$ 0.2
Stock-based compensation expense	21,408	21,228	24,522	27,139	24,848	15,279		26,933	26,465	94,297		93,525		196,108
Cost of goods sold [Member]
Shares used in the calculation of earnings (loss) per share:
Stock-based compensation expense	3,022	3,336	3,748	3,895	3,423	1,071		5,265	5,461	14,001		15,220		57,100
Research and development expenses [Member]
Shares used in the calculation of earnings (loss) per share:
Stock-based compensation expense	11,922	11,743	13,916	16,105	13,983	8,691		14,650	16,741	53,686		54,065		100,830
Selling, general and administrative expenses [Member]
Shares used in the calculation of earnings (loss) per share:
Stock-based compensation expense	$ 6,464	$ 6,149	$ 6,858	$ 7,139	$ 7,442	$ 5,517		$ 7,018	$ 4,263	$ 26,610		$ 24,240		$ 38,178

[1] Includes stock-based compensation charges as follows:      Cost of goods sold$14,001 $15,220 $57,100     Research and development$53,686 $54,065 $100,830     Selling, general and administrative$26,610 $24,240 $38,178

[2] Includes $173.0 million litigation settlement expense included in other operating expenses, net in the Consolidated Statement of Income.

XML



Income Taxes Deferred Tax Assets and Liabilities (Details) (USD $)	12 Months Ended
	Jun. 25, 2011	Jun. 26, 2010
Deferred tax assets: [Abstract]
Inventory valuation and reserves	$ 11,768,000	$ 66,087,000
Distributor related accruals and sales return and allowance accruals	21,334,000	14,168,000
Deferred revenue	2,233,000	3,187,000
Accrued compensation	56,467,000	47,500,000
Stock-based compensation	73,295,000	84,225,000
Net operating loss carryovers	20,827,000	31,450,000
Tax credit carryovers	43,285,000	46,025,000
Other reserves and accruals not currently deductible for tax purposes	10,608,000	75,782,000
Deferred tax assets, other	8,940,000	18,437,000
Total deferred tax assets	248,757,000	386,861,000
Deferred tax liabilities: [Abstract]
Fixed assets cost recovery, net	(257,647,000)	(240,463,000)
Deferred tax liabilities, other	(12,168,000)	(10,524,000)
Net deferred tax assets/(liabilities) before valuation allowance	(21,058,000)	135,874,000
Valuation allowance	(44,562,000)	(47,006,000)
Net deferred tax assets/(liabilities)	(65,620,000)	88,868,000
Valuation Allowance [Abstract]
Increase (decrease) in valuation allowance	2,444,000
Valuation allowance attributable to tax benefits of income tax deductions generated by exercise of stock options	37,400,000
Internal Revenue Service (IRS) [Member]
Deferred Tax Assets, Operating Loss Carryforwards, Components [Abstract]
Net operating loss carryforwards subject to expiration	29,100,000
State and Local Jurisdiction [Member]
Deferred Tax Assets, Operating Loss Carryforwards, Components [Abstract]
Net operating loss carryforwards subject to expiration	57,700,000
Deferred Tax Assets, Tax Credit Carryforwards [Abstract]
Tax credit carryforwards subject to expiration	8,300,000
Tax credit carryforwards with no expiration date	62,900,000
Foreign Country [Member]
Deferred Tax Assets, Operating Loss Carryforwards, Components [Abstract]
Net operating loss carryforwards with no expiration date	$ 22,500,000

XML



Financial Instruments, Balance Sheet Location (Details) (USD $) In Thousands	Jun. 25, 2011		Jun. 26, 2010
Derivatives, Fair Value [Line Items]
Notional amount of foreign exchange contracts	$ 6,121		$ (30,406)
Notional amount of total derivatives	61,971	[1]	52,366	[1]
Derivatives designated as hedging instruments [Member] | Cash Flow Hedging [Member]
Derivatives, Fair Value [Line Items]
Notional amount of foreign exchange contracts	35,629	[1]	20,085	[1]
Derivatives designated as hedging instruments [Member] | Cash Flow Hedging [Member] | Other Current Assets [Member]
Derivatives, Fair Value [Line Items]
Foreign exchange contracts, derivative assets	53		2
Derivatives designated as hedging instruments [Member] | Cash Flow Hedging [Member] | Accrued Expenses [Member]
Derivatives, Fair Value [Line Items]
Foreign exchange contracts, derivative liabilities	287		237
Derivatives not designated as hedging instruments [Member]
Derivatives, Fair Value [Line Items]
Notional amount of foreign exchange contracts	26,342	[1]	32,281	[1]
Derivatives not designated as hedging instruments [Member] | Other Current Assets [Member]
Derivatives, Fair Value [Line Items]
Foreign exchange contracts, derivative assets	273		16
Derivatives not designated as hedging instruments [Member] | Accrued Expenses [Member]
Derivatives, Fair Value [Line Items]
Foreign exchange contracts, derivative liabilities	22		614
Other Current Assets [Member]
Derivatives, Fair Value [Line Items]
Derivative assets	326		18
Accrued Expenses [Member]
Derivatives, Fair Value [Line Items]
Derivative liabilities	$ 309		$ 851

[1] Represents the face amounts of contracts that were outstanding as of June 25, 2011 and June 26, 2010, respectively

XML



Stock-Based Compensation Outstanding Options (Details) (USD $)	12 Months Ended
	Jun. 25, 2011 years	Jun. 26, 2010	Jun. 27, 2009	Jun. 28, 2008
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period [Abstract]
Range of exercise prices, lower	$ 49.95
Range of exercise prices, upper	$ 52.33
Options outstanding, number of shares	28,332,486	29,162,507	29,599,916	76,906,882
Options outstanding, weighted average remaining contractual term (in years)	3.7
Options outstanding, weighted average exercise price	$ 25.62	$ 27.05	$ 28.83	$ 35.59
Options exercisable, number of shares	16,468,585
Options exercisable, weighted average exercise price	$ 32.33
$12.00 - $18.04 [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period [Abstract]
Range of exercise prices, lower	$ 12
Range of exercise prices, upper	$ 18.04
Options outstanding, number of shares	9,496,988
Options outstanding, weighted average remaining contractual term (in years)	5.03
Options outstanding, weighted average exercise price	$ 14.10
Options exercisable, number of shares	1,731,327
Options exercisable, weighted average exercise price	$ 12.95
$18.11 - $27.45 [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period [Abstract]
Range of exercise prices, lower	$ 18.11
Range of exercise prices, upper	$ 27.45
Options outstanding, number of shares	6,428,859
Options outstanding, weighted average remaining contractual term (in years)	4.19
Options outstanding, weighted average exercise price	$ 20.49
Options exercisable, number of shares	2,603,082
Options exercisable, weighted average exercise price	$ 22.40
$28.52 - $43.00 [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period [Abstract]
Range of exercise prices, lower	$ 28.52
Range of exercise prices, upper	$ 43
Options outstanding, number of shares	10,614,912
Options outstanding, weighted average remaining contractual term (in years)	2.52
Options outstanding, weighted average exercise price	$ 35.57
Options exercisable, number of shares	10,357,209
Options exercisable, weighted average exercise price	$ 35.69
$49.95 - $52.33 [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period [Abstract]
Options outstanding, number of shares	1,791,727
Options outstanding, weighted average remaining contractual term (in years)	1.93
Options outstanding, weighted average exercise price	$ 46.12
Options exercisable, number of shares	1,776,967
Options exercisable, weighted average exercise price	$ 46.12

XML



Segment Information (Details) (USD $) In Thousands	12 Months Ended
	Jun. 25, 2011	Jun. 26, 2010	Jun. 27, 2009
Segment Reporting Information [Line Items]
Revenues	$ 2,472,341	$ 1,997,603	$ 1,646,015
Long-Lived Assets	1,308,850	1,324,436
United States [Member]
Segment Reporting Information [Line Items]
Revenues	360,310	291,539	302,648
Long-Lived Assets	972,380	983,761
China [Member]
Segment Reporting Information [Line Items]
Revenues	915,628	685,908	496,091
Japan [Member]
Segment Reporting Information [Line Items]
Revenues	163,061	131,513	120,763
Korea [Member]
Segment Reporting Information [Line Items]
Revenues	294,006	311,928	229,833
Philippines [Member]
Segment Reporting Information [Line Items]
Long-Lived Assets	204,581	216,738
Thailand [Member]
Segment Reporting Information [Line Items]
Long-Lived Assets	120,838	116,050
Rest of Asia [Member]
Segment Reporting Information [Line Items]
Revenues	283,121	223,786	169,203
Europe [Member]
Segment Reporting Information [Line Items]
Revenues	379,173	288,675	291,524
Rest of World [Member]
Segment Reporting Information [Line Items]
Revenues	77,042	64,254	35,953
Long-Lived Assets	$ 11,051	$ 7,887

XML



Summary of Significant Accounting Policies Concentration of Credit Risk (Details)	12 Months Ended
	Jun. 25, 2011 customers	Jun. 26, 2010 customers	Jun. 27, 2009 customers
Distributors [Member] | Net sales revenue [Member]
Concentration Risk [Line Items]
Concentration risk	30.00%
Avnet Electronics [Member] | Net sales revenue [Member]
Concentration Risk [Line Items]
Concentration risk	14.00%	12.00%
Avnet Electronics [Member] | Accounts receivable [Member]
Concentration Risk [Line Items]
Concentration risk	11.00%	10.00%
Samsung [Member] | Net sales revenue [Member]
Concentration Risk [Line Items]
Concentration risk	12.00%	12.00%
Samsung [Member] | Accounts receivable [Member]
Concentration Risk [Line Items]
Concentration risk	18.00%	13.00%
Net sales revenue [Member]
Concentration Risk [Line Items]
Number of other customer accounted for more than 10% of concentration risk	0	0	0
Accounts receivable [Member]
Concentration Risk [Line Items]
Number of other customer accounted for more than 10% of concentration risk	0	0	0

XML



Balance Sheet Components (Details) (USD $)	12 Months Ended
	Jun. 25, 2011	Jun. 26, 2010	Jun. 27, 2009
Accounts receivable, net:
Accounts receivable	$ 315,329,000	$ 356,760,000
Returns and allowances	(17,697,000)	(17,438,000)
Accounts receivable, net	297,632,000	339,322,000
Inventory:
Raw materials	18,419,000	16,747,000
Work-in-process	162,245,000	140,497,000
Finished goods	57,264,000	48,796,000
Inventory, Net	237,928,000	206,040,000
Property and equipment:
Land	86,257,000	87,237,000
Buildings and building improvements	313,642,000	341,734,000
Machinery and equipment	1,978,827,000	1,872,349,000
Property, plant and equipment, gross	2,378,726,000	2,301,320,000
Less accumulated depreciation	(1,069,876,000)	(976,884,000)
Property, plant and equipment, net	1,308,850,000	1,324,436,000
Depreciation expense	$ 156,300,000	$ 146,100,000	$ 191,100,000

XML



Stock-Based Compensation (Details) (USD $) Share data in Millions, unless otherwise specified	3 Months Ended								12 Months Ended															1 Months Ended			12 Months Ended	1 Months Ended		12 Months Ended		1 Months Ended	3 Months Ended	12 Months Ended																									3 Months Ended								12 Months Ended			3 Months Ended								12 Months Ended			3 Months Ended								12 Months Ended			1 Months Ended	12 Months Ended
	Jun. 25, 2011	Mar. 26, 2011	Dec. 25, 2010	Sep. 25, 2010	Jun. 26, 2010	Mar. 27, 2010	Dec. 26, 2009	Sep. 26, 2009	Jun. 25, 2011	Jun. 26, 2010	Jun. 27, 2009	Jun. 25, 2011 Cost of goods sold [Member] Stock options [Member]	Jun. 26, 2010 Cost of goods sold [Member] Stock options [Member]	Jun. 27, 2009 Cost of goods sold [Member] Stock options [Member]	Jun. 25, 2011 Research and development expenses [Member] Stock options [Member]	Jun. 26, 2010 Research and development expenses [Member] Stock options [Member]	Jun. 27, 2009 Research and development expenses [Member] Stock options [Member]	Jun. 25, 2011 Selling, general and administrative expenses [Member] Stock options [Member]	Jun. 26, 2010 Selling, general and administrative expenses [Member] Stock options [Member]	Jun. 27, 2009 Selling, general and administrative expenses [Member] Stock options [Member]	Jun. 25, 2011 Stock options [Member] years plans	Jun. 26, 2010 Stock options [Member]	Jun. 27, 2009 Stock options [Member]	Dec. 31, 2008 Stock options [Member] Tender Offer [Member]	Nov. 30, 2008 Stock options [Member] Tender Offer [Member]	Dec. 31, 2008 Stock options [Member] Officer Option Repurchase [Member]	Jun. 25, 2011 Stock options [Member] Officer Option Repurchase [Member]	May 31, 2009 Stock options [Member] Goodwill Program 2009 [Member]	Jan. 31, 2009 Stock options [Member] Goodwill Program 2009 [Member]	Jun. 25, 2011 Stock options [Member] Goodwill Program 2009 [Member]	Jun. 26, 2010 Stock options [Member] Goodwill Program 2009 [Member]	Sep. 30, 2007 Stock options [Member] Extension of Options that Would Have Expired After Reaching 10 Year Contractual Term and Cash Settlements of Expired Options [Member]	Sep. 23, 2006 Stock options [Member] Extension of Options that Would Have Expired After Reaching 10 Year Contractual Term and Cash Settlements of Expired Options [Member]	Jun. 26, 2010 Stock options [Member] Extension of Options that Would Have Expired After Reaching 10 Year Contractual Term and Cash Settlements of Expired Options [Member]	Jun. 25, 2011 Cost of goods sold [Member] Restricted stock units [Member]	Jun. 26, 2010 Cost of goods sold [Member] Restricted stock units [Member]	Jun. 27, 2009 Cost of goods sold [Member] Restricted stock units [Member]	Jun. 25, 2011 Research and development expenses [Member] Restricted stock units [Member]	Jun. 26, 2010 Research and development expenses [Member] Restricted stock units [Member]	Jun. 27, 2009 Research and development expenses [Member] Restricted stock units [Member]	Jun. 25, 2011 Selling, general and administrative expenses [Member] Restricted stock units [Member]	Jun. 26, 2010 Selling, general and administrative expenses [Member] Restricted stock units [Member]	Jun. 27, 2009 Selling, general and administrative expenses [Member] Restricted stock units [Member]	Jun. 25, 2011 Restricted stock units [Member]	Jun. 26, 2010 Restricted stock units [Member]	Jun. 27, 2009 Restricted stock units [Member]	Jun. 25, 2011 Cost of goods sold [Member] ESP Plan [Member]	Jun. 26, 2010 Cost of goods sold [Member] ESP Plan [Member]	Jun. 27, 2009 Cost of goods sold [Member] ESP Plan [Member]	Jun. 25, 2011 Research and development expenses [Member] ESP Plan [Member]	Jun. 26, 2010 Research and development expenses [Member] ESP Plan [Member]	Jun. 27, 2009 Research and development expenses [Member] ESP Plan [Member]	Jun. 25, 2011 Selling, general and administrative expenses [Member] ESP Plan [Member]	Jun. 26, 2010 Selling, general and administrative expenses [Member] ESP Plan [Member]	Jun. 27, 2009 Selling, general and administrative expenses [Member] ESP Plan [Member]	Jun. 25, 2011 ESP Plan [Member] years purchases plans	Jun. 26, 2010 ESP Plan [Member]	Jun. 27, 2009 ESP Plan [Member]	Jun. 25, 2011 Cost of goods sold [Member]	Mar. 26, 2011 Cost of goods sold [Member]	Dec. 25, 2010 Cost of goods sold [Member]	Sep. 25, 2010 Cost of goods sold [Member]	Jun. 26, 2010 Cost of goods sold [Member]	Mar. 27, 2010 Cost of goods sold [Member]	Dec. 26, 2009 Cost of goods sold [Member]	Sep. 26, 2009 Cost of goods sold [Member]	Jun. 25, 2011 Cost of goods sold [Member]	Jun. 26, 2010 Cost of goods sold [Member]	Jun. 27, 2009 Cost of goods sold [Member]	Jun. 25, 2011 Research and development expenses [Member]	Mar. 26, 2011 Research and development expenses [Member]	Dec. 25, 2010 Research and development expenses [Member]	Sep. 25, 2010 Research and development expenses [Member]	Jun. 26, 2010 Research and development expenses [Member]	Mar. 27, 2010 Research and development expenses [Member]	Dec. 26, 2009 Research and development expenses [Member]	Sep. 26, 2009 Research and development expenses [Member]	Jun. 25, 2011 Research and development expenses [Member]	Jun. 26, 2010 Research and development expenses [Member]	Jun. 27, 2009 Research and development expenses [Member]	Jun. 25, 2011 Selling, general and administrative expenses [Member]	Mar. 26, 2011 Selling, general and administrative expenses [Member]	Dec. 25, 2010 Selling, general and administrative expenses [Member]	Sep. 25, 2010 Selling, general and administrative expenses [Member]	Jun. 26, 2010 Selling, general and administrative expenses [Member]	Mar. 27, 2010 Selling, general and administrative expenses [Member]	Dec. 26, 2009 Selling, general and administrative expenses [Member]	Sep. 26, 2009 Selling, general and administrative expenses [Member]	Jun. 25, 2011 Selling, general and administrative expenses [Member]	Jun. 26, 2010 Selling, general and administrative expenses [Member]	Jun. 27, 2009 Selling, general and administrative expenses [Member]	Oct. 31, 2006 RSU Loan Program [Member]	Jun. 27, 2009 RSU Loan Program [Member]	Jun. 28, 2008 RSU Loan Program [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Number of stock plans																					5																																			1
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Stock-based compensation expense	$ 21,408,000	$ 21,228,000	$ 24,522,000	$ 27,139,000	$ 24,848,000	$ 15,279,000	$ 26,933,000	$ 26,465,000	$ 94,297,000	$ 93,525,000	$ 196,108,000	$ 2,625,000	$ 3,330,000	$ 33,380,000	$ 11,325,000	$ 15,085,000	$ 38,237,000	$ 6,120,000	$ 8,130,000	$ 21,390,000	$ 20,070,000	$ 26,545,000	$ 93,007,000												$ 9,820,000	$ 10,825,000	$ 23,350,000	$ 36,925,000	$ 33,834,000	$ 61,151,000	$ 18,944,000	$ 15,056,000	$ 16,665,000	$ 65,689,000	$ 59,715,000	$ 101,166,000	$ 1,556,000	$ 1,065,000	$ 370,000	$ 5,436,000	$ 5,146,000	$ 1,442,000	$ 1,546,000	$ 1,054,000	$ 123,000	$ 8,538,000	$ 7,265,000	$ 1,935,000	$ 3,022,000	$ 3,336,000	$ 3,748,000	$ 3,895,000	$ 3,423,000	$ 1,071,000	$ 5,265,000	$ 5,461,000	$ 14,001,000	$ 15,220,000	$ 57,100,000	$ 11,922,000	$ 11,743,000	$ 13,916,000	$ 16,105,000	$ 13,983,000	$ 8,691,000	$ 14,650,000	$ 16,741,000	$ 53,686,000	$ 54,065,000	$ 100,830,000	$ 6,464,000	$ 6,149,000	$ 6,858,000	$ 7,139,000	$ 7,442,000	$ 5,517,000	$ 7,018,000	$ 4,263,000	$ 26,610,000	$ 24,240,000	$ 38,178,000
Less: Income tax effect									25,457,000	25,041,000	67,430,000
Net stock-based compensation expense									68,840,000	68,484,000	128,678,000
Number of shares company offered to purchase from employees																									52.8
Total potential cash paid by company from offer to purchase employees shares																									22,400,000	1,800,000
Number of trading days used by Black Scholes to determine average stock price																					20 days
Shares purchased from employees																								31.9		6.2
Payment for Repurchase of Stock Options																								13,600,000
Stock based compensation expense																								75,900,000						200,000	5,400,000																																																														6,800,000	50,200,000
Stock based compensation expenses from settlements above fair value																								8,700,000
Stock based compensation expense associated with the unamortized compensation expense on previously vested options																								67,200,000
Incremental compensation expense																										1,100,000						27,500,000	118,900,000	4,300,000																																																										2,200,000
Decrease in deferred tax asset																								129,400,000
Income tax benefit									172,662,000	174,924,000	24,164,000													4,700,000
Adjustment to additional paid in capital for the difference between the deferred tax assets and tax benefits									30,546,000	(15,748,000)	(216,835,000)													124,700,000
Reversal of stock based compensation related to the true up for previously forfeited options																								52,200,000
Minimum number of years stock options must be paid out by unless vesting period is longer																											2 years
Payment threshold for settlement in RSUs, non-officers																													5,000
Payment threshold for settlement in RSUs, officers and non-officers																												5,000
Adjustments to additional paid-in capital, derivative settlement										3,512,000																						126,800,000		300,000																																																										19,400,000
Cash paid to settle RSU Loan Program																																																																																													35,600,000	25,300,000
Cash-settle restricted stock units held by employees out the US																																																																																													$ 1,900,000	$ 4,300,000
Number of stock options extended																																	8.3
Cash settlement price, percentage of daily close prices of common stock falling above which from trading suspection to option expiration																																10.00%
Purchase of employee options																																		1.1
Options contractual term, prior																					10 years
Options contractual term																					7 years

XML



Comprehensive Income (Tables)

12 Months Ended

Jun. 25, 2011

Statement of Income and Comprehensive Income [Abstract]

Schedule of Comprehensive Income (Loss) [Table Text Block]

The changes in the components of OCI, net of taxes, were as follows:

	For the Year Ended
	June 25, 2011			June 26, 2010			June 27, 2009
	(in thousands)
Net income, as reported	$	489,009		$	125,139		$	10,455
Change in unrealized gains (losses) on investments, net of tax benefit (expense) of $(189) in 2011, $770 in 2010, and $(383) in 2009	331			(1,346		)	681
Change in unrealized gains (losses) on forward exchange contracts, net of tax benefit (expense) of $(1) in 2011, $85 in 2010, and $0 in 2009	—			(150		)	—
Deferred tax on unrealized exchange gain (loss) on intercompany receivables	(2,369		)	(1,893		)	552
Actuarial gain (loss) on post-retirement benefits, net of tax benefit (expense) of $(132) in 2011, $515 in 2010 and $2,153 in 2009	(289		)	(896		)	(3,762		)
Total comprehensive income	$	486,682		$	120,854		$	7,926

Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]

The components of Accumulated Other Comprehensive Loss, were as follows:

	June 25, 2011			June 26, 2010
	(in thousands)
Deferred tax on unrealized exchange loss on long-term intercompany receivables	$	(8,081	)	$	(5,712	)
Unrealized components of post-retirement benefits	(4,841		)	(4,552		)
Cumulative translation adjustment	(1,527		)	(1,527		)
Net unrealized loss on cash flow hedges	(150		)	(150		)
Net unrealized gain on available-for-sale securities	331			—
Accumulated Other Comprehensive Loss	$	(14,268	)	$	(11,941	)